from microbiology.pl - Polish Journal of Microbiology
Transkrypt
from microbiology.pl - Polish Journal of Microbiology
P O L S K I E T O WA R Z Y S T W O M I K R O B I O L O G Ó W POLISH SOCIETY OF MICROBIOLOGISTS Polish Journal of Microbiology 2014 Polish Journal of Microbiology formely Acta Microbiologica Polonica 2014, Vol. 63, No 1 CONTENTS MINIREWIEV Use of plant extracts to control and treat AB5 enterotoxin-related diarrhea KOMIAZYK M., PALCZEWSKA M., SITKIEWICZ I., GROVES P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 ORIGINAL PAPERS Quantitative expression of Candida albicans aspartyl proteinase genes SAP7, SAP8, SAP9, SAP10 in human serum in vitro STANISZEWSKA M., BONDARYK M., MALEWSKI T., KURZĄTKOWSKI W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 The effect of oleanolic and ursolic acids on the hemolytic properties and biofilm formation of Listeria monocytogenes KUREK A., MARKOWSKA K., GRUDNIAK A.M., JANISZOWSKA W., WOLSKA K.I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 Iron shortage and bile salts play a major role in the expression of ompK gene in Vibrio anguillarum HAMOD M.A., BHOWMICK P.P., SHUKUR Y.N., KARUNASAGAR I., KARUNASAGAR I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Development of synbiotics with inulin, palatinose, α-cyclodextrin and probiotic bacteria PRANCKUTĖ R., KAUNIETIS A., KUISIENĖ N., ČITAVIČIUS D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Uropathogenic Escherichia coli isolates with different virulence genes content exhibit similar pathologic influence on vero cells OBAID J.M.A.S., MANSOUR S.R., ELSHAHEDY M.S., RABIE T.E., AZAB A.M.H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 Novobiocin sensitivity of Salmonella typhimurium dam and/or seqA mutants CHATTI A., ALOUI M., TAGOURTI J., MIHOUB M., LANDOULSI A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 The antimicrobial susceptibility of Helicobacter pylori strains isolated from children and adults with primary infection in the lower silesia region, Poland GOŚCINIAK G., BIERNAT M., GRABIŃSKA J., BIŃKOWSKA A., PONIEWIERKA E., IWAŃCZAK B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 Helicobacter pylori infection in type 1 diabetes children and adolescents using 13C urea breath test CHOBOT A., BĄK-DRABIK K., SKAŁA-ZAMOROWSKA E., KRZYWICKA A., KWIECIEŃ J., POLAŃSKA J. . . . . . . . . . . . . . . . . . . . . 63 The utility of Caco-2 cells in isolation of enteroviruses from environmental and clinical material WIECZOREK M., CIĄĆKA A., WITEK A., LITWIŃSKA B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69 Psychrotrophic lipase producers from arctic soil and sediment samples R. RASOL R., RASHIDAH A.R., NAZUHA R.S.N., SMYKLA J., WAN MAZNAH W.O., ALIAS S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75 Plant growth promotion rhizobacteria in onion production ČOLO J., HAJNAL-JAFARI T.I., ĐURIĆ S., STAMENOV D., HAMIDOVIĆ S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83 The prevalence of Anaplasma phagocytophilum in questing Ixodes ricinus ticks in SW Poland KIEWRA D., ZALEŚNY G., CZUŁOWSKA A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89 Biocontrol efficacy of different isolates of Trichoderma against soil borne pathogen Rhizoctonia solani ASAD S.A., ALI N., HAMEED A., KHAN S.A., AHMAD R., BILAL M., SHAHZAD M., TABASSUM A. . . . . . . . . . . . . . . . . . . . . . . . . . . . 95 Prevalence of EBV genotypes in Polish, Taiwanese and Arabic healthy students and association between genotypes and 30-bp deletion in the LMP-1 gene phylogenetic analysis POLZ D., PODSIADŁO Ł., STEC A., POLZ-DACEWICZ M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105 SHORT COMMUNICATIONS Microbial transformations of 3-methoxyflavone by strains of Aspergillus niger KOSTRZEWA-SUSŁOW E., DYMARSKA M., JANECZKO T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111 Zeaxanthin biosynthesis by members of the genus Muricauda SUDHARSHAN PRABHU, REKHA P.D. ARUN A.B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115 INSTRUCTION FOR AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121 INSTRUCTION FOR AUTHORS Submission of manuscripts: http://pjm.indexcopernicus.com/ Instructions for authors: http://www.pjm.microbiology.pl/ Polish Journal of Microbiology 2014, Vol. 63, No 1, 3–14 MINIREVIEW Use of Plant Extracts to Control and Treat AB5 Enterotoxin-Related Diarrhea MAGDALENA KOMIAZYK1, 2, MAŁGORZATA PALCZEWSKA1, IZABELA SITKIEWICZ3 and PATRICK GROVES1* Laboratory of Molecular Interactions and NMR, Instituto de Tecnologia Química e Biológica (ITQB-UNL), Oeiras, Portugal 2 Laboratory of Biochemistry of Lipids, Nencki Institute of Experimental Biology, Warsaw, Poland 3 Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland 1 Submitted 27 December 2013, accepted 30 December 2013 Abstract Plants contain a broad spectrum of small molecules with potential antimicrobial properties. Here, we review the antimicrobial activities of plant extracts against enterotoxic bacteria encoding AB5 toxins, including Vibrio cholerae, Shigella dysenteriae and enterotoxic Escherichia coli strains. Several plant extracts have strong antimicrobial effects and the potential to boost Oral Rehydration Therapy, which is the first line of treatment for acute diarrhea. K e y w o r d s: Escherichia coli, Shigella dysenteriae, Vibrio cholerae, AB5 enterotoxin, plant extracts 1. Introduction The World Health Organization (WHO) prepares yearly reports on the global status of diarrheal diseases (http://www.who.int/topics/diarrhoea/en/). In addition to reporting statistics for the number of cases and fatalities, the WHO identifies actions to reduce the spread of disease and improve treatments. In developed, rich countries, diarrhea is usually associated with poor hygiene standards in the food industry but in poor countries the majority of cases are related to a lack of clean water supplies and underdeveloped medical networks. Diarrheal symptoms can be caused by multiple inflammatory bowel diseases such as ulcerative colitis, Crohn’s disease or irritable bowel syndrome. However, symptoms can also be caused by a wide range of bacteria (Campylobacter sp., Clostridium sp., Staphylococcus aureus, Vibrio cholerae, Shigella dysenteriae, enterotoxic strains of Escherichia coli), viruses (rotaviruses, noroviruses) and parasites (Giardia lamblia, Entamoeba histolytica and Cryptosporidium sp.). Because of the difficulties in diagnosis and the need of rapid therapy to prevent water and ion loss, rehydration therapy is used as a first line of action. Oral Rehydration Therapy (ORT) provides a simple and rapid treatment that can be given by any adult to a suffering individual, either adult or a child, to improve recovery from diarrhea. ORT solutions are usually composed of water, sodium chloride, glucose, potassium ions and citrate and the formulation currently recommended by the WHO has an osmolarity of 245 mmol/L (Anonymous, 2002). In contrast, intravenous rehydration requires a nurse while drugs require a doctor and a significant period of time to start working. It must be stressed that ORT alleviates the symptoms and aids recovery but does not cure the source of the diarrheal episode. The treatment of diarrhea depends on the initial source, which often is not known. It has been suggested that the use of antibiotics for the treatment of diarrhea worsens the problem in cases related to infections with bacteria carrying phages encoding endotoxins (Prins, 1994). Therefore, ORT is of particular importance where the infectious agent has already been removed by the diarrheal episode. Edible plants are traditionally used by many societies to alleviate and cure diarrhea. The properties of traditional plant extracts are worth exploring as they can stop or kill bacterial growth, neutralize or deactivate enterotoxins, are cheap and readily available, can give a better flavor to ORT, provide useful microelements and vitamins, and last, but not least, edible plants do not require the same level of extensive testing or * Corresponding author: P. Groves, Molecular Interactions and NMR, Instituto de Tecnologia Química e Biológica (ITQB-UNL), Av. da República (Estação Agronómica Nacional), 2780-157 Oeiras Oeiras, Portugal; phone: (+351) 214 469 300; fax: (+351) 214 411 277; e-mail: [email protected] 4 Komiazyk M. et al. regulatory approval as new drugs. This review covers the scientific literature relevant to the use of plant extracts to treat enterotoxic bacterial disease, particularly diarrhea caused by the AB5 family of enterotoxins (V. cholera, S. dysenteriae and enterotoxin producing strains of E. coli). Together, the organisms that produce AB5 enterotoxins result in more than 200 million episodes of diarrhea per year and around 2 million deaths. The plants reviewed here provide potential leads for improving ORT formulations and properties. 2. Mode of action of enterotoxic bacteria AB5 enterotoxins are originally encoded by pro phages STX1 or STX2 of Shigella sp. (Herold, 2005), or by phage CTXφ of Vibrio sp. (McCloud, 2004). Strains of the bacteria that do not express enterotoxins, which are a majority, are usually benign. Phages can undergo horizontal transfer and infect/transfer the toxin to other bacterial species and this is the case for the STX1 and STX2 prophages with E. coli. The primary role of AB5 molecules is not known. Recently it’s been suggested 1 that AB5 enterotoxin is a weapon against protozoa and immune system cells such as nucleophiles and their production is activated by reactive oxygen species. Enterotoxic bacterial infection proceeds from the ingestion of contaminated water or food. Sufficient numbers of bacteria must survive passage through the stomach and into the intestine, where they anchor to the intestinal wall. Here, they colonize the intestinal wall and grow without any great ill-effects to the host. Once the bacterial colony reaches a certain number of cells, enterotoxin production is switched on. The assembled enterotoxin is secreted via the type II secretion system. Recent developments in research on strategies of V. cholerae to maintain fitness in different ecological niches and protein production are described in a recent review by Sikora (Sikora, 2013). Cholera is a model bacterial disease caused by microorganisms producing AB5-type enterotoxins (Beddoe et al., 2010). The molecular structure of the toxin is formed from a proper toxin – A subunit and donut-like ring of five B-subunits, Figure 1. The B-subunits, which recognize GM1 gangliosides in human cells, act as a chaperone/delivery vehicle for the A-subunit Fig. 1. Primary and 3D structural data for cholera toxin (PDB accession code 1XTC). A) Protein sequence of cholera toxin subunit A. The first 18 residues (italics) constitute a signal sequence that is removed during secretion. The A1 domain is separated from the A2 domain by ‘nicking’ – an exogenous human protease breaks the backbone chain between residue Ser212 and Met213. The A2 domain is denoted in italics and bold text. The A1 and A2 remain joined through a Cys-Cys linkage denoted by a line. B) Protein sequence of the cholera toxin subunit B. The signal peptide (italics) is removed during secretion from V. cholerae. C) Structure of cholera toxin (PDB: 1XTC) as a cartoon representation of the secondary structure elements of cholera toxin. The five B-subunits are colored in green-blue shades. The A2 subunit (magenta) forms a long helical element that is embed in the center of the donut-shaped B-subunit pentamer. The A2 subunit is linked to the A1 subunit (yellow) through disulfide bonds. B) schematic representation of the enterotoxin structure. The GM1-binding sites are situated in the B-subunits and on the opposite face of the A1 subunit. 1 Plant extracts against enterotoxic bacteria that sits on the opposite face of the donut. The B-subunits of different enterotoxic bacteria have similar secondary and tertiary structures, as well as similar modes of binding to GM1, although their primary amino acid sequences are quite distinct. The A-subunit is formed from two polypeptide chains: a long alpha-helical A2 domain that anchors the A1 domain into the hole of the B5 structure. The A1 domain, crosslinked to the A2 domain through disulfide bonds, is processed in the endoplasmic reticulum and released to the cytoplasm. The introduction of the toxin to human cells follows a specific path involving initial endocytosis of the GM1-toxin complex followed by transport to the Golgi and endoplasmic reticulum. The toxin is processed in the endoplasmic reticulum and the A1 subunit is released into the cytoplasm where subunit A1 binds to, and activates, ADP-ribosylation factor 6 (Arf6). This unwanted stimulation interferes with a range of cellular processes involving cAMP. In particular, the disregulation of cAMP levels results in the opening of ion channels and rapid loss of ions and water from the human cell which forms the diarrheal episode (Kopic and Geibel, 2010). The multi-step process of the bacterial life cycle, involvement of a bacteriophage, toxin production, transport and action provides several potential targets where the disease process can be mediated/modified. Plant extracts can inhibit the initial anchoring of bacteria to the digestive system (Birdi et al., 2010), down-regulate toxin production in bacteria (Birdi et al., 2010; Brijesh et al., 2009), inhibit the binding of toxin to GM1 (Birdi et al., 2010; J.-C. Chen et al., 2006; 2007; 2009;), close toxin-activated ion channels (Fischer et al., 2004) etc. Despite this, the majority of the reported research focuses almost exclusively on the antimicrobial properties of plants (Table I). However, it needs to be noted that concentration of studied antimicrobial plant extracts is usually much higher and expressed as minimal inhibitory concentration (MIC) in mg/ml range than those observed for antibiotics – usually in µg/ml (http://www.eucast.org/mic_distributions/). Plants have been used as a treatment and source of active substances for millennia with Ayurvedic practice and the roots of Chinese medicine providing the best established, documented and known examples. Ethnopharmacists collect the remaining local folk knowledge in various worldwide regions such as India (Dey and De, 2012; Tetali et al., 2009), Indonesia (Grosvenor, Supriono and Gray, 1995) or Nigeria (Tekwu, Pieme and Beng, 2012). In the majority of cases, little or no scientific validation has been provided for the efficacy of plant extracts against disease. Experienced practitioners of plant medicine take careful note on the method of collection and storage of the plant material, 5 as well as the preparation and use of the plant extract. Still, there is often a lack of validated identification of the bacterial species, treatment process, plant used, or use of placebo controls. This is best exemplified by making a simple internet search that often results in general list of diseases that can be cured by a particular plant, very often without any useful details on how to prepare or use the plant material. Scientists have validated the beneficial effects of many plant extracts, including those against enterotoxic bacteria, particularly the more common and readily available plants. The antimicrobial active ingredients are often hydrophobic in nature and are most efficiently obtained by organic solvent extraction such as ethanol, methanol or acetone requiring a chemical laboratory (e.g. Rajan, Thirunalasundari and Jeeva, 2011). Data are also collected for simple aqueous extracts or decoctions – basically equivalent to a cup of herbal tea or broth. While ethanol extracts might support the effects of alcoholic beverages popularly used as digestives, they are clearly unsuitable for children less than five years old who represent one of the most sensitive groups of diarrhea patients. The use of methanol or acetone as a solvent raises safety issues. While the production of essential oils through steam distillation is an energy and time consuming process, unwanted solvents can be avoided and a safer product can be produced. They also potentially work in much lower concentrations then aqueous extracts and so they make an interesting alternative. Still, in our opinion, the ideal, active plant extracts should be available from a simple cold or hot water extract. Considering this point, the reviewed literature is focused towards the use of aqueous extracts. 3. Examples of active plants, plant parts and mode of preparation Folk medicine provides the starting point for many investigations and the selection of plants and part of the plants to study. However, we must recognize that the properties of plants that have been cultivated and selected over the millennia may change. For example 1000 year old Anglo-Saxon recipes were used to test the antibacterial properties of plants such as Potentilla reptans (European cinquefoil) against wound infections and modern experiments found that plant extracts have stronger antimicrobial properties against gram negative intestinal bacteria such as E. coli than wound-infecting bacteria (S. aureus) (Watkins et al., 2012). This makes the extracts useful for a possible treatment of diarrhea, and maybe less suitable in their original use to treat skin lesions. Indian Ayurvedic medicine is based on phytomedicinal properties practiced over several millennia. Studies on Ayurvedic recipes revealed that an aqueous plant name Plant common name (plant’s part) Method of preparation Tested enteropathogens Assay MIC MeOH = 32.4 mg/ml MIC EO = 25.8 mg/ml MIC MeOH = 26.9 mg/ml MIC EO =24.1 mg/ml MBC: crude preparation – 1.25mg/ml and methanol extract – 0.85 mg/ml Vernonia polyanthes – Asia Psidium guajava Guava Methanol extract and V. cholerae O1 (Bangladesh) (leaves and bark) crude aqueous mixture 1. Agar diffusion method 2. Microdilution method (MIC and MBC) MIC MeOH = 15.9 mg/ml MIC EO = 27.6 mg/ml South Eugenia uniflora Brazilian Cherry Essential oil and methanol Sixteen E. coli strains isolated Agar dilution method America extract from human specimens in the Clinical Hospital of Botucatu Baccharis Medical School dracunculifolia – (stem bark) Rahim et al., 2010 Silva et al., 2012 Delaquis et al., 2002 Mathabe et al., 2006 The MIC is dependent on plant extract preparation and bacte rial strain. All of the plants have antimicrobial activities 0.039–0.312 mg/ml. against V. cholerae, S. dysenteriae and S. flexneri. E.coli is resistant to E. burkei, E. elephantina, S. brachypetala and S. cordatum EO from eucalyptus has very similar activity to coriander seeds (0.2% vol/vol). Ximenia caffra Tekwu et al., 2012 Reference The MIC is dependent on the solvents and is between 0.032 (MeOH N. latifoli bark extr.) and 0.512 mg/ml. Result Eucalyptus dives Eucalyptus Essential oil (EO) E.coli O157:H7, Broth microdilution Lactobacillus sp. with 0.15% agar Africa Albizia (leaves) Hexane, ethyl acetate and E. coli LMP0101U, 1. Agar disc diffusion (Cameroon)gummifera methanol (MeOH) extracts S. dysenteriae LMP0208U, 2. Broth microdilution method S. flexneri LMP0313U (MIC) with 0,5% phenol red Ficus exasperata (leaves and bark) Nauclea latifoli (leaves and bark) South Africa Elephantorrhiza (stem rhizome) methanol, acetone, ethanol V. cholerae, E. coli ATCC 35218, 1. Agar-well diffusion burkei and boiling water extracts Shigella dysenteriae, 2. Broth microdilution (MIC) Shigella flexneri, Shigella sonnei, Elephantorrhiza (stem rhizome) Shihella boydii elephantina Gymnosporia(roots) senegalensis Indigofera (whole plant) daleoides Ozoroa insignis (stem bark) Spirostachys africana (stem bark) Schotia brachypetala Huilboerboon (stem bark) Syzygium cordatum Water berry (stem bark) Region Table I Summary of antimicrobial properties of various plant extracts 6 Komiazyk M. et al. 1 plant name Plant common name (plant’s part) Method of preparation Tested enteropathogens 1. Disc diffusion 2. Broth microdilution (MIC and MBC) Assay Reference EO has antibacterial activity Burt and against E. coli Reinders, (max. MBC – 0.08–2.5 µl/ml) 2003 Result Allium sativum Garlic Water extract E. coli O157 1. Growth of E. coli on agar plates containing 1–2% of garlic extract 2. E. coli O/N culture was added to garlic extract and the number of living cells was counted on agar plates Garlic has antimicrobial activity against E. coli O157. Fresh garlic killed E. coli much faster than 1 year old garlic powder. Sasaki et al., 1999 MIC: aq extr. – 0.38 mg/ml, Rajan et al., EtOH extr. – 0.19mg/ml 2011 1. Disc diffusion method 2. Agar dilution method Mangifera indica Mango (kernel) Ethanol (EtOH) and S. dysenteriae aqueous extract MBC fruit and bark = Nwodo, et al., = 125 mg/ml. Only one E. coli 2011 strain was resistant to 250 mg/ml tamarind extract. Leaves have the lowest antimicrobial activity. Asia Tamarindus indica Tamarind Ethanol, hot and cold E. coli from diarrheal stools 1. Agar diffusion method (leaves, stemp water extracts (7 strains) E. coli ATCC 11775 2. Macrodilution method bark, fruit pulp) (MIC and MBC) North Caesalpinia Poinciana Methanol and aqueous E. coli ATCC 25922 (control), Agar dilulution These plant extracts were Alanís, et al., America pulcherrima extracts clinical isolates (1, 2, 4 and 8 mg/ml) tested at concentration 2005 (Mexico) of E. coli 0157:H7, S. ssonnei of 8 mg/ml and found Chiranthodendron Mexican and S. flexneri to inhibit the growth pentadactylon hand tree of tested strains. Chrysactinia – Methanol extracts have better mexicana antimicrobial activities than aqueous solutions Geranium (roots and mexicanum aerial part) Punica granatum pomegranate Asia Cinnamomum cinnamon (bark) water, ethanol and E. coli O157:H7, 1. E. coli was cultured with Cinnamon bark has Muthuswamy, (Sri Lanka) zeylanicum petroleum ether-based E. coli ATCC 25921, three different concentrations antibacterial activity against et al., 2007 extracts, essential oil E. coli ATCC25922 of cinnamon extract. E. coli. The antibacterial Senhaji, and E. coli ATCC11105 2. Identification of the anti- compound is cinnamic et al., 2007 microbial compound aldehyde. 3. Broth microdilution(MIC) 4. Disc diffusion North Origanum vulgare oregano Essential oil E.coli O157:H7 America (Caribbean) Thymus vulgaris thyme Region Table I continued 1 Plant extracts against enterotoxic bacteria 7 MBC: E. coli – 0.625 mg/ml and Vibrio spp. – 0.31–1.25 mg/ml Hajlaoui et al., 2010 Illicium verum Star anise ethanol and petroleum E. coli extracts Standard agar cup plate Antimicrobial activity of star method – active coumpounds anise is mainly due were studied to anethole De et al., 2002 Asia (India) Azadirachta indica neem (leaves) methanol extract V. cholerae (NB2 and SG24) 1. Disc diffusion MBC = 10 mg/ml Thakurta P. – belonged to O1 and O139, 2. Broth microdilution MIC > 5 mg/ml et al. PC4, PC9, PC11, PC14 (MIC and MBC) serotypes 1. Disc diffusion 2. Brothmicro dilution (MIC and MBC) Mathabe et al., 2006 Mazumder R., et al. Reference Cuminum cyminum Cumin (seeds) Essential oil E. coli ATCC 35218 and 11 Vibrio spp. strains Result Tea has antimicrobial activity Bandyoagainst studied bacteria. padhyay Growth of most E. coli strains et al., 2005 was inhibited between 10–20 µg/ml; Shigella spp.: 20–30 µg/ml and V.cholerae: 10–30 µg/ml. Assay Camellia sinensis tea (leaves) Alcohol extract – dried and 111 baterial strains were tested Agar dilution method brown powder was used including: 15 E. coli, 24 Shigella spp. and 23 V. cholerae Tested enteropathogens The lowest activity against tested bacteria with water extract (MIC: 0.156–0.3 mg/ml). With other solvents – MIC: 0.078 mg/ml Method of preparation Punica granatum (rind and roots) methanol, acetone, ethanol E. coli UP 2566, S. dysenteriae 1. Agar well diffusion method and boiling water extracts IOA-108, V. cholerae, (150 mg/ml) E. coli ATCC 35218 2. Broth microdilution (MIC) common name (plant’s part) MIC: E. coil AM 8/98 – 2–5 µg/ml; S. dysenteriae, E. coli VC sonawave 3:37C and E. coli CD/99/1 – 150 µg/ml; V. cholerae – 100–150 µg/ml; L.arabinosus –150–200 µg/ml plant name Plant Asia Curcuma longa Tumeric leaves Methanol extract E. coil AM 8/98, S. dysenteriae 1, 1. Agar dilution method 2 and 6, E. coli VC sonawave 2. Disc diffusion 3:37C, E. coli CD/99/1, V. cholerae 865, Lactobacillus arabinosus CD /99/1 Region Table I continued 8 Komiazyk M. et al. 1 plant name common name (plant’s part) Method of preparation Tested enteropathogens Assay Eucalyptus sp. Eucalyptus leaves) Casuarina She-oak equisetifolia (bark and leaves) Zizyphus jujuba Jujube (leaves) Syzgium cumini Jamun (bark and leaves) Syzygium Clove aromaticum (bud and oil) Saussurea lappa (roots) Acorus calamus Sweet flag (rhizome) Allium cepa Onion (leaves) Camelia sinensis Tea (leaves) Europe Vaccinium myrtillus Blueberry Lyophilized berry extract E. coli ATTC 11775, 1. Agar diffusion method (berries) and phenolic compounds E. coli CM871 2. Bacteria growth curve Lactobacillus sp. (7 strains) Rubus idaeusRaspberry measurement – bacteria grew (berries) with 0.5, 1 or 5 mg/ml berry Vaccinium vitisidaca Lingonberry extracts (berries) Ribes nigrum Blackcurrant (berries) Rubus chamaemorus Cloudberry (berries) Vaccinium oxycoccus Cranberry (berries) Hippophae Sea buckthorn rhamnoides berry (berries) Fragaria ananassa Strawberry (berries) Holy Basil 70% alcohol extract E. coli UP 2566, Agar well diffusion method (whole plant) S. dysenteriae IOA-108 (150 mg/ml) – 45 Indian plants were tested White mulberry (leaves) Indian sarsaparilla (roots) Plant Asia (India Ocimum sanctum Morus alba Hemidesmus indicus Region Table I continued Finnish berry extracts (1 mg/ml) have animicrobial activity against E. coli (except Blackcurrant to ATTC 11775). All studied probiotic bacteria are resistant to these extracts 150 mg/ml of plants extracts can inhibit growth of S.dysenteriae and E. coli. But ork better against E. coli. 150 mg/ml of plants extracts with similar efficacy can inhibit growth of E. coli and S. dysenteriae 150 mg/ml of plants extracts can inhibit growth of S. dysenteriae and E. coli. Extracts work better against Shigella. Result Puupponen-Pimiä et al., 2001 Ahmad and Beg 2001 Reference 1 Plant extracts against enterotoxic bacteria 9 plant name common name (plant’s part) Method of preparation Tested enteropathogens Result 1. Disc diffusion MBC: E. coli – 4 µl/ml and 2. Broth microdilution and V. cholerae – 1 µl/m (MIC and MBC) Assay Creeping cinquefoil (aerial parts and roots) MIC EtOH = 43.4 mg/ml MIC EO = 28.2 mg/ml Matricaria Chamomile Essential oil and methanol chamomilla extract Burt and Reinders, 2003 Origanum vulgare Oregano Essential oil E. coli O157:H7 1. Disc diffusion EO has antibacterial activity 2. Broth microdilution against E. coli (MIC and MBC) Adiguzel et al., 2009 Zomorodian et al., 2012 Silva et al., 2012 Delaquis et al., 2002 Nepeta cataria Catnip (plants at Methanol extract and E. coli A1, Shigella spp., 1. Disc diffusion MIC MeOH: 31.25 µg/ml flowering stage) essential oil E. coli ATCC 43894 2. Broth microdilution MIC EO: 125µg/ml (MIC and MBC) Sixteen E. coli strains isolated Agar dilution method from human specimens in the Clinical Hospital of Botucatu Medical School Watkins et al., 2012 Mahboubi and Haghi, 2008 Reference Methanol extract has better Burt and antimicrobial activity than Reinders, aqueous. Methanol extract 2003 of thyme inhibits 100% growth of all tested strains. EO from coriander leaves have almost two times less antimicrobial activity than seeds (0.4%vol/vol) and is similar to dill. (0.2%vol/vol). 1. Disc diffusion 2. Broth microdilution (MIC and MBC) 3. Agar dilulution (1, 2, 4 and 8 mg/ml) Europe/Asia Anethum graveolens Dill Essential oil E. coli O157:H7, Broth microdilution Lactobacillus sp. with 0.15% agar Coriandrum sativum Coriander (leaves and seeds) Thymus vulgaris Thyme Essential oil, methanol E. coli O157:H7, and aqueous extracts E. coli ATTC 25922 (control), S. sonnei–1,2 and S. flexneri–1,2 Potentilla reptans Agrimonia eupatoria Agrimony (aerial Red wine, ethanol E. coli (UEL 57) Microdilution method (MIC) 0.2 mg/ml of root aq parts and roots) (25% or 75%) and boiling and EtOH. extract inhibit water extracts (aq) > 60% E. coli growth Squaw Mint Essential oil E. coli ATCC 8739, V. cholerae (flowering aerial Inaba parts) Plant Europe Mentha pulegium Region Table I continued 10 Komiazyk M. et al. 1 1 Plant extracts against enterotoxic bacteria decoction of guava leaves (Psidium guajava) and unripe bael fruit (Aegle marmelos) was found to have weak bacteriostatic/bacteriocidal properties (Birdi et al., 2010; Brijesh et al., 2009). The study also included tests of adherence/invasion potential of different bacterial species producing enterotoxins to human cells in the presence of plant extract. Because extracts of both plants inhibited the adherence and invasion of bacteria, they could play a positive role in the treatment of bacterial infection by inhibiting the initial colonization of the digestive system by the bacteria. This is a very important but rarely studied phenomena despite the fact that disruption of attachment – the first stage of bacterial infection – is a key property to prevent disease onset. Finding and using plants with this properties could be crucial in case of infections caused by hemolytic strains causing bloody diarrhea that are the most damaging and difficult forms of diarrhea to treat, requiring hospitalization, antibiotic treatment and which cannot currently be alleviated by ORT alone. The method in which plant extracts are prepared contributes greatly to its efficacy. Prolonged heat treatment might degrade active ingredients present in the initial plant extract or lead to chemical modifications and an increase in the concentration of active ingredients. Examples of different treatment outcomes depending on the extract preparation were described by Rahim et al. and Birdi (Rahim et al., 2010; Birdi et al., 2010). Birdi et al. found that extract of guava (P. guajava) leaves were more effective against antibiotic-resistant V. cholerae strains than Birdi, however, Rahim prepared a cold water extract of the guava leaves whereas Birdi heated and reduced the plant extracts (Rahim et al., 2010; Birdi et al., 2010). This suggests that heating may destroy part of the antibacterial properties of the guava leaves although Rahim et al. did not find that heating of their samples reduced their efficacy (Rahim et al., 2010). Variable antimicrobial properties of particular plant extracts can be commonly found in the literature, which stresses the fact that careful attention must be paid to sample collection, storage and preparation, as well as the bacteria strains used in subsequent studies. The specificity of antimicrobial activities of plant extracts towards pathogenic bacterial strains as compared with benign strains are rarely tested. An example of a study addressing this issue is the test of 26 Mexican plant extracts against non-pathogenic E. coli and the enterotoxic E. coli O157:H7, amongst others (Alanís et al., 2005). The aqueous extracts used in these studies showed a much better specificity for the pathogenic E. coli O157:H7 strain over a non-pathogenic E. coli strain when compared to methanolic extracts. Carica papaya (papaya), Ocimum basilicum (basil), Matricaria chamomilla (chamomile) and Thymus vulgaris (thyme) are commonly known plants reported with such anti- 11 microbial specificity. Patient recovery rates and reestablishing gut flora, which can take several weeks following hospitalization, are an important consideration with respect to diarrhea. The retention of any beneficial bacteria in the digestive system by the selective action of plant extracts has much to be recommended. Organic solvents, chiefly ethanol and methanol, are often used to obtain active ingredients from plant extracts but using them in the treatment of patients with acute diarrhea is highly questionable. A refluxed ethanolic extract of cinnamon (Cinnamomum zey lanicum) inhibited the growth of Listeria inocua and E. coli O157:H7 but an aqueous extract was ineffective (Muthuswamy, Rupasinghe and Stratton, 2007). The 50-fold dilution of the ethanolic extracts means that the final solution still contains 2% ethanol, which is unsuitable for the treatment of dehydrated patients, particularly children. Senhaji found that the essential oil of the same plant, obtained without organic solvents, was effective against E. coli O157:H7 (Senhaji, Faid and Kalalou, 2007). In this case pure essential oil could be a second choice for studies, after simple water extracts. Plant metabolite concentrations often vary during the growth cycle and in different parts of the plant so a consistent level of therapeutic molecules is an important consideration. For Nepeta cataria (catnip), the antibacterial properties of essential oils distilled at three different stages of plant growth were tested (Zomorodian et al., 2012). In this case, consistent results were obtained across the growth stages which uphold specificity for S. aureus and Shigella sp. over E. coli. It is worth noting that the essential oil content of catnip tea will be much lower than the levels of essential oils reported to have an antibacterial effect and also that catnip tea is not recommended for women during pregnancy or lactation (Ernst, 2002). A range of European berries (blueberry, raspberry, lingonberry, blackcurrant, strawberry, cloud berry, sea buckthorn berry and cranberry) were found to be more active against E. coli and other pathogenic bacteria compared to Lactobacillus sp. (Puupponen-Pimiä et al., 2001). However, the samples were first extracted with 70% acetone and processed to remove sugars. It is not possible to estimate the amount of fruit required providing equivalent levels of active material and if a low concentration of fruit extract could replace part of the sugar component in ORT. Positive data for raspberry fruit and cordial at 10% dilution has also been reported (Ryan, Wilkinson and Cavanagh, 2001). While neat fruit juices are generally not recommended for the treatment of diarrhea, these studies support the potential inclusion of natural, rather than artificial, fruit flavors in ORT formulas. Publications naturally report positive antimicrobial properties of plant extracts but it is not always easy to 12 1 Komiazyk M. et al. gauge their effectiveness. Plant extract yields and other essential data are often unreported and this adds to difficulties in comparing the different experimental methods used between publications. Mathabe surveyed the effect of plant extracts on several bacterial species, including V. cholerae and Shigella sp. (Mathabe et al., 2006). They used extracts from different parts of 21, locally used plants. Punnica granatum (pomegranate), as clearly stated in the abstract, was the best known plant to give positive data. However, it is only on reading the full paper that it is pomegranate root that provided the positive data and not the juice or fruit. The reported MIC for the hot water extract of pomegranate root (0.156 µg/ml) is a lower concentration than would be expected from a teabag (1–2 g of plant material) in a mug of hot water (about a third of a liter) although exact extract yields were not reported. The cold water extract of tamarind (Tamarindus indica) fruit was very effective against a range of bacteria, including clinical isolates of E. coli that caused infantile diarrhea (Nwodo et al., 2011). A cold water extract from 1 g plant material (1 teabag) per liter of water (about 3 mugs) was sufficient to achieve a bacteriocidal effect against E. coli (Nwodo et al., 2011). Extracts of mango kernel (Mangifera indica), including a cold water extract, were effective against S. dysenteriae (Rajan, Thirunalasundari and Jeeva, 2011). The abstract of this paper is unambiguous as it states clearly that the data were obtained with mango kernel. The cold water extract was effective at a concentration of 1.5 g dry plant material per liter of water (Rajan, Thirunalasundari and Jeeva, 2011). Hajlaoui found that essential oil from cumin (Cuminum cyminum) was active against Vibrio sp. and E. coli (Hajlaoui et al., 2010). However, the extraction yields and MICs suggest a high concentration of plant material is required to obtain an effective extraction (> 15 g/liter means at least three teabags in a mug of water). Pairs of aqueous plant extracts can have a greater efficacy than their single counterparts (Han and Guo, 2012). The common traditional Chinese medicine pair of Angelica sinensis and Sophora flavescens was tested against four different bacteria. Neither plant had significant antibacterial properties when used alone but did so when used together. Specific interactions and effects of foods on pharmaceutical action are known. The adverse effect of grapefruit juice on a wide range of drugs is well documented (Hanley et al., 2011). Essential oils of thyme and oregano were effective against E. coli O157:H7 in disk diffusion and microplate (MIC) assays although this was the only bacterium tested (Burt and Reinders, 2003). This means that we cannot rule out a general antimicrobial effect that will also kill beneficial bacteria in the digestive tract. The principal ingredient of thyme oil, thymol, is used in mouthwashes as an antibacterial and antifungal agent but there are no safe recommendations about its use in food. Oregano oil is generally recognized as safe by the FDA at a consumption level of 200 mg a day (Food. Listing of Food Additive Status Part II. US Food and Drug Administration Web Site. http://www.fda.gov/ Food/FoodIngredientsPackaging/FoodAdditives/ ucm191033.htm#ftnO). The bacteriostatic and bacteriocidal properties of oregano varied with the presence of other added ingredients (agar and soy lecithin). Garlic is considered beneficial for a wide range of medical problems. Included as a 1% additive to media, garlic was active against several bacteria, including E. coli O157:H7 (Sasaki et al., 1999). Fresh garlic extract and allicin, the principal compound in garlic suspected of carrying antimicrobial properties, had equal or better activity than five tested antibiotics against a range of antibiotic resistant strains of Shigella sp., eneterotoxic E. coli and V. cholerae. (Ahsan et al., 1996). Allicin is an unstable molecule and the effectiveness of garlic is highly dependent on the source of the plant material, method of preparation, as well as the ages of the plant material and extract. Allicin is not the only active component of garlic, Politi et al. identified a polysaccharide component isolated from garlic that binds to the B-subunit of cholera toxin to confer antitoxin properties (Politi et al. 2006). 4. Avenues for future research The majority of published works in the field focus on the antimicrobial properties of plant extracts. Few studies test the specificity of plant extracts for infectious over benign bacterial strains. The toxicity of plant extracts to humans should also be considered, particularly when highly concentrated fractions are used, or parts of the plant that are not normally ingested. Pharmaceutical practice focuses on developing one drug or treatment to target a specific and weak point in the disease mechanism. In principal, a mixture of plant extracts may present a synergistic effect against several stages of the infection cycle, specificities against a wide range of bacteria and overall lead to obtaining a more effective remedy for diarrhea. The search for beneficial plant extracts would benefit from multi-disciplinary, collaborative, large-scale screening approaches. The first task is to select plant materials that are generally considered safe for human consumption (including children and pregnant/lactating women) as based on literature searches. Plant material should be collected at different growth stages and from different varieties of plant. Screening of fresh, stored and dried plant materials should be performed. Plant extracts should be prepared with cold water, hot 1 13 Plant extracts against enterotoxic bacteria water and boiling/refluxing extractions – toxic solvents should be avoided. The long-term stability of the extracts in solution and/or as freeze-dried powders should be compared. Antimicrobial screens should be based around wellestablished protocols to measure bacteriostatic and bacteriocidal properties of the plant extracts. However, it is important to test a range of enterotoxic and benign strains of bacteria in order to obtain ideas on the specificity of plant extracts. Advanced protocols based on mammalian cell cultures to test the anti-adhesion and anti-invasion properties of plant extracts on bacterial cell cultures are critical to the discovery of plant extracts that can counter hemolytic strains of enterotoxic bacteria. Protocols to measure the downregulation of toxin production (rtPCR) and toxin secretion by plant extracts are worth carrying out to ascertain if plant extracts are capable of slowing diarrheal episodes. Returning to sample selection, combinations of optimal plant extracts should be tested in combination to ensure that their full activity is maintained or synergy obtained. The final aim is to have ready-to use ORT in solution and sachets of dried ORT to be dissolved in clean water. These products fulfill the aim of treating diarrhea but prevention and control of the disease might be aided with sachets of dried plant extract (without added salt and sugar) or teabags filled with mixed plant materials. The strategy outlined above means a change from the current approach of validating plant extracts on an individual or regional basis towards a more multidisciplinary, collaborative effort. We have recently instigated a projected targeted towards AB5-producing bacteria, establishing a range of protocols in three different labs. Our antimicrobial data corroborate existing published data for a number of hot water plant extracts and reveal new, include toxicity studies on human cell lines and a number of anti-toxin properties. However, we still do not employ a full range of protocols or have instigated animal or human trials to test our suggested mixes of plant extracts. Furthermore, the AB5 family of enterotoxins represents just one group of enterotoxic pathogens that can be studied using the same set of protocols. 5. Conclusion It is not possible to compare datasets for a particular plant due to different plant sources, extract preparations and microbial screens. However, the wide variability indicates that these points are very important being very important in determining if a particular plant extract will be effective or not. A plant extract, or more likely a mixture of plant extracts, that provide a wide spectrum of antimicrobial and anti-toxin properties would provide a powerful boost to ORT formulations. It is important in such a case that a suitable antimicrobial screen is used to assay the plants before distribution or sale. A second point is that several screens are required to test plant effects against different aspects of microbial colonization, toxin release and toxicity. It is this point that is largely overlooked in favor of traditional, plate-based antimicrobial screens. Future studies would benefit from large-scale collaborative screening with an aim of improving ORT. Acknowledgement M.P. thanks the Fundaçao para a Ciência e a Tecnologia (FCT) for the postdoctoral grant (SFRH/BPD/65762/2009). P.G. thanks FCT for a Ciencia Fellowship. We acknowledge FCT and POCI, with co-participation of the European Regional Development Fund (FEDER), for financial support under project PTDC/QUI-BIQ/ 115298/2009. I.S. and M.P. were supported by the Polish-Portugal Executive Program for years 2011–2012 sponsored by the Polish Ministry of Science and Higher Education and by FCT. This work was also supported by FCT through grant no. PEst-OE/EQB/ LA0004/2011. Literature Adiguzel A., H. Ozer, M. Sokmen, M. Gulluce, A. Sokmen, H. Kilic and F. Sahin. 2009. Antimicrobial activity and chemical composition of Mentha pulegium L. essential oil. Pol. J. Microbiol. 58: 69–76. Baris Ozlem Ahmad I and A.Z. Beg. 2001. Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multidrug resistant human pathogens. J. Ethnopharmacol. 74: 113–123. Ahsan M. and A.K.A. Chowdhury. 1996. Garlic Extract and Allicin: Broad Spectrum Antibacterial Agents Effective Against Multiple Drug Resistant Strains of Shigella dysenteriae type Escherichia coli and Vibrio cholerae. Phytother. Res. 10: 329–331. Alanís A.D., F. Calzada, J.A.Cervantes, J. Torres and G.M. Ceballos. 2005. Antibacterial Properties of Some Plants Used in Mexican Traditional Medicine for the Treatment of Gastrointestinal Disorders. J. Ethnopharmacol. 100: 153–157. Anonymous. 2002. WHO Drug Information. 16: 121–122. http:// apps.who.int/medicinedocs/pdf/s4950e/s4950e.pdf Bandyopadhyay D., T.P. Chatterjee, A. Dasgupta, J. Lourduraja and S.G. Dastidar. 2005. In vitro and in vivo antimicrobial action of tea: the commonest beverage of Asia. Biol. Pharm. Bull. 28: 2125–2127. Beddoe T., A.W. Paton, J. Le Nours, J. Rossjohn and J.C. Paton. 2010. Structure, Biological Functions and Applications of the AB5 Toxins. Trends Biochem. Sci. 35: 411–418. Birdi T., P. Daswani, S. Brijesh, P. Tetali, A. Natu and N. Antia. 2010. Newer Insights into the Mechanism of Action of Psidium gua java L. Leaves in Infectious Diarrhoea. BMC Complement Altern. Med. 10: 33. Brijesh S., P. Daswani, P. Tetali, N. Antia and T. Birdi. 2009. Studies on the Antidiarrhoeal Activity of Aegle marmelos Unripe Fruit: Validating Its Traditional Usage. BMC Complement. Altern. Med. 9: 47. Burt S.A. and R.D. Reinders. 2003. Antibacterial Activity of Selected Plant Essential Oils Against Escherichia coli O157:H7. Lett. Appl. Microbiol. 36:162–167. Chen J.-C., T.-Y. Ho, Y.-S. Chang, S.-L. Wu and C.-Y. Hsiang. 2006. Anti-diarrheal Effect of Galla chinensis on the Escherichia coli 14 Komiazyk M. et al. Heat-labile Enterotoxin and Ganglioside Interaction. J. Ethnophar macol. 103: 385–391. Chen J.-C., T.-Y. Ho, Y.-S. Chang, S.-L. Wu, C.-C. Li and C.-Y. Hsiang. 2009. Identification of Escherichia coli Enterotoxin Inhibitors from Traditional Medicinal Herbs by in silico, in vitro, and in vivo Analyses. J. Ethnopharmacol. 121: 372–378. Chen J.-C., L.-J. Huang, S.-L. Wu, S.-C. Kuo, T.-Y. Ho and C.-Y. Hsiang. 2007. Ginger and Its Bioactive Component Inhibit Enterotoxigenic Escherichia coli Heat-labile Enterotoxin-induced Diarrhea in Mice. J. Agric. Food Chem. 55: 8390–8397. De M., A.K. De, P. Sen and A.B. Banerjee. Antimicrobial Properties of Star Anise (Illicium verum Hook f). Phytother. Res. 16: 94–95. Delaquis P.J., K. Stanich, B. Girard and G. Mazza. 2002. Antimicrobial activity of individual and mixed fractions of dill, cilantro, coriander and eucalyptus essential oils. Int. J. Food Microbiol. 74: 101–109. Dey A. and J.N. De. 2012. Ethnobotanical Survey of Purulia District, West Bengal, India for Medicinal Plants Used Against Gastrointestinal Disorders. J. Ethnopharmacol. 143: 68–80. Ernst E. 2002. Herbal Medicinal Products During Pregnancy: are they safe? BJOG 109: 227–235. Fischer H., T.E. Machen, J.H. Widdicombe, T.J.S. Carlson, S.R. King, J.W.S. Chow and B. Illek. 2004. A Novel Extract SB-300 from the Stem Bark Latex of Croton lechleri Inhibits CFTR-mediated Chloride Secretion in Human Colonic Epithelial Cells. J. Ethnophar macol. 93: 351–357. Grosvenor P.W., A. Supriono and D. Gray. 1995. Medicinal Plants from Riau Province , Sumatra, Indonesia . Part 2: Antibacterial and Antifungal Activity. J. Ethnopharmacol. 45: 97–111. Hajlaoui H., H. Mighri, E. Noumi, M. Snoussi, N. Trabelsi, R. Ksouri and A. Bakhrouf. 2010. Chemical Composition and Biological Activities of Tunisian Cuminum cyminum L. Essential Oil: a High Effectiveness Against Vibrio spp. Strains. Food Chem. Toxicol. 48: 2186–2192. Han C. and J. Guo. 2012. Antibacterial and anti-inflammatory Activity of Traditional Chinese Herb Pairs, Angelica sinensis and Sophora flavescens. Inflammation 35: 913–919. Hanley M.J., P. Cancalon, W.W. Widmer and D.J. Greenblatt. 2011. The Effect of Grapefruit juice on Drug Disposition. Expert Opin. Drug. Metab. Toxicol. 7:267–286. Herold S., H. Karch and H. Schmidt. 2004. Shiga toxin-encoding bacteriophages-genomes in motion. Int. J. Med. Microbiol. 294: 115–121. S. Kopic and J.P. Geibel. 2010. Toxin mediated diarrhea in the 21 century: the pathophysiology of intestinal ion transport in the course of ETEC, V. cholerae and rotavirus infection. Toxins. 2: 2132–2157. Lainhart W., G. Stolfa and G. Koudelka. 2009. Shiga toxin as a bacterial defense against a eukaryotic predator, Tetrahymena thermo phila. J. Bacteriol. 191: 5116–5122. Mahboubi M. and G. Haghi. 2008. Antimicrobial activity and chemical composition of Mentha pulegium L. essential oil. J. Ethno pharmacol. 119:325–327. Mathabe M.C., R.V. Nikolova, N. Lall and N.Z. Nyazema. 2006. Antibacterial Activities of Medicinal Plants Used for the Treatment of Diarrhoea in Limpopo Province, South Africa. J. Ethnopharmacol. 105: 286–293. Mazumder R., T. Mendiratta, S.C. Mondal and A. Mazumder. 2000. Antimicrobial Potency of the Leaf – Stalk Extract of Curcuma longa (LINN). Anc. Sci. Life. 20: 92–96. McLeod S.M., H.H. Kimsey, B.M. Davis and M.K. Waldor. 2005. CTXphi and Vibrio cholerae: exploring a newly recognized type of phage-host cell relationship. Mol. Microbiol. 57: 347–356. 1 Muthuswamy S., H.P.V. Rupasinghe and G.W. Stratton. 2007. Antimicrobial effect of Cinnamon Bark Extract on Fresh-Cut Apples. J. Food Saf. 28: 534–549. Nwodo U.U., G.E. Obiiyeke, V.N. Chigor and A.I. Okoh. 2011. Assessment of Tamarindus indica Extracts for Antibacterial Activity. Int. J. Mol. Sci. 12: 6385–6396. Politi M., J. Alvaro-Blanco, P. Groves, A. Prieto, J.A. Leal, F.J. Cañada, J. Jiménez-Barbero. 2006. Screening of Garlic Water Extract for Binding Activity with Cholera Toxin B Pentamer by NMR Spectroscopy – An Old Remedy Giving a New Surprise. Eur. J. Org. Chem. 9: 2067–2073. Prins J. M., S.J.H. van Deventer, E.J. Kuijper, P. Speelman. 1994. Clinical Relevance of Antibiotic-Induced Endotoxin Release. Anti microb. Agents Chemother. 38: 1211–1218. Puupponen-Pimiä R., L. Nohynek, C. Meier, M. Kähkönen, M. Heinonen, A. Hopia and K.M. Oksman-Caldentey. 2001. Antimicrobial Properties of Phenolic Compounds from Berries. J. Appl. Microbiol. 90: 494–507. Rahim N., D.J. Gomes, H. Watanabe, S.R. Rahman, C. Chomvarin, H.P. Endtz and M. Alam. 2010. Antibacterial Activity of Psidium Guajava Leaf and Bark Against Multidrug-resistant Vibrio cholerae: Implication for Cholera Control. Jpn. J. Infect. Dis. 63:271–274. Rajan S., T. Thirunalasundari and S. Jeeva. 2011. Anti-enteric Bacterial Activity and Phytochemical Analysis of the Seed Kernel Extract of Mangifera indica Linnaeus Against Shigella dysenteriae (Shiga, Corrig.) Castellani and Chalmers. Asian Pac. J. Trop. Med. 4: 294–300. Ryan T., J.M. Wilkinson and H.M. Cavanagh. 2001. Antibacterial Activity of Raspberry Cordial in vitro. Res. Vet. Sci. 71: 155–159. Sasaki J.-I., K. Takeshi, I. Kunio, U. Hidemitsu and M. Hajime. 1999. Antibacterial Activity of Garlic Powder Against Escherichia coli O-157: H7. J. Nutr. Sci. Vitaminol. 45: 785–790. Senhaji O., M. Faid and I. Kalalou. 2007. Inactivation of Esche richia coli O157:H7 by Essential Oil from Cinnamomum Zeylani cum. Braz. J. Infect. Dis. 11: 234–236. Sikora A.E. 2013. Proteins Secreted via the Type II Secretion System: Smart Strategies of Vibrio Cholerae to Maintain Fitness in Different Ecological Niches. PLoS Pathog. 9: e1003126. Silva N.C.C., L. Barbosa, L.N. Seito and A. Fernandes Jun. 2012. Antimicrobial activity and phytochemical analysis of crude extracts and essential oils from medicinal plants. Nat. Prod. Res. 26: 1510–1514. Stolfa G. and G. Koudelka. 2013. Entry and Killing of Tetrahymena thermophila by Bacterially Produced Shiga Toxin. mBio. 4: 1–10 Tekwu E.M., A.C. Pieme and V.P. Beng. 2012. Investigations of Antimicrobial Activity of Some Cameroonian Medicinal Plant Extracts Against Bacteria and Yeast with Gastrointestinal Relevance. J. Ethnopharmacol. 142: 265–723. Tetali P., C. Waghchaure, P.G. Daswani, N.H. Antia and T.J. Birdi. 2009. Ethnobotanical Survey of Antidiarrhoeal Plants of Parinche Valley, Pune District, Maharashtra, India. J. Ethnopharmacol. 123: 29–236. Thakurta P., P. Bhowmik, S. Mukherjee, T.K. Hajra, A. Patra and P.K. Bag. 2007. Antibacterial, antisecretory and antihemorrhagic activity of Azadirachta indica used to treat cholera and diarrhea in India. J. Ethnopharmacol. 111: 607–612. Watkins F., B. Pendry, A. Sanchez-Medina and O. Corcoran. 2012. Antimicrobial Assays of Three Native British Plants Used in AngloSaxon Medicine for Wound Healing Formulations in 10th Century England. J. Ethnopharmacol. 144: 408–415. Zomorodian K., M.J. Saharkhiz, S. Shariati, K. Pakshir, M.J. Rahimi and R. Khashei. 2012. Chemical Composition and Antimicrobial Activities of Essential Oils from Nepeta cataria L. Against Common Causes of Food-Borne Infections. ISRN Pharm. 2012: 591953. Polish Journal of Microbiology 2014, Vol. 63, No 1, 15–20 ORIGINAL PAPER Quantitative Expression of Candida albicans Aspartyl Proteinase Genes SAP7, SAP8, SAP9, SAP10 in Human Serum in vitro MONIKA STANISZEWSKA1*, MAŁGORZATA BONDARYK1, TADEUSZ MALEWSKI2 and WIESŁAW KURZĄTKOWSKI1 National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland 2 Museum and Institute of Zoology Polish Academy of Science, Warsaw, Poland 1 Submitted 28 March 2013, revised 24 July 2013, accepted 16 November 2013 Abstract The different members of the secreted aspartyl proteinase (Sap) family of the human pathogenic yeast Candida albicans are proposed to play different roles during infection and are differentially expressed at various body sites. In recent reports, expression analysis has focused on the genes SAP1-6, while the expression pattern of SAP7-10 was less well studied. We analyzed the SAP7-SAP10 expression profile of C. albicans under human serum influence that may be elucidated in the course of blood infection in humans and how this in vitro expression profile is associated with hyphal formation. The phenotypes of strains were examined under scanning electron microscopy. Quantitative RT-PCR (2–∆∆CT) was used to monitor SAP expression of C. albicans wild type cells and mutants lacking SAP9 and/or SAP10. Of the four analyzed SAP genes, only SAP7 was detectably induced in the double mutant and in the wild type strains in the model that mimics bloodstream infections. On the other hand, in the wild types (isolate 83 and CAF2-1), SAP7 was expressed 0.8- or 0.4-fold less than SAP10, respectively. Our findings suggest that Sap7 may respond to the challenge of the human blood environment. Furthermore, the results support the notion that compensatory upregulation of SAP7 and SAP8 in the Δsap9/Δsap10 mutant occurs in these conditions. SAP7-10 expression was strain-specific. Our findings point to a link between morphogenesis and expression of SAP9 in serum, where these conditions induce both hyphae and SAP9, but temporal gene expression patterns might be controlled by other factors. K e y w o r d s: Candida albicans, aspartic proteinases expression, morphogenesis, blood human serum Introduction Candida albicans possesses a number of virulence attributes and among them widely studied are aspartyl proteinases (Saps) that can digest epithelial cell surface components and thereby provide an entrance into or between host cells (Dalle et al., 2010). Although plenty of data dealing with the Saps involved in the infection process have been extensively studied (Naglik et al., 2008; Rehaume et al., 2008; Schelenz, 2008) the comparative analysis of Saps expression in morphologies induced under human serum influence at human body temperature has not been described in depth. Given the role of SAP7, SAP8 and SAP9-10 in the growth of C. albicans in serum (Lermann and Morschhäuser, 2008), we asked whether those isoenzymes are expressed in C. albicans hyphal forms induced under human serum influence in vitro. In addition, we analyzed whether any differences exist in the expression level between these subfamilies. In contrast to all other members of the Sap family, the Sap9-10 proteases monitored under in vitro and in vivo conditions are independent of pH and morphotype (Hornbach et al., 2009; Schild et al., 2011). Furthermore, according to Schild et al. (2011) it seems apparent that the host associated lifestyle of C. albicans requires regulatory proteolytic digestion at different niches with different pH values. Moreover, the latter authors demonstrated that Sap9 and Sap10 influence on cell wall functions by proteolytic cleavage of cell wall proteins which are significant for morphogenesis (Schild et al., 2011). Thus, in the current study SAP9 and SAP10 expression analysis was undertaken in hyphal forms under serum influence at pH 7.1–7.4. An earlier study (Naglik et al., 2003) showed that SAP7 was found to be induced in response to infection of reconstituted human vaginal epithelium model as well as in isolates from patients. Furthermore, Taylor et al. (2005) observed that induction of SAP7 correlates with virulence in an intravenous infection model of candidiasis in mice. Many differences in the * Corresponding author: M. Staniszewska, Independent Laboratory of Streptomyces and Fungi Imperfecti, National Institute of Public Health – National Institute of Hygiene, 24 Chocimska, 00-791 Warszawa, Poland; phone: +48 22 54 21 228; fax: + 48 22 849 74 84; e-mail: [email protected] 16 1 Staniszewska M. et al. SAP gene expression profiles observed in various studies remain to be explained and more thoroughly characterized. Therefore, the aim of the study was to determine the relative levels of SAP7, SAP8, SAP9 and SAP10 transcripts in C. albicans strains in vitro at neutral pH at 18 h-growth in human blood serum (an artificial model of bloodstream infections). That may provide evidence for a role of these proteinases in C. albicans survive and escape of disseminated infection. Moreover, we determined whether any correlation might exist between overexpression of the SAP7-10 genes and true hyphae formation. Experimental Materials and Methods Strains and growth conditions. The Candida strains used in this study are listed in Table I. The stock culture of examined strains was stored on ceramic beads (MicrobankTM, Pro-Lab Diagnostics, Canada) at –70°C. Routine culturing of strains for growth in YEPD medium as well as for morphogenesis development in human serum was conducted as described previously (Staniszewska et al., 2012). The usefulness of fresh human serum in order to mimic blood serum infections and to investigate the gene expression pattern of C. albicans during such infections incubated under semi-aerobic conditions at 37°C was described by Fradin et al. (2003; 2005). Quantitative RT-PCR. Total RNA was isolated from cells according to the protocol by Amberg et al. (2005). RNA concentrations were determined by measuring absorbance at 260 nm (Nano Drop 2000, Thermo SCIENTIFIC, USA). First-strand cDNAs were synthesized from total RNA, using two-step qRT-PCR analysis (Sigma, USA) and following the recommendations of the manufacturer. Real-time RT-PCR was used to determine the quantitative levels of SAP7-10 mRNA transcripts in RNA samples using Rotor Gene 6000 (RCorbett, Qiagen, Germany). Quantitative reverse transcription-PCR assay was performed following the protocol described previously by Naglik et al. (2008) using QuantiTect Probe PCR Kit (Qiagen, Germany) according to the manufacturer’s instructions. TaqMan primer and probe (5’ FAM, 3’ TAMRA) sets were used as described previously Naglik et al. (2008). The 2–∆∆CT method was used to analyze the relative changes in gene expression from quantitative RT-PCR experiment (Livak and Schmittgen, 2001). The CT values were provided from RT-PCR instrumentation and were imported into a spreadsheet Microsoft Excel 2010. The data were analyzed using Eq. (Livak and Schmittgen, 2001), where ∆CT = Avg. sap CT – Avg. β-actin CT and ∆∆CT = ∆CT – ∆CT parental strain. Scanning electron microscopy study. To examine cell morphology, samples were prepared as described previously by Oliviera et al. (2010). Briefly, morphotypes of each strain were fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.2) for 18 h at a low temperature (5–6°C). Then, the samples were carefully washed with 0.1 M phosphate buffer (pH 7.2). Postfixation was carried out for 2 h at room temperature with 2% osmium tetroxide. Initial dehydration was accomplished by placing specimens in the following series of ethanol gradients: 50% and 70% (two times for 10 min), 95% (two times for 5 min) and 100% (two times for 1 min), respectively. Then, samples were dehydrated with acetone (two times for 30 sec.) until dried by the critical point method in liquid CO2. Subsequently, the specimens of the wild type strain were coated with gold in a vacuum evaporator and examined with a scanning electron microscope (SEM Quanta-200, FEI, Czech Republic). In the case of the mutant strains, after post-fixation morphotypes were dehydrated two times for 10 min with graded ethanol (50% and 75%) followed by dehydration with acetone (two times for 30 sec). The dried specimens were coated with osmium tetroxide and observation was done under scanning electron microscope Hitachi S-5500 (Japan). Images were assembled with Photoshop (Adobe Photoshop CS3 Extended). Cell dimensions were determined by using bars. Table I Strains used in the study Strain Parent Genotype Reference SC5314 Wild strain Gillum et al. (1984) 83 Clinical isolate Staniszewska (2009) CAI4[pCIp10]SC5314 Δura3::imm434/Δura3::imm434 + pCIp10 (Integration) Fonzi and Irwin (1993) CAF2-1SC5314 Δura3::imm434/URA3 Fonzi and Irwin (1993) Δsap9 CAI4[pCIp10] Δsap9::hisG/Δsap9::hisG + pCIp10 (Integration) Schild et al. (2011) Δsap9/10 CAI4[pCIp10] Δsap10::hisG/Δsap10::hisG Δsap9::hisG/Δsap9::hisG + pCIp10 (Integration) Schild et al. (2011) Δsap10 CAI4[pCIp10] Δsap10::hisG/Δsap10::hisG + pCIp10 (Integration) Schild et al. (2011) 1 17 Expression of C. albicans aspartyl proteinase in human serum Fig. 1. Expression of the SAP genes. The expression of SAP7, SAP8, SAP9 and SAP10 was quantified by qRT-PCR from cells in stationary growth phase in human serum at 37°C. ACT1 transcript was used as internal control and the multifold increase over the value of the wild type at 37°C is shown for each strain Results Quality control and quantitative expression of SAP7-SAP10 genes in human blood serum. SAP7, SAP8, SAP9-10 and ACT1 TaqMan primer/probe sets were calibrated and they demonstrated similar efficiency in titration experiments using C. albicans SC5314 genomic DNA (9.7–52.3 ng) in serial log10 dilutions (data not shown). The expression levels of SAP7-SAP10 genes were monitored after a 18 h period after inoculation of human serum with the C. albicans strains (Fig. 1). All SAP genes tested were detected in human serum, albeit at very low levels, except SAP7, which was expressed at relatively high levels compared to the remaining genes tested (Table II). Contrariwise, the wild type strain 83 and CAF2-1 showed slightly enhanced SAP10 expression (at least 1.2- and 2.3-fold) compared to SAP7 respectively. We therefore examined the expression of SAP7-10 genes under serum influence by comparing the expression profile among particular mutants. Considering SAP7, in the double mutant ∆sap9/Δsap10 the expression level of SAP7 was significantly higher (20-fold compared to ∆sap9 or 8.4-fold compared to ∆sap10) and so was that of SAP8 (5.0- or 3.3-fold for ∆sap9 and ∆sap10 respectively). As a result of the com- parison of the expression pattern of wild type strains it was shown that in the reference strain SC5314 SAP7 was expressed 1.5-fold compared to CAI4. Contrariwise, the wild type CAI4 displayed around 1.6-fold higher expression of SAP9 than strain 83. We demonstrated that CAF2-1 has a 2.3-fold change of SAP10 gene expression compared with either CAI4 or strain 83. Contrariwise, the wild type SC5314 showed 5-fold lower expression (compared to strain 83 and CAI4) and 11.5-fold lower expression than CAF2-1. Comparison of the expression patterns of the protease mutants and the wild types demonstrated high diversity. The expression levels of SAP7, SAP8 and SAP10 in the wild type CAF2-1 were around 3.3- and 5.0- and 46-fold higher than in mutant the ∆sap9 respectively. Moreover, in the mutant ∆sap9 SAP10 was underexpressed 20-fold vs the parental strain CAI4. In view of SAP10, the mutant ∆sap9 displayed expression from 4.0- to 21-fold lower than the wild types. Similarly, deletion of SAP9 or SAP10 appeared to have a minor influence on expression of either SAP8 or SAP9 (comparable to the wild types). Thus, ∆sap10 as well as SC5314 displayed comparable expression of SAP9 (2∆∆CT = 0.3 or 0.2 respectively). When comparing the three genes (SAP7 vs SAP8 vs SAP9) in the mutant ∆sap10 at 18 h-growth in human Table II Fold mRNA expression of SAP7 to SAP10 relative to ACT1 and normalized over the value of the wild type strains’ expression Gene a Fold mRNA expressiona in C. albicans strains CAI4 SC5314 ∆sap9 ∆sap10 ∆sap9/∆sap10 83 CAF2-1 SAP7 1.42.1 0.3 0.7 5.9 0.8 1.0 b SAP8 0.20.3 0.2 0.3 1.0 0.4 1.0 b SAP9 1.0b 0.2ND 0.2ND 0.6ND SAP10 1.0b 0.20.05 NDND 1.0 2.3 – Values are average of triplicate readings; b – Parental strain; ND – not determined 18 Staniszewska M. et al. serum, one can see a clear trend in underexpression of these genes compared to the wild types, with the exception of SAP8 upregulation (1.5-fold) compared to CAI4. Furthermore, SAP7 and SAP8 were expressed 1.4-fold and 3.3-fold higher in the wild type CAF2-1 compared to ∆sap10 respectively. Likewise, in the parental strain CAI4 SAP9 displayed 5.0-fold overexpression vs ∆sap10. The double mutant ∆sap9/Δsap10 showed an increased expression of SAP7 (2.8-fold compared to the wild type SC5314). Furthermore, Fig. 1. and Table II showed that SAP7 was clearly the most highly expressed gene at around 5.9-fold (with reference to CAF2-1) in the ∆sap9/Δsap10 mutant. Consequently, SAP8 displayed a significant overexpression in the ∆sap9/Δsap10 mutant compared to the wild types SC5314 and CAI4 (in the range 3.3 and 5.0-fold, respectively). While in the double mutant ∆sap9/Δsap10 the expression level of SAP8 was comparable to CAF2-1. Hypha-forming capability in Candida albicans strains. In order to characterize the phenotype of ∆sap, we examined the ability to undergo the dimorphic transition. For this purpose, cells were grown in liquid undiluted human serum and incubated at 37°C, cell morphology was then observed microscopically after 18-h incubation. To test this possibility, we examined which genes could prevent from the morphogenesis defect of Δsap9/rsap10 in human serum. As shown in Fig. 2. the mutants Δsap9 and Δsap9/Δsap10 exhibited decreased ability to filament compared to the wild type cells. Although, the latter mutants are able to form filaments, they fail to filament abundantly in these preferable conditions probably because the absence of SAP9 represses the dimorphic transition in C. albicans. Contrariwise, the ∆sap10 mutant formed true hyphae when grown under these conditions as revealed by microscopic examination. The deletion of genes SAP8 (data not shown) and SAP10 had no effect on morphogenesis process. Discussion Our results demonstrated that from the tested SAP7 to SAP10, only SAP7 mRNA level is significantly altered at the later stage of bloodstream infections in different genetic backgrounds (the wild types and the ∆sap mutants). Comparing the expression of SAP9 and SAP10, our assay suggested that the single mutants lacking either of these proteins do not show a significant expression increase of the other. We found that the expression levels of SAP7-10 were downregulated in all the single mutants compared with the wild types. One possible explanation for this observation may be that the single mutants have a reduced ability to survive in blood serum. Contrariwise, the double mutant Δsap9/ Δsap10 displayed overexpression of SAP7 and SAP8 1 compared to the wild types. These results support the notion that compensatory upregulation of SAP7 and SAP8 in the Δsap9/Δsap10 mutant occurred. However, the mechanism underlying how and when SAP9 and SAP10 regulate other genes as well as each other remains to be elucidated. Interestingly, lack of Sap10 had only a minor influence on SAP9 expression (4-fold higher) compared to the expression level of SAP10 in Δsap9. Recently, Schild et al. (2011) showed that although Sap9 and Sap10 exhibit near neutral pH optimum of proteolytic activity they only partially substitute each other in these conditions. In our study a lower expression of SAP10 may be related to a more limited number of potential substrates (Schild et al., 2011). In the study, the mutants lacking these proteins showed dissimilar phenotypes of Δsap9 or Δsap10, such as altered morphogenesis under human serum influence. Moreover, our data supported the results by Naglik et al. (2004) that Sap9 is probably a key proteinase that does not only promote cell wall integrity, general cell growth and fitness at mucosal surface, but as our data implied is dependent on the morphology under human serum influence. Thus, our study supports the findings of Schild et al., (2011) and in view of our data it is highly probable that Sap9 is involved in polarized growth and morphogenesis in C. albicans under human serum influence at pH 7.1–7.4. Previously, quantification of cellular forms of the wild type strain (Staniszewska et al., 2011 and 2012) showed that incubation in human serum at 37°C for 18 h resulted in transformation of almost 100% of all the observed cells to pure true hyphal forms. However, our present data demonstrated that deletion of SAP9 substantially reduces true hyphae formation compared with the wild type strains i.e., strain 83, SC5314 as well as Δsap10 under these conditions (Fig. 2). Thus, SAP9 expression may be linked to hyphal morphology even if the pleomorphism is regulated by other factors. Moreover, it was shown that incubation in undiluted serum at human body temperature did not prevent the defective hyphal growth of the mutants Δsap9 and Δsap9/Δsap10 (Fig. 2), indicating that Sap9 may be involved in the loss of cell polarity in these mutants under hyphae-forming conditions. Moreover, we showed that SAP7 and SAP8 expression could not prevent the morphogenesis defect of either Δsap9 or Δsap9/Δsap10 in undiluted human serum and expression of these genes does not induce hyphae formation. Finally, our data imply that Sap7, Sap8 and Sap10 play a minor role in morphogenesis and these genes do not compensate the SAP9 disruption in hyphae formation. Studies investigating the production of SAP mRNA (Hube et al., 1994; Taylor et al., 2005) and the virulence of SAP knockout strains (Lermann and Morschhäuser, 2008) showed that induction of SAP expression is a niche-specific phenomenon. Therefore it was necessary in our study to discover which of the tested protein- 1 Expression of C. albicans aspartyl proteinase in human serum 19 Fig. 2. Characteristics of Candida albicans strains’ phenotypes grown in undiluted human serum at 37°C for 18 h under static conditions in plastic Eppendorf vials. (A) Micrograph showing true hyphal phenotype of the C. albicans clinical strain 83. Note the dominant filament morphotypes (arrows). (B) Clumps of morphological forms of strain SC5314 can be seen. Note the germinating blastoconidial cell, indicated by an arrow and true hyphal morphologies (open arrows). (C, D) The ∆sap9 mutant exhibits budding phenotype and failure of hyphal development. Fine details of blastoconidia are discernible. (C) Oval blastoconidial mother cell (arrow) with a bud (open arrow) can be seen. Scars (arrowheads) localized polarly are observed. (D) Blastoconidial cells morphology and cellular budding (arrow) typical of strain the ∆sap9 are visible. Mutant causes filamentous growth only in a small percentage of yeast cells. Note singular hyphal morphology (open arrow). (E) The ∆sap10 mutant. Clumps of germinating blastoconidia can be seen (arrow). Hyphal induction has occurred, note long true hyphal cells indicated by arrow heads. (F) The ∆sap9/∆sap10 mutant phenotype. Yeast cells defective in cellular filamentation process are observed. Fine details of blastoconidia are discernible. Oval blastoconidial cell (arrow) and a new bud (open arrow) can be seen. Scars (s) localized polarly are observed. ases are expressed at higher level during artificial blood infection. We observed that human serum favours SAP7 expression. One reason for this unexpected result may be found in the fact that SAP7 plays a role in blood dissemination followed by interaction with human endothelial cells. These results demonstrated that SAP7 is required for the growth of C. albicans clinical isolates in human serum as the sole nitrogen source and Sap7 is normally expressed in the wild type strains and overexpressed when the remaining genes are expressed at a very low level. It was likely in our study that when C. albicans cells have to adapt and survive within the blood environment they upregulate SAP7 expression, while other genes important for growth and viability in serum are downregulated (Fradin et al., 2003; Hube et al., 1994). We therefore concluded that there is little 20 Staniszewska M. et al. correlation between the expression of the remaining SAP genes tested and the role of Sap proteins during blood infection. Furthermore, our findings were in agreement with the view that protein production is reduced in the later stage of blood infections (Fradin et al., 2003). Thus, in our opinion future experiments using patients’ blood samples should bring us closer to identifying the SAP genes and proteins that are directly involved in candidaemia in humans. Furthermore, a gradual observation of SAP7 expression during blood infection ought to be conducted which may show whether SAP7 is induced as a consequence of infection. Taylor et al., (2005) utilizing the Δsap7 mutant showed a role of proteinase Sap7 in the intravenous model of systemic candidiasis in mice which was in agreement with our in vitro blood infection model in humans. Furthermore, our study was a successful attempt in finding conditions which induce SAP7 in vitro while it was discussed (Taylor et al., 2005) that an in vitro induction of SAP7 mRNA level has not yet been detected. In conclusion, these data provided the first in vitro evidence of SAP7-10 expression in C. albicans strains under human serum influence. In this paper, due to the strong induction of SAP7, we hypothesize that it is essential for C. albicans survival and help the cells to escape from bloodstream. Thus, SAP7 may help the fungus to cause systemic infections. We also report SAP9 expression in serum, which was associated with hyphal invasive growth at the site of infection. Acknowledgement We are extremely grateful to many colleagues and all the individuals who were generous with their advice, and provided us with strains and reagents; Professor Danuta Dzierżanowska-Madalińska with the strain 83; Professor Bernhard Hube with the following strains: ∆sap9 ∆sap10 and ∆sap9-10; Gabriela Smoleńska-Sym, Ph.D with human serum. This work was supported by the NN 404 113639 grant from the Ministry of Science and Higher Education in Poland. The authors also acknowledge the financing from the National Science Centre provided in compliance with Grant No. DEC-2011/03/D/NZ7/06198. Literature Amberg, D.C., D.J. Burke and J.N. Strathern. 2005. Yeast DNA isolation, techniques and protocols 3, p. 17. In: D.C. Amberg, D.J. Burke and J.N. Strathern (eds). Methods in yeast genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. Dalle F., B. Wächtler, C. L’Ollivier, G. Holland, N. Bannert, D. Wilson, C. Labruère, A. Bonnin and B. Hube. 2010. Cellular interactions of Candida albicans with human epithelial cells and enterocytes. Cell. Microbiol. 12: 248–271. Fonzi W.A. and M.Y. Irwin. 1993. Isogenic Strain Construction and Gene Mapping in Candida albicans. Genetics 134: 717–728. Fradin C., M. Kretschmar, T. Nitchterlein, C. Gaillardin, C. d’Enfert and B. Hube. 2003. Stage-specific gene expression of Candida albicans in human blood. Molecular Microbiology 47: 1523–1543. 1 Fradin C., P. De Groot, D. MacCallum, M. Schaller, F. Klis, F.C. Odds and B. Hube. 2005. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Molecular Microbiology 56: 397–415. Gillum A.M., E.Y.H. Tsay and D.R. Kirsch. 1984. Isolation of the Candida albicans gene for orotidine-5’-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198: 179–182. Hornbach A., A. Heyken, L. Schild, B. Hube, J. Löffler and O. Kurzai. 2009. The glycosylphosphatidylinositol-anchored protease Sap9 modulates the interaction of Candida albicans with human neutrophils. Infect Immun 77: 1–9. Hube B., M. Monod, D.A. Schofield, A.J. Brown and N.A.R. Gow. 1994. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14: 87–90. Lermann U. and J. Morschhäuser. 2008. Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiol. 154: 3281–3295. Livak K.J. and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–428. Naglik J.R., G. Newport, T.C. White, L.L. Fernandes-Naglik, J.S. Greenspan, D. Greenspan, S.D. Sweet, S.J. Challacombe and N. Agabian. 1999. In vivo analysis of secreted aspartyl proteinases expression in human oral candidiasis. Infect. Immun. 67: 2482–2490. Naglik J.R., C.A. Rodgers, P.J. Shirlaw, J.L. Dobbie, L.L. FernandesNaglik, D. Greenspan, N. Agabian and S.J. Challacombe. 2003. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J. Infect. Dis. 188: 469–479. Naglik J.R., D. Moyes, J. Makwana, P. Kanzaria, E. Tsichlaki, G. Weindl, A.R. Tappuni, C.A. Rodgers, A.J Woodman, S.J. Challacombe and others. 2008. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiol. 154: 3266–3280. Oliviera M.T., A.F.L. Specian, C.G.T.J. Andrade, E.J.G. França, L. Furlaneto-Maia and M.C. Furlaneto. 2010. Interaction of Can dida parapsilosis isolates with human hair and nail surfaces revealed by scanning electron microscopy analysis. Micron 41:604–608 Rehaume L.M., T. Jouault and M. Chamaillard. 2010. Lessons from the inflammasome: a molecular sentry linking Candida and Crohn’s disease. Trends. Immunol. 31: 171–175. Schelenz S. 2008. Management of candidiasis in the intensive care unit. J. Antimicrob. Chemother. 61: i31–i34. Schild L., A. Heyken, P.W.J. Groot, E. Hiller, M. Mock, C. de Koster, U. Horn, S. Rupp and B. Hube. 2011. Proteolytic cleavage of covalently linked cell wall proteins by Candida albicans Sap9 and Sap10. Eukaryot Cell 10: 98–109. Staniszewska M. 2009. Ph.D. Thesis, Search for Candida albicans virulence factors. NIPH-NIH. Warsaw. Poland. Staniszewska M., M. Bondaryk, K. Siennicka, A. Kurek, J. Orłow ski, M. Schaller and W. Kurzątkowski. 2012. In vitro study of secreted aspartyl proteinases Sap1 to Sap3 and Sap4 to Sap6 expression in Candida albicans pleomorphic forms. Polish. J. Microbiol. 61: 247–256. Staniszewska M., D. Rabczenko and W. Kurzątkowski. 2011b. Discrimination between the enzymatic activities of Candida albicans pleomorphic forms determined using the api® ZYM test. Mycoses 54: e744–e750. doi: 10.1111/j.1439-0507.2010.02011.x Taylor B.N., H. Hannemann, M. Sehnal, A. Biesemeier, A. Schwei zer, M. Röllinghoff and K. Schröppel. 2005. Induction of SAP7 correlates with virulence in an intravenous infection model of candidiasis but not in a vaginal infection model in mice. Infect. Immun. 73: 7061–7063. Polish Journal of Microbiology 2014, Vol. 63, No 1, 21–25 ORIGINAL PAPER The Effect of Oleanolic and Ursolic Acids on the Hemolytic Properties and Biofilm Formation of Listeria monocytogenes ANNA KUREK1, KATARZYNA MARKOWSKA1, ANNA M. GRUDNIAK1, WIRGINIA JANISZOWSKA2 and KRYSTYNA I. WOLSKA1* Department of Bacterial Genetics, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland Department of Plant Biochemistry, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Warsaw, Poland 1 2 Submitted 5 September 2013, revised 5 November 2013, accepted 16 November 2013 Abstract Oleanolic acid and ursolic acid are pentacyclic triterpenoids isolated from a variety of medicinal plants, which have antibacterial activity. Listeria monocytogenes is a Gram-positive facultative pathogen, being the causative agent of listeriosis. The present study was carried out to evaluate the in vitro effect of sub-inhibitory concentrations of both triterpene acids on the pathogenicity determinants of L. monocytogenes: their hemolytic activity and biofilm forming ability. Oleanolic and ursolic acids inhibited listeriolysin O activity without influencing toxin secretion. Biofilm formation, and the viability of L. monocytogenes cells in biofilms was diminished by both compounds. Thus, both acids affected L. monocytogenes virulence. It was also demonstrated that oleanolic acid bound to the peptidoglycan of L. monocytogenes and this interaction was influenced by teichoic acids. K e y w o r d s: Listeria monocytogenes, biofilm, listeriolysin O, oleanolic acid, ursolic acid Introduction Compounds of therapeutic value extracted from medicinal plants are mostly secondary metabolites (Cowan, 1999). Oleanolic acid (OA) and ursolic acid (UA) are representatives of the pentacyclic triterpenoids whose structures are based on the isoprene moiety. Both compounds exhibit several pharmacological activities. The hepatoprotective, anti-inflammatory, antioxidant and anticancer activities of OA and UA are well documented (Ikeda et al., 2008; Pollier and Goossens, 2012). OA, UA and their derivatives also possess antibacterial activity, primarily against Gram-positive bacteria, including multidrug-resistant strains (Fontanay et al., 2008; Wolska et al., 2010). However, the broad application of OA/UA is currently restricted because their mechanism of action is still poorly understood and the side-effects on eukaryotic cells have not been fully characterized. A relatively small number of studies have investigated the cellular targets and functions affected by OA/ UA. Ren and coworkers (2005) showed that UA caused differential gene expression in Escherichia coli and substantially inhibited biofilm formation by E. coli, Pseudo monas aeruginosa and Vibrio harveyi. Subsequently, Chen and coworkers (2009) demonstrated the ability of the oleane-type triterpenoid, glycyrrhizin, to inhibit the diarrhea-inducing activity of the heat-labile enterotoxin produced by ETEC (enterotoxicogenic E. coli). The interaction between OA/UA and several other antibacterial agents – mainly conventional antibiotics – has been also reported (Ge et al., 2010). Of particular interest is their synergistic action with β-lactam antibiotics against Staphylococcus aureus and Staphylococcus epi dermidis (Kurek et al., 2012) and the ability to induce stress response (Grudniak et al., 2011). The Gram-positive pathogen Listeria monocytogenes is the causative agent of listeriosis, a disease that has increased markedly in Europe in recent years (Allerberger and Wagner, 2010). Listeriolysin O (LLO) is considered as a major virulence determinant of Listeria (Kayal and Charbit, 2006; Schnupf and Portnoy, 2007). Recent studies showed new roles for intracellular LLO, such as control of autophagy upon vacuolar escape, and revealed the extracellular activities of LLO, for example induction of bacterial entry into the cells and modulation of immune activity (Hamon et al., 2012). L. monocyto genes forms biofilms with a structure that varies greatly from one strain to another. Bacteria living in biofilms are less susceptible than planktonic cells to antimicrobial * Corresponding author: K.I. Wolska, Department of Bacterial Genetics, Institute of Microbiology, Faculty of Biology, University of Warsaw, Miecznikowa St. 1, 02-096 Warsaw, Poland; phone: + 48 22 55 41 302, fax: + 48 22 55 41 402; e-mail: [email protected] 22 Kurek A. et al. agents, especially antibiotics (Renier et al., 2011). The factors responsible for this enhanced resistance include restricted penetration of antimicrobials into the biofilm structure, decreased growth rate and the expression of possible resistance genes (Lewis, 2001). For this reason, the ability to grow in a biofilm is known to enhance the pathogenicity of certain bacterial species. It was previously proved that the cell wall constitutes a cellular target of OA/UA activity against the facultative pathogen Listeria monocytogenes. Both these pentacyclic triterpenoids affected morphology and enhanced autolysis of bacterial cells, influenced autolysis of the isolated cell wall, inhibited peptidoglycan turnover and quantitatively changed the profile of muropeptides obtained after the digestion of peptidoglycan with mutanolysin (Kurek et al., 2010). So far there is no available information on the ability of peptidoglycan to bind either OA or UA. The aim of the present study was to gain some insight into the effect of OA/UA on L. monocytogenes virulence factors. The influence of these compounds on the secretion and activity of listeriolysin O, biofilm formation and L. monocytogenes viability in biofilms was examined. As peptidoglycan is involved in L. monocy togenes biofilm formation, the ability of UA/OA to bind this compound was also studied. Experimental Materials and Methods Bacterial strain, medium and reagents. Listeria monocytogenes (PCM 1291) was obtained from the Polish Culture Collection, Wrocław, Poland. The bacteria were grown in tryptic soy broth with yeast extract – TSYEB at 37°C. OA, UA and all other reagents were purchased from Sigma. OA containing a tritium-labeled hydroxyl group (3H-OA, 1 mg mL–1, activity 5.1 GBq mmol–1) was provided by the Department of Plant Biochemistry, Faculty of Biology, University of Warsaw. Measurement of the hemolytic activity of L. monocytogenes. An overnight culture of L. monocytogenes was grown in TSYEB medium with constant shaking. After dilution to attain an A600 of 0.1, the cultures were incubated further to an A600 of 0.5 in medium supplemented with sub-inhibitory concentrations of OA or UA as required. Samples of 1 mL were centrifuged and 20 µL aliquots of the supernatants were incubated with a 1% suspension of sheep red blood cells in phosphatebuffered saline (PBS), pH 6.5, in a total volume of 1 mL at 37°C for 30 min. In the control set of experiments sheep red blood cells were incubated only with OA/UA in the conditions described above. After centrifugation, the supernatants were collected and their absorbance 1 at 410 nm was measured. The extent of hemolysis was calculated as the percentage of the complete hemolysis achieved by lysing erythrocytes with 1% SDS. Determination of the LLO concentration in culture supernatants. An overnight L. monocytogenes culture was diluted to an A600 of 0.1 and then divided into separate samples. One sample served as a control, while sub-inhibitory concentrations of OA or UA were added to others and incubation was continued to an A600 of 0.5. Cells were harvested by centrifugation, and proteins from the supernatants were precipitated and concentrated using 10% tichloroacetic acid (TCA). The protein concentration in each sample was estimated using the bicinchoninic acid assay (Brown et al., 1989). Samples containing 5 µg of precipitated protein were subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) and the resolved protein bands were transferred to polyvinylidene difluoride (PVDF) membranes. The membranes were incubated with rabbit anti-LLO polyclonal antibody (Abcam, UK, 1:1500 dilution) for 1 h, washed, then incubated with goat anti-rabbit IgG – alkaline phosphatase conjugate, washed again and finally developed using 5-bromo-4-chloro-3-indolyl phosphate and nitro-blue tetrazolium (BCIP/NBT) in carbonate buffer as the chromogenic substrate. Images of the membranes were captured and analyzed using Image Master VDS (Fujifilm) and Image Master 1D Elite version 301 programs (NonLinear Dynamics, UK). Quantitative determination of biofilm formation and measurement of cell viability in biofilms. Bacterial biofilms were developed in wells of polystyrene microtiter plates containing 200 µL samples of culture diluted in TSYEB medium supplemented with 0.45% glucose and various amounts of the tested compounds. The lowest concentration of a compound that inhibited biofilm growth, as determined by crystal violet staining, was taken as the minimal biofilm inhibitory concentration (MBIC) (Smith et al., 2008). To determine the amount of biofilm in the wells of polystyrene microtiter plates, those formed after 24 h in the presence of OA, UA or with control samples were stained with crystal violet and, after brief washing with 0.85% NaCl, ethanol was added to each well to solubilize the crystal violet and the dye concentration in this wash was estimated by measuring the A570 with a microtiter plate reader (Sunrise, Tecan, Switzerland). To measure cell viability in biofilms, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) staining method was employed (Kairo et al., 1999) with minor modifications (Walencka et al., 2005). The intensity of the violet color of the resulting formazan was determined by measuring the A550 with a microtiter plate reader. Measurement of the ability of OA to bind peptido glycan. Peptidoglycan was isolated from L. monocyto 1 Effect of OA and UA on the pathogenicity determinants of L. monocytogenes genes cells following the procedure described by Korsak and coworkers (2005). The final peptidoglycan preparations were divided into two parts: one part was lyophilized and the second was treated with 5% TCA in order to remove teichoic acids. The prepared peptidoglycan samples were suspended in distilled water (1 mg mL–1) and amounts of 100 µg were incubated with 3 H-OA (0.05, 0.25, 0.5 or 1 µg) for 30 min at room temperature. The binding reactions were terminated by adding a 10-fold excess of unlabeled OA followed by 5 min incubation. The samples were centrifuged (16,000 g, 10 min), then the resulting pellets were washed with distilled water and analyzed using a scintillation counter. In the negative controls, the cell wall fragments in the binding reaction were replaced by water. Statystical analysis. Data are shown as means of at least three experiments ± SD. Statistical significance of the differences between experimental groups was calculated using two-tailed unpaired Student’s test. p value < 0.05 was considered statistically significant. Results and Discussion The hemolytic activity of the supernatants of L. monocytogenes cultures treated with 0.5× or 0.75× minimal inhibitory concentration (MIC) of OA/UA and an untreated control culture was determined. MIC values of both compounds were 8 g mL–1 as determined previously (Kurek et al., 2012). Both triterpene acids inhibited LLO hemolytic activity. Compared with the control, the inhibition observed in cultures treated with 0.75 × MIC of OA or UA amounted to 2.5-fold and 2.8-fold, respectively (Fig. 1). As it was demonstrated Fig. 1. Effect of OA and UA on LLO activity in L. monocytogenes culture supernatants. The results are the means of three independent experiments and the error bars indicate standard deviations (*p < 0.05 vs control). 23 Fig. 2. Influence of OA and UA on LLO concentration in L. monocytogenes culture supernatants. A representative Western blot is shown. MW – molecular weight standard; lane 1 – control culture without added OA/UA; lanes 2–4 – cultures treated with 0.25 MIC, 0.5 MIC and 0.75 MIC of OA, respectively; lanes 5–7 – cultures treated with 0.25 MIC, 0.5 MIC and 0.75 MIC of UA, respectively. that triterpenoids are able to form complexes with sterols (Osbourn, 1996) and cholesterol are present in erythrocyte membrane, the influence of OA/UA on erythrocytes in the absence of LLO was determined in the control experiments. It was shown that OA and UA in concentration 0.015 × MIC, i.e. equivalent to 0.75 × MIC present in LLO-containing supernatants (supernatants were diluted 50 × in hemolytic activity assay, see Material and Methods) did not cause the lysis of erythrocytes. Analysis of SDS-PAGE followed by Western blotting demonstrated that the level of LLO in the culture supernatants was not diminished by treatment with either OA or UA (Fig. 2). The differences between densitometric measurement of peak areas did not exceeded 10%. The synthesis of LLO was also not influenced by either of these compounds, since the amount of this cytolysin in whole cell lysates was unchanged by OA/UA treatment (data not shown). LLO is translated as a precursor polypeptide of 529 residues and its N-terminal signal sequence is cleaved after protein secretion (Mengaud et al., 1988). The results of the present study indicate that OA and UA do not interfere with the functioning of the LLO secretion apparatus. Elucidation of the reason of the reduction of LLO hemolytic activity, for example by inhibiting initial binding to the erythrocyte membrane or subsequent step of pore formation, demands further experiments. In the control experiment the complexation capability of OA or UA with listeriolysin was checked in nondenaturing polyacrylamide gel shift assay (Mori et al., 2004) using 2.5 µg of LLO and 0.08 µg or 0.12 µg OA or UA. No protein band shift was observed. The ability of L. monocytogenes to form biofilms in the presence of OA/UA was estimated by crystal violet staining. OA and UA were added at 0.125, 0.25 or 0.5 minimal biofilm inhibitory concentration (MBIC). MBICs of both compounds were substantially higher than respective MICs (24 µg mL–1). Both compounds inhibited cell adhesion to the surface of polystyrene multiwell plates. Decreases in biofilm formation of about 15% and > 60% were observed in the presence of 0.25 × MBIC and 0.5 × MBIC of OA/UA, respectively. In the presence of 0.125 × MBIC of OA or UA, the biofilm biomass was decreased by only about 12.6% and 8.8%, 24 1 Kurek A. et al. Table I Influence of OA/UA on L. monocytogenes biofilm formation OA/UA concentration [MBIC] A570 Table II Binding of radioactive OA to L. monocytogenes peptidoglycan 3 OA UA Control 2.493 ± 0.049 2.493 ± 0.049 0.125 × MBIC 2.179 ± 0.038* 2.293 ± 0.015 0.25 × MBIC 2. 097 ± 0.042* 2.175 ± 0.021* 0.5 × MBIC 0.984 ± 0.037* 0.861 ± 0.032* The results are the means of three independent experiments ± standard deviation. MBICs of both OA and UA were 24 µg mL–1. * Difference statistically significant (*p < 0.05 vs control). respectively (Table I). The cell viability was reduced by 14% and 22% in the presence of 0.125 × MBIC of OA or UA and by 42% and 56% in the presence of 0.5 × MBIC of OA or UA, respectively (Fig. 3). Bacterial biofilms development is a multi-step process and their formation is influenced by a number of environmental factors including temperature, growth medium, pH and the nature of the surface (Moltz, 2005). Moreover, numerous molecular determinants are involved in the early stages of biofilm formation and the late stage of biofilm development among them is flagellum-mediated motility (O’Neil and Marquis, 2006). We previously observed that swarming-type, but not swimming-type nor twitching-type, motility of Pseudomonas aeruginosa was severely inhibited by OA and UA (data not shown), therefore it may be speculated that OA/UA can dimi nish L. monocytogenes biofilm formation by negatively influencing its swarming movement ability. It has been also established that peptidoglycan plays an important role in L. monocytogenes biofilm formation. Previous results from our laboratory showed that peptidoglycan metabolism was affected by OA/UA H-OA concentration [μg mL–1] Radioactivity of peptidoglycan (dpm per sample) – Teichoic acids + Teichoic acids 0.5* 322.52 ± 55.32 134.57 ± 54.85 2.5* 469.33 ± 57.20 148.11 ± 46.84 5* 573.99 ± 35.19 320.02 ± 143.40 10 875.92 ± 31.12 864.62 ± 63.14 The presented values are the means of three independent experiments after subtraction of the background value ± standard deviation. * Difference statistically significant (*p < 0.05). (Kurek et al., 2010). In the present study we found that tritium-labeled OA bound to isolated peptidoglycan and that the teichoic acids, long anionic polymers threading through peptidoglycan layers that are crucial in protecting bacteria against harmful molecules and environmental stresses (Xia et al., 2010) only partially inhibited this binding (Table II). Taken together these results suggest that changes induced by OA and UA in the peptidoglycan structure of L. monocytogenes influence biofilm formation. In conclusion, we have demonstrated that oleanolic and ursolic acids affect the virulence factors of L. mono cytogenes. Both triterpene acids inhibit listeriolysin O activity without influencing its secretion and they also diminish the ability of this species to grow in biofilms. Acknowledgements This work was financially supported by Polish Ministry of Science and Higher Education grants no. N 304 11732/4332 and NN 302 027937. Literature Fig. 3. Effect of OA and UA on the viability of L. monocytogenes cells in a biofilm. The results are the means of three independent experiments and the error bars indicate standard deviations (*p < 0.05 vs control). Allerberger F. and M. Wagner. 2010. Listeriosis: a resurgent foodborne infection. Clin. Microbiol. Infect. 16: 16–23. Brown R.E., K.L. Jarvis and K.J. Hyland. 1989. Protein measurements using bicinchoninic acid: elimination of interfering substances. Anal. Biochem. 180: 136–139. Chen J.C., T.Y. Ho, Y.S. Chang, S.L. Wu, C.C. Li and C.Y. Hsiang. 2009. Identification of Escherichia coli enterotoxin inhibitors from traditional medical herbs by in silico, in vitro and in vivo analyses. J. Ethnopharmacol. 121: 372–378. Cowan M.M. 1999. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 12: 564–582. Fontanay S., M. Grare, J. Mayer, C. Finance and R.E. Duval. 2008. Ursolic, oleanolic and betulinic acids: Antibacterial spectra and selectivity indexes. J. Ethnopharmacol. 120: 272–276. Ge F., F. Zeng, S. Liu, N. Guo, H. Ye, Y. Song, J. Fan, X. Wu, X. Deng, Q. Jin et al. 2010. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis. J. Med. Microbiol. 59: 567–572. Grudniak A.M., A. Kurek, J. Szarlak and K.I. Wolska. 2011 Oleanolic and ursolic acids affect the expression of the cysteine 1 Effect of OA and UA on the pathogenicity determinants of L. monocytogenes regulon and stress response in Escherichia coli. Curr. Microbiol. 62: 1331–1336. Hamon M.A., D. Ribet, F. Stavru and P. Cossart. 2012. Listeriolysin O: the Swiss army knife of Listeria. Trends Microbiol. 20: 360–368. Ikeda Y., A. Murakami and H. Ohigashi. 2008. Ursolic acid: an antiand proinflammatory triterpenoid. Mol. Nutr. Food Res. 52: 26–42. Kairo S.K., J. Bedwell, P.C. Tyler, A. Carter and M.J. Corbel. 1999. Development of tetrazolium salt assay for rapid determination of viability of BCG vaccines. Vaccine 17: 2423–2428. Kayal S. and A. Charbit. 2006. Lysteriolysin O: a key protein of Listeria monocytogenes with multiple functions. FEMS Microbiol. Rev. 30: 514–529. Korsak D., M. Popowska and Z. Markiewicz. 2005. Analysis of the murein of a Listeria monocytogenes EGD mutant lacking functional penicillin binding protein 5 (PBP5). Pol. J. Microbiol. 54: 339–342. Kurek A., A.M. Grudniak, M. Szwed, A. Klicka, Ł. Samluk and K.I. Wolska. 2010. Oleanolic acid and ursolic acid affect peptidoglycan metabolism in Listeria monocytogenes. Anton. Leeuven. Int. J. Gen. Mol. Microbiol. 97: 61–68. Kurek A., P. Nadkowska, S. Pliszka and K.I. Wolska. 2012. Modulation of antibiotic resistance in bacterial pathogens by oleanolic acid and ursolic acid. Phytomedicine 19: 515–519. Laemmli U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685. Lewis K. 2001. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45: 999–1007. Mengaud J., M.F. Vincente, J. Chenevert, J.M. Pereira, C. Geoffroy, B. Gicquel-Sanzey, F. Baquero, J.C. Perez-Diaz and P. Cossart. 1988. Expression in Escherichia coli and sequence analysis of the lysteriolysin O determinant of Listeria monocytogenes. Infect. Immun. 56: 766–772. Moltz A.G. 2005. Formation of biofilms by Listeria monocytogenes under various growth conditions. J. Food Prot. 68: 92–97. 25 Mori M., M. Yoneyama, T. Ito, K. Takahashi, F. Inagaki and T. Fujita. 2004. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Biol. Chem. 279: 9698–9702. O’Neil H.S. and H. Marquis. 2006. Listeria monocytogenes flagella are used for motility, not as adhesins, to increase host cell invasion. Infect. Immun. 74: 6675–6681. Osbourn A.E. 1996. Preformed antimicrobial compounds and plant defense against fungal attack. Plant Cell 8: 1821–1831. Pollier J. and A. Goossens. 2012. Oleanolic acid. Phytochemistry 77: 10–15. Ren D., R. Zuo, A.F.G. Barrios, L.A. Bedzyk, G.R. Eldridge, M.E. Pasmore and T.K. Wood. 2005. Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract ursolic acid. Appl. Environ. Microbiol. 71: 4022–4034. Renier S., M. Hébraud and M. Desvaux. 2011. Molecular biology of surface colonization by Listeria monocytogenes: an additional facet of an opportunistic Gram-positive foodborne pathogen. Environ. Microbiol. 13: 835–850. Schnupf P. and D.A. Portnoy. 2007. Listeriolysin O: a phagosomespecific lysin. Microb. Infect. 9: 1176–1187. Smith K. A. Perez, G. Ramage, D. Lappin, C.G. Gemmell and S. Lang. 2008. Biofilm formation by Scottish clinical isolates of Staphylococcus aureus. J. Med. Microbiol. 57: 1018–1023. Walencka E., B. Sadowska, S. Różalska, W. Hryniewicz and B. Różalska. 2005. Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication. Pol. J. Microbiol. 54: 191–200. Wolska K.I., A.M. Grudniak, B. Fiecek, A. Kraczkiewicz-Dowjat and A. Kurek. 2010. Antibacterial activity of oleanolic and ursolic acids and their derivatives. Centr. Eur. J. Biol. 5: 543–553. Xia G., T. Kohler and A. Peschel. 2010. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int. J. Med. Microbiol. 300: 148–154. Polish Journal of Microbiology 2014, Vol. 63, No 1, 27–31 ORIGINAL PAPER Iron Shortage and Bile Salts Play a Major Role in the Expression of ompK Gene in Vibrio anguillarum MOHAMMED A. HAMOD1, 2*, PATIT P. BHOWMICK1, YASSAMIN N. SHUKUR2, IDDYA KARUNASAGAR1 and INDRANI KARUNASAGAR1 Department of Fishery Microbiology, Karnataka Veterinary, Animal and Fisheries Sciences University, College of Fisheries, Mangalore – 575 002, India. 2 Department of Biotechnology, College of Sciences, University of Baghdad, Baghdad – 10070, Iraq 1 Submitted 6 October 2013, revised 30 December 2013, accepted 1 February 2014 Abstract The outer membrane protein K, OmpK first identified in Vibrio parahaemolyticus has been shown to be a receptor for a broad host range vibriophage KVP40 infecting members of the Vibrionaceae. In the study, the effect of culture conditions on the expression of ompK in V. anguillarum was studied using real-time PCR. The expression increased significantly in the presence of bile salts and iron chelating agent 2, 2’ bipyridine, suggesting a role for this protein in bile resistance and also in iron acquisition by V. anguillarum. OmpK induction by iron limitation and the presence of bile salts was reconfirmed by western blot technique after growing the cells in trypticase soy broth supplemented with bile salts, blood and 2, 2’ bipyridine. We surmise that the expression of OmpK protein of V. anguillarum is bile salt and iron chelating agent-dependent. K e y w o r d s: Vibrio anguillarum, OmpK expresion, Real-time PCR, Western blot, bile salt, iron deprivation Introduction Vibrio anguillarum, a marine bacterium belonging to the family Vibrionaceae is a major bacterial pathogen of marine and estuarine fish throughout the world (Myhr et al., 1991). V. anguillarum infection results in fatal haemorrhagic septicaemia in marine fish when the immune system of fish is compromised or when the mucosal surfaces are damaged (Croxatto et al., 2007). The outer membrane of Gram-negative bacteria consists of phospholipids and proteins. The proteins make up to 50% of the outer membrane mass. In recent years, these outer membrane proteins have attracted attention, since they have an important role in the hostbacteria interaction in adherence, uptake of nutrients including iron from the host, and subverting host defense mechanisms (Li et al., 2008). To date, studies on V. anguillarum outer membrane proteins have focused on OmpU, the major outer membrane protein present in large quantities and OM2, the induced outer membrane protein, which is known to be linked with virulence of the organism (Pedersen et al., 1997; Simón et al., 1996; Wang et al., 2003). However, more interest has been given to the role of membrane proteins involved in iron uptake such as FetA and FvtA. Recently it was demonstrated that the expression of these proteins decreases spectacularly with iron readiness (Naka and Crosa, 2012). Some Omps play a role in efflux of salinity, therefore their expression increases with the rise of salt concentration (Davey et al., 1998, Kao et al., 2009). Although the presence of OmpK has been demonstrated in V. cholerae, V. parahaemolyticus, V. harveyi and V. alginolyticus (Inoue et al., 1995a), only the protective efficacy of V. alginolyticus OmpK against fish vibriosis caused by V. alginolyticus has been reported (Qian et al., 2008). Therefore in this study, we attempted to look for OmpK at DNA and protein level; in addition, we also studied the expression of ompK gene by real-time PCR and the effect of different culture conditions on the expression to get an insight on the role of this outer membrane protein in V. anguillarum. Experimental Materials and Methods Bacterial strain and growth condition. V. anguil larum NB10 kindly provided by Dr. Sahul Hameed (Abdul Hakeem College, India) was maintained at * Corresponding author: M.A. Hamod, Department of Biotechnology, College of Sciences, University of Baghdad, Baghdad – 10070, Iraq; phone: +964 7715130069; fax: +91 824 2246384, e-mail: [email protected] 28 Hamod M.A. et al. –80°C in nutrient broth containing 30% glycerol (Sanyo Corporation, Japan). The culture was set up by inoculating 5 ml of sterile trypticase soya broth (TSB) supplemented with 1% NaCl and incubated overnight at 28°C. Nucleic acid extractions. DNA extraction was carried out from 1 ml of V. anguillarum culture using the method described by Ausubel et al., 1995. The DNA pellet was resuspended in Tris-EDTA buffer (10 mM Tris-Cl, 1 mM EDTA, pH 8). RNA extraction and purification was done by RNeasy Protect Bacteria Mini Kit (Qiagen, USA) according to the protocol described by the manufacturer. Extracts were subsequently treated with DNase I (Fermentas International Inc., Canada), according to manufacturer’s guidelines to remove any remaining DNA. Primer design. To study the ompK gene of V. anguillarum, the primers F-k502: GGCTTCCAAATTTCAACCAA and R-k699: TTTAAGGCCGTAGCCAACAG were designed using the Primer3 software ((http:// biotools.umassmed.edu/bioapps/primer3 www.cgi), based on the ompK gene (GenBank accession no. FJ705222.1). The primers F-rpoA: CGTAGCTGAAGGCAAAGATGA and R-rpoA: AGCTGGAACATAACCACGA previously reported by Defoirdt et al., 2007 were used to amplify rpoA, which served as an internal standard gene. Effect of growth conditions. The experiment was carried out in 100 ml TSB inoculated with 1 ml overnight culture followed by incubation at 28°C. To study the effect of NaCl on V. anguillarum growth, bacteria were grown in TSB supplemented with the following NaCl concentrations; 1% (control), 2%, 3% and 4%. To study the effect of bile salts, the culture was grown in media containing 0.1%, 0.2%, and 0.4% bile salts, and also grown in media free of bile salt (control). The effect of blood was determined by using 1%, and 2% of fresh blood; culture grown in media without blood were taken as control. The effect of the iron chelating agent 2, 2’-bipyridine was studied by growing the bacteria with or without 20 mM 2, 2’-bipyridine. The effect of a combination of 1% blood and 100 mM of 2, 2’-bipyridine was also studied. cDNA synthesis. Reverse transcription was carried out according to the protocol of Fermentas Life Sciences (Fermentas International Inc., Canada). Briefly, the RNA was reverse transcribed to cDNA from 2 μg of RNA using 2 μl of reverse primer (100 ng/μl) and 0.5 μl of RevertAid H minus (Fermentas International Inc., Canada) at 42°C for 1 h. OmpK cDNA was tested by PCR using primers F-k502, and R-k699 and cDNA of the internal standard gene (rpoA subunit) was tested by PCR using primers F-rpoA and R-rpoA. cDNA samples were stored at –20°C for further use. Real-time PCR analysis. Quantification of expression level of the ompK gene was done by real-time PCR 1 using 7300 Real-time PCR System (Applied Biosystems, Foster city, USA). Validation of the real-time PCR was done by amplifying serial dilutions of cDNA synthesized from 1 µg of RNA isolated from bacterial samples (Livak and Schmittgen, 2001). to carry out relative quantification using the 2–ΔΔct formula. The appropriate primer concentrations (200 nM for ompK and 300 nM for rpoA) were used for thermal cycling which included an initial activation at 50°C for 2 min, initial denaturation at 95°C for 10 min followed by 45 cycles of denaturation at 95°C for 15 s, primer annealing at 60°C for 45 s and elongation at 72°C for 30 s and a melting-curve program (95°C for 15 s and 60°C for 30 s). This was performed for each gene to check for amplification of the targeted fragments. Each reaction was performed in triplicate and the average value was considered for data analysis and statistical validation. Amplification data was recorded at the end of each elongation step. Analysis of relative gene expression was performed using the 2–ΔΔct method of Livak and Schmittgen (2001). The expression of the target genes was normalized to the endogenous control by calculating ΔCT and expressed relative to a calibrator by calculating ΔΔCT (ΔΔCT = ΔCT target – ΔCT calibrator). The control values (5 h time interval, 0.5% NaCl, 0% bile salt, iron and 2, 2’-bipyridine) of each experimental condition were used as calibrator. The expression level of the ompK gene in each condition of the study was tested by an independent sample student t-test for calculating ΔCt data. Significance level was taken at 5%. Western blotting. Bacteria grown under different culture conditions that resulted in a significant difference in the production of ompK gene were harvested by centrifugation at 4000 g for 10 min and were lysed by discontinuous sonication on ice at 20–30 W with six 10 s bursts followed by centrifugation at 5000 g for 20 min to remove the unlysed cells. Cell lysates were resolved in 15% SDS-PAGE (without staining) and electrotransferred onto nitrocellulose blotting membrane (Pall, New York, USA) at a constant voltage of 50 V for 1 h according to our previous article (Hamod et al., 2012). The membrane was blocked with 3% bovine serum albumin (BSA) overnight at 4°C. This was followed by three times washes with phosphate buffer saline containing 0.05% Tween-20 (PBST) followed by 3 washes with phosphate buffer saline (PBS) (1 min each time). The protein bands on the membrane were allowed to react with the rabbit anti-OmpK serum developed by us as described in our previous work (Hamod et al., 2012) diluted 1:100 with gentle agitation at room temperature for 1 h, followed by washing and further incubation with horse radish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G antibodies (Sigma, Missouri, USA) diluted 1:1000 for 1 29 Expression of ompK in V. anguillarum Fig 1. Expression of V. anguillarum ompK gene (a) in the presence of different concentrations of bile salts (b) in the presence of 1% blood, 2% blood, 20 Mm 2, 2’-bipyridine and 1% blood with 100 Mm 2, 2’-bipyridine. The error bars represent the standard deviation of three independent measurements of ΔΔCT based on bacterial mRNAs. Data that are significantly different (P < 0.01) from the calibrator are marked with an asterisk. 1 h. The reaction was carried out by dipping the membrane in tetramethylbenzidine solution (Merck, India) after thorough washing with PBS, stopped by rinsing with distilled water and visualized. Results Effect of culture conditions on the expression of ompK gene. Study on the effect of varying salt concentrations on growth and OmpK expression of V. anguil larum NB10 showed that NaCl concentrations up to 3% had a minimal effect. Expression of ompK at 2% NaCl (2.74 fold) was observed to be higher than at 1%, 3% and 4% of NaCl. The growth of V. anguillarum NB10 seemed to decrease with increasing bile salt concentration in the medium while the expression of ompK increased with increase in bile salt concentration (Fig. 1a). Expression of ompK gene was the highest at 0.4% bile salt concentration (5.8 fold) (Fig. 1a). Supplementation of iron chelating agent 2, 2’-bipyridine increased ompK 5.7 fold (Fig. 1b). On supplementation of culture medium with fresh human blood, the expression of ompK decreased (Fig. 1b). When both 20 mM 2, 2’-bipyridine and blood were supplemented, ompK expression was reduced to 2.3 fold compared to 5.7 fold in the presence of 2, 2’-bipyridine alone (Fig. 1b). Western blot analysis. Positive bands with molecular weight of 28 KDa were seen only in the lanes containing cell lysates of V. anguillarum grown with 0.4% of bile salts, 20 mM bipyridine, and 1% of blood with 100 mM bipyridine (Fig. 2). No bands appeared in the other lanes containing the cell lysates of V. anguillarum grown with 4% NaCl, 2% blood supplement or bacteria grown in TSB without any supplementation. Discussion V. anguillarum is a causative agent of vibriosis in finfish and invertebrates such as bivalves and crustaceans. Vibriosis results in massive losses to the aquaculture 30 Hamod M.A. et al. Fig. 2. Western blot for V. anguillarum OmpK grown inpresence of bile salts, NaCl, bipyridine and blood. Protein marker (M), TSB (1), 0.4% bile salt (2), 4% NaCl (3), 2% of blood (4), 20 mM bipyridine (5), 1% of blood and 100 mM bipyridine(6). industry (Garcia et al., 1997). V. anguillarum NB10 initially isolated by Norqvist et al., 1989 was the representative isolate chosen for this study, since it belongs to serotype O1, which is globally accepted as a highly pathogenic serotype. Since serotype O1 assumes variable outer membrane profile under different conditions (Simón et al., 1996), the use of a strain of this serotype would be appropriate for the study of any novel outer membrane protein. Gram-negative bacteria such as V. anguillarum are surrounded by a bilayer outer membrane in which proteins are interspersed. Porins in bacterial outer membranes have a regulatory role in nutrient uptake, facilitating the transport of specific nutrient molecules (Achouak et al., 2001; Nikaido, 1994). Few outer membrane proteins such as OmpA and general porins are constitutively expressed in high levels in the cell whereas the majority of outer membrane proteins are induced with increased synthesis occurring only under certain circumstances (Koebnik et al., 2000). A 26 kDa outer membrane protein, OmpK common to Vibrio species was first reported by Inoue et al. (1995a; 1995b) and shown to serve as a receptor for a broad-host-range vibriophage, KVP40. Although the genes encoding OmpK in V. cholerae, V. harveyi and V. alginolyticus are similar (Inoue et al., 1995a), variations for this gene in terms of the number of amino acids they encode have been reported for V. alginolyticus and V. harveyi (Li et al., 2008; Qian et al., 2008). So far, there has been no report on the structure and functions of ompK gene in V. anguillarum. Polyclonal antibody was raised against the purified recombinant OmpK protein in rabbit in our work (Hamod et al., 2012). Surprisingly a positive band was detected only in the case of purified OmpK protein. The protein in the cell lysate of V. anguillarum was undetected by Western blot. It has been reported that expression of OMP is related to environmental condi- 1 tions like temperature, salinity, availability of nutrients and oxygen (Nandi et al., 2005). Real-time PCR technique, a reliable quantitative method for measuring gene expression (Nielsen and Boye, 2005) was used in this study to determine the effect of varying environmental factors such as salt concentration, bile salt concentration and iron chelating agent on the expression of ompK gene in V. anguillarum. V. anguillarum, a marine bacterium, well recognized as a pathogen of marine and estuarine fish, encounters different osmotic environments. The outer membrane proteins have a crucial role in maintaining the osmotic state of the organism during any salt stress. In this study growing V. anguillarum at salt concentrations higher than 2%, which is the optimum for its growth, did not upregulate ompK expression suggesting that ompK probably is not involved in osmoregulation. On the contrary, using the proteomic approach of Kao et al., 2009 showed that both ompU and ompW are highly expressed at 3.5% NaCl and are possibly involved in osmoregulatory function in V. anguillarum. V. anguillarum being a fish pathogen, when ingested by fish is likely to be exposed to bile in the fish gut and therefore might be in possession of mechanisms for survival in the gut environment. Our study shows that expression of ompK is upregulated in the presence of bile salts. Though growth seemed to be suppressed at 0.4% bile salt (data not shown), expression of ompK was 5 fold higher (Fig. 1a) suggesting a role for this protein in bile resistance. Wang et al., 2003 showed OmpU to play a role in bile resistance in V. anguillarum. In Escherichia coli two outer membrane proteins OmpF and OmpC confer bile salt resistance. While OmpF is sensitive to bile salt concentration changes at low temperature and salinity, OmpC responds to alteration in bile salt concentration at elevated temperature (Nikaido and Rosenberg, 1983). Similarly, we suggest that in V. anguillarum, in addition to OmpU (Wang et al, 2003), OmpK may also be playing an important role in bile salt resistance and its uptake. Iron uptake mechanisms are involved in conferring virulence to V. anguillarum. Two iron uptake mechanisms have been reported in this organism viz production of anguibactin and vanchrobactin (Lemos et al., 1988). We observed that expression of ompK was induced in the presence of iron chelating agent 2, 2’-bipyridine and this is partially offset if blood is present in the medium (Fig. 1b), which probably suggests that OmpK in V. anguillarum responds to changes in iron level in the environment. Therefore, V. anguillarum strain was grown in TSB medium supplemented with 20 m mol–1 2, 2’-bipyridine, 0.4% bile salt, 4% NaCl, 2% of blood and combination of biypiridine and blood for the detection of OmpK protein by Western blot. A band with 28 kDa (Fig. 2) was 1 Expression of ompK in V. anguillarum visualized in the case of V. anguillarum strain grown in bile salt, bipyridine and combination of blood and bipyridine. This result further confirms the role of OmpK protein in bile salt resistant and iron uptake. Acknowledgment The first author gratefully acknowledges the research fellowship awarded by DBT-TWAS Ph.D programme and also thankfully acknowledges the support of the University of Baghdad. Literatures Achouak W., T. Heulin and J.M. Pagés. 2001. Multiple facets of bacterial porins. FEMS Microbiol Lett. 199: 1–7. Ausubel F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith and K. Struhl. 1995. Short Protocols in Molecular Biology: A compendium of methods from Current Protocol in Molecular Biology. New York John Wiley and Sons. Croxatto A., J. Lauritz, C. Chen and D. Milton. 2007. Vibrio anguillarum colonization of rainbow trout integument requires a DNA locus involved in exopolysaccharide transport and biosynthesis. Environ. Microbiol. 9: 370–382. Davey M.L., R.E.W. Hancock, L.M. Mutharia. 1998. Influence of culture conditions on expression of the 40-kilodalton porin protein of Vibrio anguillarum serotype O2. Appl Environ Microbiol. 64: 138–146. Defoirdt T., C.M. Miyamoto, T.K. Wood, E.A. Meighen, P. Sorgeloos, W. Verstraete and P. Bossier. 2007. The natural furanone (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone disrupts quorum sensing-regulated gene expression in Vibrio harveyi by decreasing the DNA-binding activity of the transcriptional regulator protein LuxR. Environ. Microbiol. 9: 2486–2495. Garcia T., K. Otto, S. Kjelleberg and R. Nelson. 1997. Growth of Vibrio anguillarum in Salmon intestinal mucus. App. Environ. Micro biol. 63: 1034–1039. Hamod M.A., M.S. Nithin, Y.N. Shukur, I. Karunasagar and I. Karunasagar. 2012. Outer membrane protein K as a subunit vaccine against V. anguillarum. Aquaculture. 354–355: 107–110. Inoue T., S. Matsuzaki and S. Tanaka. 1995a. A 26 kDa outer membrane protein, OmpK, common to Vibrio species is the receptor for a broad-host-range vibriophage. KVP40. FEMS Microbiol. Lett. 125: 101–106. Inoue T., S. Matsuzaki and S. Tanaka. 1995b. Cloning and sequence analysis of Vibrio parahaemolyticus ompK gene coding a 26-kDa outer membrane protein, OmpK, that serves as receptor for a broad-host-range vibriophage, KVP40. FEMS Microbiol. Lett. 134: 245–249. Kao D.Y., Y.C. Cheng, T.Y. Kuo, S.B. Lin, C.C. Lin, L.P. Chow and W.J. Chen. 2009. Salt-responsive outer membrane proteins of Vibrio anguillarum serotype O1 as revealed by comparative proteome analysis. J. Appl. Microbiol. 106: 2079–2085. 31 Koebnik R., Locher K.P and P. Van Gelde. 2000. Structure and function of bacterial outer membrane proteins: barrels in a nut shell. Mol. Microbiol. 37: 239–253. Lemos M.L., P. Salinas, A.E. Toranzo, J.L. Braja and J.H. Crosa. 1988. Chromosome-mediated iron uptake system in pathogenic strain of V. anguillarum. J. Bacteriol. 170: 1920–1925. Li N., Bai J., S. Wu, X. Fu, H. Lao, Y. Xing and C. Shi. 2008. An outer membrane protein, OmpK, is an effective vaccine candidate for Vibrio harveyi in Orange-spotted grouper (Epinephelus coioides). Fish Shellfish Immun. 25: 829–833. Livak K.J. and T.D. 2001. Schmittgen. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25: 402–408. Miller E.S., J.F. Heidelberg, J.A. Eisen, W.C. Nelson, A.S. Durkin, A. Ciecko, T.V. Feldblyum, O. White, I.T. Paulsen, W.C. Nierman, J. Lee, B. Szczypinski and C.M. Fraser. 2003. Complete genome sequence of the broad-host-range vibriophage KVP40: comparative genomics of a T4-related bacteriophage. J. Bacteriol. 185: 5220–5233. Myhr E.L., J.L. Larsen, A. Lillehaug, R. Gudding, M. Heum and T. Hástein. 1991. Characterization of Vibrio anguillarum and closely related species isolated from farmed fish in Norway. Appl. Environ. Microbiol. 57: 2750–2757. Nandi B., R.K. Nandy, A. Sarkar and A.C. Ghose. 2005. Structural features, properties and regulation of the outermembrane protein W (OmpW) of Vibrio cholerae. Microbiology 151: 2975–2986. Naka H. and J.H. Crosa. 2012. Identification and characterization of a novel outer membrane protein receptor FetA for ferric enterobactin transport in Vibrio anguillarum 775 (pJM1). Biometals. 25: 125–133. Nielsen K. and M. Boye. 2005. Real-time quantitative reverse transcription-PCR analysis of expression stability of Actinobacillus pleuropneumoniae housekeeping genes during in vitro growth under iron-depleted conditions. Appl Environ Microbiol. 71: 2949–2954. Nikaido H. and E.Y. Rosenberg. 1983. Porin channels in Esch erichia coli: studies with liposomes reconstituted from purified proteins. J. Bacteriol. 153: 241–252. Nikaido H. 1994. Porins and specific diffusion channels in bacterial outer membranes. J. Biol. Chem. 296: 3905–3908. Norqvist A., W.A. Hagstr and H. Wolf-Watz. 1989. Protection of rainbow trout against vibriosis and furunculosis by the use of attenuated strains of Vibrio anguillarum. Appl. Environ. Microbiol. 55: 1400–1405. Pedersen K., L. Gram, D.A. Austin and Austin B. 1997. Pathogenicity of Vibrio anguillarum serogroup O1 strains compared to plasmids, outer membrane protein profiles and siderophore production. J. Appl. Microbiol. 82: 365–371. Qian R., Z. Xiao, C. Zhang, W. Chu, L. Wang, H. Zhou, Y. Wei and L. Yu. 2008. A conserved outer membrane protein as an effective vaccine candidate from Vibrio alginolyticus. Aquaculture. 278: 5–9. Simón M., A. Mathes, A. Blanch and H. Engelhardt. 1996. Characterization of a porin from the outer membrane of Vibrio anguil larum. J. Bacteriol. 178: 4182–4188. Wang S., J. Lauritz, J. Jass and D. Milton. 2003. Role for the major outer-membrane protein from Vibrio anguillarum in bile resistance and biofilm formation. Microbiology 149: 1061–1071. Polish Journal of Microbiology 2014, Vol. 63, No 1, 33–41 ORIGINAL PAPER Development of Synbiotics with Inulin, Palatinose, α-Cyclodextrin and Probiotic Bacteria RAMINTA PRANCKUTĖ*, ARNOLDAS KAUNIETIS, NOMEDA KUISIENĖ and DONALDAS ČITAVIČIUS Department of Microbiology and Biotechnology, Vilnius University, LT-03100, Vilnius, Lithuania Submitted 20 June 2013, revised 20 October 2013, accepted 16 November 2013 Abstract Success in creating a synbiotic depends on compatibility between the chosen components – prebiotic and probiotic. In this work the interactions between Lactobacillus sp. strains isolated from yogurts and type strains of Lactobacillus sp. and Lactococcus sp., and the dependence of their growth and antibacterial activity on three oligosaccharides (OS) – palatinose, inulin and α-cyclodextrin were investigated. All isolated lactobacilli produce antibacterial compounds, which possibly are the bacteriocins of Lactobacillus casei ATCC334 strain. Results of growth analysis with different OS revealed that part of lactobacilli isolated from yogurts can effectively ferment inulin and may be used for the development of synbiotics. Palatinose and Lactobacillus acidophilus could be used as symbiotics with effective antibacterial activity. One of the types of Lactococcus sp. strains can assimilate palatinose and α-cyclodextrin, so they both can be used as components of synbiotics with the investigated lactococci. Results of this analysis suggest that the investigated isolated and type strains of Lactobacil lus sp. and Lactoccocus sp. can be useful as probiotics in the development of synbiotics. Together with prebiotics – palatinose, inulin and α-cyclodextrin, the synbiotics, which could regulate not only the growth of beneficial bacteria in the gastrointestinal tract, but also their antibacterial activity, can be created. K e y w o r d s: Lactobacillus sp., Lactococcus sp., bacteriocin, probiotic, synbiotic Introduction Synbiotic is a combination of probiotic and prebiotic, which can synergistically promote the growth of beneficial bacteria or newly added species in the colon (Macfarlane et al., 2008). During the development of new synbiotic products it is very important to ascertain prebiotic and probiotic interactions and influence of prebiotic on probiotic growth and antibacterial activity. Prebiotics are described as non-digestible poly-or oligosaccharides that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of beneficial bacteria in the colon (Gibson and Roberfroid, 1995). Prebiotics themselves have many health promoting properties. Moreover, there is evidence that they can help modulate the growth of gut microbiota and stimulate bacteriocin production (Kunova et al., 2011; Patel and Goyal, 2012). Inulin, palatinose and α-cyclodextrin used in this work are generally recognized as safe (GRAS) food additives (Wagner et al., 2008; Holub et al., 2010). Inulin is one of the most comprehensively studied OS and is widely recognized as a bifidogenic prebiotic (Bosscher et al., 2006; Patel and Goyal, 2012). Inulin is a liner polymer consisting of β-(2→1)-fructosyl-fructose linkages (Roberfroid, 2007). Palatinose is a reducing sugar, composed of glucose and fructose moieties, joined with α-1,6-glycozil bonds. Commercially palatinose is made from sucrose by enzymatically reorganizing glycosyl bonds (Holub et al., 2010). Cyclodextrins (CDs) are circular oligosaccharides, composed of glucose residues linked by α-1,4-glycosyl bonds. The hydrophilic part of the molecule is faced to the outside of the ring, and the hydrophobic part is inside the ring (del Valle, 2004; Wagner et al., 2008). Commercially cyclodextrins are produced from a starch. These molecules are widely used in pharmacy, chemistry and food industry due to their ability to form inclusion complexes (del Valle, 2004). Although βCD is more industrially used due to its lower price, αCD is characterized by better solubility in water (140 mg/ml) than βCD (18 mg/ml, 25°C) (Szejtli, 2004). Inulin, palatinose and α-cyclodextrin can act in many health promoting ways, like stimulating immune system, reducing the amounts of pathogenic (Bacillus sp., Escherichia coli, Campylobacter jejuni, Salmonella * Corresponding author: R. Pranckutė, Department of Microbiology and Biotechnology, Vilnius University, M.K. Čiurlionio str. 21/27, Vilnius, Lithuania, LT-03100; phone: +37052398210; e-mail: [email protected] 34 1 Pranckutė R. et al. enteritidis (Bosscher et al., 2006; Zhang et al., 2008)) or oral plaque bacteria (Porphyromonas gingivalis (Ueno et al., 2012)); reducing the risk of colon cancer; reducing triglycerides, fatty acids and cholesterol amounts in the blood and thus preventing cardiovascular diseases and decreasing the risk of obesity and type II diabetes (Wagner et al., 2008; Ooi and Liong, 2010; Patel and Goyal, 2012). Although these OS also have sweetness due to their indigestibility they are characterized by low glycaemic index (for example, palatinose has about half the sweetness of sucrose, but its glycaemic index is only 32 (Holub et al., 2010)). This makes them even more favorable food additives for diabetic patients. Like most prebiotics, inulin, palatinose and α-cyclo dextrin are not digested in the upper gastrointestinal tract (except palatinose), which makes them available and longer lasting carbon sources for beneficial colon bacteria, like bifidobacteria (Bosscher et al., 2006; Goderska et al., 2008) and lactobacilli (Kunova et al., 2011). However, most investigations are focused on the influence of these OS on bifidobacteria and little is known about how they affect lactobacilli and other beneficial bacteria from other genera, like lactococci, widely used in the food industry (Pan et al., 2008; Gänzle and Follador, 2012). Most of them produce various antibacterially active compounds and bacteriocins among them (Chen et al., 2006). Not much research is done in this area, but there is evidence that bacteriocins may have various effects on the gut microbiota, like facilitating the introduction of the producing strain into the gastrointestinal tract, inhibiting the invasion of competing and pathogenic strains, modulating the composition of the gut microbiota and influencing the host immune system (Dobson et al., 2012). While bacteriocin production is often growthassociated and is dependent on carbon availability, slow digestion of prebiotics is very important as they are much longer-lasting carbon sources and mostly fermented only in the colon (Macfarlane et al., 2008). In addition to this, it is important to clarify the effect of prebiotics on the growth and antibacterial activity of probiotic bacteria (Chen et al., 2006). It is shown that inulin stimulates the secretion of bacteriocins by Lactobacillus paracasei CMGB16 strain (Vamanu and Vamanu, 2010). However, little is known about the influence of αCD and palatinose on probiotic bacteria, but it has been shown that αCD can maintain the growth of Lactobacillus casei and increase the amounts of bifidobacteria (Jo et al., 2007). The analysis of L. casei supragenome has revealed that the bacterial strains of this species should be able to ferment inulin, palatinose and many other OS (Broadbent et al., 2012), which could be useful parts of synbiotics for diabetic patients. However, not many investigations of these properties have been made in vitro. Experimental Materials and Methods Strain isolation from yogurts. The sources of Lactic Acid Bacteria (LAB) were probiotic yogurts: “Actimel” and “Bifi”. For the isolation of strains, 1 g of each yogurt were added to 99 ml of 0.85 % sterile saline solution. Tenfold serial dilutions of the samples were made and appropriate dilutions were streaked on de Man, Ragosa and Sharpe (MRS) agar plates (Kormin et al., 2001). The plates were incubated for two days under anaerobic conditions at 37°C by placing a gas pack in the anaerobic jar (Merck). Bacterial strains and growth conditions. Six Lacto bacillus sp. and two Lactococcus sp. type strains were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ): Lactobacillus acidophi lus DSM 20079 (LA), Lactobacillus delbrueckii subsp. bulgaricus DSM 20081 (LD), Lactobacillus curvatus DSM 20010 (LC), Lactobacillus sakei subsp. sakei DSM 20017(LS), Lactococcus lactis subsp. lactis DSM 20481 (LL) and L. lactis subsp. lactis DSM 20729 (LL2) (abbreviations of strains used further in the work are given in the brackets). Isolated and type strains of Lactobacillus sp. were cultured in MRS broth (Merck) or basal MRS (Saminathan et al., 2010). Type strains of Lactococcus sp. were grown in broth No. 92 (DSMZ culture medium list), which consisted of Tryptic Soy Broth (TSB, Merck), supplemented with 0.3% Yeast Extract (YE, Difco). Isolated strains were cultured aerobically or anaerobically, with (100 rpm) or without agitation, at 30°C. Type strains of L. acidophillus and L. delbrueckii subsp. bul garicus were grown under anaerobic conditions, at 37°C. Other type strains were cultured aerobically, at 30°C. Oligosaccharide substrates. Three different commercially available oligosaccharides were used in this study: inulin (Inl) (Alfa Aesar), palatinose hydrate (Pal) (TCI) and α-cyclodextrin (Ctd, αCD) (Merck). Stock solutions of these oligosaccharides were prepared in sterile distilled water and filter sterilized with 0.22 μm filters (Roth). The sterile oligosaccharide solutions were added to autoclaved basal MRS medium to obtain final oligosaccharide concentration of 1% (w/v). Glucose (Merck), which was a favourable carbohydrate source for all used LAB strains, was used as control (Saminathan et al., 2010). Partial identification of isolated strains. Genomic DNA of isolated strains was extracted using GeneJet DNA Extraction Kit (Thermo Fisher Scientific). Universal bacterial 16S rDNA primers (27F and 1492R, Thermo Fisher Scientific) were used for PCR reactions. Reaction products were sequenced at the Sequencing Center of the Institute of Biotechnology. In silico data analysis was performed using the NCBI Blast programme (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 1 Development of synbiotics with oligosaccharides and probiotic bacteria In order to determine the variety of strains isolated from yogurts, we performed PCR reaction with all strains genomic DNA and universal BOX primers. Results were analyzed by agarose gel electrophoresis (Sambrook and Russell, 2001). Antibacterial activity assay. The antibacterial activity of strains was determined using the spot-on-lawn method (Kormin et al., 2001) with modifications. The tested strain was grown overnight in the middle of Petri dish with an appropriate agar medium. Then the layer of agar medium with inoculated other presumably sensitive strain was poured on top of the grown culture. The agar media with inoculated strain was prepared by adding 20% of 1.2 OD culture inoculum into an appropriate agar media. Isolated and type strains were tested against each other. Agar well diffusion assay. 0.5 cm diameter wells were made, using sterile plastic pipette tips, in the agar media with inoculated sensitive strain, prepared as described above. Culture samples were taken every two hours from the beginning of culture cultivation in liquid media. Samples were centrifuged and the serial twofold dilutions of the cell free supernatants were made. The amount of 100 µl of every dilution was poured into the prepared wells and plates were incubated overnight at the temperature appropriate for the used indicator strain. Clear zones round the wells after incubation indicate the inhibitory activity, which was expressed quantitatively as arbitrary units per milliliter (AU/ml). The arbitrary unit (AU) was defined as the reciprocal of the highest dilution able to produce a clear zone of growth inhibition of the indicator strain (Vera Pingitore et al., 2007). Disintegration of cells. Samples (5 ml) of the grown cultures were taken every 6 h from the beginning of growth. Samples were centrifuged, cells were suspended in 5 ml of phosphate buffer (pH 6.0) and then disrupted with the ultrasound disintegrator. Obtained cell disintegrate was filtered through 0.22 µm filter (Roth) or centrifuged (5 min, 14 000 × g). In order to determine the antibacterial activity, 100 µl of the filtered, centrifuged and untreated disintegrates were tested using agar welldiffusion assay using A20 strain as indicator. Identification of bacteriocins. Primers (20 pairs in total) used in this work were described in scientific publications or constructed using typical well known bacteriocin encoding gene sequences from the Genbank database (http://www.ncbi.nlm.nih.gov/Genbank/ index.html), are listed in Table I. Results Isolation of bacteria from yogurts. Since the morphology of bacteria grown on the MRS medium did not have any differences, 9 strains of Lactobacillus sp. iso- 35 lates were randomly selected: 4 strains from “Actimel” yogurt (“Danone”) (A isolates) and 4 from “Bifi” yogurt (UAB “Rokiškio pienas”) (B isolates). The amount of Lactobacillus sp. bacteria in examined yogurts was estimated at 108 cells in 1 gram of yogurt. These data coincide with the information given by the producers. For a more detailed identification of the isolates 16S rDNA analysis was made. Results have shown that the isolated strains are most similar to L. casei and L. paracasei subsp. tolerans species (reliability of BLAST analysis results is 100%). Implementation of BOX-PCR reaction, used to estimate the variety of bacterial strains among isolates, has revealed distribution of strains in the profiles, fully complying with strains origin from different yogurts (data not shown). Antagonistic activity assay of isolated strains. 3 strains from group A and 3 strains from group B were selected for the antagonistic activity assay. Using spoton-lawn method it was determined that all isolated lactobacilli strains were able to produce clear zones inhibiting the growth of the strains, used as indicator (isolated strains were tested against each other). Results, given in Table II, reflect the antagonistic spectrum of the tested strains. The obtained results allow us to assert that stains belonging to groups A and B produce antibacterially active compounds. The size of the formed clear zones (Table II.) shows that the antibacterial compound of B group strains is more active or a larger amount of it is produced. Antibacterial activity of isolated and type strains. Antibacterial activity of 3 isolated (A11, B13, A20) and 6 type strains against each other was determined and phenotypically evaluated (Table III.). Results have shown that LL2 strain possesses the highest antibacterial activity among type strains. The antibacterial spectrum and ability to inhibit the growth of tested strains of this strain did not differ from antibacterial spectrum and activity of isolated lactobacilli strains A11, A20 and B13. However, only LD strain had no antibac terial activity against any of the tested strains and was sensitive to all antibacterial compounds secreted by the tested strains. Identification of bacteriocins produced by isolated and type strains. One of the possibilities to identify secreted bacteriocins is a search of bacteriocin encoding genes in the genomes of analyzed strains. For this purpose we used 20 pairs of primers constructed in accordance with genes of well known bacteriocins (GeneBank Database) or selected from scientific publications (Table I.). All primers were used for PCR reactions with genomic DNA of 15 strains (9 isolated and 6 type strains). The results of the size and sequence analysis of the obtained PCR products can be divided into five groups: 1) Two PCR products compatible with genes encoding nisin by their size and results of 36 1 Pranckutė R. et al. Table I Primers used for bacteriocin genes identification in studied bacterial strains. No Primer (abbrevation) Tm, °C Sequence Expected product (size, bp) Source 1 1BACTP (1) F: 5’-TGA AGA TGT ATT TGG GTG CGT-3’ R: 5’-CAG GAG TTG CTG GTG TTG TT-3’ 57 (Digaitiene Lakticin 3147 (257) 58 et al., 2012) 2 2BACTP (2) F: 5’-GCG CCT GCA GGG CTT TCT TTC GAT CAC GAT-3’ R: 5’-GCG CGT CGA CGG TTC GAT AGT TCG TGC TT-3’ 75 Pediocin PA (541) 75 (Digaitiene et al., 2012) 3 3BACTP (3) F: 5’-CTA TGT ACA CCC GGT TGT AA-3’ R: 5’-TTT ATG AAC TAG GCG AAT CA-3’ 56 Nizin (590) 52 (Digaitiene et al., 2012) 4 4BACTP (4) F: 5’-ACA GGT GGA AAA TAT TAT GGT A-3’ R: 5’-TTT TGC TTA TTA TTT ATT CCA G-3’ 55 Sakacin P (150) 51 (Digaitiene et al., 2012) BACTA164- 5 -NIZLL (A) F: 5’-ATG AGT ACA AAG ATT TTA ACT TGG ATT GGT-3’ R: 5’-ATA AAC GAA TGC ACT TAT GAT GTT ACT GT-3’ 64 Nizin 63 (Swetwiwathana et al., 2009) BACTWNC- F: 5’-CCG GAA TTC ATA AGG AGG CAC TCA AAA TG-3’ 6 -NIZLL (W) R: 5’-CGG GGT ACC TAC TAT CCT TTG ATT TGG TT-3’ 69 Nizin A 69 (Millette et al., 2008) 7 LacS (L) F: 5’-ATG GAA TTR TTR CCR ACK GCY GCY GTY YTR TA-3’ R: 5’-ATG RTG TTT RGC NSW RTA YTT-3’ 72 Lakticin S 54 (Rodrígues et al., 1995) 8 m2163 (63) F: 5’-AAA CAT ATG AAA CGA AAG TGC CCC AAA AC-3’ R: 5’-TTT GAA TTC GCG ACG ATC TCT TGA ACA TTC-3’ 66 Class II bacteriocin (Kuo Y.-C. 68(≤ 300) et al., 2012) 9 m2386 (86) F: 5’-ATT CAT ATG GAC AGC ATC CGT GAT GTT TC-3’ R: 5’-TTT GAA TTC GCT GCC AGA ACA AGT TGG TT-3’ 68 Class II bacteriocin (Kuo Y.-C. 68 (≤ 300) et al., 2012) 10 m2393 (93) F: 5’-GCT CAT ATG GAA AAC GGT GGT TTA TGG TCA-3’ R: 5’-AAA GAA TTC GGA ATC CCA GAA TGG CAG C-3’ 69 Class II bacteriocin (Kuo Y.-C. 69 (≤ 300) et al., 2012) 11 m2405 (5) F: 5’-CAA CAT ATG GCC AAG CGA CGC-3’ R: 5’-CGA GAA TTC CGC TAC TAT TTC CC-3’ 63 Class II bacteriocin (Kuo Y.-C. 63 (≤ 300) et al., 2012) 12 m2406 (6) F: 5’-TCA CAT ATG AAA AAG AAA TTT GAT TGT GCT-3’ R: 5’-TAA GAA TTC GCC CAC TTC TTT AC-3’ 63 Class II bacteriocin (Kuo Y.-C. 59(≤ 300) et al., 2012) 13 AcdT (AT) F: 5’-ATG ATT TCA TCT CAT CAA AAA ACG-3’ R: 5’-CTA AAAACC GTC AGT ATA ACG AAG GC-3’ 57 Acidocin 8120 65 (141) 14 CurA (CA) F: 5’-GCG CAG GAA TGA TTT CTG TAG GC-3’ R: 5’-GCT CTG CCT TCA AAT TAG ACC CTC-3’ 65 Curvacin A (179) 65 This work This work F: 5’-GCG CAG GAA TGA TTT CTG TAG GC-3’ 15 CurA2 (CA2) R: 5’-TGG GAT CAT TTG GCG TCT GC-3’ 65 Curvacin A and This work 60 imunity gene (837) 16 SakA (SA) F: 5’-GCG CAG AGG AGA TTC TTA GTT ATG-3’ R: 5’-CAT TCC AGC TAA ACC ACT AGC CC-3’ 64 Sakacin A (197) 65 This work 17 SakP (SP) F: 5’-GCA GAA GTA ACA GCA ATT ACA GGT GG-3’ R: 5’-CGC TAG CGT ATT CTT AGA ATA GTG TGC-3’ 66 Sakacin P (622) 67 This work 18 92 F: 5’-ATG AAA AAA CAA GAA ACA CAA TTG TTT GAA GC-3’ R: 5’-TCA TCT AAA AAT CTG AGT CAA TCC CC-3’ 65Prebakteriocin 63 (186) This work 19 94 F: 5’-TTG GGT GGA AAG GAA ACA CGG TTA TTT CAG GC-3’ R: 5’-TCA AAG CCA AAC GCT CAA CCC GCC-3’ 72Prebakteriocin 69 (192) This work 20 111 F: 5’-ATG ACA GAC AAA CGT GAAACT TTA ATG TCG-3’ R: 5’-GTA ATG CCC CCA AAC AAT GGG AAT GG-3’ 67 Prebakteriocin 68(333) This work BLAST analysis (primers 3 and W, genomic DNAs of LL2 and LL strains respectively, Table I). 2) PCR products, obtained with 5 primers constructed for detection of new bacteriocins of L. casei ATCC334 (63, 86, 93, 405, 406) (Kuo et al., 2013) and genomic DNAs of isolated strains. Sequences of the products had homo logy with the sequences of new bacteriocins, mentioned before. 3) PCR products obtained with primers constructed according to prebacteriocin genes found in the genome of L. casei BDII strain (Genbank Database, GI: 385821700) (primers 92, 94 and 111 (Table I.), genomic DNAs of isolated strains), which were compatible with 1 Development of synbiotics with oligosaccharides and probiotic bacteria Table II Results of antibacterial spectrum of isolated strains. Sensitive strain A11 A15 A20 B1 B4 B13 Secreting strain A11 +++ + + + A15 + +++ + + A20 + + + ++ B1 ++ +++++ ++ ++ B4 ++ +++++ + B13 +++ ++++++ ++ ++ + “+” – diameter of the clear zone arround the secreting culture exeeds 1.5 mm; “++” – clear zone ≤ 2.5 mm, “+++” – zone > 2.5 mm. Table III Results of antibacterial activity of isolated and type strains. Sensitive strain A11 B13 A20 A11 + ++ LA LD LL LL2 LC LS + +++++++++ ++ ++ B13 +++ +++ + +++++++++ ++ ++ Secreting strain A20 + + ++ +++++++++ ++ ++ LA +/– +/–+/– ++ + + +/– + LD– – – – ––– – LL +/––+/––+/––+/–– + + + + LL2 +++++++++ ++ +++ +++ LC – +/–+/– +/– ++ + + + LS ++/–++/–++++ “+/––” – clear zone is visible only by the borders of the secreting culture; “+/–” – clear zone is hardly visible, ≤ 0.5 mm; “+” – clear zone ≤ 1.5 mm; “++” – clear zone ≤ 2.5 mm, “+++” – clear zone > 2.5 mm. the prebacteriocin genes by their size and sequence. However, more detailed in silico analysis of these products, using Bactibase database (http://bactibase. pfba-lab-tun.org/physicochem), has shown that, most likely, these genes do not encode bacteriocins. 4) PCR products, obtained with primers for well known bacteriocin genes and genomic DNAs of isolated and some of the type strains (primer for nisin (3) with genomic DNA of isolated, LL and LA strains; primer for lacticin 3147 (1) with genomic DNA of isolated and LD strains; primer for curvacin A (CA2) with genomic DNA of isolated and LD strains), which were not compatible with these bacteriocin genes by their size and sequence analysis, but were identified as hypothetical or unrelated function proteins. 5) No PCR products were obtained with 7 primers for the well known bacteriocin genes (pediocin PA (2), sakacin P (4 and SP), sakacin A (SA), lacticin S (L), acidocin 8120 (AT), curvacin A (CA) (Table I)) and genomic DNAs of all strains. Ability of the isolated and type strains to assimilate OS. Considering the results of BLAST and BOXPCR analysis, only strains A11 and B13 were used for 37 further experiments, as they represent different groups of BOX-PCR profiles and possess the highest antibacterial activity among the strains of their groups (Table II.). Data from the graphs presented in Fig. 1. (A and B) suggest that in all cases both A11 and B13 strains most weakly assimilate palatinose hydrate. On the other hand, inulin is poorly assimilated only by strain A11 (Fig. 1A). The growth of strain B13 with inulin is equi valent to the growth of this strain with glucose, except that the exponential growth phase begins about 4 h later (Fig. 1B). The increase of OS concentration does not influence the growth of strains. Analysing the influence of different carbon sources (glucose, inulin and palatinose) on the type strains of Lactobacillus sp. and Lactococcus sp., the following was determined: 1.In the medium with glucose as an only carbon source L. lactis subsp. lactis strains (LL and LL2) grew faster than strains LS and LA. LL and LL2 strains reached the stationary phase after 6 and 8 h respectively (Fig. 1C and D), while strains LS and LA reached this phase of growth after 14 and 28 h respectively (Fig. 1E and F). Evaluation of growth time and cell density at the beginning of the stationary phase suggests that strain LL2 grows fastest in the medium with glucose. 2.Strain LL assimilates palatinose best among the type strains (Fig. 1C). The culture reaches cell density of 1.2 OD in the beginning of stationary phase after 14 h of growth, while assimilation of inulin is ineffective – maximum reached OD was 0.5. 3.The assimilation of inulin and palatinose by strain LS is completely ineffective (Fig. 1E). 4.Strain LL2 equally poorly assimilates both inulin and palatinose. Only 0.5 OD cell density is reached in the beginning of the stationary phase, after 5 h of growth (Fig. 1D). 5.LA also ineffectively assimilates inulin and palatinose. The stationary phase with the cell density of 0.5 OD is reached after 12 h in the medium with inulin and only after 24 h when growing with palatinose (0.45 OD) (Fig. 1F). The MRSb medium becomes opaque after addition of αCD and it becomes impossible to track the alterations of OD. Therefore, the influence αCD on the growth of strains was analysed only with strains LL and LL2. Results (Fig. 1C and D) have shown that αCD is actively assimilated by LL2 strain. Evaluation of antibacterial activity of isolated strains. Antibacterial activity of culture supernatants was evaluated by the well-diffusion method during the growth (Vera Pingitore et al., 2007). Strain A20 was used as indicator for the evaluation antibacterial activity of the isolated strains, while testing on agard medium by spot-on-lawn method it demonstrated the highest 38 Pranckutė R. et al. 1 Fig. 1. OS influence on the growth and antibacterial activity of isolated and type strains of Lactobacillus sp. and Lactococcus sp. Curves are marked with abbreviations of used OS: Glu – glucose; Pal – palatinose; Inl – inulin; Cdt – α-cyclodextrin. Concentration of OS – 1 %, ×2 – 2 % (w/v). A – OS influence on the growth of A11 strain. B – OS influence on the growth of B13 strain. C – OS influence on the growth of L. lactis subsp. lactis (LL) strain. D – OS influence on the growth of L. lactis subsp. lactis (LL2) strain. E – OS influence on the growth of L. sakei subsp. sakei (LS) strain. F-OS influence on the growth of L. acidophilus (LA) strain. G – OS influence on the antibacterial activity of L. lactis subsp. lactis (LL2) strain. H – OS influence on the L. acidophilus (LA) strain. sensitivity to the antibacterial compounds secreted by other isolated strains (Table II). However, no antibacterial activity was detected while testing supernatants from the cultures grown in the liquid medium. The negative results could be caused by: •interaction between antibacterial compound and cell surface; •accumulation of antibacterial compound inside the cell; •low concentration of the secreted antibacterial compound. Accordingly, the cultivation of strains A11 and B13 was repeated after addition of 0.5% and 1% of Tween-80, which should reduce the interaction between proteins and cell surface and also enlarge the amount of antibacterial compound in the culture supernatant (the initial concentration of Tween-80 in the MRS medium is 0.1%). However, no clear zones were detected after repeated evaluation of antibacterial activity of culture supernatants. Culture samples (5 ml) were taken every 6 hours from the beginning of growth. The samples were centri- 1 Development of synbiotics with oligosaccharides and probiotic bacteria fuged and cells were disintegrated. Antibacterial activity of filtered, centrifuged and untreated cell disintegrates was tested by the well-diffusion assay, but no antibacterial activity was detected. Aiming to increase the amount of antibacterial compound, A11 and B13 strains were grown in the liquid medium till the end of exponential growth phase. 50 ml of every culture supernatants were salted out with 80% saturation of ammonium sulphate. Suspension of proteins was dialyzed in the phosphate buffer and concentrated up to 2 ml of volume. The antibacterial activity of the crude protein extracts was tested by the well-diffusion method, but no definite clear zones were detected. Another factor that could influence the production of bacteriocins is a deficiency of certain minerals. So strains A11 and B13 were grown in medium supplemented with combination of minerals, which were optimized in our laboratory to the growth and bacteriocin production of bacteria from other genera. It was shown that addition of NaHSO4 and MnSO4 to the medium (MnSO4 is an ingredient of MRSb medium) almost completely inhibits the growth of strain A11, but in the case of strain B13, these minerals only prolong the lag phase of growth. Other used combinations of minerals practically have no influence on the growth of the strains. However, culture supernatants did not possess any antibacterial activity either. It is known that pH of the growth medium strongly influences to the bacteriocin expression. But no antibacterial activity in culture supernatants after changing the pH of the growth medium from 5.6 to 7.2 was detected. OS influence on bacteriocin secretion. Strain A20 was replaced with LL as indicator strain (Table III.) and the antibacterial activity of A11 and B13 culture supernatants repeatedly grown with different carbon sources (glucose or 1% OS) was evaluated by welldiffusion assay. In this case about 2 mm of diameter unclear transparency zones around the wells with the culture supernatants after 12 and 14 h of growth were detected. The activity of secreted putative bacteriocins was minor – after diluting the supernatants only two times the activity was not detected. LL2, LS, LD and LC strains were also used as indicators but no clear zones had been detected around the wells with A11 and B13 strains grown in liquid medium culture supernatants either. No antibacterial activity was detected in culture supernatants while analyzing the influence of OS on the type strains, although all type strains, sensitive to the grown strains respectively (Table III.), were used as sensitive. Positive results were obtained only with strains LL2 and LA while using LS and LC strains as indicators. The antibacterial activity of strain LL2 culture supernatants was tested using LC strain as indicator, 39 as it is characterized by the highest sensitivity to the bacteriocin secreted by LL2 strain (Table III). After 6 h of growth of this strain in the medium with glucose or α-cyclodextrin, the antibacterial activity of culture supernatants was two times higher (80 AU/ml) when grown with αCD, than with glucose (40 AU/ml), although the cell density of the culture grown with glucose at that moment was almost two times bigger, than grown with αCD (1.5 OD and 0.8 OD respectively) (Fig. 1G). These results show that αCD positively influences bacteriocin production or activity. While growing the strain in the medium with inulin or palatinose, the antibacterial activity was detected only after 8 h (20 AU/ml). That suggests that strain LL2 is not capable of assimilating palatinose and inulin and, therefore, the antibacterial activity of culture supernatants is very weak (Fig. 1G). It should be noted that culture supernatant, obtained after 10 h of growth with αCD, maintains the same activity as after 8 h of growth (320 AU/ml), and while growing in the medium with glucose, the activity of culture supernatant decreases two times (Fig. 1G). Strain LS is characterized by high sensitivity to the antibacterial compound produced by strain LA (Table III). Due to this fact, this strain was used as indicator for evaluation of the antibacterial activity of strain LA grown in the liquid medium. Besides, both these strains can be cultivated in the MRS medium. Diverse influence of OS on the antibacterial activity of LA strain, grown with different carbon sources – glucose, palatinose and inulin was shown (Fig. 1H). During the growth of this strain, the antibacterial activity of culture supernatant occurred in the 8th hour of growth. Culture supernatants of 16, 20 and 24 hours possessed the highest activity (320 AU/ml) during the exponential growth phase of the investigated strain. Cell density of the LA culture after 8 h of growth in the medium with glucose or with palatinose practically does not differ. Although the antibacterial activity of the culture supernatant with palatinose is two times lower, the activities becomes equal after 28 h of growth, when the culture ends the exponential growth in the medium with glucose and is already in the stationary phase in the medium with palatinose (Fig. 1F and H). The cell density of the culture is equal (0.5 OD) after 12 h of growth in the medium with glucose and in the medium with inulin, but the antibacterial activity of the culture supernatant with inulin is 8 times lower. The antibacterial activity decreases two times after 16 h of growth in the medium with inulin and becomes undetectible after 20 h. It should be noted that the growth of the LA strain measuring the cell density of the cultures in the media with inulin and palatinose only slightly differs (1.25 times) (Fig. 1F). However, the antibacterial 40 1 Pranckutė R. et al. activity of culture supernatants with palatinose at those hours, when it is possible to evaluate the antibacterial activity of the supernatants with inulin, is at least 8 times higher (Fig. 1H). Discussion Three oligosaccharides were used in this work: palatinose and inulin, characterized by low caloricity and prebiotic properties, and α-cyclodextrin – practically not investigated as a component of synbiotics. The possibility to use these prebiotics in the development of synbiotics for healthy and especially for diabetic people, may be an effective mean for enhancement of the immune system and prevention of colon infections by pathogenic microorganizms. Probiotics are the second component of synbiotics. One of the ways by which probiotics may influence proliferation of pathogenic bacteria in the gastrointestinal tract are bacteriocins, secreted by them. In this work, it has been demonstrated that Lactobacillus sp. strains, isolated from “Activia” and “Bifi” yogurts, are bacteriocin producers. In solid medium clear transparent zones, indicating growth inhibition of the sensitive strain, independently of whether glucose or OS were used as an only carbon source, were obtained. However, no antibacterial activity was detected in the liquid media. According to the literature, there was shown, that in many cases LAB strains exhibits antibacterial activity on solid but not in liquid media. However, further investigations showed that most of these bacteriocins could be produced also in liquid media, but only under optimized conditions (MaldonadoBarragán et al., 2009). We did not succeed to obtain crude extracts of these bacteriocins, although all methodical procedures usual for bacteriocin extraction were carried out. However, the obtained PCR products suggests that they may be the newly characterized bacteriocins of L. casei ATCC 334 (Kuo et al., 2013). Furthermore, analysis results of the ability to ferment the used carbon sources and influence of microelements on the growth of A11 and B13 strains confirm the distribution of isolated lactobacilli strains into two physiological groups, compatible with BOX-PCR profiles and isolation sources. These results suggest that B group lactobacilli have specific genetic systems enabling them to ferment inulin. However, palatinose is not assimilated by strains belonging to both A and B groups. In the case of two type L. lactis and two type Lac tobacillus strains it was determined that in the growth media with different OS as an only carbon source L. lac tis subsp. lactis strains demonstrated good fermentation of α-cyclodextrin, almost equal to that of glucose. However, Lactococcus sp. strains differ in the efficiency of palatinose assimilation – LL stands out of all tested strains for the ability to ferment palatinose. It shows that this strain has specific enzymes, required for the transport and hydrolysis of this disaccharide. LS strain is totally unable to assimilate inulin and palatinose. On the other hand, LA strain ferments these OS inefficiently. Analysis of the influence of glucose, palatinose, inulin and α-cyclodextrin on the bacteriocin expression of LL and LL2 strains shows that in the case of glucose and α-cyclodextrin bacteriocins appear in the medium in the late stationary phase, which suggests that these antibacterial substances, according to PCR results – possibly nisin, are released into the growth medium during the lysis of cells. The analysis of isolated lactobacilli in the medium with inulin as an only carbon source show that this OS can be used as a prebiotic to create synbiotics with B group lactobacilli isolated from yogurts. According to the analysis of L. casei genomes, carried out by Broadbent and coworkers (2012), members of this species are able to ferment inulin. This and the results of 16S rDNA analysis suggest that our isolated strain B13 belongs to the L. casei species. Palatinose and LA strain could be used as synbiotics with the effective antibacterial activity. The same property would be characteristic of a synbiotic based on α-cyclodextrin and strain LL2. The presented results offer the possibility to create synbiotics on the basis of probiotics – Lactobacillus sp. and Lactococcus sp. and prebiotics – palatinose, inulin and α-cyclodextrin, which could regulate not only the growth of different lactobacilli and lactococci, but also the efficiency of their antibacterial activity. Acknowledgements This work was supported by the “ThermozymOS” project (Grant No. SVE-08/2011) of the Research Council of Lithuania. Literature Bosscher D., J. Van Loo and A. Franck. 2006. Inulin and ologofructose as prebiotics in the prevention of intestinal infections and diseases. Nutr. Res. Rev. 19(2): 216–26. Broadbent J.R., E.C. Neeno-Eckwall, B. Stahl, K. Tandee, H. Cai, W. Morovic, P. Horvath, J. Heidenreich, N.T. Perna, R. Barrangou and J.L. Steele. 2012. Analysis of the Lactobacillus casei supragenome and its influence in species evolution and lifestyle adaptation. BCM Genomics 13: 533. Chen Y.-S., S. Srionnual, T. Onda and F. Yanagida. 2007. Effects of prebiotic oligosaccharides and trehalose on growth and production of bacteriocins by lactic acid bateria. Lett. Appl. Microbiol. 45: 190–193. Digaitiene A., Å.S. Hansen, G. Juodeikiene, D. Eidukonyte and J. Josephsen. 2012. Lactic acid bacteria isolated from rye sourdoughs produce bacteriocin-like inhibitory substances active against Bacillus subtilis and fungi. J. Appl. Microbiol. 112: 732–742. Dobson A., P.D. Cotter, R.P. Ross and C. Hill. 2012. Bacteriocin Production: a Probiotic Trait? Appl. Environ. Microb. 78(1): 1–6. 1 Development of synbiotics with oligosaccharides and probiotic bacteria Gänzle M.G. and R. Fallador. 2012. Metabolism of oligosaccharides and starch in lactobacilli: a review. Food Microbiol. 340(3): 1–15. Gibson G.R. and M.B. Roberfroid. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125: 1401–1412. Goderska K., J. Nowak and Z. Czarnecki. 2008. Comparison of the growth of Lactobacillus acidophilus and Bifidobacterium bifidum species in media supplemented with selected saccharides including prebiotics. Acta Sci. Pol. 7(2): 5–20. Holub I., A. Gostner, S. Theis, L. Nosek, T. Kudlich, R. Melcher and W. Scheppach. 2010. Novel findings of the metabolic effects of the low glycaemic carbohydrate isomaltulose (PalatinoseTM). Brit. J. Nutr. 103: 1730–1737. Jo A., D. Nakata, K. Terao, M. Otani and K. Sano. 2007. New Synbiotics by the combination of α-cyclodextrin and lactic acid bacteria, Proceedings of 25th Cyclodextrin Symposium in Japan Tottori, Japan. p. 144–145. Kormin S., G. Rusul, S. Radu and F.H. Ling. 2001. Bacteriocinproducing lactic acid bacteria isolated from traditional fermented food. Malays. J. Med. Sci. 8(1): 63–68. Kunová G., V. Rada, I. Lisová, Š. Ročková and E. Vilková. 2011. In vitro Fermentability of Prebiotic Oligosaccharides by Lactobacilli. Czech. J. Food Sci. 29(Special Issue): 49–54. Kuo Y.-C., C.-F. Liu, J.-F. Lin, A.-C. Li, T.-C. Lo and T.-H. Lin. 2013. Characterisation of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334. Appl. Microbiol. Biotechnol. 97(1): 237–246. Macfarlane G.T., H. Steed and S. Macfarlane. 2008. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J. Appl. Microbiol. 104: 305–344. Maldonado-Barragán A., J.L. Ruiz-Barba and R. Jiménez-Díaz. 2009. Knockout of three-component regulatory systems reveals that the apparently constitutive plantaricin-production phenotype shown by Lactobacillus plantarum on solid medium is regulated via quorum sensing. Int. J. Food Microbiol. 130(1): 35–42. Millette M., G. Carnut, C. Dupont, F. Shareck, D. Archambault and M. Lacroix. 2008. Capacity of Human Nisin-and PediocinProducing Lactic Acid Bacteria To reduce Intestinal Colonization by Vancomycin-Resistant Enterococci. Appl. Environ. Microbiol. 74(7): 1997–2003. Ooi L.-G. and M.-T. Liong. 2010. Cholesterol-Lowering Effects of Probiotics and Prebiotics: A Review of in Vivo and in Vitro Findings. Int. J. Mol. Sci. 11: 2499–2522. Pan X., T. Wu, L. Zhang, L. Cai and Z. Song. 2009. Influence of oligosaccharides on the growth and tolerance capacity of lactobacilli 41 to simulated stress environment. Lett. Appl. Microbiol. 48: 362–367. Patel S. and A. Goyal. 2012. The current trends and future perspectives of prebiotics research: a review. 3 Biotech 2: 115–125. Roberfroid M.B. 2007. Inulin-Type Fructans: Functional Food Ingredients. J. Nutr. 137: 2493S–2502S. Rodríguez J.M., L.M. Cintas, P. Casaus, A. Suárez and P.E. Hernández. 1995. PCR Detection of the Lactocin S Structural Gene in Bacteriocin-Producing Lactobacilli from Meat. Appl. Environ. Microbiol. 61(7): 2802–2805. Sambrook J. and D.W. Russell. 2001. Molecular cloning; a laboratory manual. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory. Saminathan M., C.C. Sieo, R. Kalavathy, N. Abdullah and Y.W. Ho. 2010. Effect of prebiotic oligosaccharides on growth of Lactobacillus strains used as probiotic for chickens. Afr. J. Microbiol. Res. 5(1): 57–64. Swetwiwathana A., T. Zendo, J. Nakayama and K. Sonomoto. 2009. Identification of Nisin Z producing Lactococcus lactis N12 associated with traditional Thai fermented rice noodle (Kanom Jien). As. J. Food. Ag-Ind. 2(02): 116–125. Szejtli J. 2004. Past, present and future of cyclodextrin research. Pure Appl. Chem. 76(10): 1825–1845. Ueno C., A. Jo, D. Nakata, K. Terao, M. Otani, K. Sano, T. Oshima and N. Naeda. 2012. Enhacement of Antibacterial Activity of Manuka Honey on Periodontal Pathogenic Bacteria with α-Cyclodextrin, Proceedings of 29th Cyclodextrin Symposium. Hoshi univ., Tokyo, Japan. p. 198–199. del Valle E.M.M. 2004. Cyclodextrins and their uses: a review, Pro cess Biochem. 39(9): 1033–1046. Vamanu E. and A. Vamanu. 2010. The influence of prebiotics on bacteriocin synthesis using the strain Lactobacillus paracasei CMGB16. Afr. J. Microbiol. Res. 4(7): 534–537. Vera Pingitore E., E. Salvucci, F. Sesma and M.E. Nader-Macías. 2007. Different strategies for purification of antimicrobial peptides from Lactic Acid Bacteria (LAB), p. 557–568. In: Mendez-Vilas A. (Ed.). Communicating Current Research and Education Topics and Trends in Applied Microbiology. Microbiology Series n° 1, Vol. 2. Formatex, Spain. Wagner E.M., K.-L.C. Jen, J.D. Artiss and A.T. Remaley. 2008. Dietary alpha-cyclodextrin lowers LDL-C and alters plasma fatty acid profile in LDLr-KO mice on a high-fat diet. Metabolism 57(8): 1046–1051. Zhang H.-M., Z. Li, K. Uematsu, T. Kobayashi and K. Horikoshi. 2008. Antibacterial activity of cyclodextrins against Bacillus strains. Arch. Microbiol. 190: 605–609. Polish Journal of Microbiology 2014, Vol. 63, No 1, 43–49 ORIGINAL PAPER Uropathogenic Escherichia coli Isolates with Different Virulence Genes Content Exhibit Similar Pathologic Influence on Vero Cells JAMIL M.A.S. OBAIDA, *, SAMIRA R. MANSOURB, MOHAMMED S. ELSHAHEDYC, TARIK E. RABIED and ADEL M.H. AZABE a Medical Research Institute, Alexandria University, Egypt; b Faculty of Science, Suez Canal University, Egypt Faculty of Veterinary Medicine, Suez Canal University, Egypt; d Faculty of Agriculture, Suez Canal University, Egypt e Veterinary Serum and Vaccine Research Institute Abbasia-Cairo, Egypt c Submitted 11 January 2013, revised 27 February 2013, accepted 18 October 2013 Abstract Uropathogenic Escherichia coli are the major causative agent of urinary tract infection – they may simultaneously express a number of virulence factors to cause disease. The aim of this study was to investigate the relation between virulence factors content of fifteen UPEC isolates and their pathogenic potential. The isolates belonged to the five serotypes O78:K80, O114:K90, O142:K86, O164 and O157. Nine of the virulence factors have been explored, ibeA, pap, sfa/foc, cnf1, hly, fyuA, pil, ompT and traT. Virulence factors profiling of the isolates revealed a different content ranging from 22% to 100% of the virulence genes explored. The pathogenic capacity of all fifteen isolates when tested on Vero cells showed that the cytotoxicity for all tested strains on Vero cells was approximately equal and enhanced after growth in syncase broth, leading mainly to cell lysis. The toxic effects reduced slightly after heat treatment of the toxin, and greatly after formalin detoxification, but not all the deleterious effect was abolished. Endotoxin also has cytotoxic effects on Vero cells, but longer time is needed for cytolysis which is greatly diminished with formalin treatment. In conclusion, our study revealed that pathogenic strains of UPEC can exert their pathogenic effect on live cells or system with limited virulence factors gene content. K e y w o r d s: cytolysis, UPEC, urinary tract infection, Vero cells, virulence factors Introduction Urinary tract infections (UTI) are probably the most common bacterial infections. Bacteria responsible for UTI often originate from the faecal and perineal flora. Under normal circumstances, these bacteria are cleared from the urinary system by effective protective mechanisms. If, however, they overcome these mechanisms, they can colonize the lower urinary tract. Subsequent progress is determined by the host susceptibility and bacterial virulent factors (Kaper et al., 2004; Wullt, 2002). Several in vitro and in vivo models of infection have provided insights into the progression of uropathogenic Escherichia coli (UPEC)-induced UTI (Justice et al., 2004). The unique ability to colonize different sites and to cause a UTI is potentially due, at least in part, to the versatile genome of UPEC, which are able to remodel their genetic repertoire by acquiring and losing virulence attributes. A number of virulence determinants facilitate the ability of UPEC to colonize the urinary tract and exert cytopathic effects, including type 1 fimbriae, P fimbriae, Dr adhesins, hemolysin, cytotoxic necrotizing factor 1, flagella, capsule polysaccharide, lipopolysaccharide O antigen, and iron transport systems (Hagan and Mobley, 2007; Slavchev et al., 2009). The distribution of virulence properties can also vary depending on host characteristics and type of infection. It has been found that these virulent genes are the distinguishing factor between pathogenic and non-pathogenic strains of E. coli (Bisi-Johnson et al., 2011). According to the conventional notion pathogens can develop from commensals by acquisition of virulence-associated genes located for example on pathogenicity islands or plasmids, and the commensal-to-pathogen shift in E. coli is bi-directional (Klemm et al., 2007). The question is how many virulent genes are sufficient for UPEC to produce pathogenic properties? To give insight for answering this question, we studied many UPEC strains freshly isolated from patients with urinary tract infection after complete cultural, biochemical and serological identification, explored them * Corresponding author: J. M.A.S. Obaid; Alexandria, 151 Abdelnaser St. Egypt; phone: 002-01140644194; e-mail: jamilobaid@ yahoo.com 44 1 Obaid J.M.A.S. et al. for virulence factor genes and studied the pathogenic effect of their cell-free culture supernatant in vitro on tissue culture of Vero cells (green monkey kidney cells). Experimental Materials and Methods Sample collection. A total of 15 UPEC isolates obtained in counts of > 105 cfu/ml and in pure growth, from routine urine cultures (William and Parasuraman, 2001) of urinary tract infected patients presenting to the urology department in Ismailia university hospital, Suez canal university, Egypt. Identification of isolates was done using standard microbiological techniques (Cheesbrough, 1993). Serotyping for each pathogenic strain was performed by standard techniques as described by Ørskov and Ørskov (1984) using a commercial kit of Denka Seiken Co. LTD. Virulence factor profiling with PCR. DNA was extracted from UPEC isolates cultured on Luria broth, with spin column according to the instructions of the manufacturer Bioer co. China. Amplification was performed in a 25 µl reaction mixture containing 8 µl of DNA template, 0.1 µl of each of nine primers (0.1–0.2 µM) from Bio Basic Inc., Canada and 8 µl of ready to go master mix 1X (containing thermostable DNA polymerase, dNTPs, reaction buffer with (NH4)2SO4, MgCl2 and Triton X-100, stabilizers) from Jena Bioscience co., Germany. PCR tubes were filled to 25 μl volume with PCR-grade water.The reaction was carried out in a PCR thermal cycler (Techgen co., USA) according to Takahashi et al. with modification in the following schedule: preheating at 94°C for 10 min followed by 32 cycles of denaturation at 94°C for 1 min, annealing at 60°C or 55°C, and extension at 72°C for 2 min, with a final extension at 72°C for 7 min (Table I). The PCR products were electrophoresed on 2% agarose gels, then stained with ethidium bromide, and examined under UV transillumination (Takahashi et al., 2006). Tissue culture preparation (Vero cells). Vero cells were supplied as 90% confluent monolayer sheet in growth medium with10% new born calf serum. The confluent monolayer sheet was trypsinized with trypsin-versin 0.25% to separate the individual cells. The cells were distributed in tissue culture microtiter plate in which each well contained 103 cell/ml and were cultivated at 37°C in a 5% CO2 atmosphere until the monolayer was confluent. Exotoxin production. The selected strains were seeded in nutrient and syncase broth and then incubated for 24 h at 37°C in rotary shaker. Cultures were later centrifuged at 1800 xg for 30 min. The superna- tants were then filtered through 0.22 mm Millipore filters. Two parts of exotoxins from syncase broth for each isolates were treated with heat and formalin. Endotoxin production. Endotoxin was obtained following the procedure of Clugston and Nielson, in which bacterial suspension was harvested in PBS, and the toxin obtained after ten cycles of freezing and thawing (Culgston and Nielsen, 1974). One part of endotoxin for each isolate was formalin treated. Toxigenicity test in cell cultures. Toxin preparations were added to the cell culture in maintenance medium consisting of MEM supplemented with 2% fetal bovine serum (Caprioli et al., 1983; Slavchev et al., 2009). The assays were incubated for 24 h at 37°C. The control consisted of cell monolayer containing maintenance media, PBS, nutrient broth, syncase broth or 0.05% formalin alone after staining, cells were examined with inverted microscope (Olympus 1X70-S8F2, Olympus Optical Co., LTD. Japan). Results Serotypes. The 14 UPEC isolates belonged to 5 serogroups, while one of the isolate had no detectable reaction when available somatic and capsular antigens reagent were tested. This strain was identified as untypable. Five of these isolates have antigenic formula O78:K80 which represented 33% of the isolates and four isolates have antigenic formula O114:K90 (27% of the isolates). However, two of the isolates were with antigenic formula O142:K86 (13% of the isolates). Another two of the isolates were O164 antigen (13% of the isolates) and one isolate with formula O157 somatic antigen (7% of the isolates) and neither of them with unidentified capsular antigen (Table II). Virulent factor gene profiles of UPEC isolates. Nine virulent factor genes were explored for all fifteen UPEC isolates. Of the fifteen strains obtained only one (strain 11) carried all tested virulent gene factors. However, two strains showed the presence of 78% of tested genes, and other two UPEC strains showed 67% of the nine virulent genes. Four strains showed evidence for pathogenicity by detection of the most virulence gene factors, which represent 56% of the tested genes. Among the rest of the UPEC strains, four strains showed the presence of 44% of virulence gene factors, and two strains showed fewer virulence gene, i.e. 22% and 33%, respectively. The distribution patterns of virulent factor genes of our isolated UPEC strains are presented in Table II. The high prevalence one is traT gene, with 100% frequency within tested strains, followed by fyuA which was 93%. The third most prevalent gene was ompT gene with incidence of 87%. Genes with lower incidence among 605’-CCCGGGTCATAGTGTTCATC-3’ 605’-CACGGTTCAGCCATCCCTGAG-3’ 207 pil ompT 559 traT 290 5’-AACAAGGATAAGCACTGTTCTGGCT-3’ Pap sfa/foc cnf1 hly ompT traT fyuA VG content (%) 801353 401387 100 9327 O114 K90 O78 K80 O78 K80 O114 K90 O78 K80 O164 k Untypable +–– ––+ ++– 44 ––– ––+ ++– 33 O142 K86 O157 k Untypable +–++–+ ++– 67 ––++–+ ++– 56 O114 K90 O164 k Untypable +–++–+ ++– 67 +–– +–+ ++– 56 O142 K86 O114 K90 Untypable O78 K80 3 4 5 6 7 8 9 10 11 12 13 14 15 Gene’s incidence (%) – + – – + + + + 56 +–++–+ +++ 78 +++ +++ +++ 100 +–+ ––– ++– 44 +++ ––+ +++ 78 – +–– –++ ++– 56 +–– ––+ ++– 44 +–– ––– +–– 22 O78 K80 +–– ––+ ++– 44 Pil Virulence genes (VG) ibeA 5’-GGTGTGGTGCGATGAGCACAG-3’ 5’-ATCTAGCCGAAGAAGGAGGC-3’ 5’-CATTCGCCTGTAAAACCGCC-3’ 5’-TGATTAACCCCGCGACGGGAA-3’ 2 UPEC serotypes ibe f/r Primer used traT f/r ompT-f/r fimH f/r FyuA f/r hly 1/2 cnf 1/2 5’-CTCCGGAGAACTGGGTGCATCTTAC-3’ sfa/foc 1/2 5’-AAGATGGAGTTTCCTATGCAGGAG-3’ 1 Strain No. 605’-ATAACACGCCGCCATAAGCC-3’ FyuA 880 5’-AGGCAGGTGTGCGCCGCGTAC-3’ Forward sequence 5’-GCAACAGCAACGCTGGTTGCATCAT-3’ pap 3/4 Table II Distribution of virulent genes within UPEC serotypes and gene’s incidence rate. 60 555’-CGCAGTAGGCACGATGTTGTA-3’ hly 1,177 5’-ACCATATAAGCGGTCATTCCCGTCA-3’ 605’-CGGAGGAGTAATTACAAACCTGGCA-3’ 605’-CATTCAGAGTCCTGCCCTCATTATT-3’ cnf1 498 sfa/foc 410 555’-TGGTGCTCCGGCAAACCATGC-3’ 605’-AGAGAGAGCCACTCTTATACGGACA-3’ 170 Reverse sequence 336 Annealing Temp. °C pap Product size (bp) ibeA VF gene Table I Virulence factors genes primer sets used for PCR. Johnson & Stell, 2000 Johnson et al., 2000 Tseng et al., 2001 Johnson & Stell, 2000 Yamamoto et al., 1995 Yamamoto et al., 1995 Yamamoto et al., 1995 Yamamoto et al., 1995 Johnson & Stell, 2000 Reference 1 Uropathogenic E. coli isolates with different virulence genes 45 46 1 Obaid J.M.A.S. et al. Fig. 1. Normal Vero cell monolayer after incubation for 24 hours with sterile broth. 300X the detected virulent gene factors were 27% for ibeA and 13% for both hly and pap. Cytotoxic effects of UPEC on Vero cells. Cytopathic effects were observed in 15 culture filtrates and endotoxin preparations of UPEC strains. After incubation there were changes from monolayer spindle-shaped cells characteristic of normal Vero cells to abnormal shapes and arrangements, in addition to complete lysis which represented the major cytopathological effect (Fig. 1 and 2). These effects are expressed as percentage and cytopathological scores for comparison. Percent of lysed cells on nutrient broth compared to syncase broth showed that significant higher numbers of lysed cells were observed in syncase broth as untreated exotoxin. However, treated filtrates, for all strains, showed significantly less virulence compared to the same syncase broth growth medium of untreated filtrate. Formalin treated-filtrates showed less pathologic effect compared to untreated filtrates, obtained from cells grown in syncase broth, or to heat-treated filtrates. All UPEC strains showed 100% cell lysed after incubation for 24 hrs except for strains 2 and 9 which showed 80% lysis when grown in syncase broth. Generally, we can conclude that cytopathic effects were varied among the UPEC strains when grown in nutrient broth but less virulent effect when compared to those recorded in syncase broth or heat-treated filtrates. When exotoxins obtained from Syncase broth were treated with heat, the complete lysis of cells decreased Fig. 2. Complete Vero cell lysis with debris after incubation with exotoxin of UPEC isolate prepared in syncase broth for 24 hours. 300X to approximately 50–70% lysis with debris. The remaining cells showed some distortions of the cytoplasm with conserved nuclei and clumped chromatin but still even a short rim of cytoplasm around. When treating the UPEC exotoxins obtained from syncase broth with formalin, the cell lysis decreased to about 10–20% in all UPEC strains and the monolayer kept its general architecture. Few cells show slight enlargement, and some showed loss of nuclear or cytoplasmic membrane. Few cells showed with cell dendrites. The cytopathological effect of untreated UPEC endotoxins on Vero cells is shown in Fig. 3. It’s mainly effects were pathological changes with no cell lysis. The Vero cell monolayer sheet with most strains lead to lost their communication and makes the cells to be separated with shrinking. Most cells were distorted without distinction between nucleus and cytoplasm. Most of the cytoplasm was taken up by vacuolation. When the cell lysate was treated with formalin the most pathological changes disappeared. Discussion Pathogenesis is a multi-factorial process which depends on the immune status of the host, the nature of the species or strain and the number of organisms in the initial exposure. The pathogenic mechanisms of urinary tract infection have already been investigated 1 Uropathogenic E. coli isolates with different virulence genes Fig. 3. Vero cell shrinkage after incubation with untreated endotoxin of UPEC isolate for 24 hours, no discrimination between nucleus and cytoplasm. 300X in detail. UPEC strains initiate infection by binding to the superficial bladder epithelial cells that line the luminal surface of the bladder. This adherence prevents the pathogen from being washed out by the urine flow. Subsequently, bladder cells internalize the UPEC, a process that is considered an escape mechanism to protect the bacteria from the host immune system. However, internalization causes exfoliation of the superficial bladder cells harboring internalized bacteria into the urine. Before clearance, intracellular bacteria start to replicate and induce host cytokine responses, leading to the symptoms of UTI (Marquis et al., 1995; Schilling et al., 2001; Mulvey, 2002; Schmidt and Hensel, 2004). UPEC strains express a collection of strain-specific anti-host weapons called virulence markers (that include virulence factors), these markers specified bacteria to be pathogenic as mentioned later. The five serogroups were classified toxigenic E. coli either O78 and O114, pathogenic E. coli O142, O157 or O114 and invasive E. coli as O164 according to the classification described by Scheutz and Strockbine (Scheutz and Strockbine, 2001). Most of them were isolated previously from urine cultures of UTI patients (Olesen et al., 1994; Gonzalez et al., 1997; Klapproth et al., 2000; Abullah and Al-Moslih, 2005; Ananias and Yano, 2008). E. coli O157 which is mainly enterohaemorrhagic pathotype, isolated here from urine may be a transmission from the intestine, as in India there was a urinary Gram negative isolate, which studied by 47 sequencing and phylogenetic analysis showed 100% similarity to reference strain E. coli O157 (Nandy et al., 2007). Other evidence for the suspected uropathogenicity of this strain was the sharing of 41.8% of genes not found in K12 (non-pathogenic strain) with the prototype CFT073 UPEC (Landraud et al., 2004). Cytotoxic effect of UPEC toxin on Vero cells using different media and different treatment is a good and applicable effect study for pathogenicity extent of UPEC in vitro, which yielded a wide array of cytopathological effects worthy to be studied. Using Syncase broth in the production of exotoxin, it was striking because of great difference and severity in cytopathological effects compared with that produced upon using nutrient broth. This may attribute to the increased production of toxins with casamino acids, which is the major constituent of syncase broth with low carbohydrate and iron. Increased toxin up to three fold with this media was proved with recombinant cholera toxin previously (Osek et al., 1995). These toxins caused a complete Vero cell lysis, and this strong effect persists with small concentrations of toxins. The toxins produced by UPEC here were thought to be more than one type because some of these Verotoxins (toxic to Vero cells) was detoxified with heat while others detoxified with formalin, the last one was still effective even after formalinization, in contrast with known Vero toxin and Shiga toxin, which were inactivated by heat (Caprioli et al., 1983; Carbonell et al., 1997; Speirs et al., 1997). Vero cells cytopathic effect of treated toxin in non lysed cells presented as enlarged cells, cell membrane change and little nuclear membrane change. Freeze-thaw lysate affects cell as a whole leading to inability to distinguishing the cytoplasm and nucleus. These may be due to cell preparation for apoptosis, vacuolation and loss of continuation between cells present may enhance this suggestion. This effect was negated after endotoxin formalinization. In essence, the ability of pathogenic bacteria to cause disease in a susceptible host is determined by multiple virulent factors acting individually or together at different stages of infection, so bacteria equipped with virulent genes coded for these VFs. Several of these virulent genes are involved in increasing the pathogen’s fitness and adaptability. Some researchers described the use of VFs genes content for the prediction of UTI status. Johnson et al., (2005) found that the predictors of pyelonephritis included three traditionally recognized uropathogenic traits adhesins genes (pap, afa/dra, and sfa/ foc), and meningitis-associated trait (ibeA). Vranes et al. noted that the strains isolated from patients with acute pyelonephritis were found to mostly express all five or four virulence markers (O-serogroup, adhesin 48 Obaid J.M.A.S. et al. type, motility, production of hemolysin, and the amount of capsular polysaccharide antigen) tested, while the less virulent strains were detected in the group of patients with chronic pyelonephritis. The lowest virulence was observed among the strains isolated in the group of patients with asymptomatic bacteriuria (Vranes et al., 2001). To what extent can these VFs bring about the net pathological effect? We investigated VFs genes or socalled pathogenicity genes content of the isolates. It was obvious that for all isolates with a different content of VFs genes, all were produce a destructive pathogenic effect (complete cell lysis) on Vero cells equally, i.e. no significant difference between those isolates with high VFs gene content and those with low VFs gene. In vivo other conditions affect the environment of infection. As one can see, cytotoxins, secretion systems, fimbriae and others can be virulent factors in some conditions, colonization factors in other conditions and symbiosis factors in yet other conditions. Pathogenic and commensal microorganisms appear to employ similar or even identical molecular mechanisms to express their pathogenic or symbiotic potential (Hentschel et al., 2000). In particular, both pathogenic and symbiotic bacteria must actively manipulate the host immune system to make it possible for them to colonize the body. Any microorganisms will be pathogenic or commensal in a given context, under given conditions. It is the interplay between the context and the intrinsic features of a microbe that make it pathogenic or safe (Swiatczak et al., 2011). The major conclusion of our study is that pathogenic strains of UPEC can exert their pathogenic effect on living cells or systems with a few amount of virulent factors gene content in a given condition with a given context of host factors and molecules in the environment. Disclosures The authors have no financial conflicts of interest. Literature Abdullah A.A. and M.I. Al-Moslih. 2005. Prevalence of asymptomatic bacteriuria in pregnant women in Sharjah, United Arab Emirates. East Mediterr. Health J. 11: 1045–1052. Ananias M. and T. Yano. 2008. Serogroups and virulence genotypes of Escherichia coli isolated from patients with Sepsis. Braz. J. Med. Biol. Res. 41: 877–883. Bisi-Johnson M.A., C.L Obi, S.D. Vasaikar, K.A. Baba and T. Hattori. 2011. Molecular basis of virulence in clinical isolates of Esche richia coli and Salmonella species from a tertiary hospital in the Eastern Cape, South Africa. Gut Pathog. 3: 9. Caprioli A., V. Falbo, L.G. Roda, F.M. Ruggeri and C. Zona. 1983. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. Infect. Immun. 39: 1300–1306. 1 Carbonell G.V., A.F. Alfieri, A.A.M. Alfieri, M.C. Vidotto, C.E. Levy, A.L.C. Darini and R.M. Yanaguita. 1997. Detection of cytotoxic activity on Vero cells in clinical isolates of Serratia marces cens. Braz. J. Med. Biol. Res. 30: 1291–1298. Cheesbrough M. 1993. Medical laboratory manual for tropical countries, vol II. 2nd ed. ELBS, University Press Cambridge, Great Britain. Clugston R.E. and N.O. Nielsen. 1974. Experimental edema disease of swine (E. coli Enterotoxemia). I. Detection and preparation of an active principle. Can. J. Comp. Med. 38: 22–28. Gonzalez R., C. Diaz, M. Marino, R. Cloralt, M. Pequeneze and I. Perez-Schael. 1997. Age-specific prevalence of Escherichia coli with localized and aggregative adherence in Venezuelan infants with acute diarrhea. J. Clin. Microbiol. 35: 1103–1107. Hagan E.C. and H.L. Mobley. 2007. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect. Immun. 75: 3941–3949. Hentschel U., M. Steinert and J. Hacker. 2000. Common molecular mechanisms of symbiosis and pathogenesis. Trends Microbiol. 8: 226–231. Johnson J.R., T.T. O’Bryan, D.A Low., G. Ling, P. Delavari, C. Fasching, T.A Russo, U. Carlino and A.L. Stell. 2000. Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele 3. Infect. Immun. 68: 3327–3336. Johnson J.R. and A.L. Stell. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181: 261–273. Johnson R.J., K. Owens, A. Gajewski and M.A. Kuskowski. 2005. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J. Clinic. Microbiol. 43: 6064–6072. Justice S.S., C. Hung, J.A. Theriot, D.A. Fletcher, G.G. Anderson, M.J. Footer and S.J. Hultgren. 2004. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. PNAS 101: 1333–1338. Kaper J.B., J.P. Nataro and H.L. Mobley. 2004 Pathogenic Esche richia coli. Nat. Rev. Microbiol. 2: 123–140. Klapproth J.A., I.C.A.Scaletsky, B.P. Mcnamara, L. Lai, C. Malstrom, S.P. James and M.S. Donnenberg. 2000. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect. Immun. 68: 2148–2155. Klemm P., V.Hancock and M.A. Schembri. 2007. Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect. Immun. 75: 3688–3695. Landraud L., C.Pulcini, P.Gounon, G. Flatau, P.Boquet and E. Lemichez. 2004. E. coli CNF1 toxin; a two-in-one system for hostcell invasion. Int. J. Med. Microbiol. 293: 513–518. Marquis H., V. Doshi and D.A. Portnoy. 1995. The broad-range phospholipase C and a metalloprotease mediate listeriolysin O-independent escape of Listeria monocytogenes from a primary vacuole in human epithelial cells. Infect. Immun. 63: 4531–4534. Mulvey M.A. 2002. Adhesion and entry of uropathogenic Esche richia coli. Cell. Microbiol. 4: 257–271. Nandy P., A.R.Thakur and S.R. Chaudhuri. 2007. Characterization of bacterial strains isolated through microbial profiling of urine samples. J. Biol. Sci. 7: 44–51. Olesen B., H.J. Komos, F. Orskov and I. Orskov. 1994. Cluster of multiresistant Escherichia coli O78:H10 in Greater Copenhagen. Scand. J. Infect. Dis. 26: 406–410. Ørskov F. and I. Ørskov. 1984. Serotyping of Escherichia coli. Methods Microbiol. 14: 43–112. Osek J., M. Lebens and J. Holmgren. 1995. Improved medium for large-scale production of recombinant cholera toxin B subunit for vaccine purposes. J. Microbiol. Methods 24: 117–123. 1 Uropathogenic E. coli isolates with different virulence genes Scheutz F. and N. Strockbine. 2001. Genus Escherichia, In: Bergey’s manual of Systematic Bacteriology, 2nd ed. volume 2 part B, Springer USA. Schilling J.D., M.A. Mulvey and S.J. Hultgren. 2001. Dynamic interactions between host and pathogen during acute urinary tract infections. Urology 57(6 Suppl 1): 56–61. Schmidt H. and M. Hensel. 2004. Pathogenicity islands in bacterial pathogenesis. Clin. Microbiol. Rev. 17: 14–56. Slavchev G., E. Pisareva and N. Markova. 2009. Virulence of uropathogenic Escherichia coli. J. Cult. Collect. 6: 3–9. Speirs J.I., S. Stavric and J. Konowalchuk. 1997. Assay of Esche richia coli heat-labile enterotoxin with Vero cells. Infect. Immun. 16: 617–622. Swiatczak B., M. Rescigno and I.R. Cohen. 2011. Systemic features of immune recognition in the gut. Microbes Infect. 13: 983–991. Takahashi A., S. Kanamaru, H. Kurazono, Y. Kunishima, Y. Tsukamoto, O. Ogawa and S. Yamamoto. 2006. Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, viru- 49 lence genes, and O-serogroup profiles. J. Clinic. Microbiol. 44: 4589–4592. Tseng C.C., J.J. Huang, W.C. Ko, J.J. Yan and J.J. Wu. 2001. Decreased predominance of papG class 2 allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities. J. Urol. 166: 1643–1646. Vranes J., S. Schonwald, N. Sterk-Kuzmanoviæ and B. Ivanèiæ. 2001. Low virulence of Escherichia coli strains causing exacerbation of chronic pyelonephritis. Acta clin. Croat. 40: 165–170. Williams P.J. and M. Parasuraman. 2001. Urine. In: Myer’s and Koshi’s Manual of Diagnostic Procedures in Medical Microbiology and Immunology/Serology. Vellore: Department of Microbiology, Christian Medical College and Hospital. pp. 57–62. Wullt B. 2002. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int. J. Antimicrob. Agents 221: 605–621. Yamamoto S., A. Terai K. Yuri H. Kurazono Y. Takeda and O. Yoshida. 1995. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol. Med. Microbiol. 12: 85–90. Polish Journal of Microbiology 2014, Vol. 63, No 1, 51–56 ORIGINAL PAPER Novobiocin Sensitivity of Salmonella typhimurium dam and/or seqA Mutants ABDELWAHEB CHATTI1*, MERIEM ALOUI2, JIHEN TAGOURTI2, MOUADH MIHOUB2 and AHMED LANDOULSI2 Laboratoire de traitement des eaux usées, Centre des Recherches et Technologies des Eaux, Technopole Borj-cédria, BP 273- Soliman 8020 2 Laboratoire de Biochimie et Biologie moléculaire, Faculté des Sciences de Bizerte, Faculté des Sciences de Bizerte, Zarzouna 7021, Université de Carthage, Tunisie 1 Submitted 4 January 2013, revised 22 August 2013, accepted 16 November 2013 Abstract This study was carried out to determine the effects of novobiocin, a gyrase inhibitor, on the growth, survival, motility and whole cell proteins of S. Typhimurium dam and/or seqA strains. Our results showed that the dam and seqA/dam mutants are the most sensitive to novobiocin, compared to wild type and seqA strains. Surprisingly, the motility of seqA mutants increased after exposure to novobiocin only in stationary phase cells. All the other strains showed a significant decrease in their motility. The analysis of protein profiles of all strains demonstrated several modifications as manifested by the alteration of the expression levels of certain bands. Our work is therefore of great interest in understanding the effects of novobiocin on S. Typhimurium and the involvement of DNA methylation. K e y w o r d s: Salmonella, DNA methylation, seqA, motility, novobiocin, proteins Introduction DNA methylation is a mechanism by which bacteria regulate gene expression and control several cellular processes such as transposition, DNA replication, segregation of chromosomal DNA and mismatch repair. It has been proved that Dam protein regulates gene expression and virulence of S. Typhimurium (Heithoff et al., 1999; Balbontin et al., 2006). Indeed, lack of Dam methylation disturbs the expression of std fimbriae. Heithoff et al. (Heithoff et al., 1999) have demonstrated that methylation at specific GATC sequences of promoters is crucial for transcription and alterations in the degree of methylation at promoter sequences may influence gene expression. Dam methyltransferase and regulatory proteins, such as Cap, Lrp, or OxyR compete for overlapping sites in or near promoters (Chatti and Landoulsi, 2008). Oshima et al. (2002) demonstrated that the promoters of most Dam controlled genes contained GATC sequences that overlap with recognition sites for fumarate nitrate reduction (Fnr) and catabolite activator protein (CAP) regulators. These authors suggested that the GATC network regulation takes place upstream of the coding sequences and that it is the consequence of an interaction with a regulatory protein like Fnr or CAP. Like the Dam methyltransferase, it has been demonstrated that seqA also profoundly affects the transcription of various genes (Lobner-Olesen et al., 2003). In Escherichia coli, the product of the seqA gene is the main negative regulator of chromosome replication initiation (Lu et al., 1994, Slater et al., 1995). SeqA protein binds preferentially to hemi-methylated GATC sites and sequesters the oriC region immediately after replication (Boye et al., 1996). SeqA can also specifically bind to fully-methylated GATC sequences, not only hemimethylated, if regions other than oriC are considered. Our previous results have demonstrated that lack of seqA attenuates the virulence of S. Typhimurium in the mouse model (Chatti et al., 2007). Jakomin et al. (2008) proved that std operon is regulated by SeqA protein. The effect of SeqA on plasmid topo logy has been also demonstrated (Norunn and Skarstad, 1999). Indeed, it has been shown that the seqA mutation increases negative superhelicity of chromosomal and plasmid DNA (Klungsøyr and Skarstad, 2004). So, these findings may reflect a similar effect of SeqA on chromosome topology. * Corresponding author: A. Chatti, Laboratoire de Traitement des Eaux Usées, Centre des Recherches et Technologies des Eaux, Technopole Borj-cédria, BP 273- Soliman 8020, Tunisie; phone: 216 79 325 199; fax: 216 79 325 802; e-mail: [email protected] 52 1 Chatti A. et al. It was demonstrated that novobiocin (a member of the coumermycin family of antibiotics) inhibits bacterial DNA replication and transcription. Novobiocin inhibits the DNA gyrase (Gellert et al., 1976), an enzyme that catalyzes the ATP-dependent introduction of negative superhelical turns into circular double-stranded DNA. Gyrase is needed for processes that require negatively superhelical DNA, such as DNA replication, transcription, DNA repair, and recombination (Chatterji et al., 2001). Also, it has been reported that novobiocin affects membrane integrity, nucleic acid synthesis, and cell wall synthesis (Smith and Davis, 1967). In this study, we investigated the effects of novobiocin treatment on the survival, motility and whole cell proteins of seqA and/or dam mutants of S. Typhimurium. Experimental Materials and Methods Bacterial strains and growth conditions. Bacterial strains used in this study, derived from the wild type strain S. Typhimurium 14028 are SV1610 (dam228::MudJ) SV4752 (ΔseqA1) and SV4784 (dam225::MudJ/ΔseqA1) (Jakomin et al., 2008). Overnight cultures of Salmonella were grown in nutrient broth (NB) medium and diluted into 50 ml of fresh sterile broth medium. Bacteria were routinely incubated in nutrient broth (NB) (Pronadisa, Spain) at 37°C overnight with shaking (200 rpm). Novobiocin was added at various concentrations directly to the flask and turbidity was monitored by measuring the optical density at 600 nm of the medium. Survival study. The strains to be tested were incubated overnight at 37°C in NB. Appropriate dilutions of bacteria (108 cfu/ml) were made in sterile PBS solution buffer containing various concentration of novobiocin or no drug (0, 80, 200 and 400 µg/ml) and incubated for 1 to 4 hours at room temperature. At the given time points, 100 µL of cultures were plated on Nutrient agar, after which the resulting colonies were counted and the fractional survival was calculated. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) determination by broth dilution. For MIC and MBC determinations, serial dilutions of novobiocin were prepared. The tubes were incubated at 37°C overnight with shaking and the highest dilution in which there were no growth was recorded as the MIC. For MBC testing, aliquots (20 µl) of broth from tubes containing no growth were plated onto solid medium and again incubated overnight at 37°C. The highest dilution in which there were no survivors was recorded as the MBC. In the above method, controls for each strain were performed using the sterile liquid medium without novobiocin. All MICs and MBCs were confirmed by triplicate assays. Motility assays. Bacterial strains were grown in NB broth at 37°C overnight with agitation. The bacteria were then diluted 1:100 with fresh NB and incubated at 37°C with shaking. Cells were considered to be in exponential and stationary phases when they reach an optical density of 0.5 and 1, respectively. Bacterial culture (50 μl) was spotted onto an NB plate with 0.3% agar and incubated at 37°C. The concentration of novobiocin used to study the motility of all strains was 200 µg/ml. The swimming motility was estimated by measuring the diameter of the bacterial zone after incubation at 37°C during 24 hours. Media used for swarming consisted of 0.5% bacto-agar with 8 g/liter nutrient broth, to which 5 g/liter glucose was added. Swarm plates were typically allowed to dry at room temperature overnight before being used. Whole cell proteins extraction. Pellets were resuspended in TRIS buffer (20 mM, pH 7.5) containing EDTA (5 mM) and MgCl2 (5 mM). The cells were lysed by sonication. The cell debris was removed by centrifugation at 14 000 × g for 10 min at 4°C. The supernatant containing extracted proteins was stored at –20°C until further analysis. Protein concentration was determined according to the method of Lowry (1959). Statistical. The experiment was repeated three times, and statistical significance was calculated using Student’s t test. Results Effect of novobiocin on the growth of mutants. To study the effect of the novobiocin on Salmonella growth, different concentrations ranging from zero to 400 µg/ml were tested. Compared with the control cell suspensions without novobiocin, we observed a modification of the classical cell growth curves of the different strains. Fig. 1 shows the basic phenomena observed in the inhibition of cell growth by novobiocin. The results showed that the antimicrobial activity of novobiocin increases with concentration. These two mutants do not reach the stationary phase after treatment with novobiocin at a concentration of 400 μg/ml. As the novobiocin concentration was increased, so did the duration of the lag phase whereas the rate of the growth after inhibition decreased and the cell density at which stationary phase was entered also decreased. The duration of the lag phase was proportional to the novobiocin concentration and variable according to the different Salmonella strains tested. Effects of novobiocin on the survival of the mutants. The percentage of strains’ survival was fol- 1 53 Novobiocin sensitivity of S. typhimurium dam and/or seq A Fig. 1. Growth kinetics of Salmonella typhimurium and its isogenic mutants (dam, seqA and dam/seqA) under different concentrations of novobiocin: 0 µg/ml (black square), 80 (without marker), 200 µg/ml (white triangle) and 400 µg/ml (X). lowed for 4 hours. Control strains were used for comparative study. Significant differences between all strains were mainly observed after treatment during 1 hour. The results obtained showed that the dam and seqA/dam strains are significantly more sensitive to novobiocin, compared to the other strains (Fig. 2). seqA mutant was significantly more resistant than dam and seqA/dam strains. Determination of MIC and MBC. The MIC and MBC values obtained are expressed in terms of the novobiocin concentration (Table I). The MIC values shown were determined by broth dilution. MICs range from 0.6 to 1.1 mg/ml of novobiocin. The MBC values range from 2 mg/ml to 5.6 mg/ml. The double mutant dam/seqA presents the lowest MBC value. Novobiocin alters the motility of mutants. The motility of novobiocin-treated bacteria was investigated (Fig. 3A). Statistical analysis showed significant differences in the motility of wild type, dam and seqA/dam at exponential phase after drug exposure. At stationary phase, significant difference was observed only in dam and dam/seqA strains (Fig. 3A). Effect of novobiocin on the whole cell proteins. The whole cell proteins of S. Typhimurium and its isogenic mutants were analyzed using SDS-PAGE. When comparing the whole cell preparations on SDS-PAGE, Table I MIC and MBC of novobiocin for Salmonella typhimurium (wild type) and isogenic seqA and/or dam mutants Fig. 2. Novobiocin sensitivity of Salmonella typhimurium and its isogenic seqA and/or dam mutants. Results mentioned are the means of three repetitions. The survival assay was estimated by counting the colony forming units (CFU). The experience was monitored for 4 hours. MIC (mg/ml) MBC (mg/ml) MBC/MIC WT 1.1 ± 0.11 5.6 ± 0.21 5.09 seqA 1.1 ± 0.14 5.0 ± 0.13 4.54 dam 0.6 ± 0.09 2.5 ± 0.13 4.16 dam/seqA 0.6 ± 0.05 2.0 ± 0.08 3.33 54 1 Chatti A. et al. Table II Ratio of protein levels in each strain before and after drug treatment. Only bands in Line L1 to L6 are analyzed. B: band, the number refers to the column. L1 L2 L3 L4 L5 L6 B1/B51.151.055 1.4031.23 1.1421.211 B2/B61.49 1.0001 1.220 1.042 3.05 0.607 B3/B7 1.27 1.0033 1.22 1.098 3.125 1.064 B4/B8 1.31 1.22131 1.33 1.185 3.21 1.222 of some proteins for all tested strains. Changes of protein bands are estimated by calculating the ratio of band area before and after novobiocin treatment. Table II shows the changes observed after drug treatment. Discussion Fig. 3. The motility of exponential (A) and stationary phase (B) cells treated (grey) and untreated (white) strains. * Significant difference (p < 0.05). changes in protein profiles were observed under the two growth conditions. Therefore, as shown in Fig. 4, changes were manifested either by disappearance or modification of the expression level. In the absence of novobiocin, the alteration of protein profiles of dam and/or seqA was manifested by modification of the expression level of certain bands. After exposure to novobiocin, we noted changes of the expression level Fig. 4. The whole cell proteins of Salmonella typhimurium and its isogenic dam and/or seqA mutants in the absence (Column 1 to 4) or presence (Column 5 to 8) of novobiocin. Column 1 and 5: WT, Column 2 and 6: dam: Column 3 and 7: seqA, Column 4 and 8: dam/seqA. Arrows indicated the lines which show the most bands alterations. It is well known that supercoiling can influence promoter activity (Wang and Lynch, 1993). Thus, DNA supercoiling affects binding of regulatory proteins, such as Dam and SeqA. In our previous work, we suggested that GATC sites could regulate virulence and stress response of S. Typhimurium (Chatti and Landoulsi, 2008). The growth of wild-type, dam, seqA and dam/seqA mutants were detected in the presence and absence of novobiocin. There was no difference in the growth rates between wild-type and seqA mutant str ains of S. Typhimurium in NB medium with or without novobiocin. However, our results showed that the growth of dam and seqA/dam was the most sensitive mutants. Soutourina et al. (2001) have demonstrated that novobiocin (200 and 400 µM) induces a small decrease of the growth rate for Pseudomonas and Enterobacter. E. coli dam mutant was previously shown to be more sensitive to novobiocin than the wild type strain (Onogi et al., 2000). To assess the effect of the seqA and/or dam deletions on the in vitro susceptibility to novobiocin, we determined the MICs and MBCs as well as the loss of viable counts after exposure to 400 µg/ml of novobiocin. The MICs of novobiocin were not affected by the seqA inactivation but decreased in dam and seqA/dam strains. The viable losses in time kill experiments confirm also that the seqA mutant is the most resistant compared to the dam and dam/seqA. Several studies have proved that dam strains are the most sensitive mutant toward many stresses such as hydrogen peroxide, bile (Chatti et al., 2012; Badie et al., 2007). However, all the mutants were more sensitive than the parent wild type strain. Therefore, novobiocin-induced gyrase inhibition can be expected to cause DNA strand breaks. Hence, it is not surprising that dam mutants, which suffer a basal level of MutHLS-induced DNA breaks, are more sensitive. Bacterial motility is a complex phenotype that is modu- 1 Novobiocin sensitivity of S. typhimurium dam and/or seq A lated by many regulators. In this study, we found that seqA mutants did not show significant defects in motility, unlike WT, dam and dam/seqA strains under this drug during exponential phase. The stationary culture of these strains demonstrated a significant increase of the motility of seqA mutant and a significant decrease in the motility of both of dam and seqA/dam mutants. However, the motility of WT strain did not change in the stationary phase. These findings suggest the implication of the nucleoid-associated protein FIS which modulate the dynamics of DNA supercoiling during the growth phase (Traversa et al., 2001). Fis promoter is activated by high negative superhelicity of the DNA in vivo and in vitro (Schneider et al., 2000). In addition, it has been proved that CRP-cAMP modulates fis expression and the inhibition of DNA gyrase represses the expression of several CRP-cAMP sensitive genes. Taken together, we can suggest that phase dependant motility especially for seqA mutant could be the consequences of a direct or indirect action of FIS and/or CRP-cAMP (Soutourina et al., 2002). The reduction in motility has been observed in E. coli in the presence of DNA gyrase inhibitors (Schneider et al., 2000). In the presence of novobiocin, a more than two fold decrease in the flhDC activity was obtained in E. coli (Soutourina et al., 2002). Also, inhibiting the DNA gyrase promotes the FimBmediating inversion from OFF to ON and therefore it was concluded that DNA supercoiling determines the directionality of the FimB-mediated recombination (Dove and Dorman, 1994). The decrease of motility in Salmonella in the presence of novobiocin supports the link between the DNA supercoiling and motility regulation. Therefore, motility could be modulated by alteration of DNA topology, resulting from interactions between Dam or SeqA and the regulatory regions. Whole cell proteins were investigated in the presence or absence of novobiocin. Our results showed that this drug alters the protein profiles of all strains. These changes as manifested by disappearance or modification of the expression levels of several bands. These data suggest that proteins of these strains are associated with growth and survival in the presence of novobiocin. The function of these proteins is subject to further investigation. However, changed proteins could be under the control of CRP-cAMP regulon. Further analysis by 2-DE would be needed for a better separation of proteins and more accurate estimation of sizes and to elucidate their role in bacterial response to novobiocin. In conclusion, we suggest the involvement of DNA supercoiling on the DNA methylation control of several cellular processes. The difference in the sensitivity toward novobiocin may be due to the fatty acid composition of the membrane of each strain. Further studies on the effects of gyrase inhibitors on virulence genes expression and the deletion of gyrA and/or gyrB in seqA 55 and/or dam mutants could help researchers to understand the relationship between DNA methylation and DNA supercoiling. Acknowledgment This work was supported by: «Ministère de l’Enseignement Supérieur; Faculté des Sciences de Bizerte-Département de Bio logie». We thank Pr. Casadesus J. for providing Salmonella strains. Literature Badie G., D.M. Heithoff, R.L. Sinsheimer and M.J. Mahan. 2007. Altered levels of Salmonella DNA adenine methylase are associated with defects in gene expression, motility, flagellar synthesis, and bile resistance in the pathogenic strain 14028 but not in the laboratory strain LT2. J. Bacteriol. 189: 1556–1564. Balbontín R., G. Rowley, M.G. Pucciarelli, J. López-Garrido, Y. Wormstone, S. Lucchini, F. García-del Portillo, J.C.D. Hinton and J. Casadesús. 2006. DNA adenine methylation regulates virulence gene expression in Salmonella enterica serovar Typhimurium. J. Bacteriol. 188: 8160–8168. Boye E., T. Stokke, N. Kleckner and K. Skarstad. 1996. Coordinating DNA replication initiation with cell growth: differential roles for DnaA and SeqA proteins. Proc. Natl. Acad. Sci. USA 93: 12206–12211. Chatterji M., S. Unniraman, S. Mahadevan and V. Nagaraja. 2001. Effect of different classes of inhibitors on DNA gyrase from Myco bacterium smegmatis. J. Antimicrob. Chemother. 48: 479–485. Chatti A., D. Daghfous and A. Landoulsi. 2007. Effect of seqA mutation on Salmonella typhimurium virulence. J. Infect. 54: e241–e245. Chatti A. and A. Landoulsi. 2008. The DNA-methylation state regulates virulence and stress response of Salmonella. C.R. Biol. 331: 648–654. Chatti A., N. Messaoudi, M. Mihoub and A. Landoulsi. 2012. Effect of hydrogen peroxide on the motility, catalase and superoxide dismutase of dam and/or seqA mutant of Salmonella Typhimurium. World J. Microbiol. Biotechnol. 28: 129–33. Dove S.L. and C.J. Dorman. 1994. The site-specific recombination system regulating expression of the type 1 fimbrial subunit gene of Escherichia coli is sensitive to changes in DNA supercoiling. Mol. Microbiol. 14:975–988. Gellert M., M.H. O’dea, T. ITOH and J-I. Tomizawa. 1976. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc. Natl. Acad. Sci. USA 73: 4474–4478. Heithoff D.M., R.L. Sinsheimer, D.A. Low and M.J. Mahan. 1999. An essential role for DNA adenine methylation in bacterial virulence. Science 284: 967–970. Jakomin M., D. Chessa, A.J. Baumler and J. Casadesus. 2008. Regulation of the Salmonella enterica std Fimbrial Operon by DNA Adenine Methylation, SeqA, and HdfR. J. Bacteriol. 190: 7406–7413. Klungsøyr H.K. and K. Skarstad. 2004. Positive supercoiling is generated in the presence of Escherichia coli SeqA protein. Mol. Microbiol. 54: 123–31. Lobner-Olesen A., M. Marinus and F. Hansen. 2003. Role of SeqA and Dam in Escherichia coli gene expression: a global microarray analysis. Proc. Natl. Acad. Sci. USA 100: 4672–4677. Lowry O.H., N.J. Rosenbrough and A.L. Farr. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–275. Lu M., J.L. Campbell, E. Boye and N. Kleckner. 1994. SeqA: a negative modulator of replication initiation in E. coli. Cell 77: 413–426. Norunn K.T. and K. Skarstad. 1999. Escherichia coli SeqA protein affects DNA topology and inhibits open complex formation at oriC. EMBO J. 18: 4882–4888. 56 Chatti A. et al. Onogi T., M. Yamazoe, C. Ichinose, H. Niki and S. Hiraga. 2000. Null mutation of the dam or seqA gene suppresses temperaturesensitive lethality but not hypersensitivity to novobiocin of muk null mutants. J. Bacteriol. 182: 5898–5901. Oshima T., C. Wada, Y. Kawagoe, T. Ara, M. Maeda, Y. Masuda, S. Hiraga and H. Mori. 2002. Genome-wide analysis of deoxyadenosine methyltransferase-mediated control of gene expression in Escherichia coli. Mol. Microbiol. 45: 673–675. Slater S., S. Wold, M. Lu, E. Boye, K. Skarstad and N. Kleckner. 1995. E. coli SeqA protein binds oriC in two different methyl-modulated reactions appropriate to its roles in DNA replication initiation and origin sequestration. Cell 82: 927–926. Schneider R., A. Travers and G. Muskhelishvili. 2000. The expression of the Escherichia coli fis gene is strongly dependent on the superhelical density of DNA. Mol. Microbiol. 38: 167–176. 1 Smith D.H. and B.D. Davis. 1967. Mode of Action of Novobiocin in Escherichia coli. J. Bacteriol. 93:71–79 Soutourina O.A., E.A. Semenova, V.V. Parfenova, A. Danchin and P. Bertin. 2001. Control of Bacterial Motility by Environmental Factors in Polarly Flagellated and Peritrichous Bacteria Isolated from Lake Baikal. App. Environ. Microbiol. 67: 3852–3859. Soutourina O.A., E. Krin, C. Laurent-Winter, F. Hommais, A. Danchin and P.N. Bertin. 2002. Regulation of bacterial motility in response to low pH in Escherichia coli: the role of H-NS protein. Microbiology 148: 1543–1551. Traversa A., R. Schneider and G. Muskhelishvili. 2001. DNA supercoiling and transcription in Escherichia coli : The FIS connection. Biochimie 83:213−217. Wang J.C. and A.S. Lynch. 1993. Transcription and DNA supercoiling. Curr. Opin. Genet. Dev. 3: 764–768. Polish Journal of Microbiology 2014, Vol. 63, No 1, 57–61 ORIGINAL PAPER The Antimicrobial Susceptibility of Helicobacter pylori Strains Isolated from Children and Adults with Primary Infection in the Lower Silesia Region, Poland GRAŻYNA GOŚCINIAK1, MONIKA BIERNAT1*, JOANNA GRABIŃSKA1, ALDONA BIŃKOWSKA1, ELŻBIETA PONIEWIERKA3 and BARBARA IWAŃCZAK2 1 Department of Microbiology, Wroclaw Medical University IInd Department and Clinic of Pediatric Gastroenterology and Nutrition, Wroclaw Medical University, 3 Department and Clinic of Gastroenterology and Hepatology, Wroclaw Medical University 2 Submitted 27 April 2013, revised 22 August 2013, accepted 16 November 2013 Abstract The resistance of microorganisms to antibiotics has become a serious issue in recent years in the therapy of bacterial infections. This problem also concerns the treatment of infections caused by Helicobacter pylori strains. The aim of this study was to evaluate the frequency of primary resistance of H. pylori strains isolated from children and adults. The subject of the research was 105 strains of H. pylori isolated from children and 60 strains from adults in the Lower Silesia Region in the years 2008–2011. Antimicrobial susceptibility to the following antibiotics was assessed: amoxicillin (AC), clarithromycin (CH), metronidazole (MZ), tetracycline (TC), levofloxacin (LEV) and rifabutin (RB). Among the strains isolated from children, 33.3% were resistant to CH, 44.8% to MZ whereas 1.9% of strains were resistant simultaneously to CH, MZ and LEV. Among 60 strains isolated from adults, 23.3% were resistant to CH, 66.7% to MZ, and 6.7% to LEV. Moreover, 16 multidrug resistant strains were isolated from adults, including 12 resistant to CH and MZ, 3 to MZ and LEV, and 1 to CH, MZ and LEV. All examined strains were susceptible to AC, TC and RB. The high incidence of resistance to CH and MZ suggests that standard triple therapies may not be useful as first-line treatment in Poland without earlier susceptibility testing. K e y w o r d s: Helicobacter pylori, adults, children, resistance Introduction Colonization of the human gastric mucosa with Helicobacter pylori induces chronic gastritis and peptic ulcer disease. In addition, H. pylori plays a role in pathogenesis of gastric cancer and cancer of the mucosa-associated lymphoid tissue (Mishra, 2012). Treatment of H. pylori infection usually includes a combination of two antimicrobial agents (among amoxicillin, metronidazole and clarithromycin) and a proton pump inhibitor or bismuth salts. The ideal antimicrobial therapy should have an eradication rate of at least 90% and a low incidence of significant side effects and the drugs should be available worldwide. However, more recent publications have suggested that this level has fallen alarmingly to around 70% in many areas and even as low as 60% in some other regions (Kadayifci et al., 2006). Attempts are being made to use traditional therapeutic patterns in combination with various probiotics, e.g. Lactobacillus acidophilus (Da Silva Mendeiros et al., 2011). The success of the therapy depends on several factors, but one of the most important seems to be the increasing resistance of H. pylori strains to antibiotics (Glupczynski et al., 2001). Drug susceptibility of H. pylori strains is changeable both in different regions of the world and in different regions of the same country, so it is essential to have knowledge of the local profile of drug susceptibility of microorganisms in order to choose the most effective therapy. The aim of this study was to assess the primary resistance of H. pylori strains isolated from children and adults in the Lower Silesia Region in Poland. Experimental Material and Methods The study was performed on 165 strains isolated from pediatric and adult patients of the Lower Silesia Region in the years 2008–2012. Our study involved 105 children aged 4–18 and 60 adults aged 19–89 who * Corresponding author: M. Biernat, Department of Microbiology, Wroclaw Medical University, Chałubińskiego Street 4, 50-368 Wrocław, Poland; phone: +48 71 784 12 86; fax. +48 71 784 01 17; e-mail: [email protected] 58 1 Gościniak G. et al. underwent endoscopic examination of the upper gastrointestinal tract due to complaints from the upper gastrointestinal tract, such as abdominal pain, nausea, or vomiting suggesting the presence of pathology. Patients had not been previously diagnosed and treated for H. pylori infection. Patients who had previously had H. pylori infection or received antibiotics within the last 2 months were excluded. Other exclusion criteria were parasitic diseases, allergies and autoimmune diseases. Informed written consent was obtained from each patient. The study was approved by the Bioethics Committee of Wroclaw Medical University, Approval No. 226/2011. Biopsies from the antrum and, in the case of present changes, from the corpus were taken from each patient during endoscopy of the upper gastrointestinal tract for histopathology and microbiology. Biopsies collected for microbiological examination were placed immediately after collection in sterile saline (0.15 M NaCl) and processed within two to three hours in a microbiological laboratory. The isolation and identification of strains were performed as described previously. [5] After the primary isolation and identification, the strains were kept frozen at –70°C in Brucella broth containing 15% glycerol. Then the drug to six antibiotics- amoxicillin (AM), clarithromycin (CH), metronidazole (MZ), tetracycline (TC), levofloxacin (LEV) and rifabutin (RB) sensitivity – was determined by gradient diffusion (E-test, BioMerieux) with the method described by Glupczynski et al. (2001). Criteria for interpretation of results were as follows: MIC (µg/mL) for resistant strains: amoxicillin > 0.5, clarithromycin> 1, metronidazole > 8, tetracycline > 1, levofloxacin > 0.5 and rifabutin > 1 (Glupczynski et al., 2001; Megraud and Lehours, 2007). Statistical analysis was performed by chi-square test with or without Yates’ correction and chi-square test among age groups. A p value < 0.05 was considered significant for all tests. Results The total resistance of strains isolated from adults and children is shown in Table I. Among the strains isolated from children, susceptibility was indicated in 40 (38.1%) strains and 65 (61.9%) were resistant. Among the resistant strains, 35 (33.3%) were resistant to CH, including 18 (17.1%) resistant only to CH, 15 (14.3%) to CH and MZ and 2 (1.9%) to CH, MZ and LEV. Resistance to MZ was detected among 47 (44.8%) strains, 30 (28.6%) were resistant only to MZ and the others were multidrug resistant. Among 60 strains isolated from adults, 42 (70%) were resistant to at least one antibiotic, including the total resistance to CH amounting to 23.3% (n = 14), to MZ 66.7% (n = 40), and to LEV Table I A comparison of the frequency of primary resistance of H. pylori isolated from children and adults. Resistance Children (105) No. % Adults (60) Total (165) No. No. % % CH (total) 3533.315 25.050 30.3 CH (single) 18 CH+MZ 1514.313 21.728 17.0 17.1 0 0.0 18 10.9 CH+MZ+LEV 2 1.9 2 3.3 4 2.4 MZ (total) 4744.842 70.089 53.9 MZ (single) 3028.624 40.054 32.7 MZ+CH 1514.313 21.728 17.0 MZ+CH+LEV 2 1.9 2 3.3 4 2.4 MZ+LEV 0 0.0 3 5.0 3 1.8 LEV (total) 2 1.9 7 11.7 9 5.5 LEV (single) 0 0.0 2 3.3 2 1.2 MZ+CH+LEV 2 1.9 2 3.3 4 2.4 MZ+LEV 0 0.0 3 5.0 3 1.8 No – number, CH – clarithromycin, MZ – metronidazole, LEV – levofloxacin 6.7% (n = 4). H. pylori strains resistant to levofloxacin were resistant in 75% to clarithromycin and/or metronidazole. Moreover, 16 multidrug resistant strains were isolated from adults, including 12 resistant to CH and MZ, 3 to MZ and LEV, and 1 to CH, MZ and LEV. No strains were resistant to AM, TC and RB (Table II). In order to analyze the drug resistance of H. pylori strains depending on age, patients were divided into 6 age groups (2–7, 8–12, 13–18, 19–44, 45–64, > 65 years) (Fig. 1). The resistance of strains to clarithromycin was the highest among children aged 13–18; the percentage of strains resistant to this antibiotic decreases with age. However, in the case of metronidazole, a gradual increase of resistant strains was found, the highest percentage being noted in the group aged 45–64 (78%). Strains resistant to levofloxacin were found among the oldest children and in the group of adults aged 45–64 (14.8%). The percentage of strains resistant to both CH and MZ remained steady among children in all age groups (14–16%) and adults (18.5–25%). Strains resistant to CH, MZ and LEV were observed in the group aged 14–64 at a similar level (3.7–4.8%). Discussion In the last decade one of the most important problems of contemporary medicine has become the resistance of micro-organisms to antibiotics. This problem does not exclude H. pylori bacilli. It is acknowledged that the appropriate course of antibiotic therapy contributes to the eradication of this micro-organism in 1 59 The antimicrobial susceptibility of H. pylori strains Table II In vitro activity of six antimicrobial agents against H. pylori Antibiotic Resistant strains No. % (95% confidence interval) MIC50 CH 50 30.3 (26.9–33.7) 0.016 MZ 89 53.9 (44.41–63.47) 16 MIC90 1.5 Range 0.016–256 126 0.016–256 LEV 9 5.5 (3.69–7.22) 0.064 0.125 0.002–32 AM 0 0 (0.0–0.0) 0.016 0.016 0.016–256 RB 0 0 (0.0–0.0) 0.02 0.02 0.002–32 TC 0 0 (0.00–0.01) 0.023 0.047 0.016–256 No – number, CH – clarithromycin, MZ – metronidazole , LEV – levofloxacin, AM – amoxicillin, TC – tetracycline, RB – rifabutin, MIC50 – Minimum Inhibitory Concentration required to inhibit the growth of 50% of organisms, MIC90 – Minimum Inhibitory Concentration required to inhibit the growth of 90% of organisms about 80% of patients (Selgrad and Malfertheiner, 2011). According to Graham and Shiotani an effective antibiotic therapy should contribute to the eradication of this micro-organism in 90–94% of patients and an excellent therapy ≥ 95% (Graham and Shiotani, 2008). The phenomenon of drug resistance of H. pylori strains is significant in the case of eradication therapy. In the classical therapy (IPP + AC+CH or IPP + MZ + CH) the most significant is H. pylori resistance to clarithromycin, which, with maintained susceptibility to MZ, lowers the effectiveness of eradication to 66% and 35% respectively (Megraud, 2004). Multicenter studies conducted in 2008–2009 by Megraud et al. concerning the primary resistance of H. pylori strains indicated that 31.8% of strains isolated from children and 17.5% of strains isolated from adults were resistant to clarithromycin. However, the resistance of strains to metronidazole was 25.7% and 34.9% respectively (Megraud et al., 2013). Our studies have indicated high resistance to clarithromycin among children (33%) and adults (25%). The resistance of examined strains to metronidazole in both groups was considerably higher (average 53.9%). Since the mid-1990s, the gradual increase of H. pylori primary resistance to applied antibiotics has been observed. In Poland, the percentage of strains resistant to clarithromycin varies depending on the region, from 21% to 28% (Karczewska et al., 2011, Dzierżanowska-Fangrat et al., 2005, Andrzejewska et al., 2009). A diverse level of resistance to clarithromycin was noted in other countries (5.6–36%). The resistance rates in Europe (11.1%), Fig. 1. Resistance of H. pylori strains in different age groups. 60 1 Gościniak G. et al. Asia (18.9%) and America (29.3%) significantly differ (De Francesco et al., 2010). In Europe we can observe large differences in resistance of strains to clarithromycin between northern (10.0%) and southern Europe (20.0%) (Megraud et al., 2013). Ten years ago, in Poland, the level of strains resistance to metronidazole was in the range 27–52% (average 37%) (Dzierżanowska-Fangrat et al., 2002) and regional variation was observed. Children from the Lower Silesia region have the highest noted resistance, at 52%. A lower percentage of resistant strains could be observed in children from Warsaw (37%), Wielkopolska Region (45%), Kujawsko-Pomorskie Region (20%) and from Łódzki Region (18%) (Bąk-Romaniszyn et al., 2004; Łaszewicz, 2003). The frequency of primary resistance to metronidazole among adults in Europe fluctuated between 28% and 44%. No significant differences were found between southern and northern parts of the continent (respectively – 29.7% and 28.6%). It was noted, however, that the resistance of strains is considerably higher in western and in central Europe (43.8%) (Megraud et al., 2013). In connection with more frequent usage of both clarithromycin and metronidazole in H. pylori eradication therapy, the steady increase of strains resistant to two antibiotics at the same time was noted. Towards the end of the 1990s, such resistance was low in Europe and amounted to only 0.8–9.1% (Boyanova, 2009; Elviss et al., 2004). In 2009, in Spain 17.2% of strains were noted to be resistant to both clarithromycin and metronidazole among children (Aqudo et al., 2009). In our study, the percentage of strains primarily resistant to clarithromycin and metronidazole was 14% among children and 21.7% among adults (average 17%). Similar results were obtained in other regions of Poland (13–15.5%) (Dzierżanowska-Fangrat et al., 2005). The growth tendency also shows the resistance of strains to levofloxacin and currently in Europe, from 7% to 13% of H. pylori strains were noted to be resistant. In southern Poland, this resistance level is 12% (Karczewska et al., 2012; Megraud et al., 2013). In our study total primary resistance to LEV was 5.5%, including resistance in children (1.9%) and in adults (11.7%). Moreover, alarmingly, in our region we have observed 1.9% of strains resistant among children and 3.3% among adults to three antibiotics simultaneously. Multidrug-resistant H. pylori strains were also observed in other countries, such as Italy, Bulgaria and Taiwan (Boyanova and Mitov, 2010; Yang et al., 2010). In this work no resistance of H. pylori strains to amoxicillin, tetracycline and rifabutin was noted. Other authors also have not found resistance to these antibiotics (Megraud et al., 2013; Karczewska et al., 2011; Gościniak et al., 2004). Primary amoxicillin resistance has been low (< 2%) in Europe but higher (6–59%) in Africa, Asia and South America (Boyanova and Mitov, 2010; Yang et al., 2010). Resistance to tetracycline is low (< 3%) all over the world, except for Africa, where it amounts to 44% (De Francesco et al., 2010). The observed low resistance to rifabutin so far is very low, 1.3%, and the effectiveness of therapy with rifabutin is good, 73%. Treatment of H. pylori infections with rifabutin is promising, especially after failures of eradication with standard antibiotics such as: amoxicillin, metronidazole, clarithromycin, levofloxacin, and tetracycline (Gisbert and Calvet, 2012). However, it should be remembered that the low resistance of H. pylori to rifabutin arises from using this antibiotic only to treat Mycobacterium tuberculosis (Nishizawa et al., 2011). In conclusion, high incidence of resistance to CH and MZ suggests that standard triple therapies may not be useful as first-line treatment in Poland without earlier susceptibility testing. The use of antibiotics for other indications seems to be the major risk factor for development of primary resistance. The authors declare no conflict of interest. Literature Andrzejewska E., A. Szkaradkiewicz and T. Karpiński. 2009. Antimicrobial resistance of Helicobacter pylori clinical strains in the last 10 years. Pol. J. Microbiol. 4: 301–305. Aqudo S., T. Alarcon, L. Cibrelus, P. Urruzuno, M.J. Martinez and M. Lopez-Brea. 2009. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children. Rev. Esp. Quimioter. 22: 88–92. Bąk-Romaniszyn L. and I. Płaneta-Małecka. 2004. Przyczyny niepowodzenia eradykacji zakażenia Helicobacter pylori. Ped. Wsp. Gastroenterol Hep. Żyw. Dziecka 4: 387–392. Boyanova L. 2009. Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria. J. Med. Microbiol. 58: 930–935. Boyanova L. and I. Mitov. 2010. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev. Anti. Infect. Ther. 8: 59–70. Da Silva Mendeiros J.A, T.M.F.O. Goncalves, L. Boyanova, M.I. de Correia Pereira, J.N. da Silva Paiva de Carvalho, A.M. de Sousa Pereira, and A.M. Silverio Carbita. 2011. Evaluation of Helicobacter pylori eradication by triple therapy plus Lacto bacillus acidophilus compared to triple therapy alone. Eur. J. Clin. Microbiol. Infect. Dis. 30: 555–559. De Francesco V., F. Georgio, C. Hassan, G. Manes, L. Vannella, C. Panella, E. Ierardi, and A. Zullo. 2010. Worldwide H. pylori antibiotic resistance: a systematic review. J. Gastointestin. Liver Dis. 19: 409–414. Dzierżanowska-Fangrat K., E. Rożynek, D. Celińska-Cedro, P. Jóźwiak, K. Madaliński and D. Dzierżanowska. 2002. Primary resistance of H. pylori to antimicrobial agents in Polish children. Acta Micriobiol. Pol. 51: 255–263. Dzierżanowska-Fangrat K., E. Rożynek, D. Celińska-Cedro, M. Jarosz, J. Pawłowska, A. Szadkowski, A. Budzyńska, J. Nowak, W. Romańczuk, R. Prosiecki and others. 2005. Antimicrobial resistance of Helicobacter pylori in Poland: a multicenter study. Int. J. Antimicrob. Agents 26: 230–234. 1 The antimicrobial susceptibility of H. pylori strains Elviss N.C., R. J. Owen, J. Xerry, A.M. Walker and K. Davies. 2004. Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J. Antimicrob. Chemioter. 54: 435–440. Gisbert J.P. and X. Calvet. 2012. Rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment. Pharmacol. Ther. 35: 209–221. Glupczynski Y., F. Megraud, M. Lopez-Brea and L.P. Andersen. 2001. European multicenter survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 20: 820–823. Glupczynski Y, N. Broutet, A. Cantagrel, L.P. Andersen, T. Alarcon, M. Lopez-Brea and F. Megraud. 2002. Comparison of the E-test and agar dilution method for antimicrobial susceptibility testing of Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 21: 549–552. Gościniak G. Y. Glupczyński, S. Goutier, C. Van Den Borre, J.P. Butzler and A. Przondo-Mordarska. 1998. Prevalence of antibiotic resistance in Helicobacter pylori strains in Poland. Clin. Micro bial. Infect. 12: 726–728. Gościniak G., B. Iwańczak, A. Przondo-Mordarska, J. Grabińska and F. Iwańczak. 2004. High Level of resistance to metronidazole and clarithromycin in Helicobacter pylori isolated from pediatric patients in Poland. Folia Microbiol. 49: 133–136. Graham D.Y. and A. Shiotani. 2008. New concepts of resistance in the treatment of Helicobacter pylori infections. Nature Clin. Practice Gastroenterol. Hepatol. 5: 321–331. Kadayifci A., Buyukhatipoglu H., Cemil Savas M. and I. Simsek. 2006. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin. Ther. 28: 1960–1966. 61 Karczewska E, I. Wojtas-Bonior, E. Sito, M. Zwolińska-Wcisło and A. Budak. 2011. Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland. Pharmacol. Rep. 63: 799–807. Karczewska E., K. Klesiewicz, I. Skiba, I. Wojtas-Bonior, E. Sito, K. Czajecki, M. Zwolińska-Wcisło and A. Budak. 2012. Variability in prevalence of Helicobacter pylori strains resistant to clarithromycin and levofloxacin in Southern Poland. Gastroenterol. Res. Pract. doi: 10.1155/2012/418010. Łaszewicz W. 2003. H. pylori infection in Poland – epidemiological study in children and adults (in Polish). Acad. Med. Bialostocensis 30–39. Megraud F. 2004. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53: 1374–1384. Megraud F. and P. Lehours. 2007. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev. 20: 280–322. Megraud F., S. Coenen, A. Versporten, M. Kist, M. Lopez-Brea, A.M. Hirschl, L.P. Andersen, H. Goossens, Y. Glupczynski on behalf of the Study Group participants. 2013. Helicobacter pylori resistance to antibiotic in Europe and its relationship to antibiotic consumption. Gut 62: 34–42. Mishra S. 2012. Is Helicobacter pylori good or bad? Eur. J. Clin. Microbiol. Infect. Dis. Doi: 10.1007/s10096-012-1773-9. Nishizawa T., H. Suzuki, J. Matsuzaki, H. Muraoka, H. Tsuqawa, K. Hirata and T. Hibi. 2011. Helicobacter pylori resistance to rifabutin in the last 7 years. Antimicrob. Agents Chem. 55: 5374–5375. Selgrad M. and P. Malfertheiner. 2011. Treatment of Helicobacter pylori. Curr. Opin. Gastroenterol. 27: 565–570. Yang J.C., P.I. Lee and P.R. Hsueh. 2010. In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998–2007. Eur. J. Clin. Micro biol. Infect. Dis. 29: 1369–75. Polish Journal of Microbiology 2014, Vol. 63, No 1, 63–67 ORIGINAL PAPER Helicobacter pylori Infection in Type 1 Diabetes Children and Adolescents Using 13C Urea Breath Test AGATA CHOBOT1*, KATARZYNA BĄK-DRABIK2, ELIZA SKAŁA-ZAMOROWSKA3, AGNIESZKA KRZYWICKA1, JAROSŁAW KWIECIEŃ2 and JOANNA POLAŃSKA4 Clinical Hospital No1, Zabrze, Poland; 2 Medical University of Silesia, Katowice, Poland 3 Upper Silesian Center of Child’s Health, Katowice, Poland 4 Data Mining Group, Silesian University of Technology, Gliwice, Poland 1 Submitted 8 August 2013, revised 31 October 2013, accepted 16 November 2013 Abstract There is a 10–30% prevalence of HP infection in the general pediatric population in Poland. This study aimed to determine its prevalence in T1DM children in Upper Silesia, Poland and estimate its influence on metabolic control of patients. We studied 149(82♀) children with T1DM (duration > 12 months, mean HbA1c) and 298(164♀) age-matched controls. In all cases height and weight z-scores and Cole’s index were assessed. In T1DM patients additionally glycated hemoglobin A1c and T1DM duration were analyzed. Presence of HP infection was determined using 13C-isotope-labeled urea breath test (UBT) (fasting and 30min after ingestion 75 mg of 13C urea). HP infection was present in 17 (11.4%) T1DM patients and in 49 (16.4%) controls (p > 0.05). T1DM patients presented higher values of anthropometric parameters than healthy controls (weight SDS 0.25[–0.46÷0.84] vs. –0.25[–1.06÷0.26], height SDS 0.09[–0.60÷0.69] vs. –0.31[–1.17÷0.48] and Cole’s index 103%[93÷111%] vs. 97%[86÷106%]; for all p < 0001). Within both groups – T1DM children and controls – no differences regarding sex, age and any of the anthropometric parameters were determined. T1DM duration and HbA1c showed no relation to prevalence of HP infection. Prevalence of HP infection in pediatric T1DM patients is similar to that of healthy peers and shows no relation to glycemic control. Key words: Helicobacter pylori, HbA1c, type 1 diabetes, urea breath test Introduction Helicobacter pylori (HP) causes one of the most common chronic infections worldwide. This is a gramnegative, spiral-shaped pathogenic bacterium that specifically colonizes the gastric epithelium and is related to chronic gastritis and duodenitis, peptic ulcer disease and functional gastrointestinal motor disorders (Marshall and Warren, 1984; Wotherspoon et al., 1991). The remote consequences of a chronic infection, which appear especially in adulthood, include: peptic ulcer, mucosa-associated lymphoid tissue (MALT) lymphoma and gastric cancer. The prevalence of HP infection varies between countries and depends on the age and socio-economical status. It is estimated that in developed European countries 10–30% of the population is infected, however most cases remain asymptomatic. In developing countries the prevalence in the adult population raises even up to 70% (Goh et al., 2011). In previous research the prevalence of HP infection in the general pediatric population in Poland was assessed to be 30% (Iwańczak et al., 2004). Nowadays the frequency of infection seems to be lower than formerly reported. An assessment by Żabka et al. (2010) revealed a 10% prevalence and a most recent publication showed that the frequency of HP infection in healthy children in Poland was 15.7% (Krusiec-Świdergoł et al., 2010). It is known that patients with diabetes are more prone to infection than healthy people. This is probably because of the fact that both cellular and humoral immune systems are perturbed, especially in the context of poor glycemic control with severe complications (de Luis et al., 1998; Mustapha et al., 2005). Many studies have evaluated the prevalence of the HP infection in diabetic patients, but the epidemiological relationship remains controversial (Ariizumi et al., 2008; Ciortescu et al., 2009; Ojetti et al., 2001, 2010; Otto-Buczkowska, * Corresponding author: A. Chobot, Clinical Hospital No1, 3 Maja 13–15, 41-800 Zabrze, Poland; phone: 0048 323704267; e-mail: [email protected] 64 1 Chobot A. et al. 2012; Stępkowski and Grzeszczak, 2009). Furthermore, publications investigating HP infection in children and adolescents with type 1 diabetes (T1DM) are sparse and their conclusions contradictory (Arslan et al., 2000; Colombo et al., 2002; Khalil et al., 2007; Ojetti et al., 2010; Toporowska-Kowalska et al., 2006, 2007). Some researchers revealed higher prevalence of HP infection in diabetic patients in general as well as in the pediatric population with T1DM (Ariizumi et al., 2008; Arslan et al., 2000; Ciortescu et al., 2009; de Luis et al., 1998; Ojetti et al., 2001, 2010; Otto-Buczkowska, 2012; Stępkowski and Grzeszczak, 2009). Nevertheless, the results of other authors have not confirmed such observations (Ciortescu et al., 2009; Colombo et al., 2002; Khalil et al., 2007; Ojetti et al., 2001; ToporowskaKowalska et al., 2006, 2007). The studies in T1DM subjects yielded also additional data on the relationship between HP infection and glycemic control, although their conclusions are also not unequivocal. On one hand, there are reports of a negative impact of HP infection on HbA1c levels (Toporowska-Kowalska et al., 2006, 2007), but discordant conclusions have also been published (Candelli et al., 2003; Colombo et al., 2002; Khalil et al., 2007). A supplementary interesting assessment revealed that the eradication of HP infection did not improve the metabolic control in a short-term follow-up (Candelli et al., 2004, 2012; Khalil et al., 2007). Although a study by Begue et al. (1999) demonstrated that HP eradication might decrease HbA1c. The aim of the present study was to determine the prevalence of HP infection in children and adolescents with T1DM in Upper Silesia, Poland and to estimate the influence of HP presence on metabolic control of the patients. Experimental Material and Methods Patients. The study group comprised of 149 (82 female and 67 male) T1DM children and adolescents, aged 13.4 ± 3.4 years. Volunteers from the regional out-patient diabetes clinic were enrolled using the following criteria: DM duration > 12 months, no history of antibiotic or proton pump inhibitor therapy in the past 4 weeks. The patients were examined between July 2011 and June 2012. Table I. shows the detailed characteristics of the studied patients. The control group consisted of 298 age- and sex-matched children and adolescents (164 female and 134 male) with no known glucose metabolism disorders – characteristics are presented in Table I. This group was enrolled from a large cohort (n = 1253) of children investigated Table I Characteristics and comparison of the study and control groups. UBT result N Age [yrs] T1DM Patients Controls Total 149 Total 298 P 13.4 ± 3.4 13.3 ± 3.3 ns Weight Z-score 0.25 ± 0.93–0.25 ± 1.07<0.001 [–0.46 ÷ 0.84] [–1.06 ÷ 0.26] Height Z-score 0.09 ± 0.97–0.31 ± 1.23<0.001 [–0.60 ÷ 0.69] [–1.17 ÷ 0.48] Cole’s index [%] T1DM Duration [yrs] HbA1c [%] 103 ± 1397 ± 15 [93 ÷ 111] [86 ÷ 106] <0.001 4.6 ± 3.5 7.69 ± 1.63 Legend: N – number of children, ± SD, [± 95% CI], SDS – standard deviation score, T1DM – Type 1 diabetes mellitus, UBT – urea breath test, HbA1c – hemoglobin A1c during the program “Good diagnosis-Treatment-Live” carried out at the Clinical Hospital No 1 in Zabrze, Poland between March 2010 and June 2012. Methods. In all T1DM patients Z-score for height and weight, Cole’s index and glycated hemoglobin A1c (HbA1c) were assessed. Height and weight in T1DM patients were measured using a standardized scale and the Martin stadiometer. HbA1c measurements were carried out in the same laboratory using the recommended high pressure liquid chromatography (HPLC), which is a DCCT reference method. The normal range for this laboratory is < 6%. The presence of HP infection was determined in all subjects by means of a breath test (UBT) with 13C isotope-labeled urea, which was performed fasting. Breath samples – at baseline and 30 minutes after ingestion of 75 mg of 13C isotope-labeled urea – were collected in 650 ml aluminized bags with one-way valves. An infrared spectrophotometer (IRIS, Wagner GMBH, Germany) was used to measure the 12CO2/13CO2 ratio. The results of the test were considered positive if C13 concentration (delta over baseline, DOB [o/oo]) raised in the exhaled air by more than 4.0‰ (Żabka et al., 2010). Statistical analysis. Statistical analysis was performed with the R software (www.bioconductor.org). Descriptive statistics were calculated for all analyzed parameters, and adequate figures were generated. To detect the outlying values Tukey’s criterion was used. To check distribution normality Lilliefors test was employed. The verification of the variance homogeneity hypothesis was carried out using the F or Bartlett statistic. ANOVA algorithm and Student’s t test were performed for comparative analysis of normally distributed variables. In the case of a distribution other than normal, we used the non-parametric ANOVA 1 65 H. pylori infection in type 1 diabetes children Kruskal-Wallis test and Mann-Whitney U test to verify the concordance between groups. Pearson’s or Spearman’s correlation coefficients were used to estimate the associations between two variables – depending on the distribution of the analyzed continuous variables. Storey’s multiple testing correction algorithm of the p value was used. For the analysis of discrete variables the χ2 test or likelihood-ratio G test was performed. In each case an appropriate contingency table was constructed. The results were considered as significant at p < 0.05. Ethical considerations. This study was approved by the institutional ethical committee of the Medical University of Silesia, Katowice, Poland. Results HP infection was present in 17 (11.4%) of T1DM patients. No differences between genders were found. Additionally no relation of the UBT result to age as well as any of the anthropometric parameters – height z-score, weight z-score, Cole’s index – was determined (Table II). Parameters associated to T1DM – disease duration as well as HbA1c – showed no relation to the prevalence of HP infection (Table II). Within the control group a positive UBT result was obtained in 49 (16.4%) cases. Similar as in the T1DM group no differences regarding sex, age and no relation to the investigated anthropometric parameters were found (Table II). The comparison of the frequency of HP infection in T1DM patients and non-diabetic children revealed no discrepancy. All anthropometric parameters – height and weight z-scores as well as the Cole’s index – were significantly higher in T1DM patients (Table I). Discussion This study was performed using the UBT as a gold standard method (Koletzko et al., 2011). It was conducted in a large number of T1DM pediatric patients presenting quite good metabolic control (HbA1c 7.69%). The observed frequency of HP infection among the non-diabetic cohort (approximately 16%) was similar to the newest reports regarding the general polish pediatric population, which demonstrated a decrease of the prevalence in comparison to the past decade (Iwańczak et al., 2004; Krusiec-Świdergoł et al., 2010; Żabka et al., 2010). The results of former studies investigating HP infection in patients with T1DM are contradictory and there are only few publications concerning the pediatric population (Arslan et al., 2000; Ciortescu et al., 2009; Colombo et al., 2002; de Luis et al., 1998; Ojetti et al., 2001; Toporowska-Kowalska et al., 2006, 2007). Some of them revealed a higher prevalence of HP infection in children with T1DM (Arslan et al., 2000; de Luis et al., 1998). However, our findings and the results of other authors have not confirmed such observations (Candelli et al., 2003; Ciortescu et al., 2009; Colombo et al., 2002; Khalil et al., 2007; Ojetti et al., 2001; ToporowskaKowalska et al., 2006, 2007). Given the facts mentioned in the former paragraph it seems justified to make an assumption that the prevalence of HP infection in T1DM children is the same as in healthy peers. The frequency of HP infection in the studied patients is lower than in earlier publications (Candelli et al., 2003; Colombo et al., 2002; Toporowska-Kowalska et al., 2006, 2007). This might be explained by the fact that some of the studies were based on a serological screening that does not distinguish past and present infections Table II T1DM patients and non-diabetic subjects – comparison between subgroups according to the UBT result. UBT result N Age [yrs] T1DM Patients Controls Positive 17 Negative 132 P Positive 49 Negative 249 P 13.3 ± 3.3 13.9 ± 3.6 Ns 13.9 ± 3.2 13.2 ± 3.3 Ns Weight Z-score 0.34 ± 0.970.24 ± 0.93Ns–0.39 ± 1.02–0.22 ± 1.08Ns [–0.21 ÷ 0.94] [–0.46 ÷ 0.83] [–1.22 ÷ 0.16] [–1.01 ÷ 0.30] Height Z-score –0.01 ± 1.090.10 ± 0.96Ns–0.48 ± 1.48–0.28 ± 1.18Ns [–0.60 ÷ 0.69] [–0.60 ÷ 0.69] [–1.27 ÷ 0.60] [–1.16 ÷ 0.46] Cole’s index [%] 105 ± 12103 ± 13Ns 97 ± 1697 ± 17Ns [96 ÷ 109] [92 ÷ 111] [86 ÷ 107] [86 ÷ 106] T1DM Duration [yrs] 5.3 ± 3.94.4 ± 3.4Ns [2.8 ÷ 7.8] [1.9 ÷ 6.4] HbA1c [%] 7.82 ± 1.427.60 ± 1.66Ns [6.90 ÷ 8.70][6.60 ÷ 8.15] Legend: N – number of children, ± SD, [± 95%CI], SDS – standard deviation score, T1DM – Type 1 diabetes mellitus, UBT – urea breath test, HbA1c – hemoglobin A1c, ns – not significant 66 1 Chobot A. et al. as well as by the general decrease of HP infection in Polish and European children during the last decade (Colombo et al., 2002; Iwańczak et al., 2004; KrusiecŚwidergoł et al., 2010; Żabka et al., 2010). In our study T1DM children with a confirmed HP infection did not differ significantly in terms of metabolic control and disease duration. No association between HP infection and HbA1c was also found by other authors (Candelli et al., 2003; Colombo et al., 2002; Khalil et al., 2007). In addition HP eradication was shown to have no impact on metabolic control (Candelli et al., 2004, 2012; Khalil et al., 2007). However, in the former study in T1DM polish children, those infected with HP presented higher HbA1c levels (Toporowska-Kowalska et al., 2007). Also Begue et al. (1999) suggested a positive relation between HP eradication and metabolic control. These discrepancies might be related to the differences between the study groups, especially regarding age, race and socioeconomic status. Moreover, the link between HP infection and metabolic control might be indirect (i.e. HP is known to influence the gastric motility and was shown to affect insulin resistance and may in this way influence blood glucose and HbA1c levels) and therefore difficult to determine clearly (Gen et al., 2010; Toporowska-Kowalska et al., 2006). The relation between HP infection and diabetes duration was investigated only by few other researchers, but all findings are similar to our results (Candelli et al., 2003; Colombo et al., 2002; Khalil et al., 2007; Toporowska-Kowalska et al., 2006, 2007). Epidemiological studies suggest that the prevalence of HP infection should rise with age (Krusiec-Świdergoł et al., 2010). Despite that fact research conducted in T1DM children showed no significant relation between HP infection and age (Khalil et al., 2007; ToporowskaKowalska et al., 2006, 2007). Our results revealed also no dissimilarities in age between HP positive and negative children in both groups – T1DM and controls. Because HP was in the past described to potentially impair growth in the pediatric population, our study also assessed the standardized anthropometric parameters of T1DM patients and non-diabetic controls (Krusiec-Świdergoł et al., 2010). All mean values for both groups remained well within the normal ranges (90–110% for Cole’s index and –1.0–1.0 for Z-scores), although both cohorts differed significantly by all of the anthropometric measurements. As expected T1DM children had slightly higher mean weight and height Z-scores as well as a little higher mean Cole’s index. Nonetheless, within both groups HP positive and negative children presented no discrepancies regarding the analyzed anthropometric parameters. The strong aspects of this study are – except for the ones mentioned in the beginning of the discussion – the race and ethnical homogeneity of the studied groups. Nonetheless, because patients were not randomly chosen for this study, the presented data cannot be considered to represent the incidence of HP infection in the whole pediatric T1DM population in Poland. The observed prevalence of HP infection in children and adolescents with T1DM is similar to that of healthy peers. No evidence for a relationship between the glycemic control and presence of HP infection in patients with T1DM could be determined. Acknowledgements This study was partially financed by the grant SUT-BK/ RAU1/2013/10. Agata Chobot received partial financing by MNiSW IP2012 007672. Literature Ariizumi K., T. Koike, S. Ohara, I. Yoshifumi, A. Yasuhiko, I. Katsunori, I. Akira, O. Yoshiromo and S. Tooru. 2008. Incidence of reflux esophagitis and Helicobacter pylori infection in diabetic patients. World J. Gastroenterol. 14: 3212–3217. Arslan D., M. Kendirci, S. Kurtoglu and M. Kula. 2000. Helicobacter pylori infection in children with insulin dependent diabetes mellitus. J. Pediatr. Endocrinol. Metab. 13: 553–556. Begue R.E., A. Mirza, T. Compton, R. Gomez and A. Vargas. 1999. Helicobacter pylori infection and insulin requirement among children with type 1 diabetes mellitus. Pediatrics. 103: e83. Candelli M., D. Rigante, G. Marietti, E.C. Nista, F. Crea, F. Bartolozzi, A. Schiavino, G. Pignataro, N.G. Silveri, G. Gasbarrini and others. 2003. Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. Pediatrics. 111: 800–803. Candelli M., D. Rigante, G. Marietti, E. C. Nista, F. Crea, A. Schiavino, G. Cammarota, G. Pignataro, S. Petrucci, G. Gasbarrini and others. 2004. Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. J. Pediatr. Gastro enterol. Nutr. 38: 422–425. Candelli M., D. Rigante, A. Schiavino, M. Gabrielli, F. Crea, L. Minguell Del Lungo, G. Pignataro, E. Sacco, S. Monaco, N. Gentiloni Silveri and others. 2012. High reinfection rate of Helicobacter pylori in young type 1 diabetic patients: a three-year follow-up study. Eur. Rev. Med. Pharmacol. Sci. 16: 1468–1472. Ciortescu I., C. Sfarti, M. Stan, M. Graur and C. Stanciu. 2009. Prevalence of Helicobacter pylori infection in patients with diabetes mellitus. Rev. Med. Chir. Soc. Med. Nat. Iasi. 113: 1048–1055. Colombo C., P.A. Tomasi, G.F. Meloni, A.M. Marinaro, A. Ogana and T. Meloni. 2002. Seroprevalence of Helicobacter pylori in children with type 1 diabetes mellitus in Sardinia. Diabetes. Nutr. Metab. 15: 91–95. Gen R., M. Demir and H. Ataseven. 2010. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. Southern Medical Journal. 103: 190–196. Goh K.L., W.K. Chan, S. Shiota and Y. Yamaoka. 2011. Epidemio logy of Helicobacter pylori infection and public health implications. Helicobacter 16; Suppl 1: 1–9. Iwańczak F., E. Madorskowska, M. Kaczmarski, L. Bąk-Romani szyn, I. Płaneta-Małecka, W. Romańczuk, B. Iwańczak, T. Pytrus, M. Czerwionka-Szaflarska, G. Mierzwa and others. 2004. Badania epidemiologiczne częstości występowania zakażenia Helicobacter pylori u dzieci w Polsce (in Polish). Pediatria Współczesna 4: 345–350. 1 H. pylori infection in type 1 diabetes children Khalil T., H. Dorchy, M. Scaillon and C. Melot. 2007. Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes. Presse Med. 36: 1191–1195. Koletzko S., N.L. Jones, K.J. Goodman, B. Gold, M. Rowland, S. Cadranel S. Chong, R.B. Colletti, T. Casswall, Y. Elitsur and others. 2011. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J. Pedi atr. Gastroenterol. Nutr. 53: 230–243. Krusiec-Świdergoł B., J. Kwiecień, K. Jonderko, L. Strój, A. Kasicka-Jonderko and B. Błońska-Fajfrowska. 2010. Decreasing prevalence of Helicobacter pylori infection in children in Poland. Przegląd Gastroenterologiczny 5: 279–284. de Luis D.A., H. de la Calle, G. Roy, C.M. de Argila, S. Valdezate, R. Canton and D. Boixeda. 1998. Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 39: 143–146. Marshall B.J. and J.R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1: 1311–1315. Mustapha S., E. Sellers and H. Dean. 2005. Are children with type 1 diabetes immunocompromised? CMAJ 16; 173: 341. Ojetti V., R. Pellicano, S. Fagoonee, A. Migneco, M. Berrutti and A. Gasbarrini. 2010. Helicobacter pylori infection and diabetes. Minerva Med. 101: 115–119. 67 Ojetti V., D. Pitocco, G. Ghirlanda, G. Gasbarrini and A. Gasbarrini. 2001. Role of Helicobacter pylori infection in insulin-dependent diabetes mellitus. Minerva Med. 92: 137–144. Otto-Buczkowska E. 2012. The helicobacter pylori infection is problem in diabetic patients? (in Polish) Przegląd Medyczny Uni wersytetu Rzeszowskiego i Narodowego Instytutu leków w Warszawie 2: 252–255. Stępkowski T. and W. Grzeszczak. 2009. Comparison of Helicobacter pylori infection prevalence in patients with or without type 2 diabetes. Experimental and Clinical Diabetology 9: 29–32. Toporowska-Kowalska E., K. Wasowska-Królikowska, A. Szadkowska and J. Bodalski. 2007. Helicobacter pylori infection and its metabolic consequences in children and adolescents with type 1 diabetes mellitus. Med. Wieku Rozwoj 11: 103–108. Toporowska-Kowalska E., A. Szadkowska, J. Bodalski and K. Wąsowska-Królikowska. 2006. Ocena ryzyka zakażenia Helico bacter pylori u dzieci i młodocianych chorych na cukrzycę typu I (in Polish). Ped. Pol. 81: 409–412. Wotherspoon A.C., C. Ortiz-Hidalgo, M.R. Falzon and P.G. Isaac son. 1991. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338: 1175–1176. Żabka A., J. Kwiecień, K. Bąk-Drabik, A. Krzywicka, J. Porębska and W Pieniążek. 2010. Czy częstość zakażeń H. pylori u dzieci w wieku od 3 do 18 lat spada? (Doniesienie wstępne) (in Polish). Probl. Med. Rodz. 2: 18–20. Polish Journal of Microbiology 2014, Vol. 63, No 1, 69–73 ORIGINAL PAPER The Utility of Caco-2 cells in Isolation of Enteroviruses from Environmental and Clinical Material MAGDALENA WIECZOREK*, AGNIESZKA CIĄĆKA, AGNIESZKA WITEK and BOGUMIŁA LITWIŃSKA. National Institute of Public Health – National Institute of Hygiene, Department of Virology, Warsaw, Poland Submitted 2 September 2013, revised 30 October 2013, accepted 16 November 2013 Abstract The work presented here demonstrates the utility of Caco-2 cells in the isolation of enteroviruses (EVs) from environmental and clinical materials. Thirty-two samples of cerebrospinal fluid positive in Pan-entero RT-PCR were taken for EV strain isolation in cell culture. Out of the 32 samples analysed, 22 (68.75%) were positive for enteroviruses by isolation in Caco-2 cells, and 10 (31.25%) were positive by isolation in RD cells. High viral titre in clinical specimens resulted in rate increase for isolation in Caco-2 cells and RD cells (87.5% and 50%, respectively). Also, the probability of isolation of enteroviruses from sewage in Caco-2 cells was 20 times higher that in RD cells. We proved that Caco-2 cells were more effective than RD cells in enterovirus isolation, irrespective of the material used in the inoculation process. K e y w o r d s: Caco-2 cells, cerebrospinal fluid, enteroviruses, sewage Introduction Enteroviruses (EVs) are members of the Picor naviridae family, a large and diverse group of small RNA viruses characterized by a single-positive-strand genomic RNA. They affect millions of people worldwide each year, and are often found in the respiratory secretions and stool of an infected person. Infection can result in a wide variety of symptoms ranging from mild respiratory illness (common cold), through hand, foot, and mouth disease, acute haemorrhagic conjunctivitis, aseptic meningitis, and myocarditis, to severe neonatal sepsis-like disease and acute flaccid paralysis. (Tapparel, 2012) The classic method for diagnosis of infection with EVs has been virus isolation by cell culture from stool samples, throat swabs, or cerebrospinal fluid (CSF). Cell culture is still the best method for determining the occurrence of infectious viruses in environment, as well. Viral isolation is possible in a variety of cell lines; however, no single cell line is optimal for all EVs. PCR methods for detecting enteroviruses have been developed during the past decade. Many studies have shown that PCR is more sensitive and rapid than virus isolation for the diagnosis of enteroviral infection. Although detection by PCR reveals the presence of viral RNA, it does not indicate the infectivity of the virus. The determination of viral infectivity is important especially in environmental monitoring. The detected genomic material may be present in otherwise defective virus particles that are not able to bind to or replicate in the host cells. Knowing if a virus is infectious is important from a public health perspective to determine if there is a public health concern. The infectivity of viruses may be determined with the use of cell cultures, such as Caco-2 and RD (Terletskaia-Ladwig et al., 2008; Sedmak et al., 2005). Caco-2 cell line is a continuous line of heterogeneous human epithelial colorectal adenocarcinoma cells. It has been found that Caco-2 cells support the growth of many viruses, including enteroviruses, rotaviruses, adenoviruses, and astroviruses (Hamza 2011; Pinto et al., 1995). However, WHO recommended RD cells for isolation of polioviruses and other enteroviruses. Most of the enterovirus serotypes have been propagated in RD cells, but in practice isolation from clinical and environmental material is often unsuccessful (Lipson et al., 1988; Witek et al., 2011). The present study was conducted to obtain information about the utility of Caco-2 cell in the isolation of enteroviruses from environmental (sewage) and clinical samples (CSF). CSF is not a simple material for enterovirus strains isolation, because the enterovirus load is lower than in faeces during enteroviral meningitis, and also is rich in replication-defective particles. Sewage is * Corresponding author: M. Wieczorek, Chocimska 24 Str., 00-791 Warsaw, Poland; phone: +48 22 54 21 230, fax: +48 22 54 385; e-mail: [email protected] 70 1 Wieczorek M. et al. a heterogeneous material rich in factors such as metals, humic acids, and other organic matter which can be toxic for cells. Our goal was to compare EVs’ isolation from this material in Caco-2 and RD cells. Experimental Materials and Methods CSF samples. Cerebrospinal fluid samples were obtained in 2011 and 2012 from patients with suspicion of enteroviral infection, and sent to the Laboratory of Virology in the National Institute of Health for viral diagnostics. Thirty-two samples of CSF positive in Pan-entero RT-PCR were taken for EV strain isolation in cell culture. These samples were divided into two groups: strong positive – with intensive band after RT-PCR reaction and weak positive – with not clearly seen band. A volume of 200 µl of cerebrospinal fluid was inoculated into tubes with RD and Caco-2 cells. The tubes were incubated at 37°C. Each specimen underwent two passages in RD and Caco-2 cells. Samples demonstrating viral cytopathic effect (CPE) were identified by neutralization assay using specific antisera (National Institute of Public Health and the Environment, the Netherlands). Sewage samples. Samples of raw sewage were processed according to the protocol described earlier (Zurbriggen et al., 2008). Tubes with monolayer of RD and Caco-2 cells in maintenance medium were inoculated with 100 μl of sewage sample; before inoculation, samples were incubated with different concentrations of trypsin (from 0 to 50 μg/ml) for different times (from 0 min to 2 h) at 37°C and next were added to those tubes. Cytopathic effects were read daily for 7 days, and two passages were performed. Supernatant fluids from samples demonstrating viral CPE were used for the RT-PCR detection to confirm the presence of the virus. Four independent experiments were performed. RNA extraction and RT-PCR. Viral RNA was extracted from 140 µl of CSF, cell culture supernatant or concentrated sewage using spin columns (Qiagen) following the manufacturer’s instructions. RT-PCR was carried out using Pan-enterovirus primers for enterovirus detection based on the WHO manual (WHO, 2004). This set of primers produces a product of 114 bp and has been designed to detect and amplify a genome segment present at the 5’-UTR of the enterovirus genomes. RT-PCR amplification was performed: one cycle of reverse transcription at 45°C for 20 min; one cycle of denaturation at 94°C for 2 min; 30 cycles of denaturation at 94°C for 30 s; annealing at 55°C for 30 s; elongation at 70°C for 30 s followed by one cycle of elongation at 70°C for 7 min. Reaction mixtures were then held at 4°C. Amplification products were analysed in 2% agarose gels, GelRed-stained, and examined under a UV DNA trans-illuminator. Statistical analysis. Received data were analysed with Statgraphics for Windows, Centurion, v.XV. StatPointTech.Inc. USA. Simple linear regression and multiple regression model was used to estimate relationships among variables. Results A total of 177 cerebrospinal fluid samples were obtained in 2011 (59) and 2012 (118) from patients with suspicion of enteroviral infection, and sent to the Laboratory of Virology in the National Institute of Health for viral diagnosis. Of 177 CSF samples, 85 (48%) samples were positive in RT-PCR reaction (36% in 2011 and 60% in 2012). Thirty-two CSF samples were selected from all positive samples. These samples were divided into two groups: strong positive (16) – with intensive band after RT-PCR reaction and weak positive (16) – with not clearly seen band. A volume of 200 µl of cerebrospinal fluid was inoculated into tubes with RD and Caco-2 cells according to WHO procedures. Out of the 32 samples analysed, 22 (68.75%) were positive for enteroviruses by isolation in Caco-2 cells, and 10 (31,25%) were positive by isolation in RD cells (Table I). There were two positive isolations in RD cells (12.5%) in the group of weak-positive samples unlike isolation in Caco-2 cells – 50.0% (8) positive results. The best results were obtained in the group of strongpositive samples (intensive band) isolated in Caco-2 cells – 87.5% positive results. However, positive isolation from this group of material in RD cells was much lower (50.0%). Serotyping revealed the predominance of echovirus 6 (E6), followed by E11. Samples of sewage were collected from several locations around Poland in 2011. Samples were evaluated Tabele I Enteroviruses isolation from CSF in RD and Caco-2 cells. RT-PCR Pan-entero results Strong-positive Weak-positive No. of samples 16 Total no. of samples 32 (100%) 16 RD Total RD Caco-2 Total Caco-2 positive isolation positive isolation positive isolation positive isolation 8 (50.0%) 14 (87.5%) 10 (31.25%) 2 (12.5%) 8 (50.0%) 22 (68.75%) 1 71 The utility of Caco-2 cells in isolation of enteroviruses Table II Sewage samples analysis for enteroviruses in RD cells. Incubation time Tryspin concentration (μg/ml) 0’ 10’ 30’ 1 h 2 h No of positive results 0 0000 0000000000000000 0 P = 0 P = 0 P = 0 P = 0 P = 0 P = 0 5 0000 00000000 0000+000 1 P = 0 P = 0 P = 0 P = 0 P = 0.25 P = 0.05 10 0000 0000000000000000 0 P = 0 P = 0 P = 0 P = 0 P = 0 P = 0 50 0000 +000000000000000 1 P = 0 P = 0.25 P = 0 P = 0 P = 0 P = 0.05 No of positive results 0 P = 0 1 P = 0.06 0 P = 0 0 P = 0 1 P = 0.06 P – propability; 0 – lack of cytopathic effect; + – characteristic enterovirus cytopathic effect. Table III Sewage samples analysis for enteroviruses in Caco-2 cells. Incubation time Tryspin concentration (μg/ml) 0’ 10’ 30’ 1 h 2 h No of positive results 0 +++0 +++0+++0 +000++00 12 P = 0.75 P = 0.75 P = 0.75 P = 0.25 P = 0.50 P = 0.60 5 +000 +++0 ++00 ++00+++0 11 P = 0.25 P = 0.75 P = 0.50 P = 0.50 P = 0.75 P = 0.55 10 +++0 +++0+++0 +000++00 12 P = 0.75 P = 0.75 P = 0.75 P = 0.25 P = 0.50 P = 0.60 50 +000 +000+++0 ++00+000 8 P = 0.25 P = 0.25 P = 0.75 P = 0.50 P = 0.25 P = 0.40 No of positive results 8 10 11 6 8 P = 0.50P = 0.62P = 0.69P = 0.38P = 0.50 P – propability; 0 – lack of cytopathic effect; + – characteristic enterovirus cytopathic effect. by RT-PCR assay for the presence of enteroviruses. Positive samples were pooled and isolated in Caco-2 and RD cells. Before inoculation, sewage samples were incubated with different concentrations of trypsin (from 0 to 50 μg/ml) for different times (from 0 min to 2 h) at 37°C. Among 80 samples isolated in RD cells, only 2 were positive (Table II) in contrast to 43 positive samples in Caco-2 cells (Table III). The probability of isolation in RD cells (P = 0.025) was 20 times lower that in Caco-2 cells (P = 0.538). The processing of samples before inoculation (different concentrations of trypsin and different incubation times) did not significantly influence on the isolation of enterovirus strains in RD and Caco-2 cells. There was no significant difference between incubation time and concentration of trypsin and positive results of isolation. All samples demonstrating characteristic cytopathic effect were positive in Pan-enterovirus RT-PCR. Thus, it confirmed that observing cytopathic effect was connected with the presence of enterovirus. Discussion There is currently no cell line that supports the growth of all enterovirus serotypes. Different cell lines such as HEL, Caco-2, RD, HEp2, A549, and buffalo green monkey kidney cells (BGMK) are used for isolation of enteroviruses (Schmidt et al., 1975; Kok et al., 1998; Buxbaum et al., 2001; Otero et al., 2001; Buck et al., 2002). In this study, Caco-2 cell line was used for isolation of enteroviruses from sewage and cerebrospinal samples. In addition to Caco-2 cells, samples were also evaluated by RT-PCR assay for the presence of enteroviruses, and isolated in RD cells. Caco-2 cells were more effective in enterovirus isolation than RD cells. The rates of enterovirus isolation for 32 samples of cerebrospinal fluid positive in RT-PCR assay were 68.75% by Caco-2 cells, in contrast to 31.25% by RD cells. The high viral titre in clinical specimen (intensive band after PCR reaction) resulted in rate increase for isolation in Caco-2 cells and RD cells (87.5% and 50%, respectively). 72 1 Wieczorek M. et al. Also, the probability of isolation of enteroviruses from sewage in Caco-2 cells was 20 times higher that in RD cells. All positive isolations in Caco-2 cells were observed in the first passage; it was impossible in RD cells. In the case of RD cells, all positive isolations were observed in the second passage. The cell culture of Caco-2 cells after inoculation was in good condition for several days in contrast to RD cell culture. RD cells showed rapid degeneration due to non-specific toxicity of the specimen (sewage). Negative results of isolation in RD cells are probably a consequence of the presence of compounds that are toxic for cells. The presence of factors such as metals, humic acids, and other organic matter can interfere with cell growth. Toxic or inhibitory compounds which can impair the sensitivity of cell culture and molecular systems are found frequently in environmental samples (Murrin and Slade 1997; Reynolds et al., 1996). Toxicity in cell culture can be variable; excessive toxicity causes widespread cell death while limited toxicity may adversely affect virus attachment to cells. It is interesting to note that in a study by Reigel (1985), different viruses from clinical material replicated in Caco-2 cells: enteroviruses (coxsackieviruses B1-B6, poliovirus types 1-3, most echoviruses and coxsackieviruses A), adenoviruses, herpes simplex virus types 1 and 2, measles viruses, respiratory syncytial viruses, parainfluenza type 2 viruses, and to a lesser extent rubella and mumps viruses. However, Caco-2 cells are not popular in environmental analysis. Our study demonstrates that the resistance of Caco-2 cells for cytotoxic components from sewage is of crucial importance. It should also be considered that in years with high activity of types growing well in cell culture, the sensitivity of cell culture can be higher than in years with lower enterovirus activity (Roth et al., 2007). The addition of trypsin does not affect enterovirus isolation. The proteolytic enzymes have been reported to have several effects on cell cultures and virus cultivation. Enzyme treatment enhanced infectivity in most enteric viruses, for example in reoviruses (Rutjes et al., 2009). Trypsin treatment is not recommended in enterovirus isolation. That enzyme can cleave some enterovirus capsid protein, but usually does not affect infectivity. The high probability of enteroviruses’ isolation in Caco-2 cells in our study demonstrates that sewage testing may be very useful in epidemiological study of enteroviruses circulating in the population. Sewage surveillance system has been shown to be more sensitive than reporting of clinical cases of serious illness in a community (Sinclair et al., 2008; Bosch et al., 2008). Data regarding the occurrence of viruses in raw sewage may provide an overview of the epidemiology of virus infections circulating in the community, and at the same time may reveal the occurrence of asymptomatic infections (Pinto et al., 2007; Lodder et al., 2012). The usefulness of community sewage testing to monitor the presence of polioviruses in the face of the circulation of wild-type poliovirus in the community has been demonstrated in the Netherlands (Van der Avoort et al., 1995) and Finland (Poyry et al., 1988), and similar testing of sewage may be useful for the monitoring of echoviruses and coxsackieviruses. In conclusion, using Caco-2 cells for virus isolation in sewage seems to be very promising for environmental surveillance of enterovirus circulation and epidemiology, with all the significant effects that this may have on public health. Therefore, it is always important to consider the limitations imposed by the toxicity of environmental samples when selecting cells for viral isolation. Also, the isolation of enterovirus strains from clinical material (e.g. cerebrospinal fluids) with the use of Caco-2 cells seems to be very promising. Acknowledgments This study was supported by Ministry of Science and Higher Education of Poland grant NN 404 113 839. Literature Bosch A., S. Guix, D. Sano and R.M. Pinto. 2008. New tools for the study and direct surveillance of viral pathogens in water. Curr. Opin. Biotechnol. 19: 295–301. Buck G.E., M. Wiesemann and L. Stewart. 2002. Comparison of mixed cell culture containing genetically engineered BGMK and CaCo-2 cells (Super E-Mix) with RT-PCR and conventional cell culture for the diagnosis of enterovirus meningitis. J. Clin. Virol. 25: S13–S18. Buxbaum S., A. Berger, W. Preiser, H.F. Rabenau and H.W. Doerr. 2001. Enterovirus infections in Germany: comparative evaluation of different laboratory diagnostic methods. Infection. 29: 138–142. Hamza I.A., L. Jurzik, K. Uberla and M. Wilhelm. 2011. Methods to detect infectious human enteric viruses in environmental water samples. Int. J. Hyg. Environ. Health. 214: 424–436. Kok T.W., T. Pryor and L. Payne. 1998. Comparison of rhabdomyosarcoma, buffalo green monkey kidney epithelial, A549 (human lung epithelial) cells and human embryonic lung fibroblasts for isolation of enteroviruses from clinical samples. J. Clin. Virol. 11: 61–65. Lipson S.M., R. Walderman, P. Costello and K. Szabo. 1988. Sensitivity of rhabdomyosarcoma and guinea pig embryo cell cultures to field isolates of difficult-to-cultivate group A coxsackieviruses. J. Clin. Microbiol. 26: 1298–1303. Lodder W.J., A.M. Buisman, S.A. Rutjes, J.C. Heijne, P.F. Teunis and A.M. de Roda Husman. 2012. Feasibility of quantitative environmental surveillance in poliovirus eradication strategies. Appl. Environ. Microbiol. 78: 3800–3805. Murrin K. and J. Slade. 1997. Rapid detection of viable enteroviruses in water by tissue culture and semi-nested polymerase chain reaction. Water Sci. Technol. 35: 429–432 Otero J.R., L. Folgueira, G. Trallero, C. Prieto, S. Maldonado, M.J. Babiano and I. Martinez-Alonso. 2001. A-549 is a suitable cell line for primary isolation of coxsackie B viruses. J. Med. Virol. 65: 534– 536. 1 The utility of Caco-2 cells in isolation of enteroviruses Pinto R.M., D. Alegre, A. Dominguez, W.M. El-Senousy, G. Sanchez, C. Villena, M.I. Costafreda, L. Aragones and A. Bosch. 2007. Hepatitis A virus in urban sewage from two Mediterranean countries. Epidemiol. Infect. 135: 270–273. Pinto R.M., R. Gajardo, F.X. Abad, and A. Bosch. 1995. Detection of fastidious infectious enteric viruses in water. Environ. Sci. Technol. 29: 2636–2638. Poyry T., M. Stenvik and T. Hovi. 1988. Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Appl. Envi ron. Microbiol. 54: 371–374. Reigel F. 1985. Isolation of human pathogenic viruses from clinical material on CaCo2 cells. J. Virol. Methods. 12: 323–327. Reynolds K.A., C.P. Gerba and I.L. Pepper. 1996. Detection of infectious enteroviruses by an integrated cell culture-PCR procedure. Appl. Environ. Microbiol. 62: 1424–1427. Roth B., M. Enders, A. Arents, A. Pfitzner and E. TerletskaiaLadwig. 2007. Epidemiologic aspects and laboratory features of enterovirus infections in Western Germany, 2000–2005. J. Med. Virol. 79: 956–962. Rutjes S.A., W.J. Lodder, A.D. van Leeuwen and A.M. de Roda Husman. 2009. Detection of infectious rotavirus in naturally contaminated source waters for drinking water production. J. Appl. Microbiol. 107: 97–105. Schmidt N.J., H.H. Ho and E.H. Lennette. 1975. Propagation and isolation of group A coxsackieviruses in RD cells. J. Clin. Microbiol. 2: 183–185. Sedmak G., D. Bina, J. Macdonald and L. Couillard. 2005. Nine-year study of the occurrence of culturable viruses in source 73 water for two drinking water treatment plants and the influent and effluent of a Wastewater Treatment Plant in Milwaukee, Wisconsin (August 1994 through July 2003). Appl. Environ. Microbiol. 71: 1042–1050. Sinclair R.G., C.Y. Choi, M.R. Riley and C.P. Gerba. 2008. Pathogen surveillance through monitoring of sewer systems. Adv. Appl. Microbiol. 65: 249–269. Tapparel C., F. Siegrist, T.J. Petty and L. Kaiser. 2013. Picornavirus and enterovirus diversity with associated human diseases. Infect. Genet. Evol. 14: 282–293. Terletskaia-Ladwig E., S. Meier, R. Hahn, M. Leinmuller, F. Scheider, and M. Enders. 2008. A convenient rapid culture assay for the detection of enteroviruses in clinical samples: comparison with conventional cell culture and RT-PCR. J. Med. Microbiol. 57: 1000–1006. Van der Avoort H., J. Reimerink, A. Ras, M. Muldres and A. van Loon. 1995. Isolation of epidemic poliovirus from sewage during the 1992–3 type 3 outbreak in The Netherlands. Epidemiol. Infect. 114: 481–491. WHO. 2004. Polio laboratory manual. WHO/IVB/04.10. World Health Organization, Geneva, Switzerland. Witek A., M. Brzóstkowska, A. Diuwe and M. Wieczorek. 2011. Identification of infection agent in diagnostic material from patients with suspicion of enteroviral meningitis (in Polish). Przegl. Epide miol. 65:557–560. Zurbriggen S., K. Tobler, C. Abril, S. Diedrich, M. Ackermann, M.A. Pallansch and A. Metzler. 2008. Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine. Appl. Environ. Microbiol. 74: 5608–5614. Polish Journal of Microbiology 2014, Vol. 63, No 1, 75–82 ORIGINAL PAPER Psychrotrophic Lipase Producers from Arctic Soil and Sediment Samples R. RASOL1, 2, A.R. RASHIDAH1*, R. SITI NUR NAZUHA1, J. SMYKLA3, W.O. WAN MAZNAH1 and S.A. ALIAS4 School of Biological Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia Faculty of Applied Sciences, Universiti Teknologi MARA, 40450 Shah Alam, Malaysia 3 Department of Biodiversity, Institute of Nature Conservation, Polish Academy of Sciences, Krakow, Poland Present address: Department of Biology and Marine Biology, University of North Carolina Wilmington, 01 S. College Rd., Wilmington, NC 28403, USA 4 National Antarctic Research Center, Institute of Graduate Studies, University of Malaya, 50603 Kuala Lumpur, Malaysia 1 2 Submitted 12 March 2013, revised 27 September 2013, acepted 16 November 2013 Abstract Culturable microorganisms were successfully isolated from soil and sediment samples collected in 2011 on the northern coast of Hornsund, West Spitsbergen. A total of 63 single colony isolates from three sampling sites obtained were subjected to temperature dependence study to assess whether they are obligate psychrophilic or psychrotrophic strains. From initial temperature screening, only 53 psychrotrophic isolates were selected that are capable of growing between 4–28°C. The rest that were capable of tolerating higher temperatures up to 37°C were not included in this study. These isolates were chosen for lipase enzyme screening confirmation with the standard plate assay of olive oil and fluorescent dye Rhodamine B. Six lipase positive isolates were also subjected for subsequent lipase enzyme plate screening on tributyrin, triolein, olive oil and palm oil agar. Lipase production by these six isolates was further assayed by using colorimetric method with palm oil and olive oil as the substrate. These isolates with promising lipase activity ranging from 20 U/ml up to 160 U/ml on palm oil and olive oil substrate were successfully identified. Molecular identification by using 16S rRNA revealed that five out of six isolates were Gram-negative Proteobacteria and the other one was a Gram-positive Actinobacteria. K e y w o r d s: Arctic soil, lipase, psychrotroph Introduction Polar ecosystems are extensively prospected for obligate psychrophilic and psychrotrophic microbes in order to discover the unique adaptabilities of their enzymes (de Pascale et al., 2012). It is evident that these ongoing research have yield fruitful discoveries of varieties of microbial communities capable of producing cold-active enzymes. In the Arctic region, several bioprospecting studies had led to the findings of a diverse range of bacteria capable of producing cold-active enzymes. A study of bacterial diversity from sediment samples along a transect from the snout of the Arctic Midtre Lovenbreen glacier up to the melt water streams uncovered 32 groups of bacteria, with 14 exhibiting cold-active enzyme activities (Reddy et al., 2009). Sea ice that provides a large pool of organic matters housed several bacterial communities capable of producing cold-active hydrolytic enzymes. Arctic sea ice samples from Canada Basin yield 338 bacterial strains having diverse enzyme producing capabilities, with lipase being the highest (Yu et al. 2009). Sea ice and seawater sampled from Spitzbergen fjords, possessed 116 psychrophilic and psychrotrophic strains; with protease enzyme producers accounted for more than half of the isolated bacteria (Groudieva et al., 2004). A total of 103 bacterial isolates from 47 phylotypes were isolated from eight sediment and one soil samples of two Arctic fjords of Kongsfjorden and Ny-Ålesund, Svalbard with 56% showing either amylase or lipase or both activities (Srinivas et al., 2009). The Finnish Lapland exhibited large annual temperature variations and freeze/thaw events as compared to other Arctic areas. Various ecosystems of Finnish Lapland sampled in Männistö and Häggblom (2006) revealed 331 bacterial strains with protease and lipase producers detected in 59 and 66 isolates. Extensive research on cold-loving microorganism was carried out because there is a growing prospect of cold-adapted enzymes in the industries. These enzymes were functional at varied and demanding * Corresponding author: A.R. Rashidah, School of Biological Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia; phone/fax: 604 - 6534006 / 604 - 6565125; e-mail: [email protected]; [email protected] 76 1 Rasol R. et al. industrial conditions. Cold adapted enzymes are in favor because of their ability to save energy, reduce mesophilic microbial contamination and the ease of mild heat-inactivation to terminate the cold-adapted enzymes catalysis (Groudieva et al., 2004). Lipase catalyze both the hydrolysis and synthesis of ester bonds in long-chain acylglycerol (C ≥ 10) (Jaeger and Reetz, 1998) resulting in the formation of an alcohol and a carboxylic acid (de Pascale et al., 2008). Most of microbial lipase showed high activity between 30°C and 50°C, while alternatively cold active lipase showed high specific activity at lower temperatures. This caused them to become a preferable choice to suit diverse industrial processes (Mayordomo et al., 2000). Due to their interesting property of high activity at low temperatures, production of frail compounds such as synthesis of chiral intermediates would make cold-active lipase as their prime choice. Structural modification in coldactive lipase by an increased flexibility of the polypeptide chain due to higher proportion of amino acids (de Pascale et al., 2012) ease substrate accommodation at low temperatures (Joseph et al., 2008). Cold-active lipase is also reported to work under low water condition due to its high flexibility. In the industry, reverse hydrolysis of substrates in low water conditions are preferable because they are able to lower down water activity besides having improved yields (Tutino et al., 2009). Besides the need of finding novel cold-active lipase that possess industrial applications, based on protein database from (http://www.ncbi.nlm.nih.gov/protein), least numbers of cold-active lipase structures have been solved. Structure-function and catalytic activity studies of cold-active lipase will be able to help the scientific community in understanding cold adaptation. This will also lead to steps in designing and engineering lipase for specific applications in the future. Therefore, in this study, we attempt to search and identify the lipase producing ability of bacterial isolates from Arctic that are capable of producing cold-active lipase enzyme. Experimental Materials and Methods Study area and sample collection. The field survey and sampling for this study took place during the 2011 boreal summer (August 2011) on the northern coast of Hornsund, Wedel Jarlsberg Land, West Spitsbergen in the vicinity of the Polish Polar Station “Hornsund” (77°00'04"N, 15°33'37"E). Climate of this area is strongly affected by oceanic influence. However, climatic conditions are very variable and characterized by low temperature, low precipitation and strong foehn winds. The average annual air temperature is – 4.4°C, with average monthly temperatures ranging between – 11.3°C in January and + 4.4°C in July, and average annual precipitation reaches only ca. 300–400 mm (Marsz and Styszyńska 2007). A total of twelve sampling locations representing a range of habitats with a diversity of soil physical and chemical characteristics were sampled (data not shown). In this preliminary study, only three sample sites described in Table I were analyzed for this work. Isolates were named according to sites where they were sampled; isolate from soil sample collected at the site A were named ARA(I), isolates from sediment sample collected at the site A were named as ARA(II), and isolates from soil samples collected at the site B and C were named ARB and ARC respectively. At each sampling location, 10 g of soil or sediment was obtained covering the surface to 10 cm depth using a sterile spatula. As for site C, soil from the bottom of the pond was sampled. The samples were collected with using a sterile spatula and placed into sealed sterile Falcon tubes. Then the samples were refrigerated at 4°C, and subsequently transported at this temperature, taking 6 days in transit to the National Antarctic Research Center, Kuala Lumpur, Malaysia, where they were stored at –20°C until further analysis (Ali et al., 2013). Table I Details of sampling locations in the Hornsund area where soil and sediment samples were collected (after Ali et al., 2013). Designation Air temperature (°C) Air Soil pH Water Altitude m asl 4.55 7.00 5.98 11 Site B (soil) ARB Skjerstranda at the foothill Dried runnel of Trulsenfjellet 77°01’28.50” N 15°12’52.74” E 7.30 9.55 – 23 Site C (soil) ARC Ralstranda (southern part), at the foot Pond of Rotjesfjellet, near Revelva river 77°00’24.12” N 15°20’36.54” E 5.85 8.50 5.2416 Sites Site A (soil) ARA(I) Site A ARA(II) (sediment) Location Fugleberrgsletta, neighbourhood of the Hornsund Station 77°00’06.00” N 15°31’54.60” E Habitat Vertebrate-influenced pond 1 77 Psychrotrophic lipase producers Isolation of culturable bacterial strains. An amount of 1 g of soil and sediment were inoculated into 100 ml of nutrient broth medium and grown at 15°C, 150 rpm for 15 days (Leonov, 2010). After the incubation period, the samples were serially diluted 10–6 in sterile cold distilled water and isolated on nutrient agar plates. Single colonies obtained with obviously different macroscopic characteristics were subcultured on fresh nutrient agar plates three times to produce pure colony isolates. Temperature dependence study. In order to differentiate an obligate psychrophilic and psychrotrophic strain growth, isolates obtained that were in pure colony forms were screened by growing on nutrient agar plates and incubated at three different temperatures which were 4°C (in the refrigerator), 28°C ± 2°C (at room temperature) and 37C (in the incubator). Room temperature fluctuates at ± 2°C during day and night time. Plate screening for lipase. Confirmation of lipase activity via plate screening was done by using the standard Rhodamine B fluorescent assay. Isolates were grown on Rhodamine B agar (1% v/v olive oil and 10 ml of Rhodamine B stock 0.01% w/v). Lipase production on Rhodamine B medium was monitored by orange fluorescence as seen with UV light at 350 nm. Subsequently, lipase activities on lipase positive isolates were also screened using olive oil (1% v/v) agar, palm oil (0.5% v/v) agar, tributyrin (1% v/v) agar and triolein (1% v/v agar). Halo zones seen were considered as positive for lipase production. Tween 20 (0.1% v/v) was added as inducers to all plates except the ones that used tributyrin as substrate. This is due to the fact that initial plate screening without any inducers’ addition failed to detect halo zones in all substrates of triolein, olive oil and palm oil. Standard curve of free fatty acids. A series of oleic acid mixture with isooctane ranging from 0–1000 µmol was prepared in test tubes. The standard curve of free oleic acids vs. absorbance at 715 nm was determined according to Kwon and Rhee (1986). Standard curve of oleic acid was constructed to determine the lipase activity of each isolate during lipase assay. Lipase assay. Fatty acids released by six lipase positive isolates as confirmed by plate screening were measured by colorimetric method according to Eltaweel et al. (2005) with modification. Cultures that had been grown for 5 days at 15°C with olive oil (1% v/v) or palm oil (0.5% v/v) as the substrate were centrifuged at 4,000 rpm to separate the cells and the extracellular enzymes. An amount of 1 ml of crude extracellular enzymes from the supernatant was mixed with 1.48 ml of 100 mM phosphate buffer pH 7, 0.02 ml of 20 mM CaCl2 . 2H20 and 2.5 ml of olive oil emulsion in 1% poly(vinyl alcohol)(1:3 v/v). The mixture was incubated for 30 minutes at 15°C with the agitation rate of 180rpm. An amount of 1 ml of 6 N HCl and 5 ml isooctane was added to terminate the reaction. The mixture was hand shaken and allowed to separate for 10 minutes. Finally, 4 ml of the upper isooctane layer which contained liberated fatty acids were transferred to a fresh tube containing 0.2 ml of cupric acetate-pyridine reagent and further mixed by vortexing vigorously until foamed. After half an hour at room temperature, absorbance at 715 nm was determined on the isooctane that contained dissolved free fatty acids. One unit of lipase activity was equivalent to 1 µmole of fatty acid released per ml/min at 15°C. Morphology and molecular identification. Morphology of the six lipase positive isolates was identified through Gram staining and molecular identification by using 16S rRNA analysis. DNA from each isolate was extracted using modified CTAB method (Sambrook and Russell, 2001). The genomic DNA of each isolate was subjected to amplification of the 16S rRNA gene using 27F and 1492R primer pairs. Sequences obtained were aligned using ClustalW (MEGA 5.10) and subjected to BLAST analysis for species identification. Results Isolation of culturable bacteria. A total of 63 single colony isolates were obtained from the three sample sites (Table II), comprising 21 soil isolates from site A (named as ARA(I) isolates), 8 sediment isolates from site A (named as ARA(II) isolates), 27 soil isolates from site B (named as ARB isolates) and finally 7 soil isolates from site C (named as ARC isolates). Temperature dependence study. All isolates were subjected to temperature dependence study to differentiate whether they are obligate psychrophiles or psychrotrophs. Based on growth temperatures used which was 4°C, 28°C ± 2°C and 37°C, each isolate was grouped to three different groups. Isolates that only grew at 4°C were most probably obligate psychrophiles that cannot tolerate growth temperatures higher than 20°C. Isolates capable of growth at both 4°C and 28°C ± 2°C can be grouped as facultative psychrophiles or psychrotroph that tolerated growing temperatures up to 30°C. However, those that also grew at 37°C tolerated such a huge range of temperatures were not included in this study as the aim was to isolate bacteria that adapt to low temperatures. The isolates designation, growing ability at three different incubation temperatures and colony color were given in Table II. From Site A, three soil isolates, ARA (I) 6, 15 and 19 were capable of growing at 37°C (in addition to 4°C and 28°C ± 2°C). These isolates were removed from further analyses. This left only 18 soil isolates for further lipase screening process. For some of the isolates, the growth medium turned brown/black during the isolates incubation. However, this characteristic was only recorded 78 Table II List of isolates, their temperature dependence and macroscopic characteristics. For details on sampling sites location and characteristics see Table I. Sampling site and substratum 1 Rasol R. et al. Isolate Incubation temperature 4°C 28°C ± 2°C 37°C Site A (soil) ARA(I) 1 / /* – ARA(I) 2 / /* – ARA(I) 3 / /* – ARA(I) 4 / /* – ARA(I) 5 / / – ARA(I) 6 / /* /* ARA(I) 7 / / – ARA(I) 8 / / – ARA(I) 9 / /* – ARA(I) 10 / / – ARA(I) 11 / / – ARA(I) 12 / /* – ARA(I) 13 / / – ARA(I) 14 / /* – ARA(I) 15 / /* /* ARA(I) 16 / / – ARA(I) 17 / / – ARA(I) 18 / / – ARA(I) 19 / /* /* ARA(I) 20 / / – ARA(I) 21 / / – Site A (sediment) ARA(II) 1 / / / ARA(II) 2 / / – ARA(II) 3 / / – ARA(II) 4 / / – ARA(II) 5 / / / ARA(II) 6 / / / ARA(II) 7 / / – ARA(II) 8 / / – Site B(soil) ARB 1 / / – ARB 2 / / – ARB 3 / / – ARB 4 – – – ARB 5 / / – ARB 6 / / – ARB 7 / / – ARB 8 / / – ARB 9 / / – ARB 10 / / – ARB 11 / / – ARB 12 / – – ARB 13 / / – ARB 14 / / – ARB 15 / / – ARB 16 / / / Table II continued Sampling site and substratum Isolate Incubation temperature 4°C 28°C ± 2°C 37°C Site B(soil) ARB 17 / / / ARB 18 / / – ARB 19 / / – ARB 20 / / – ARB 21 / / – ARB 22 / / – ARB 23 / / – ARB 24 / / – ARB 25 / / – ARB 26 / / – ARB 27 / / / Site C (soil) ARC 1 / / – ARC 2 / / – ARC 3 / / – ARC 4 / / – ARC 5 / / – ARC 6 / / – ARC 7 / / – / Presence of growth – Absence of growth * Blackening of the agar medium in soil isolates from ARA (I), but not in the sediment samples of ARA (II). The secretion of the brownish pigment into the liquid and solid medium was analyzed through UV-Vis Spectrophotometer (UV-1800 Shimazdu) within the wavelength range of 300–800 nm with acetone as the blank. The maximum absorbance of light was measured at wavelength 320 nm, which is the wavelength absorbance for UV-B region. This high absorbance in UV-B region as well as the dark color of pigment produced (brown) was similar with the characteristics property of melanin pigment (Sajjan et al., 2010; Dastager et al., 2009). In case of sediment isolates from Site A, three pigmented sediment isolates, namely ARA(II) 1, ARA(II) 5 and ARA(II) 6, were capable of good growth at 37°C (see Table II). They were not included in the lipase screening process as well leaving only five sediment isolates for further analyses. In site B, three isolates (ARB 16, 17 and 27) were eliminated because of their excellent growth at 37C (see Table II). All three isolates were orange pigmented. Isolate ARB 4 failed to grow after subsequent subculturing. Therefore only 23 isolates were subjected to subsequent screening steps. All isolates from site C were subjected for further lipase screening studies. Plate screening for lipase. All 53 isolates selected through temperature dependence study underwent plate screening for lipase on olive oil agar plates that used Rhodamine B as the fluorescent dye. Only six iso- 1 Psychrotrophic lipase producers Table III Lipase plate screening of positive isolates Plate screening Isolate Tributyrin agar (1% v/v) Triolein agar (1% v/v) + Tween 20 (0.1% v/v) Olive oil agar (1% v/v) + Tween 20 (0.1% v/v) Olive oil agar (1% v/v) + Tween 20 (0.1% v/v) ARA(I) 5 + + + + + + + ARA(II)8+ ARB1+ + + – ARB2+ + + – ARB10+ + + – ARC1+ + + + + Presence of halo zones – Absence of halo zones lates were tested positive for lipase production which were ARA(I) 5 from Site A, sediment isolate ARA(II)8 from Site A, isolate ARB1, ARB2, ARB10 from Site B, and isolate ARC1 from Site C. Pictures of all the positive plates can be seen in Fig. 1. Their morphology obtained through Gram staining is also given in Fig. 1. Besides, the 16S rRNA blast results were also included. Based on 16S rRNA analysis, lipase positive isolates were dominated by Gram-negative bacteria and only one Gram-positive (ARB1) was detected to produce lipase. Isolate ARA(I)5, ARB2, ARB10 and ARC1 belong to the Gammaproteobacteria group. Isolate ARA(II)8 which was also a Gram-negative bacterium belongs to the Betaproteobacteria group. Isolate ARB1 was the only Gram-positive isolate belonging to the Actinobacteria phylum, which is a high G+C content bacterium. Low percentage of similarities in some of the isolates suggested that some of the isolates might be new species. In the plate screening method that was done using tributyrin, triolein, olive oil and palm oil substrates, some of the plates (refer Table III) includes addition of Tween 20 that acted as inducers. Isolate ARB1, ARB2 and ARB10 failed to show the presence of halo zones on palm oil agar plates. Lipase assay. Lipase production was assayed by using palm oil and olive oil. The results are given in Fig. 2. Fig. 2 shows that four isolates – ARA (I) 5, ARA (II) 8, ARB2 and ARB10 prefer olive oil rather than palm oil as their substrate. ARB1 and ARC1 did not follow this pattern, and these isolates utilize palm oil better than olive oil up to 40% better in ARC1. Discussion Temperature dependence study. In the present study, all of obtained isolates were psychrotrophs. According to Markúsdóttir et al. (2013), psychrotrophs can support growth at 0°C, but have an optimal growth 79 between 20°C to 30°C. In the present study, most of the isolates grew faster at incubation temperature 28°C ± 2°C. However, the colonies that grew at 4°C looked healthier. Isolates that are capable of withstanding a wider range of growth temperature are found in environments that experience high seasonal and/or diurnal temperature fluctuations, e.g. the sub-Arctic regions (Markúsdóttir et al., 2013). On the contrary, there are also cases of isolates from permanently cold environments that have high proportion of psychrotrophs. For instance, a study on the diversity of culturable bacteria in Arctic sea ice from Spitzbergen fjords revealed that most of the isolates were psychrotrophic rather than obligate psychrophiles (Groudieva et al., 2004). Sampling of the present study was conducted in summer; therefore the thawed layer of soil/sediment would select fast growing organisms capable of exploiting the moderate temperatures and higher nutrient availability (de Pascale et al., 2012). Plate screening for lipase. Tributyrin was a common substrate to confirm lipase activity in most studies. However, in the present study, other longer chain fatty acids substrates were incorporated for plate screening besides the initial step that used fluorescent dye Rhodamine B to confirm lipase activities. This is due to the fact that shorter chain tributyrin can also be a target of the esterase enzyme. Lipase that possesses a broader substrate range will not only hydrolyze tributyrin, but other longer chain fatty acid substrates such as triolein, palm oil and olive oil. Unlike esterases, lipases are known to attack emulsified form of insoluble longchain fatty acids substrate (Fojan et al., 2000). This characteristic is a consequence of the ‘interfacial activation’ phenomenon, where emulsions form caused enhancement of lipase activity (Tutino et al., 2009). Henne et al. (2000) also reported that tributyrin positive clones were unable to hydrolyze p-nitrophenyl esters during lipase assay. This is a common attribute of the esterase enzyme. Initially, all isolates screened with olive oil, palm oil agar and triolein agar showed negative results. Therefore, there is a need for inducers presence in the medium. Tweens (polyoxyethylene esters) were found to induce lipase production effectively in Candida rugosa, but Tweens themselves do not act as carbon sources (Zhang et al., 2003). Therefore Tween 20 was added as inducers in plate screening with olive oil and palm oil carbon sources in subsequent experiments and this resulted in appearance of halo zones. Lipase assay. Lipase activity is affected by the carbon length of the fatty acid and the number and position of the double bonds (Long, 2009). Olive oil with the main component of unsaturated oleic acid possess double bonds that can be broken and used easier than palm oil with higher content of saturated palmitic acid that might be harder to break. However, ARB1 and 80 Rasol R. et al. 1 1 Psychrotrophic lipase producers 81 Fig. 1. Lipase positive identified isolates on Olive oil + Rhodamine B agar Fig. 2. Lipase activity on palm oil (light shade) and olive oil (dark shade) ARC1, which grow better on palm oil, probably have some properties that allow easy assimilation of saturated lipids. The nature of that process is unknown and requires further investigations. Morphology and molecular identification. Most of the work done on bioprospecting at Arctic habitats discovered higher numbers of Gram-negative strains as compared to Gram-positive strains. Srinivas et al. (2009) reported the isolation of 38 Gram-negative strains and 9 Gram-positive strains. The low abundance of Gram-positive was due to the fact that low temperature slowed down growth of Gram-positive isolates. The Gram-negative strains in the present study were dominated by pseudomonads. Männistö and Häggblom (2006) also hypothesized that Pseudomonas sp. inhibits the growth of certain Gram-negative bacteria. The resulting isolates group of this present study as determined by 16S rRNA analysis was in agreement with most of bioprospecting work on Arctic environments, where Proteobacteria, CFB (Cytophaga-Flavobacterium-Bacteroidetes) group, low and high G + C Gram-positive genera (Srinivas et al., 2009, Reddy et al., 2009, Groudieva et al., 2004) predominates. In the present study, lipase producing isolates were dominated by Proteobacteria; particularly Gammaproteobacteria where four of the isolates were pseudomonads. Pseudomonads are well known for their metabolic versatility, simple nutrient requirements and genetic adaptability (Markúsdóttir et al., 2013). Most of the pseudomonads from this group bear closest similarities with Pseu domonas fluorescens species group, a common isolate found in cold habitats. Meyer et al. (2004) reported the isolation of high numbers of Pseudomonas sensu stricto genus in the cold alpine Colorado soil, in which P. fluo rescens group falls into the main cluster. In the present study, another group of betaproteobacteria, Janthinobacterium agaricidamnosum was also found to produce lipase. Tindall et al. (2000) isolated two strains of Janthinobacterium lividum (clusters 1a and 1b) from a mat in Dry Valleys, Antarctica. Janthino bacterium agaricidamnosum isolated from the present study was related to Janthinobacterium lividum. These are two well known species in the genus Janthinobacte rium (Tindall 2004). Psychrotrophic Arthrobacter strains were usually found in the Arctic soils, different Antarctic environments and on various glaciers. They were also abundant in subterranean cave slits (Margesin et al., 2004). Juck et al. (2000) reported high G+C Gram-positive coldadapted microorganisms especially from the genera Arthrobacter dominating hydrocarbon contaminated soils; believed to play a role in hydrocarbon degradation. Strong research interest in cold-active lipase has led to efforts in cloning and expression of respective lipase 82 Rasol R. et al. genes in the lab currently. Besides that, ecological significance of the lipase enzyme that was present in these six isolates needs further investigation especially on the soil composition of the sampling sites. This is due to the need to discover the source and types of lipids used by these isolates. Acknowledgements The authors wish to express their gratitude to Universiti Sains Malaysia for financial support (grant no. 304/PBIOLOGI/6311118), Universiti Teknologi MARA, Ministry of Science, Technology and Innovation Malaysia and Ministry of Higher Education Malaysia as well as to Mr Muhammad Adlan Abdul Halim for sampling aid. We also thank the Department of Polar Research of the Institute of Geophysics Polish Academy of Sciences for providing logistical support during the fieldwork, and the team at the Polish Polar Station “Hornsund” for their hospitality and assistance. Funding for this work was provided by the Polish Ministry of science and Higher Education (within the program “Supporting International Mobility of Scientists” and grant no. NN305376438 to JS), the Malaysia Antarctica Research Program (MARP) and University of Malaya (UM) (OCAR TNC(P&I) 2011 Account No. (A-55001-DA000-B21520). Literature Ali S.H., S.A. Alias, H.Y. Siang, J. Smykla, K.-L. Pang, S.-Y. Guo and P. Convey. 2013. Studies on diversity of soil microfungi in the Hornsund area, Spitsbergen. Polish Polar Research 34(1): 39–54 Dastager S., W.-J. Li, A. Dayanand, S.-K. Tang, X.-P. Tian, X.-Y. Zhi, L.-H. Xu and C.-L. Jiang. 2009. Seperation, identification and analysis of pigment (melanin) production in Streptomyces. African Journal of Biotechnology 5(11). de Pascale D., A.M. Cusano, F. Autore, E. Parrilli, G. di Prisco, G. Marino and M.L. Tutino. 2008. The cold-active Lip1 lipase from the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 is a member of a new bacterial lipolytic enzyme family. Extremophiles 12: 311–323 de Pascale D., C. de Santi, J. Fu and B. Landfald. 2012. The microbial diversity of Polar environments is a fertile ground for bioprospecting. Marine Genomics 8: 15–22 Eltaweel M.A., R.N.Z.R.A. Rahman, A.B. Salleh and M. Basri. 2005. An organic solvent-stable lipase from Bacillus sp. strain 42. Annals of Microbiology 55(3): 187–192 Fojan P., P.H. Jonson, M.T.N. Peterson and S.B. Peterson. 2000. What distinguishes an esterase from a lipase: a novel structural approach. Biochimie 82: 1033–1041 Grouediva T., M. Kambourova, H. Yusef, M. Royter, R. Grote, H. Trinks and G. Antranikian. 2004. Diversity and cold-active hydrolytic enzymes of culturable bacteria associated with Arctic sea ice, Spitzbergen. Extremophiles 8: 475–488. Henne A., R.A. Schmitz, M. Bömeke, G. Gottschalk and R. Daniel. 2000. Screening of Environmental DNA Libraries for the Presence of Genes Conferring Lipolytic Activity on Escherichia coli. Applied and Environmental Microbiology 66(7): 3113–3116 Jaeger K. and M.T. Reetz. 1998. Microbial lipases form versatile tools for biotechnology. TibTech 16 : 396–403 Joseph B., P.W. Ramteke and G. Thomas. 2008. Cold active microbial lipases: Some hot issues and recent developments. Biotechnology advances 26: 457–470 Juck D., T. Charles, L.G. Whyte and C.W. Greer. 2000. Polyphasic microbial community analysis of petroleum hydrocarbon-contaminated soils from two northern Canadian communities. FEMS Micro biology Ecology 33: 241–249 1 Kwon D.Y. and J.S. Rhee. 1986. A simple and rapid colorimetric method for determination of free fatty acids for lipase assay. JAOCS 63: 89–92. Leonov S.L. 2010. Screening for Novel Cold-active Lipases from Wild Type Bacteria Isolates. Innovative Romanian Food Biotechno logy 6 : 12–17. Long K. 2009. Unlocking the miracle of lipases. Research Inaugural Lecture at Auditorium Mardi Serdang on the 22 October 2009. Assessed on the 24 September 2012 from http://www.mardi.gov. my/c/document_library/get_file?uuid=71e0d6b4-3661-4301-a994dff8272d8d56&groupId=10138. Männistö M.K. and M.M. Häggblom. 2006. Characterization of psychrotolerant heterotrophic bacteria from Finnish Lapland. Sys tematic and Applied Microbiology 29: 229–243. Margesin R., P. Schumann, C. Sproer and A.M. Gounot. 2004. Arthrobacter psychrophenolicus sp. nov., isolated from an alpine ice cave. International Journal of Systematic and Evolutionary Microbio logy, 54: 2067–2072 Markúsdóttir M., S. Heiðmarsson, A. Eyþórsdóttir, K.P. Magnússon and O. Vilhelmsson. 2013. The natural and anthropogenic microbiota of Glerá, a sub-arctic river in northeastern Iceland. Inter national Biodeterioration and Biodegradation 84: 192–203. Marsz A. and A. Styszyńska. 2007. Klimat rejonu Polskiej Stacji Polarnej w Hornsundzie – stan, zmiany i przyczyny (Climate of the Polish Polar Stadion in Hornsund – the state, changes and reasons). Wydawnictwo Akademii Morskiej w Gdyni, Gdynia: pp. 376 (in Polish) Mayordomo I., F. Randez-Gil and J.A. Prieto. 2000. Isolation, Purification, and Characterization of a Cold-Active Lipase from Aspergillus nidulans. J. Agric. Food Chem. 48: 105–109. Meyer A.F., D.A. Lipson, A.P. Martin, C.W. Schadt and S.K. Schmidt. 2004. Molecular and metabolic characterization of cold-tolerant alpine soil Pseudomonas sensu stricto. Applied Envi ronmental Microbiology 70: 483–489. Reddy P.V.V., S.S.S.N. Rao, M.S. Pratibha, B. Sailaja, B. Kavya, R.R. Manorama, S.M. Singh, T.N.R. Srinivas and S. Shivaji. 2009. Bacterial diversity and bioprospecting for cold-active enzymes from culturable bacteria associated with sediment from a melt water stream of Midtre Lovenbreen glacier, an Arctic glacier. Research in Microbiology 160: 538–546. Sajjan S., V. Yaligara and T. Karegoudar. 2010. Purification and Physiochemical Characterization of Melanin Pigment from Klebsiella sp. GSK. Journal of Microbiology and Biotechnology 20(11), 1513–1520. Sambrook J. and D.W. Russell. 2001. Molecular cloning: in laboratory manual. 3rd edition; Cold Spring Harbor Laboratory; New York. Srinivas, T.N.R., S.S.S.N. Rao, P.V.V. Reddy, M.S. Pratibha, B. Sailaja, B. Kavya, K. Hara Kishore, Z. Begum, S.M. Singh and S. Shivaji. 2009. Bacterial Diversity and Bioprospecting for ColdActive Lipases, Amylases and Proteases, from Culturable Bacteria of Kongsfjorden and Ny-Ålesund, Svalbard, Arctic. Current Microbio logy 59: 537–547 Tindall B.J. 2004. Prokaryotic Diversity in the Antarctic: The Tip of the Iceberg Microbial Ecology 47: 271–283 Tindall B.J., E. Brambilla, M. Steffen, R. Neumann, R. Pukall, M.R. Kroppenstedt and E. Stackebrandt. 2000. Cultivatable micro bial biodiversity: gnawing at the Gordian knot. Environmental Micro biology 2(3): 310–318 Tutino M.L., G. Prisco, G. Marino and D. Pascale. 2009. Coldadapted esterases and lipases : From fundamentals to application. Protein and Peptide Letters 16: 1172–1180. Yu Y., H. Li, Y. Zeng and B. Chen. 2009. Extracellular enzymes of cold-adapted bacteria from Arctic sea ice, Canada Basin. Polar Biology 32:1539–1547 Zhang L.Y., D.Z. Wei and W.Y. Tong. 2003. Effective inducers for lipase production by Candida rugosa. Annals of Microbiology 53 (4): 499–504 Polish Journal of Microbiology 2014, Vol. 63, No 1, 83–88 ORIGINAL PAPER Plant Growth Promotion Rhizobacteria in Onion Production JOSIP ČOLO1, TIMEA I. HAJNAL-JAFARI2*, SIMONIDA ĐURIĆ2, DRAGANA STAMENOV2 and SAUD HAMIDOVIĆ1 1 Faculty of Agricultural and Food Sciencies, Bosnia and Herzegowina 2 Faculty of Agriculture, University of Novi Sad, Novi Sad, Serbia Submitted 18 June 13, revised 14 September 2013, accepted 16 November 2013 Abstract The aim of the research was to examine the effect of rhizospheric bacteria Azotobacter chroococcum, Pseudomonas fluorescens (strains 1 and 2) and Bacillus subtilis on the growth and yield of onion and on the microorganisms in the rhizosphere of onion. The ability of microorganisms to produce indole-acetic acid (IAA), siderophores and to solubilize tricalcium phosphate (TCP) was also assessed. The experiment was conducted in field conditions, in chernozem type of soil. Bacillus subtilis was the best producer of IAA, whereas Pseudomonas fluores cens strains were better at producing siderophores and solubilizing phosphates. The longest seedling was observed with the application of Azotobacter chroococcum. The height of the plants sixty days after sowing was greater in all the inoculated variants than in the control. The highest onion yield was observed in Bacillus subtilis and Azotobacter chroococcum variants. The total number of bacteria and the number of Azotobacter chroococcum were larger in all the inoculated variants then in the control. The number of fungi decreased in most of the inoculated variants, whereas the number of actinomycetes decreased or remained the same. K e y w o r d s: growth and yield of onion, PGP rhizobacteria, rhizospheric microorganisms Introduction Plant growth promoting rhizobacteria (PGPR) affect plant growth directly or indirectly by producing growth substances such as indole-acetic acid, gibberelic acid and cytokinins (Verma et al., 2010; Garcia de Salamone et al., 2001), fixing dinitrogen from the atmosphere and providing the plant with this element (Boddey and Dobereiner, 1995) and by being antagonistic towards phytopathogenic microorganisms (Velivelli et al., 2012). In recent decades, different PGPR have been studied, including nitrogen-fixing bacteria from Azotobacter genus and bacteria which produce growth substances and act as antagonists, such as Bacil lus and Pseudomonas (McSpadden-Gardener, 2004; Benizri et al., 1998). The interaction between rhizobacteria and plants is not always stable in nature, thus positive results obtained in controlled conditions cannot always be replicated in field conditions (Jarak et al., 2012). The effect of PGPR varies as a result of environmental factors, which may affect both the growth of bacteria and the plant. The effect of the introduced bacteria also depends on plant physiology and agronomic conditions of cultivation. In order to achieve an optimum interaction between rhizobacteria and the plant root, it is necessary to examine the way in which rhizobacteria affect the plant and microorganisms in soil and whether this influence changes due to environmental factors, including the presence of other microorganisms, as well (Stamenov et al., 2012a). Onion (Allium cepa) is an important vegetable plant. Due to its high adaptability, there are numerous populations and varieties of onion grown under various environmental conditions. Onion contains a large amount of carbohydrates and a small amount of proteins and fats. The biological value of onion lies in its mineral substances and vitamins. Apart from a significant amount of mineral salts, especially potassium and sulphur salts, and different oligoelements, onion abounds in vitamins (B1, B2, C, E, K), carotene (provitamin A), glycosides, etheric oils, plant hormones similar to insulin, as well as bacteriostatics (Slimestad et al., 2007). The root system of onion has low absorbing and penetrating abilities, therefore it requires an ample amount of easily accessible nutrients in the root zone. The amount of easily accessible nutrients which is necessary for optimum yield is 60–140 kg N, 60–120 kg P2O5 and 60–180 kg K2O per hectare (Kumar, 2001). Recently, * Corresponding author: T.I. Hajnal-Jafari, Department of Microbiology, Faculty of Agriculture, Dositeja Obradovica Sq. No. 8; phone: +381 21 4853 425; e-mail: [email protected] 84 Čolo J. et al. plant growth promoting rhizobacteria (PGPR) have come into focus as bacteria which can provide a part of necessary nutrients. The aim of the study was to examine the effect of PGPR Bacillus subtilis, Pseudomonas fluorescens and Azotobacter chroococcum on germination, growth and yield of onion, as well as on the microbiological activity in the rhizosphere during the vegetation period of onion. Experimental Material and Methods Bacterial strains. The bacteria used in the study included Azotobacter chroococcum, Pseudomonas fluo rescens strain 1, Pseudomonas fluorescens strain 2 and Bacillus subtilis (from Department of Microbiology, Faculty of Agriculture, Novi Sad, Serbia). The microorganisms were propagated in appropriate nutrient media (Handbook of Microbiological Culture Media, 2000): Azotobacter chroococum in nitrogen-free medium with mannitol, Pseudomonas fluorescens in King B medium (Himedia, India), and Bacillus subtilis in nutrient agar (NA) (Torlak, Serbia). Indole-acetic acid (IAA) production. IAA production was examined using Gordon and Weber method (Gordon and Weber, 1951). Using Salkowski reagent (1 ml 0.5 M FeCl3 in 50 ml 35% HClO4) the production of IAA in a medium containing 0, 200 and 500 µg/ml of L-tryptophane was determined. The volumes of 100 µl of 24 h bacterial culture (standardized to OD600 of 0.625), were introduced into 100 ml of liquid media: Pseudomonas into King B medium, Bacillus into NA medium and Azotobacter into nitrogen-free medium with mannitol. After 24 h and 48 h, incubation at 28°C, 5 ml of the suspension was centrifuged at 1,957 × g for 15 minutes. An amount of 2 ml of Salkowski reagent was added into 1 ml of supernatant. Twenty-five minutes later, the intensity of the development of pink colour was measured at 530 nm. Phosphate solubilization. The ability of isolates to solubilize tricalcium phosphate (TCP) (CaCO3(PO4)2) was investigated in a Pikovskaya medium (amount g l–1: KCl 0.2 g, MgSO4 × 7H2O 0.1 g, glucose 10 g, yeast extract 0.5 g, FeSO4 × 7H2O 0.002 g, MnSO4 × H2O 0.002 g, (NH4)2 SO4 0.5 g, Ca3(PO4)2 5 g). An amount of 1 ml bacterial culture, respectively (standardized to OD600 of 0.625) was introduced into the cooled medium, poured into a Petri dish and carefully mixed. After five days of incubation at the temperature of 28°C, transparent zones around the colonies were measured. Siderophore production. The ability of siderophore production was determined by the method 1 of Milagres et al. (1999), using chrome azurol agar (CAS agar). Appropriate nutrient media for Bacil lus, Pseudomonas and Azotobacter were poured into Petri dishes. After they had solidified, the media were cut into halves and one half was removed. CAS agar was poured into the empty halves of the Petri dishes. The bacteria were introduced into the halves with the nutrient medium. The incubation lasted five days at the temperature of 28°C. In those strains which produce siderophores, the blue-green colour of CAS agar turned into orange along the demarcation line between the two media. Field experiment. The experiment was conducted in Backi Brestovac (Vojvodina, Serbia), in carbonate chernozem soil. The soil was characterized by the following properties: pH in H2O : 8.06, pH in KCl: 7.19, % CaCO3 : 4.62, % humus: 2.63, % N: 0.13, mg P2O5/100 g soil: 22.27, mg K2O/100 g soil: 18.12. The experimental design was a randomized, complete block with four replications. The size of the experimental plots was 10 m2 (10 m long, 1 m wide). The sowing was performed on 12 March, 2012. The spacing in a row was 5 cm and 25 cm between the rows. Bacterial treatments. The onion seed (Damascus f1 hybrid, Holland) was inoculated with four bacterial strains: 1. Azotobacter chroococcum; 2. Bacillus subtilis; 3. Pseudomonas fluorescens, strain 1; 4. Pseudomonas fluorescens, strain 2; and with a mixture of strains Azo tobacter chroococcum + Bacillus subtilis + Pseudomonas fluorescens, strain 1+ Pseudomonas fluorescens, strain 2 (ratio 1 : 1 : 1 : 1). The control was not inoculated. An amount of 50 ml of the inoculum having the density of 108/ml was introduced into 200 g of sterile peat. The inoculated peat was applied into rows, directly to the onion seed. Standard agrotechnical practices were applied during the vegetation period. The effect of inoculation on onion growth. The germ growth was observed five and ten days after the inoculation. The onion seeds were washed with sterile tap water and placed on plastic trays with a moist filter paper. The trays were covered and placed to the incubator at 28°C. After 48 hours the shoots of equal length were selected. The onion roots were dipped into a bacterial suspension (108 CFU/ml) for 1.5 hours. In the control the roots were moistened in sterile water. Then the onion seedlings were placed on the tray with a moist filter paper, covered and incubated at 28°C. After five and ten days the length of the roots and the shoots was measured. The plant height and the dry mass were measured three months after the sowing (the phase of 5–6 leaves). The bulb size and the bulb weight were measured three months after the sowing and at the end of the vegetation period (early August). The onion yield (t/ha) was determined at the end of the vegetation period. 1 85 Onion growth promotion by rhizobacteria The effect of inoculation on the microbial population in the rhizosphere of onion. The rhizospheric soil was sampled for the purpose of microbial analysis 30, 90 and 150 days after sowing. The number of microorganisms was determined by the method of agar plates in the appropriate nutrient medium: The total microbial count was performed in soil agar, (dilution 10–6), the fungi in potato-dextrose agar (Hy media) (dilution 10–4), the number of actinomycetes in Krasiljnikov agar (Hy media) (dilution 10–5), the total number of bacteria in nutrient agar (NA) (Torlak, Belgrade) (dilution 10–6) and the number of azotobacter in Fiodorov medium (Hy media) (dilution 10–2). All microbial analyses were performed in three replications and the average number for all three samplings was calculated per 1.0 g of absolutely dry soil. Data analysis. Statistical analysis was performed by using the statistical software STATISTICA, version 12.0 (Hamburg, Germany). The significance of each treatment was established by one way ANOVA and the means were separated by Fisher’s test (P ≤ 0.05). Results and Discussion Indole-acetic acid (IAA) production. Indole-acetic acid (IAA) is the main auxin in plants, controlling many important physiological processes including cell enlargement and division, tissue differentiation, and responses to light and gravity. Diverse bacterial species (Bacillus spp, Streptomyces sp., Rhizobium sp., Azoto bacter, Pseudomonas) possess the ability to produce IAA (Ahmad et al., 2005). According to Loper and Schorth (1986), 80% of bacteria isolated from the rhizosphere are capable of producing IAA. In our research, all the strains were producing IAA. The best production was observed after 48 hours of incubation in the presence of 500 µg/ml of L-tryptophan (Table I). The best producer of IAA was Bacillus subtilis. Phosphate solubilization and siderophore production. Phosphorus is found in soil in its organic and inorganic compounds. PGPR play a role in transforming inaccessible compounds (both organic and inorganic) into forms accessible to plants. Bacterial strains belonging to the genera Pseudomonas, Bacillus, Rhizobium, Azotobacter, Achromobacter, Agrobacterium, Micrococcus, Aerobacter, Flavobacterium and Erwinia are capable of solubilizing insoluble phosphate compounds such as tricalcium phosphate and dicalcium phosphate (Rodriguez and Fraga, 1999). Our research has shown that both Pseudomonas fluorescens strains are better TCP solubilizers than Bacillus and Azotobacter (Table II). Ravindra Naik et al., (2008) tested 443 strains of Pseudomonas. Their research showed that 80 strains (18%) produced phosphate solubilization on Pikov skaya’s agar medium by inducing clear zones. Fluo rescent pseudomonad strains have also been reported as phosphate solubilizers due to the excretion of organic acids by many other researchers (Bano and Musarrat, 2004; Cattelan et al., 1999; Pandey and Palani, 1998). Siderophores are high-affinity Fe3+ chelating compounds. In cases when accessible iron is lacking, plants and microorganisms produce siderophores which take Fe3+ out of its componds, bind it and form a Fe3+ siderophore complex. This complex is transported to the surface of a bacterial cell or root cells, transported into the cell and reduced to Fe2. Plants are capable of binding the bacterial Fe3+ siderophore complex, thus PGPR help in providing the plant with iron (Kalinowski et al., 2000). It has been proved that a large number of rhizo spheric microorganisms, including Bacillus subtilis, Pseudomonas sp. and Azotobacter sp., produce siderophores (Jankiewicz, 2006, Jarak et al., 2012). In this research, Pseudomonas fluorescens strains were better siderophore producers (Table II). This is in accordance to investigation of Djurić et al. (2011). In their work, three siderophore-producing isolates of Pseudomonas fluorescens were detected. Parani and Saha (2012) also proved the existence of three siderophore producing Pseudomonas strains. Onion growth. As PGPR produce plant hormones, the use of these bacteria usually enhances germination and early plant growth. In this research, the seed inoculation affected onion germination and growth Table I Indole-acetic acid (IAA) production (µg IAA/ml) Microorganisms after 24 h L-tryptophan µg/ml 0 200 after 48 h L-tryptophan µg/ml 500 0 200 500 Pseudomonas fluorescens 12.42 5.39 7.07 5.32 12.82 12.93 Pseudomonas fluorescens 21.93 3.18 3.25 7.06 Bacillus subtilis Azotobacter chroococcum 7.68 11.00 12.07 19.7520.5316.93 26.8931.71 3.73 6.238.285.56 9.3210.4 The datas are mean values of three repetitions. 86 1 Čolo J. et al. Table II Phosphate solubilization and siderophore production Microorganisms Phosphate solubilization (halo zonesmm/5 day) Siderophore production (halo zonesmm/5 day) Pseudomonas fluorescens 17.34 6.70 Pseudomonas fluorescens 29.55 7.50 Bacillus subtilis 5.655.20 Azotobacter chroococcum 4.503.50 The datas are mean values of three repetitions. Azotobacter chroococcum Germ length (mm) 5 days 10 days 8.9011.80 Bacillus subtilis 8.408.90 Pseudomonas fluorescens 1 6.00 10.20 Pseudomonas fluorescens 2 6.20 9.60 Mixture 6.908.40 Control 4.909.10 LSD 0.05 1.22 1.25 The datas are mean values of ten repetitions. Table IV The effect of PGPR on the onion growth sixty days after inoculation Treatment Length of Mass of the above the above ground ground part (cm) part (g) Bulb mass (g) 1. Azotobacter chroococcum 44.0029.00 2.26 2. Bacillus subtilis 46.0027.56 1.86 3. Pseudomonas fluorescens 1 44.66 20.96 2.20 4. Pseudomonas fluorescens 2 45.16 15.00 2.36 5. Mixture 35.96 30.56 1.16 6.Control 32.8024.80 2.20 LSD 0.05 6.51 12.95 Treatment Bulb diameter (cm) Bulb mass (g) Yield (t/ha)* Azotobacter chroococcum 7.33173.6634.73 Bacillus subtilis 7.00144.0028.80 Pseudomonas fluorescens 1 7.66 111.33 22.26 Pseudomonas fluorescens 2 6.80 121.66 24.33 Mixture 7.33130.0026.00 Control 6.33 88.0017.60 LSD 0.05 1.40 35.52 7.10 The datas are mean values of ten repetitions. * calculated value Table III The effect of PGPR on the germ length of onion Treatment Table V The effect of PGPR on the bulb size and onion yield 1.18 The datas are mean values of ten repetitions. (Table III, Table IV). Five days after the inoculation, the seedling was longer in all the inoculated variants than in the control, whereas ten days after the inoculation, the stimulating effect was visible in the variants with Azotobacter chroococcum and Pseudomonas fluorescens strains. Sixty days after the inoculation the length of the part above the ground was greater in all the inoculated variants than in the control. The fresh mass of the part above the ground was smaller in the variants inocu- lated with Pseudomonas fluorescens strains, whereas the fresh mass of the bulb was greater in all the inoculated variants (apart from the variant with the mixture of strains). However, the increase was not statistically significant. This could be explained by the high variability of the data within treatments. The effect of the treatments was not strong enough to produce a statistically significant result. Similar results were shown by Jarak et al. (2006) who reported a better germ development and early growth of alfalfa and red clover with the use of azotobacter, rhizobia and actinomycetes. Similarly, Stamenov et al. (2012b) reported that PGPR enhance the growth of English ryegrass. Joo et al. (2005) inoculated the pepper seed with Penibacillus polymyxa and Bacillus subtilis. In all the inoculated variants, the length and the mass of the above ground part and root significantly increased. Onion yield. At the end of the vegetation period, onion bulbs were taken out and their size and yield were measured (Table V). The bulb diameter was larger in all the inoculated variants but the increase was of no statistical significance. The bulb weight and the yield significantly increased in the variants with Azoto bacter chroococcum, Bacillus subtilis and the mixture of the inoculants. Both Azotobacter chroococcum and Bacillus subtilis take part in other important processes apart from promoting plant growth. Azotobacter can fix 60–80 kg N/ha and thus partly provide the plant with this element (Yanni and El-Fattah, 1999, Kennedy et al., 2004), whereas Bacillus subtilis is a bioagent against phytopathogenic fungi (Kloepper et al., 2004). These properties certainly promote plant growth and increase onion yield. The use of azotobacter results in an increased yield of other plant species, too. Kumar et al. (2001), and Hajnal Jafari et al. (2012) reported that the use of azotobacter led to an increased yield of wheat and maize. The research conducted in field experiments by Mrkovacki et al. (2012) showed that inoculation of sugar beet with Azotobacter chroococcum resulted in an 1 87 Onion growth promotion by rhizobacteria Table VI The effect of PGPR on the number of microorganisms in the onion rhizosphere Treatment Azotobacter chroococcum Bacillus subtilis TN 106g–1 TB 106g–1 AC 105g–1 F 104g–1 AZ 102g–1 329.00249.9011.94 3.05 168.01 1069.901227.28 26.05 24.72 153.05 Pseudomonas fluorescens 1 63.94 1039.75 11.51 4.80 106.06 Pseudomonas fluorescens 2 439.82 995.24 29.92 10.33 115.34 Mixture 663.661029.96 24.99 Control 165.40 95.5723.79 14.34 70.20 LSD 0.05 196.55 215.80 6.08 3.61 109.50 3.50 29.42 The datas are mean values of three repetitions. TN – total number of microorganismas; TB – total number of bacteria; AC–number of actinomycetes; F–number of fungi; AZ–number of azotobacter increased root yield and amount of extractable sucrose from the sugar beet. Nieto and Frankenberger (1991) investigated the effect of Azotobacter chroococcum on the morphology and growth of maize in vitro, in a greenhouse and in the field, and concluded that the plant growth was enhanced thanks to hormone production by azotobacter. Microbial population in onion rhizosphere. The microbial diversity in the rhizosphere depends on root exudates, soil properties, agrotechnical measures and ecological factors. In this research, the number of the investigated groups of microorganisms was large and typical of fertile soils such as chernozem (Table VI). Plants exude various organic and inorganic substances through their roots into the rhizosphere. The larger the number of monosaccharides and easily disintegrable organic acids in the rhizosphere, the larger the number of rhizospheric microorganisms. Onion roots exude aminoacids, sugars and organic acids which influence positively the rhizosphere (Tawaraya et al., 1995) creating favorable conditions for different microorganisms. Introducing microbiological fertilizers into soil can change the number and species of the indigenous microbial population. In this research, the total number of microorganisms (apart from treatment with Pseudomonas fluorescens strain 1), the total number of bacteria and the number of azotobacter increased in all the inoculated variants (Table VI). The number of fungi decreased in most of the inoculated variants, whereas the number of actinomycetes decreased or remained the same. In conclusion, we demonstrated that the applied microorganisms produce IAA and siderophores and solubilize TCP. Azotobacter chroococcum is also capable of fixing atmospheric nitrogen. Bacillus subtilis has an antagonistic effect on phytopathogenic fungi and Pseudomonas fluorescens produces other biologically active substances such as hydrogen cyanide (HCN) and gibberellins. Some Pseudomonas fluorescens strains are used as biocontrol agents because they protect plant roots from phytopathogenic fungi such as Fusarium and Pythium. The introduction of these microorganisms into the rhizosphere leads to activation of useful microbiological processes, increase in the number of bacteria and decrease in the number of fungi. These PGPR species are already being used in the production of wheat, maize, sugar beet, rice, pepper, tomato, cucumber etc. The obtained results have shown that PGPR can also be used in onion production. Acknowledgements This research is part of a project TD31027 financed by the Ministry of education and science, Republic of Serbia. Literature Ahmad F., I. Ahmad and M.S. Khan. 2005. Indole acetic acid production by the indigenous isolates of Azotobacter and fluorescent Pseudomonas in the presence and absence of tryptophan. Turk. J. Biol. 29: 29–34. Bano N. and J. Musarrat. 2004. Characterization of a novel carbo furandegrading Pseudomonas sp. with collateral biocontrol and plant growth promoting potential. FEMS Microbiol Lett. 231: 13–17. Benizri E., A. Courtade, C. Picard and A. Gucker t. 1998. Role of maize root exudates in the production of auxins by Pseudomonas fluorescens M.3.1. Soil Biol. Biochem. 30: 1481–1484. Boddey R.M. and J. Dobereiner. 1995. Nitrogen fixation associated with grasses and cereals: recent progress and perspectives for the future. Fert. Res. 42: 241–250. Cattelan A.J., P.G. Hartel and F.F. Furhmann. 1999. Screening for plant growthpromoting rhizobacteria to promote early soybean growth. Soil Sci. Soc. Am. J. 63: 1670–1680. Djurić S., A. Pavić, M. Jarak, S. Pavlović, M. Starović, R. Pivić and D. Jošić. 2011. Selection of indigenous fluorescent pseudomonad isolates from maize rhizospheric soil in Vojvodina as possible PGPR. Romanian Biotechnol. Lett. 16 (5): 6580–6590. García de Salamone I.E., R.K. Hynes and L.M. Nelson. 2001. Cytokinin production by plant growth promoting rhizobacteria and selected mutants. Can. J. Mcrobiol. 47: 404–411. Gordon S.A. and R.P. Weber. 1951. Colorimetric estimation of indoleacetic acid. Plant Physiol. 26: 192–197. 88 Čolo J. et al. Hajnal-Jafari T., D. Latković, S. Djurić, N. Mrkovački and O. Najdenovska. 2012. The use of Azotobacter in organic maize production. Research. J. Agricultural. Sci. 44(2): 28–32. Handbook of Microbiological Culture Media (International Ed.). 2000. Scharlau Microbiology, Barcelona, Spain. Jankiewicz U. 2006. Syntesis of siderophores by soil bacteria of the genus Pseudomonas under various culture conditions. Acta Sci. Pol. Agricultura 5: 33–44. Jarak M., D. Đukić and J. Čolo. 2006. The effect of bacterization and liming in the production of red clover. Grassland Science in Europe 11: 291–293. Jarak M., N. Mrkovački, D. Bjelić, D. Jošić, T. Hajnal-Jafari and D. Stamenov. 2012. Effects of plant growth promoting rhizobacteria on maize in greenhouse and field trial. African J. Microbiol. Research 6: 5683–5690. Jarak M., S.Đurić and J. Čolo. 2007. The effect of rhizobia, Azoto bacter and Actinomycetes on the early growth of alfalfa and red clover. Book of Abstracts Power of microbes in Idustry and Environ ment, Zadar, Croatia p. 10. Joo G.J., Y.M. Kin, J.T. Kim, I.K. Rhee, J. Kim and I.J. Lee. 2005. Gibberellins producing rhizobacteria increase endogenous gibberellins content and promote growth of red peppers. J. Microbiol. 43: 510–515. Kalinowski B.E., L.J. Liermann, S. Givens and S.L. Brantley. 2000. Rates of bacteria-promoted solubilization of Fe from minerals: a review of problems and approaches. Chemical Geology 169: 357–370. Kennedy I.R., A.I.M.A. Choudhury and M.L. KecSkes. 2004. NonSymbiotic bacterial diazotrophs in crop-farming systems: can their potential or plant growth promotion be better exploited? Soil Boil. Biochem. 36: 1229–1244. Kloepper J.W., C.M. Ryu and S. Zhang. 2004. Induced systemic resistance and promotion of plant growth by Bacillus spp. Phytopa thology 94: 1259–1266. Kumar A. 2001. Influence of nitrogen and potassium application on growth, yield and nutrient uptake by onion (Allium cepa). Indian J. Agronomy 46: 742–746. Kumar V., R.K. Behl and N. Narula. 2001. Establishment of phosphate-solubilizing strains of Azotobacter chroococcum in the rhizosphere and their effect on wheat cultivars under green house conditions. Microbiol. Res. 156: 87–93. Loper J.E. and M.N. Schroth. 1986. Influence of bacterial sources of indole-3-acetic acid on root elongation of sugarbeet. Phytopatho logy 76: 386–389. McSpadden-Gardener B.B. 2004. The nature and application of biocontrol microbes: Bacillis spp. ecology of Bacillus and Paenibacillus spp. in agricultural systems. Phytopathology 94: 661–664. 1 Milagres A.M.F., A. Machuca and D. Napoleao. 1999. Detection of siderophore production from several fungi and bacteria by a modification of chrome azurol S (CAS) agar plate assay. J. Microbiol. Methods 37: 1–6. Mrkovacki N., S. Mezei, L. Kovacev, D. Bjelic, M. Jarak, S. Tyr and T. Veres. 2012. Effect of Azotobacter chroococcum application on production characteristics of sugar beet and microorganisms in sugar beet rhizosphere. Listy cukrovarnicke a reparske 128: 50–55. Nieto K.F. and W.T. Frankenberger Jr. 1991. Influence of adenine, isopentylalcohol and Azotobacter chroococcum on the vegetative growth of Zea mays. Plant Soil 135: 213–221. Pandey A. and L.M.S. Palani. 1998. Isolation of Pseudomonas cor rugata from Sikkim himalayas. World J. Microbiol. Biotechnol. 14: 411–413. Parani K. and B.K. Saha. 2012. Prospects of using phosphate solubilizing Pseudomonas as Bio Fertlizer. European J. Biol. Sci. 4(2): 40–44. Ravindra Naik P., R. Gurusamy, K.B. Narayanan and S. Natarajan. 2008. Assessment of genetic and functional diversity of phosphate solubilizing fluorescent pseudomonads isolated from rhizospheric soil. BMC Microbiol. 8: 230. Rodríguez H. and R. Fraga. 1999. Phosphate solubilizing bacteria and their role in plant growth promotion. Biotechnol. Adv. 17: 319–339. Slimestad R., T. Fossen and I.M. Vågen. 2007. Onions: a source of unique dietary flavonoids. J. Agric. Food Chem. 55 (25): 10067–10080. Stamenov D., M. Jarak, S. Djurić, T. Hajnal-Jafari and S. Andjel ković. 2012a. The effect of azotobacter and actinomycetes on the growth of english ryegrass and microbiological activity in its rhizosphere. Research J. Agricultural. Sci. 44: 93–99. Stamenov D., M. Jarak, S. Đurić, D. Milošev and T. Hajnal-Jafari. 2012b. Plant growth promoting rhizobacteria in the production of English ryegrass. Plant Soil Environ. 58 (10): 477–480. Tawaraya K., S. Watanabe, E. Yoshida and T. Wagatsum. 1995. Effect of onion (Allium cepa) root exudates on the hyphal growth of Gigaspora margarita. Mycorrhiza 6: 57–59. Velivelli S., E. O’Herlihy, B. Janczura, J. Ghyselinck and P. De Vos. 2012. Efficacy of Rhizobacteria on plant growth promotion and disease suppression in vitro. Acta Horticulturae. 961: 525–532 . Verma P., J. Yadav, K. Nath, T. Lavakush and V. Singh. 2010. Impact of Plant Growth Promoting Rhizobacteria on Crop Production. International J. Agricultural Research 5: 954–983. Yanni Y.G. and F.K.A. El-Fattah. 1999. Towards integrated biofertilization management with free living and associative dinitrogen fixers for enhancing rice performance in the Nile delta. Symbiosis 27: 319–331. Polish Journal of Microbiology 2014, Vol. 63, No 1, 89–93 ORIGINAL PAPER The Prevalence of Anaplasma phagocytophilum in Questing Ixodes ricinus Ticks in SW Poland DOROTA KIEWRA1*, GRZEGORZ ZALEŚNY2 and ALEKSANDRA CZUŁOWSKA1 Department of Microbial Ecology and Environmental Protection, Institute of Genetics and Microbiology, University of Wroclaw 2 Department of Invertebrate Systematics and Ecology, Institute of Biology, Wroclaw University of Environmental and Life Sciences 1 Submitted 9 July 2013, revised 4 October 2013, accepted 16 November 2013 Abstract Ticks constitute important vectors of human and animal pathogens. Besides the Lyme borreliosis and tick-borne encephalitis, other pathogens such as Babesia spp., Rickettsia spp., and Anaplasma phagocytophilum, are of increasing public health interest. In Poland, as in other European countries, Ixodes ricinus, the most prevalent tick species responsible for the majority of tick bites in humans, is the main vector of A. phagocytophilum. The aim of the study was to estimate the infection level of I. ricinus with A. phagocytophilum in selected districts, not previously surveyed for the presence of this agent. Sampling of questing ticks was performed in 12 forested sites, located in four districts (Legnica, Milicz, Lubań, and Oława) in SW Poland. Altogether, 792 ticks (151 females, 101 males, and 540 nymphs) representing I. ricinus were checked for the presence of A. phagocytophilum. The average infection level was 4.3%, with higher rate reported for adult ticks. The highest percentage of infected adults was observed in Milicz (17.4%) and the lowest in Oława (6.8%). The abundance of questing I. ricinus in all examined sites as well as the infection with A. phagocytophilum indicate for the first time the risk for HGA transmission in SW Poland. K e y w o r d s: Anaplasma phagocytophilum, Ixodes ricinus, Poland Introduction The geographical range of tick-borne diseases (TBD), identification of new pathogens, as well as the increase of TBD incidence makes TBD a serious public health problem. Besides Lyme borreliosis and tickborne encephalitis, which are monitored in Poland, other TBD caused by Babesia spp., Rickettsia spp., and Anaplasma phagocytophilum, are of increasing public health interest. Anaplasma phagocytophilum, a small gram-negative obligate intracellular alfaproteobacteria, is a tick-borne rickettsial bacterium that replicates in mammalian granulocytes but also in the salivary gland and midgut cells of ticks (Rikihisa, 2011). It causes human granulocytic anaplasmosis (HGA), previously known as human granulocytic ehrlichiosis (HGE), but also the disease in horses, dogs, sheep, and cats (Rar and Golovljova, 2011; Severo et al., 2012). HGA is an emerging disease with varying symptoms, from asymptomatic seroconversion to non-specific symptoms like fever, malaise, myalgia and headache, up to fatal disease (Dumler et al., 2005; Zwoliński et al., 2007; Rar and Golovljova 2011). The majority of confirmed HGA cases, including the first case of HGA recorded in the early 1990s (Rikihisa, 2011), have been reported from the USA. In Europe, the prevalence of HGA infection is significantly lower, although human cases have been accounted for the majority of European countries, including Poland (Tylewska-Wierzbanowska et al., 2001; Grzeszczuk et al., 2009; Rikihisa, 2011). Anaplasma phagocytophilum DNA has been detected in several species of hard ticks (Ixodes scapularis, I. paci- ficus, I. spinipalpis, I. ricinus, I. persulcatus, I. trianguli ceps, I. ventalloi, I. ovatus, Dermacentor silvarum) in the United States, Europe, and Asia (Rar and Golovljova 2011; Rikihisa, 2011). In Poland, but also all over Europe, I. ricinus, the most prevalent tick species responsible for the majority of tick bites in humans, is the main vector of A. phagocytophilum. I. ricinus has a three-host live cycle: larvae and nymphs feed mostly on small to medium-sized animals, and adults prefer large-sized mammals. Ticks (larvae, nymphs, or adults) acquire A. phagocytophilum from infected hosts * Corresponding author: D. Kiewra, Department of Microbial Ecology and Environmental Protection, Institute of Genetics and Microbiology, University of Wroclaw; e-mail: [email protected] 90 1 Kiewra D. et al. through a blood meal, and they can maintain the bacterium through subsequent moultings (transstadial passage), but not by transovarial transmission (Rikihisa, 2011). In Europe, a wide range of mammalian species is infected with A. phagocytophilum (Rar and Golovljova, 2011). However, it is worth noting that the zoonosis potential and host infectivity of A. phagocytophilum depend on genetic variations of strain, due to the host tropism of this bacterium (Severo et al., 2012). Thus, humans are susceptible to limited strains only. The wild host reservoir for strains that infect humans (Ap-ha) is poorly known (Massung et al., 2002; Rikihisa, 2011; Michalik et al., 2012). The aim of the study was to estimate the infection level of I. ricinus with A. phagocytophilum in selected districts of Lower Silesia, SW Poland, not hitherto surveyed for the presence of this agent. PCR product for nested-PCR. The positive control contained Anaplasma DNA from a diagnostic kit, whereas the negative control contained sterile water. The amplification was performed in a BioRad T100TM Thermal Cycler. The amplification included initial denaturation for 2 min at 95°C, subjected to 40 cycles (for a second reaction 30 cycles) of 30 s denaturation at 94°C, 30 s for the annealing reaction at 55°C, 60 s extension at 72°C and final extension for 5 min at 72°C. The separation of the nested PCR products was carried out on a 1.5% agarose gel with the addition of ethidium bromide in the TBE buffer. Product of 546 bp was regarded as a positive result. Statistical analysis. The results were analysed using STATISTICA v.10 software. The χ2 test, Kruskal-Wallis ANOVA test and Mann-Witheney test were applied. Probability at p < 0.05 was regarded as significant. Experimental Materials and Methods Tick collection. Sampling of questing ticks was performed in 12 forested sites, located in four districts in SW Poland: Lubań (sites: L1, L2, L3), Milicz (M1, M2, M3), Legnica (Leg1, Leg2, Leg3) and Oława (O1, O2, O3). Ticks were collected by flagging method during spring peak of tick activity, from April to June 2011, at least once a month in each site. Collected ticks were placed in plastic tubes and kept in the refrigerator. The identification of species and life instar was carried out in stereomicroscope, based on the key provided by Siuda (1993). Detection of A. phagocytophilum in I. ricinus ticks. DNA for PCR was extracted from I. ricinus by lysis in ammonium hydroxide (Rijkpema, 1996). The isolates from nymphs and adults were used for the detection of A. phagocytophilum. Due to the predominance of nymphs in the population, the PCR reactions for nymphs were carried out in pools (5 specimens per pool), which increased the representation of this particular instar and reduced the costs of analysis. Thus, for the calculation of the level of infection in nymphs minimal infection rate (MIR) was used (calculated on the assumption that in each positive pool of tested nymphs only one was infected). The procedure was carried out for 30 samples from each of the 12 monitored sites. To estimate the presence of A. phagocytophilum the diagnostic kit (PK24N DNA Gdańsk) was used. The detection was based on amplification of 16S rDNA by nested PCR reaction. The reaction was performed in a reaction volume of 50 µl containing 42 µl Master Mix PCR-OUT for first and PCR-IN for second amplification, 5 µl dNTPs mixture, 1 µl DNA polymerase TaqNova, and 2 μl of the processed tick sample or 2 µl Results In total, 2507 host-seeking ticks (148 larvae, 1314 nymphs, 478 females, and 567 males) identified as Ixodes ricinus were collected in four districts. Ticks were present in each of 12 sites. However, the tick density varied between districts (H = 235.2; p < 0.01) with the highest prevalence in Lubań (Table I). Altogether, 792 I. ricinus ticks (151 females, 101 males, and 540 nymphs) were tested for the presence of A. phago cytophilum. Infected ticks were found in all districts. The average infection rate was 4.3%. The infection rate in adults was higher than in nymphs (χ2 = 37.093; p < 0.001). The minimum infection rate was 1.3% in nymphs and 10.7% in adults (Table II). The highest level of nymph infection was recorded in Legnica district (3.1%), while no infected nymphs were found in Lubań district. The highest rate of infected adults was found in Milicz (17.4%) and the lowest one in Oława (6.8%). However, the differences beetwen districts were not statistically significant, both for nymphs and adults (χ2 = 4,321; p = 0,229, χ2 = 3.547; p = 0.314, respectively). A higher infection rate was observed in females in comparison to males (15.2% and 3.9% respectively, Table I The average density of I. ricinus in four districts in south-western Poland from April to June 2011. District The average number of I. ricinus ticks collected by one person in 30 min n ♀ ♂ Total Lubań 26.5 4.8 4.435.7 Milicz 10.2 4.8 7.222.2 Legnica 3.4 4.9 5.013.3 Oława 4.0 4.1 3.711.8 1 91 Infection level of I. ricinus ticks with A. phagocytophilum in SW Poland Table II Anaplasma phagocytophilum infected I. ricinus ticks in four districts in south-western Poland in 2011. A. phagocytophilum infected I. ricinus ticks District nymphs* number of tested females positive (%) Lubań170 number of tested males positive (%) number of tested positive (%) females & males number of tested positive (%) 0 37 10.8 19 5.2 56 8.9 Milicz220 1.8 23 26.1 23 8.7 46 17.4 Legnica65 3.1 47 17.0 30 3.3 77 11.7 Oława851.2 4411.4290 736.8 Total 540 1.3 151 15.2101 3.9 252 10.7 * nymphs were tested in pools consisting of five specimens χ2 = 8.037; p = 0.004). The highest level of infection in females was found in Milicz and in Legnica districts (26.1% and 17.0% respevtively), and the lowest one (10.8%) – in Lubań district. The infection level in males varied between 0 (Oława district) and 8.7% (Milicz district). There were no statistically significant differences between the density of adult ticks in districts, and the level of their infection (Z = –0.282; p = 0.778) Discussion The occurrence of questing Ixodes ricinus ticks is a major factor of tick-borne infection in humans. Previous studies on ticks as vectors of pathogens, carried out in Lower Silesia, were focused mainly on the presence of spirochetes of Borrelia burgdorferi s.l., regarded as the etiological agent of Lyme borreliosis (Kiewra, 2005; Kiewra et al., 2002, 2006). Lyme borreliosis is still considered the most common tick-borne disease in the Northern Hemisphere (Stanek et al., 2012). However I. ricinus can harbour also other pathogens (including bacteria, viruses and protozoa) (Franke et al., 2013). Human granulocytic anaplasmosis (HGA) has been recently recognized as a tick-borne emerging disease, which is spread over USA, Europe and Asia. In Europe, the first confirmed case of HGA was reported in 1997, in Slovenia (Petrovec et al., 1997), whereas the first cases of acute human granulocytic ehrlichiosis were described in 2001 in Poland (Tylewska-Wierzbanowska et al., 2001). It is worth noting, that A. phagocytophilum infection can be asymptomatic, and many infections can be unrecognized (Dumbler et al., 2005). In Poland, questing I. ricinus ticks infected with A. phagocytophilum were found in north, north-eastern, eastern and central-eastern parts of the country (Stańczak et al., 2004; Grzeszczuk et al., 2002, 2004; Tomasiewicz et al., 2004; Wójcik-Fatla et al., 2009; Sytykiewicz et al., 2012). During present studies, the observed abundance of questing ticks in all examined localities in Lower Silesia, and also the infection of I. ricinus with A. phagocytophilum in Legnica, Milicz, Lubań, and Oława districts, has revealed for the first time the risk for HGA transmission in SW Poland. The prevalence of infected I. ricinus with A. phagocy tophilum was 4.3%. Similar level of infections, varying between 2% and 6%, depending on the area, were recorded in Lower Saxony, Germany (Templin et al., 2013), whereas the one in urban areas of Kosice, Slovakia reached 2.2% (Vichova et al., 2013), and 2.6% in Belarus (Reye et al. 2013). As many as 8.7% questing I. ricinus were found to be infected with A. phagocy tophilum in north-eastern Poland (Grzeszczuk et al., 2004), 8.5% in central-eastern Poland (Sytykiewicz et al., 2012), 13.1% in mid-eastern Poland (Tomasiewicz et al., 2004), 14% in northern Poland (Stańczak et al., 2004). During the present studies no significant differences in infection rates between the districts were observed. However, the infection prevalence can depend on a study area and it may also vary depending on the year of study (Grzeszczuk and Stańczak, 2006a). A. phagocytophilum has been found not only in questing ticks but also in ticks removed from human skin. For example, 23.7% I. ricinus ticks removed from patients in north-eastern Poland were infected (Grzeszczuk and Stańczak, 2006b). A high prevalence of A. phagocytophi lum was also detected in engorged ticks from potential reservoir hosts such as roe deer (Overzier et al., 2013). The studies from the territory of Poland have confirmed that roe deer are essential hosts for maintaining Ixodes ticks and tick-borne diseases, including A. phagocyto philum (Welc-Falęciak et al., 2013). In our study, the percentage of infected females (15.2%) was almost 4 times higher than in the males (3.9%). Females were found to be more infected than males also in other parts of Poland (Tomasiewicz et al., 2004; Grzeszczuk, 2006; Grzeszczuk et al., 2002, 2004; Stańczak et al., 2004; Sytykiewicz et al., 2012). A significantly lower positivity rate (1.3%) was recorded in nymphs compared to adults. Also other authors 92 Kiewra D. et al. (Tomasiewicz et al., 2004; Grzeszczuk, 2006; Grzesz czuk et al., 2002, 2004; Stańczak et al., 2004; Sytykiewicz et al., 2012) have shown that the nymphs are less infected than adult ticks. The observed tendency may point to the limited role of small mammals in maintaining A. phagocytophilum in examined districts, compared to large-sized mammals. In Europe, A. phagocytophilum strains associated with rodents are transmitted by I. trianguliceps, and not by I. ricinus ticks (Pangracova et al., 2013). Thus, the occurrence of I. rici nus is not sufficient to rodent infection with A. phagocy tophilum. However, I. ricinus can acquire A. phagocyto philum from large-sized mammals like cervids or wild boars, which can play a role as reservoir hosts (Michalik et al., 2009, 2012). The obtained results confirm that I. ricinus ticks infected with A. phagocytophilum are widespread in Poland and capable of maintaining the A. phagocyto philum circulation in nature. Thus, in diagnosing the tick-borne disease in SW Poland, the possibility of infection with A. phagocytophilum should be also taken into account. Acknowledgments This work was suported by the National Science Centre (NCN), Poland (Grant No. N N404 014 740). Literature Dumler J.S., K.S. Choi, J.C. Garcia-Garcia, N.S. Barat, D.G. Scorpio, J.W. Garyu, D.J. Grab and J.S. Bakken. 2005. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg. Infect. Dis. 11(12): 1828–1834. Franke J., A. Hildebrandt and W. Dorn. 2013. Exploring gaps in our knowledge on Lyme borreliosis spirochaetes-updates on complex heterogeneity, ecology, and pathogenicity. Ticks Tick Borne Dis. 4(1–2): 11–25. Grzeszczuk A. 2006. Anaplasma phagocytophilum in Ixodes ricinus ticks and human granulocytic anaplasmosis seroprevalence among forestry rangers in Białystok region. Adv. Med. Sci. 51: 283–286. Grzeszczuk A., B. Puzanowska and S. Zirako. 2009. Anaplasma phagocytophilum infection in patients with early Lyme borreliosis, erythema migrans, in north-eastern Poland. Clin. Microbiol. Infect. 15 Suppl 2: 17–8. Grzeszczuk A. and J. Stańczak. 2006a. Highly variable year-to-year prevalence of Anaplasma phagocytophilum in Ixodes ricinus ticks in northeastern Poland: a 4-year follow-up. Ann. NY Acad. Sci. 1078: 309–311. Grzeszczuk A. and J. Stańczak. 2006b. High prevalence of Ana plasma phagocytophilum infection in ticks removed from human skin in north-eastern Poland. Ann. Agric. Environ. Med. 13(1): 45–48. Grzeszczuk A., J. Stańczak and B. Kubica-Biernat. 2002. Serological and molecular evidence of human granulocytic ehrlichiosis focus in the Białowieza Primeval Forest (Puszcza Białowieska), north eastern Poland. Eur. J. Clin. Microbiol. Infect. Dis. 21(1): 6–11. Grzeszczuk A., J. Stańczak, B. Kubica-Biernat, M. Racewicz, W. Kruminis-Łozowska and D. Prokopowicz. 2004. Human anaplasmosis in north-eastern Poland: seroprevalence in humans and prevalence in Ixodes ricinus ticks. Ann Agric Environ Med. 11(1): 99–103. 1 Kiewra D. 2005. Dynamics of tick populations (Ixodes ricinus L) in Sleza massif and their role as the vectors of Lime boreliosis. (in Polish). Wiad. Parazytol. 51 (2):171–172. Kiewra D., E. Lonc, M. Głuszkowski and A. Malinowska. 2002. Geoclimatic influence on the prevalence of castor bean tick – Ixodes ricinus (L.). pp. 155–126. (in Polish). In: Buczek A., Błaszak C. (eds). Stawonogi w medycynie. Wydawnictwo Drukarnia LIBER. Lublin: 115–126 Kiewra D., K. Rydzanicz and E. Lonc. 2006. Prevalence of Borrelia burgdorferi s.l. in Ixodes ricinus collected from five wooded areas in Lower Silesia (Poland). W: Buczek A, Błaszak C. (eds.): Stawonogi. Znaczenie epidemiologiczne. Koliber. Lublin. 183–187. Massung R.F., M.J. Mauel, J.H. Owens, N. Allan, J.W. Courtney, K.C. Stafford III and T.N. Mather. 2002. Genetic variants of Ehrlichia phagocytophila, Rhode Island and Connecticut. Emerg. Infect. Dis. 8(5): 467–472. Michalik J., J. Stańczak, S. Cieniuch, M. Racewicz, B. Sikora and M. Dabert. 2012. Wild boars as hosts of human-pathogenic Ana plasma phagocytophilum variants. Emerg. Infect. Dis. 18(6): 998–1001. Michalik J., J. Stańczak, M. Racewicz, S. Cieniuch, B. Sikora, A. Szubert-Kruszyńska and R. Grochowalska. 2009. Molecular evidence of Anaplasma phagocytophilum infection in wild cervids and feeding Ixodes ricinus ticks from west-central Poland. Clin. Microbiol. Infect. 15 Suppl 2: 81–83. Overzier E., K. Pfister, I. Herb, M. Mahling, G.Jr Böck and C. Silaghi. 2013. Detection of tick-borne pathogens in roe deer (Capreolus capreolus), in questing ticks (Ixodes ricinus), and in ticks infesting roe deer in southern Germany. Ticks Tick Borne Dis. 4(4): 320–328. Pangracova L., M. Stanko, L. Mosansky, M. Bona, J. Kraljik, B. Vichova, B. Pet’ko and M. Derdakova. 2013. Genetic variability of Anaplasma phagocytophilum and prevalence of Neoehrlichia mikurensis in rodents as reservoir hosts. Program and Abstracts. XII International Jena Symposium on Tick-Borne Diseases. p. 51. Petrovec M., S. Lotric Furlan, T.A. Zupanc , F. Strle, P. Brouqui, V. Roux and J.S. Dumler. 1997. Human disease in Europe caused by a granulocytic Ehrlichia species. J. Clin. Microbiol. 35(6): 1556–1559. Rar V. and I. Golovljova. 2011. Anaplasma, Ehrlichia, and “Candida tus Neoehrlichia” bacteria: pathogenicity, biodiversity, and molecular genetic characteristics, a review. Infect Genet Evol. 11(8): 1842–1861. Reye A.L., V. Stegniy, N.P. Mishaeva, S. Velhin, J.M. Hübschen, G. Ignatyev and C.P. Muller. 2013. Prevalence of tick-borne pathogens in Ixodes ricinus and Dermacentor reticulatus ticks from different geographical locations in Belarus. PLoS One. 8(1):e54476. doi: 10.1371/journal.pone.0054476. Rijpkema S., D. Golubic, M. Molkenboer, N. Verbreek-De Kruif and J. Schellekens. 1996. Identification of four genomic groups of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected in a Lyme borreliosis endemic region of northern Croatia. Exp. Appl. Acarol. 20, 23–30. Rikihisa Y. 2011 Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin. Microbiol. Rev. 24: 469–489. Severo M.S., K.D. Stephens, M. Kotsyfakis and J.H. Pedra. 2012. Anaplasma phagocytophilum: deceptively simple or simply deceptive? Future Microbiol. 7(6): 719–731. Siuda K. 1993. Ticks (Acari: Ixodida) of Poland. Part II. Taxonomy and distribution. (in Polish). Warszawa. Polskie Towarzystwo Parazytologiczne. Stanek G., G.P. Wormser, J. Gray and F. Strle. 2012. Lyme borreliosis. Lancet 379(9814): 461–473. Stańczak J., R.M. Gabre, W. Kruminis-Łozowska, M. Racewicz and B. Kubica-Biernat. 2004. Ixodes ricinus as a vector of Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum and Babesia microti in urban and suburban forests. Ann. Agric. Environ. Med. 11(1): 109–114. 1 Infection level of I. ricinus ticks with A. phagocytophilum in SW Poland Sytykiewicz H., G. Karbowiak, J. Hapunik, A. Szpechciński, M. Supergan-Marwicz, S. Goławska, I. Sprawka and P. Czerniewicz. 2012. Molecular evidence of Anaplasma phagocytophilum and Babesia microti co-infections in Ixodes ricinus ticks in centraleastern region of Poland. Ann. Agric. Environ. Med. 19(1): 45–49. Templin C., B. Marchwald, S. Olbrich and J. Dreesman. 2013. Detection of a new endemic tick species in Lower Saxony, Germany, in the course of a state-wide monitoring of ticks and tick-borne diseases. Program and Abstracts. XII International Jena Symposium on Tick-Borne Diseases: p.138. Tomasiewicz K., R. Modrzewska, A. Buczek, J. Stańczak and J. Maciukajć. 2004. The risk of exposure to Anaplasma phagocyto philum infection in Mid-Eastern Poland. Ann. Agric. Environ. Med. 11(2): 261–264. Tylewska-Wierzbanowska S., T. Chmielewski, M. Kondrusik, T. Hermanowska-Szpakowicz, W. Sawicki and K. Sułek. 2001. First cases of acute human granulocytic ehrlichiosis in Poland. Eur. J. Clin. Microbiol. Infect. Dis. 20(3):.196–198. 93 Vichova B., B. Halkova, L. Pangracova, M. Stanko, M. Bona, L. Mosansky and B. Pet’ko. 2013. Occurrence of ticks (Ixodida) and tick-borne pathogens in urban areas of Kosice city, eastern Slovakia. Program and Abstracts. XII International Jena Symposium on TickBorne Diseases. p.143. Welc-Falęciak R., J. Werszko, K. Cydzik, A. Bajer, J. Michalik and J.M. Behnke. 2013. Co-infection and genetic diversity of tick-borne pathogens in roe deer from Poland. Vector Borne Zoonotic Dis. 13(5): 277–288. Wójcik-Fatla A., J. Szymańska, L. Wdowiak, A. Buczek and J. Dutkiewicz. 2009. Coincidence of three pathogens (Borrelia burgdor feri sensu lato, Anaplasma phagocytophilum and Babesia microti) in Ixodes ricinus ticks in the Lublin macroregion. Ann. Agric. Environ. Med. 16(1):151–158. Zwoliński J., J. Chmielewska-Badora, A. Wójcik-Fatla, E. Cisak, A. Buczek and J. Dutkiewicz. 2007. Human granulocytic anaplasmosis as an emerging problem of public health. Zdr. Publ. 117(2): 213–219. Polish Journal of Microbiology 2014, Vol. 63, No 1, 95–103 ORIGINAL PAPER Biocontrol Efficacy of Different Isolates of Trichoderma against Soil Borne Pathogen Rhizoctonia solani SAEED AHMAD ASAD1*, NAEEM ALI2, ABDUL HAMEED2, SABAZ ALI KHAN1, RAFIQ AHMAD1, MUHAMMAD BILAL1, MUHAMMAD SHAHZAD1 and AYESHA TABASSUM2 Department of Environmental Sciences, COMSATS University – 22060 Abbottabad, Pakistan. 2 Department of Microbiology, Quaid-i-Azam University-45320 Islamabad, Pakistan 1 Submitted 17 July 2013, revised 30 October 2013, accepted 16 November 2013 Abstract In this study, the biocontrol abilities of water-soluble and volatile metabolites of three different isolates of Trichoderma (T. asperellum, T. harzianum and Trichoderma spp.) against soil borne plant pathogen Rhizoctonia solani were investigated both in vitro and in vivo. The results showed for the first time that mycelial growth inhibition of the pathogen was 74.4–67.8% with water-soluble metabolites as compared to 15.3–10.6% with volatile metabolites in vitro. In vivo antagonistic activity of Trichoderma isolates against R. solani was evaluated on bean plants under laboratory and greenhouse conditions. We observed that T. asperellum was more effective and consistent, lowering disease incidence up to 19.3% in laboratory and 30.5% in green house conditions. These results showed that three isolates of Trichoderma could be used as effective biocontrol agents against R. solani. K e y w o r d s: Rhizoctonia solani, Trichoderma, antagonistic activity, biocontrol, soil born pathogen Introduction Crop productivity losses due to diseases can result in hunger and starvation especially in developing countries and soil borne fungi are the main causal agents decreasing crop productivity. At present, 1258 different fungal species including Rhizoctonia solani have been reported to cause these diseases or are potential threats to crop failure (Ciesielski et al., 2009; Consolo et al., 2012; Suwannarach et al., 2012). R. solani is a universal fungal pathogen, causal agent of plant roots and lower stem diseases. In Pakistan, R. solani occurs as subterranean forms; therefore, chemical control is not a viable choice until the availability of highly selective and efficient fungicides. Control measures of R. solani diseases are limited due to wide range of hosts and unavailability of resistant plant varieties (Rouf, 2002). Different strategies to control soil borne pathogens have been hypothesized. Amongst these, biological control has got the attention of most researchers (Benítez et al., 2004; Vinale et al., 2008; Consolo et al., 2012; Chakraborty et al., 2013). A large number of soil fungi have been known as potential biological control agents and among them Trichoderma exhibits the abil- ity to control the plant pathogens (Punja and Utkhede, 2003; Ting and Choong, 2009; Chaudhary et al., 2012). Trichoderma are the fast growing filamentous deuteromycetes found in a variety of soils. Due to effective biocontrol abilities of Trichoderma; many of its commercial biocontrol products are being marketed in Asia, Europe and USA but none of these are commercially available in developing countries like Pakistan (Consolo et al., 2012). The mechanisms involved in the biocontrol activity of Trichoderma spp. against plant pathogens are important in designing effective and safe biocontrol strategies (Wolska et al., 2012). Different proposed mechanisms include: mycoparasitism (attack and killing of pathogen) (Anees et al., 2010) and competitive inhibition for space and nutrients (Benítez et al., 2004). Tricho derma are also known to produce different antibiotic substances e.g. gliotoxin, gliovirin, viridin, and trichoviridin (Vinale et al., 2008). Trichoderma have also been known to inhibit the growth of pathogenic fungi by modifying the rhizosphere (Harman et al., 2004). Moreover, infestation of Trichoderma in the rhizosphere helps plant to promote nutrient/fertilizer uptake (Yedidia et al., 2003), seed germination and photosynthetic rates (Shoresh et al., 2010). * Corresponding author: S.A. Asad, Department of Environmental Sciences, COMSATS University-22060 Abbottabad, Pakistan; phone: +92 (0) 992 383 591-6; fax: +92 (0) 992 383 441; e-mail: [email protected] 96 Asad S.A. et al. To our knowledge, no work has been carried out so far to explore the biocontrol abilities of indigenous Trichoderma populations. The current research was aimed at isolating the indigenous Trichoderma spp. and gauging their biological control potential against soil born plant pathogen R. solani. Both in vitro and in vivo trials were carried out to investigate different mechanisms involved in antagonistic activity of Trichoderma species. Furthermore, the suppression of disease incidence and related effects on growth were also observed in bean plants. Experimental Materials and Methods Fungal strains. Three Trichoderma strains were isolated from agricultural soils as well as obtained from the Fungal Culture Bank of the University of the Punjab Lahore, Pakistan. A highly virulent strain of R. solani was isolated from infected bean plants. These fungal strains were maintained at 4°C on Potato Dextrose Agar (PDA) Merck, USA) with periodical sub-culturing on the same medium at 25°C. Molecular identification of Trichoderma strains. The Trichoderma isolates were identified according to the protocol of Komoń-Zelazowska et al. (2007). DNA isolation was carried out according to Castle et al. (1998). The extraction of DNA was done with NucleoMag 96 Plant Kit (Macherey Nagel, Switzerland) and King Fisher technology (Thermo, UK). The primer sequences were; EF1: 5’-ATGGGTAAGGA(A/G)GACAAGAC-3’ and EF2: 5’-GGA(G/A)GTACCAGT(G/C)ATCATGTT-3’. The DNA was quantified by using the Nano drop 1000 (Thermo Scientific, Milan, Italy). For each sample, 1 μl of DNA (50 ng/µl) was amplified and the mixture (20 µl) contained 1 µl of 10 × buffer, 0.5 mM of deoxynucleotide triphosphate each, 1 U Taq DNA polymerase (Qiagen, USA), 0.5 mM of each primer and 1.5 mM MgCl2. The PCR program was run as: 95°C, 3 min, 95°C, 1 min; 60°C, 1 min; 72°C, 3 min, 72°C, 5 min for 35 cycles. Five µl of PCR product was run on 1.5% agarose gel containing 1 µl DNA stain SYBR Safe (Invitrogen, USA) in 1 × TAE buffer at 3.3 V for 30 minutes and images were obtained with Gel Doc 1000 System (Biorad Lab., USA). Purification of PCR products was done by QIA quick PCR Purification Kit (Qiagen, Milano, Italy) and sequencing was done by Deoxy terminator cycle sequencing kit (Perkin-Elmer Applied Biosystems) by BMR Genomics (Padova, Italy). Homology of the sequences with other deposited nucleotide sequences was checked using basic Blast search program at NCBI and submitted to the website for Trichoderma species identification http://www.isth. info/tools/blast/index.php. 1 Growth profile of Trichoderma under different pH and temperature regimes. Five mm mycelial disc was cut from the margins of three days old colonies of each strain by cork borer and placed in the centre of PDA plates and incubated at 20, 25 and 30°C (Chaverri et al., 2003). The growth was optimized at different pH viz. 5, 5.5, 6, 6.5, 7, 7.5. The average colony diameters were measured for 5 days at two dimensions at right angle to each other. Biocontrol efficacy of Trichoderma against R. solani in Dual Culture Assay. A 5 mm plug of Tricho derma and R. solani was cut and incubated at 25°C as described in previous section 2.3. The control plate contained only R. solani. The mycelial growth of Tri choderma and R. solani was recorded after every 24 h, taking the radial growth at right angle to each other and calculating the average (Dennis and Webster, 1971a). Mycoparasitic activity was observed by using light microscope (Axioskop, Germany). Biocontrol efficacy of water-soluble metabolites of Trichoderma against R. solani. PDA plates containing cellophane paper were inoculated with 5 mm mycelial discs of 3 days old cultures of Trichoderma isolates and incubated at 25°C for 3 days. After 3 days cellophane paper was removed and a 5 mm disc of pathogen was placed on the same PDA plate (Dennis and Webster, 1971b). The control treatment contained only pathogen disc grown without cellophane paper. The cultures were further incubated at 25°C until the colony of pathogen was spread on whole Petri plate in control treatment. The mycelial inhibition of pathogen by Trichoderma isolates was calculated using the Eqn. 1 (Edington et al., 1971). Mycelial Inhibition % = [(C2 – C1)/C2] × 100 (Eqn. 1) Where, C1 = radial mycelial growth of R. solani in the presence of Trichoderma and C2 = radial mycelial growth of R. solani in control. Biocontrol efficacy of volatile metabolites of Trichoderma against R. solani. The PDA plates were inoculated with 5 mm mycelial discs of 3 days old growing culture of Trichoderma isolates. The lid of each plate was replaced with the bottom of other plate inoculated with 5 mm mycelial discs of pathogen. Both plates were sealed together with adhesive tape and incubated at 25°C (Dennis and Webster, 1971c). Control treatment did not contain Trichoderma isolate. The mycelial inhibition of pathogen was calculated using Eqn.1. In vivo biocontrol activity of Trichoderma species on bean plants. The bean plants were managed in growth chambers with 12 h photoperiod, 60% humidity and 25°C temperature. The inoculum was prepared according to Pugliese et al., (2008). The Trichoderma isolates and pathogen were propagated on sterilized wheat kernel medium (75 g wheat kernel/80 ml H2O) 1 97 Biocontrol efficacy of Trichoderma sp. against R. solani and incubated at 25°C in the dark for 10–15 days. Tri choderma strains at 5 g/l of inoculum were added to the plastic bags containing steam disinfected peat. Seven days after treatment, the substrate was infested with pathogen at 0.5 g/l and stored at 25°C in growth chambers. The soil of each bag was then transferred to one litre volume pots (10 × 10 × 12 cm) and bean seeds were sown at 5 seeds l–1 of peat substrate. The pots were irrigated on a daily basis with sterilized water. Commercial formulations of Trichoderma harzia num ICC 012 2.00% and Trichoderma viride ICC 080 2.00% (Remedier®, Isagro Italia Milan, Italy) were used to verify the efficacy of Trichoderma isolates. A series of samples treated with a fungicide (Tolclofos-methyl) at the time of sowing of bean seeds were maintained as chemical control. Samples treated only with R. solani were used as inoculated (disease) control and noninoculated (healthy) controls were also maintained throughout the experiment. Germination was completed five days after sowing and occurrence of any kind of disease was recorded. The plants were uprooted and washed with water. The roots were categorized using scale 0–4 where 0 = healthy plant (no infection), 1 = 25% infected root, 2 = 50% infected root, 3 = 75% infected root, 4 = 100% infected or completely dead plants depending on the appearance of elongate, sunken, red-brown lesions on roots and stems above or below the soil. The Disease index (DI %) was calculated according to Eqn. 2. DI% = [(n × 0) + (n × 0.25) + (n × 0.5) + (n×0.75) + + (n×1)] /N ×100 (Eqn. 2) Where, n = number of plants corresponding to each class, N = total number of plants observed. The Tricho derma isolates were also assessed for their effect on the growth of bean plants. Effect of inoculum dose on in-vivo biocontrol activity against R. Solani. The antagonists and the pathogen were grown on wheat kernel medium as described in previous section. Trichoderma isolates were applied at 5 and 1 g/l of peat soil in plastic bags and the bags were kept at green house conditions for one week. After one week, each bag was inoculated with R. Solani at 0.25 g/l of soil. The soil of each bag was then transferred to two litres volume pots (12 × 12 × 14 cm) and seeds were sown at 10 seeds/pot. Controls were set up along each treatment. Experimental layout and Statistical analyses. The experiments were set up in randomized complete block design with four replicates for each treatment. Statistical analysis was carried out using SPSS (version 17.0 ChicagoIL, USA). Analysis of variance (ANOVA) was performed at 5% significance level. Duncan’s HSD multiple range test was used as post-hoc analysis to compare means. Pearson’s correlation coefficient was calculated to analyze the effect of disease incidence on fresh biomass of bean plants. Results Molecular identification of Trichoderma species. Trichoderma isolates were identified on the basis of 18S RNA gene sequencing with amplification of tef1 domain at 5’ end. The sequences were compared with other nucleotide sequences at NCBI databases using Basic Local Alignment Search Tool (BLAST) and were submitted to Gene Bank (Bankit) for accession numbers. The amplicon of Trichoderma TV showed a 99% homology (808/809 and 806/808 bp) with the nucleotide sequence of T. asperellum Th021 (AB568376.1) and T. asperellum Th016 (AB568375.1) respectively while, Trichoderma TK showed 99% homology (738/739 and 738/739 bp) with nucleotide sequence of T. harzianum strain CIB T127 (EU279980.1) and T. harzianum strain DAOM 167671 (AY605783.1) respectively. The identification was confirmed by searching tef1 sequences by Tricho BLAST. Growth profile of Trichoderma species at different pH and temperature. At 25°C and 30°C, the three fungal species (T. asperellum, T. harzianum and Trichoderma spp.) showed maximum mycelial growth while, at 20°C the growth rate was considerably reduced and antagonists colonized 1/4th of the medium surface. In acidic pH range i.e., 5–6, the mycelial growth was maximum whilst, moderate growth was observed at pH 6.5 and 7.0 by antagonists. Beyond these pH limits no growth or very little growth (0.9–1.2 cm) was recorded. Biocontrol efficacy of Trichoderma against R. solani in dual culture assay. The results demonstrated a strong antagonistic potential of Trichoderma against pathogen (Fig. 1). A clear zone of interaction between antagonist and pathogen was observed where the former inhibited the growth of later after making a physical contact. Light microscopic analysis further revealed a typical coiling pattern of Trichoderma species around the hyphae of R. solani (Fig. 2). This hyphal interaction was initiated after 72 h of incubation. After seven days of incubation, pathogen hypha started to disappear and T. asperellum, T. harzianum and Trichoderma spp. completely overgrew the pathogen. Biocontrol efficacy of water-soluble and volatile metabolites of Trichoderma against R. solani. The water-soluble metabolites of all the Trichoderma isolates proved to be considerably effective in limiting the growth of R. solani. Growth inhibition was significantly higher (p < 0.01) with T. asperellum (74.4%) followed by Trichoderma spp. (70.0%) and T. harzianum (67.8%) as compared to control treatment for water-soluble 98 Asad S.A. et al. 1 Fig. 1. Antagonistic activity (dual culture assay) of Trichoderma isolates (T) against R. solani (R) at 7th day incubated at 25°C. A: T. asperellum; B: T. harzianum; C: Trichoderma spp. metabolites (Table I). All Trichoderma isolates exhibited growth inhibition of less than 20% for volatile metabolites (Table I). The values were 15.3% for T. harzianum, 11.8% for T. asperellum and 10.6% for Trichoderma spp. compared to control treatment. In vivo biocontrol activity of Trichoderma species against R. solani. The results showed that T. asperellum was the most effective biocontrol agent at all application times as it associated with the lowest disease incidence. The relative fresh biomass production was increased compared to inoculated control (p < 0.01). When the Trichoderma was applied seven days before inoculation of pathogen, all species showed an elevated (19.3 to 26.3%) biocontrol efficacy against R. solani compared Table I Effect of water-soluble (A) and volatile (B) metabolites of Trichoderma on growth inhibition of R. solani. Mycelial rowth of R. solani (cm)* Isolates 24 h 48 h 24 h % mycelial inhibition at 72 h (A) T. asperellum 0.9 ± 0.07 1.0 ± 0.14 1.2 ± 0.07 74.4** T. harzianum 0.8 ± 0.14 1.2 ± 0.07 1.5 ± 0.07 67.8 b Trichoderma spp. 1.0 ± 0.07 1.1 ± 0.07 1.4 ± 0.07 70.0 b Control (R. Solani) 1.8 ± 0.14 3.1 ± 0.00 4.5 ± 0.00 0.0 c (B) T. asperellum 1.2 ± 0.00 2.4 ± 0.14 3.8 ± 0.07 11.8 b** T. harzianum 1.2 ± 0.07 2.5 ± 0.21 3.6 ± 0.00 15.3 a Trichoderma spp. 1.2 ± 0.00 2.4 ± 0.28 3.8 ± 0.00 10.6 b Control (R. Solani) 1.3 ± 0.14 2.5 ± 0.07 4.3 ± 0.07 0.0 c *Values are means of four replicates of two independent experiments ± SE. ** Values followed by the different letters in the column are statistically different by Duncan’s HSD multiple range Test (p < 0.05). to inoculated control (54.3%) (Table II). Among the three isolates, T. asperellum showed maximum efficacy by lowering the disease incidence up to 19.3% when disease index was 54.3% in inoculated control (p < 0.01) (Table II). However, the disease incidence was 23.3% by T. harzianum and 26.3% in case of Trichoderma spp. Commercial formulation, Remedier®, proved to be less effective (p < 0.01) than the tested Trichoderma species with a disease incidence of 38.3%. In addition, relative biomass (RW) was decreased as a consequence of pathogen infection (Table II). All isolates proved to have a positive effect on the growth of bean plants yielding a higher biomass compared to healthy control ones. T. asperellum yielded highest relative biomass of 127% (p < 0.01) compared to healthy control, followed by T. harzianum providing a relative biomass of 113%. Trichoderma spp. provided lowest relative biomass (107%) among the species (Table II). In another experiment, where the antagonist was applied seven days after the pathogen, the best results were observed with T. asperellum with 19.7% disease incidence compared to inoculated control (53.3%). This antagonistic behavior was correlated with higher relative biomass i.e., 168% relative weight. Similarly, T. harzianum exhibited disease suppression of 23.2%, while the relative biomass was enhanced up to 155%. However, Trichoderma spp. showed a disease incidence of 21% but the effect on relative weight of bean plants was low (94%). The commercial formulation, Remedier® showed least biocontrol efficacy (27.7%) and lowest relative biomass (74%) compared to all tested isolates (Table II). When the Trichoderma species were evaluated for growth promoting ability, a positive effect on the relative biomass of bean plants was observed. Among the species, T. harzianum yielded a highest 1 Biocontrol efficacy of Trichoderma sp. against R. solani 99 Fig. 2. Hyphal interaction of T. asperellum and R. solani (light microscope). A: interaction of T. asperellum and R. solani; B: growing hypha of T. asperellum; C: hypha of R. solani (magnification 150 ×: bar = 40 µm); D: a; lying hypha side by side, b; attachment, c; coiling of hypha (magnification 150 ×: bar = 40 µm); E: coiling of hypha (magnification 150 ×: bar = 40 µm); F: coiling of hypha at higher magnification (600 ×: bar = 10 µm); G: pathogen hypha after contact, a; thicker septa, b; fragmented hypha/cell (magnification 150 ×: bar = 40 µm). relative biomass of 126% while, T. asperellum helped in providing 114% of relative biomass. Trichoderma spp. did not show any improvement producing 100% relative biomass (Table II). Effect of inoculum dose of Trichoderma species on in vivo biocontrol activity against R. Solani. All the Trichoderma species showed a higher control efficacy both at high and low dosages, compared to inoculated control. T. asperellum was more effective in both trials and showed a decrease in disease incidence with increase in concentration of antagonist, providing a control efficacy of 29.1 and 35.3% (p < 0.01), when applied at a dose of 5 and 1 g/l in first trial respectively. However, Trichoderma spp. and T. harzianum did not show significant differences among the treatments with high and low doses in first trial. In second trial, T. asperellum provided the lowest disease incidence but no statistical differences among treatments with dosages (p < 0.01), while Trichoderma spp. was more effective at a dose of 5 g/l with an efficacy of 35.1% (p < 0.01), compared to 39.0% disease incidence with 1 g/l dosage. The T. harzianum did not show significant difference in the disease incidence in both trials applied at both dosages. Remedier®, showed a disease index of 100 1 Asad S.A. et al. Table II In vivo antagonistic activity of Trichoderma species against R. solani on bean plants under laboratory conditions (12 h photoperiod, 25°C, 60% relative humidity) expressed as disease incidence % and bean plant fresh biomass. Trichoderma application Pathogen (0.5 g/l) Isolate Seven days before pathogen DI% Plant f. wt. (g) RW Seven days after pathogen DI% Plant f. wt. (g) RW T. harzianum + 23.3 bc* 23.8 ab 156 23.7 c 23.2 bc 155 T. asperellum + 19.3 bc 24.0 ab 161 19.7 b 23.7 ab 168 Trichoderma spp. + 26.3 c 22.0 bc 118 21.0bc 20.7 cd 94 Remedier® + 38.3 d 17.3 de 19 27.7d 19.9 de 76 T. harzianum – 0.0 a 23.8 ab 113 0.0 a 26.3 a 126 T. asperellum – 0.0 a 26.8 a 127 0.0 a 23.9 a 114 Trichoderma spp. – 0.0 a 22.5 bc 107 0.0 a 20.b cd 100 Remedier® – 0.0 a 19.4 cde 92 0.0 a 18.8 def 90 Chemical control (Tolclofos methyl) + 16.7 b 23.2 abc 24.4 ab 185 Inoculated control (Only R. solani) + 54.3 e 16.4 e Health control (No inoculation) – 0.0 a 21.1 bcd 145 17.7 b 0 52.0 e 100 0.0 a 16.8 f 17.7 ef 0 100 * Values followed by the letters are statistically different by Duncan’s HSD multiple range Test (p < 0.05). Table III In vivo antagonistic activity of Trichoderma species against R. solani on bean plants under greenhouse conditions expressed as disease incidence % and fresh biomass. Dosage (g/l) Pathogen (0.25 g/l) Plant f. wt. (g) RW T. asperellum 5 + 30.5 bc* 47.6 e 89 T. asperellum 1 Trichoderma spp. 5 + 34.5 cd 42.3 gh 75 + 35.3 cd 47.4 e 81 Trichoderma spp. T. harzianum 1 + 38.5 de 43.3 fgh 62 5 + 37.1 de 42.8 fgh 59 T. harzianum 1 + 37.3 de 46.7 ef 83 Remedier® 3 + 41.8 e 39.9 h 41 T. asperellum 5 – 0 a 57.4 ab 116 T. asperellum 1 – 0 a 53.2 cd 108 Trichoderma spp. 5 – 0 a 58.5 a 118 Trichoderma spp. 1 – 0 a 54.6 abc 111 T. harzianum 5 – 0 a 52.9 cd 107 T. harzianum 1 – 0 a 54.3 bc 110 Isolate DI % Remedier® 3 – 0 a 48.5 e 98 Chemical control (Tolclofos methyl) – + 27.2 b 46.1 efg 80 Inoculated control (Only R. solani) – + 60.4 f 33.2 i Health control (no inoculation) – – 0 a 49.4 de 0 100 * Values followed by letters are statistically different by Duncan’s HSD multiple range Test (p < 0.05). 48.8 and 34.8% in first and second trial respectively (Table III). Chemical treatment was effective in controlling the disease with an efficacy of 34.4 and 20.0% (p < 0.01) in the first and second trial respectively. All the treatments without pathogen showed a high biomass than health control (p < 0.01). The T. asperellum showed maximum biomass production of 61.2 g in first trial when 5 g/L dose was applied while in second trial the Trichoderma spp. yielded a maximum biomass of 60.5 g with same dose. In the treatments with pathogen, the above ground biomass was reduced compared to health control due to consequence of disease (Table III). The chemical treatment with tolclofos-methyl showed the highest disease suppression and was more effective than the tested fungal strains. The chemical treatment showed 16.7–17.7% disease incidence with 1 101 Biocontrol efficacy of Trichoderma sp. against R. solani Table IV Correlation between disease incidence and corresponding biomass of bean plant in different experiments. Pearson’s coefficient (r) Significance 1. Trichoderma applied seven days before pathogen (laboratory) –0.538 p = 0.01 2. Trichoderma applied seven days after pathogen (laboratory) –0.308 p = 0.08 3. Effect of concentration on biocontrol efficacy of Trichoderma (greenhouse) –0.843 p = 0.00 Experiment both types of experimental setup. A weak negative correlation was observed for the relative biomass production and disease incidence on bean plants when infested with both pathogen and Trichoderma species (r = –0.308). Moreover, the fresh biomass production of bean plants was negatively correlated (r = –0.538) with disease incidence (Table IV). Discussion The present study evaluated the biocontrol efficacy of three indigenous strains of Trichoderma isolated from agricultural land in Pakistan against soil born plant pathogen R. solani. Two Trichoderma isolates out of three used in the present study were identified on the basis of 18S rRNA and they were identified as T. asperellum and T. har zianum. Both species were previously identified as efficient biocontrol agents against several plant pathogens (Schuster and Schmoll, 2010). Likewise, these isolates showed considerable biocontrol efficacy against R. solani in in vitro and in vivo experimental conditions. Trichoderma species are distributed worldwide in the rhizospheric regions of plants and around decaying dead biomass (Kubicek et al., 2008). They are extraordinarily able to adjust to the surrounding environmental conditions by regulating their metabolism, growth and reproduction (sporulation). The pH and temperature proved to be major limiting factors affecting the growth profile of Trichoderma (Schmoll et al., 2010). The isolates in the present study showed maximum growth at 25°C under acidic pH ranging from 5–6 which establishes their mesophilic nature. These findings are in agreement with Hajieghrari et al. (2008); where optimum pH varied from 5–8 and temperature from 25–30°C among different species of Trichoderma. For the control of plant pathogenesis, Trichoderma species (mycoparasitism) (Vinale et al., 2006) and/or their extracellular metabolites can be exploited as biocontrol agents or biological fungicides. These metabolites include; volatile and water-soluble metabolites (Eziashi et al., 2006) and secondary metabolites of low molecular weight (Schuster and Schmoll, 2010). The Trichoderma isolates studied were not only able to inhibit the growth of pathogen in in vitro experi- ments (Fig. 2, Table I) but also capable of suppressing the disease incidence by the pathogen in in vivo trials (Table II, III) confirming their versatile defensive mechanisms. In this context T. asperellum proved to be the most effective among the tested isolates. T. asperel lum has been identified as a potential biocontrol agent in other studies (Osorio-Hernandez et al., 2011) where it showed in-vitro inhibition of pathogen in the range of 11–16%. Viterbo et al. (2005) characterized a protein kinase TmkA from T. asperellum, which had a key role in the regulatory pathways involved in biocontrol activity. In vitro studies revealed that Trichoderma had comparatively higher growth rates which provide them competitive advantage over the pathogen in availing space and nutrients in the medium. These species also inhibited the growth of the pathogen by secreting certain mycotoxins (Cúndom et al., 2003). Mycoparasitism is one of the major activities occurring in the antagonist-pathogen interaction, expressed in different steps in a sequence. The detection, attachment, direct penetration, and secretion of fungitoxic enzymes which leads to death of pathogen are major actions in their interface (Harman et al., 2004). The interactions of Trichoderma and pathogen in dual culture were observed under light microscope and the hyphal contact between Trichoderma and pathogen started after 48–72 h of incubation. Once the contact was established, dense hyphal coiling of Trichoderma around R. solani hypha, a characteristic response of antagonists was prominent. Similar observations were previously noted against R. solani by Almeida et al. (2007). The antagonists showed an affinity for the host cell wall which suggests that this may involve chemical bonding between functional sites of carbohydrates present on the cell wall of Trichoderma and pathogen which triggers the events leading to host wall penetration (Eziashi et al., 2007). The production of antifungal compounds also play important role in antagonistic activity of Trichoderma species. These include; antibiotics, mycotoxins and low-molecular weight secondary compounds (Schuster and Schmoll, 2010). Our results indicated that all three isolates were able to produce water-soluble metabolites that inhibited the mycelia growth of R. solani. T. asperel lum proved to be the highest producer of these metabolites, while the production of non-volatile metabolites 102 1 Asad S.A. et al. was not obvious. Therefore, the principle mechanism of antagonistic activity against pathogen was speculated as mycoparasitism (Eziashi et al., 2007) and antibiosis or due to the production of secondary metabolites as suggested by Howell (2003). These speculations were supported by the suppression of disease incidence by all Trichoderma isolates in in vivo trials on bean plants. An increased biocontrol efficacy compared to other isolates and control treatments was provided by T. asperellum in terms of application of antagonists before and after the incorporation of pathogen in the soil. Results in the present study also indicated that the inoculation of antagonist seven days before the pathogen was more effective. These results are in line with De Figueiredo et al. (2010) who studied the actions of Trichoderma against Sclerotinia sclerotiorum in bean plants. The pathogenicity was found to be reduced to 37.04% when antagonist was applied eight days before the pathogen. This approach was also recommended by Lewis and Lumsden (2001). Interestingly, Trichoderma isolates proved to be more effective in controlling the R. solani than the commercial formulation Remedier®. This indicates that it is not necessary to apply Trichoderma species in complex formulations (Harman, 2000). Additionally, the single strain of Trichoderma can be considerably capable of controlling diverse pathogens. Perhaps it would not be possible to commercialize the mixture of biocontrol strains unless there is highly significant success in biological control. Trichoderma species are well known for their abilities to promote plant growth by colonizing the roots of plants. Their interactions of antagonists with plants enhance the root proliferation and yield production by increasing uptake of nutrients (Harman et al., 2008). The fresh biomass of the bean plants was increased up to 118% when treated with the Trichoderma isolates in greenhouse trials as compared to health control (Table III), which significantly proved the ability of Tri choderma as a plant growth promoter. These findings are similar to those reported by Pugliese et al. (2008) where Trichoderma isolates controlled R. solani and increased the biomass of bean plants up to 163%. Likewise antagonists prevented 100% mortality of tomato plants coupled with an increase in plant fresh and dry weight (Montealegre et al., 2010). Shaban and ElBramawy (2011) investigated the biocontrol of damping-off and root rot diseases by combining Trichoderma spp. and Rhizobium species. They reported an overall improvement in plant growth, seed and fruit production. In the present study, the different isolates of Tricho derma showed as an effective biocontrol agents against R. solani though their efficacy varied among isolates and it was highest with T. asperellum. The biocontrol efficacy of all Trichoderma isolates was even higher than commercial formulation Remedier® in in vivo trials. Apart from suppressing the disease profile of bean plants, these isolates showed a considerable effect in promoting their general growth. Acknowledgements The authors thank the University of Torino, Italy for partial financial support to complete this project. The assistance of Massimo Pugliese, Maria Lodovica Gullino AGROINNOVA-Centre of competence for the Innovation in the Agro-Environmental Sector, University of Torino, Italy in sample analysis is gratefully acknowledged. Literature Almeida F., F. Cerqueira, R. Silva, C. Ulhoa and A. Lima. 2007. Mycoparasitism studies of Trichoderma harzianum strains against Rhizoctonia solani: Evaluation of coiling and hydrolytic enzyme production. Biotechnol. Lett. 29: 1189–193. Anees M., A. Tronsmo, V. Edel-Hermann, L.G. Hjeljord, C. Héraud and C. Steinberg. 2010. Characterization of field isolates of Trichoderma antagonistic against Rhizoctonia solani. Fungal. Biol. 114: 691–701. Benítez T., A.M. Rincón, M.C. Limón and A.C. Codón. 2004. Biocontrol mechanisms of Trichoderma strains. Intl. Microbiol. 7: 249–260. Castle A., D. Speranzini, N. Rghei, G. Alm, D. Rinker and J. Bissett. 1998. Morphological and molecular identification of Tricho derma isolates on North American mushroom farms. Appl. Environ. Microbiol. 64: 133–137. Chakraborty U., B.N. Chakraborty, A.P. Chakraborty and P.L. Dey. 2013. Water stress amelioration and plant growth promotion in wheat plants by osmotic stress tolerant bacteria. World. J. Microbiol. Biotechnol. 29: 789–803. Chaudhary V., R. Prasanna, L. Nain, S.C. Dubey, V. Gupta, R. Singh, S. Jaggi and A.K. Bhatnagar. 2012. Bioefficacy of novel cyanobacteria-amended formulations in suppressing damping off disease in tomato seedlings. World. J. Microbiol. Biotechnol. 28: 3301–3310. Chaverri P., L.A. Castlebury, G.J. Samuels and D.M. Geiser. 2003. Multilocus phylogenetic structure within the Trichoderma harzia num/Hypocrea lixii complex. Mol. Phylogenet. Evol. 27: 302–313. Ciesielski S., E. Klimiuk, J. Możejko, E. Nowakowska and T. Pokój. 2009. Changes in microbial community structure during adaptation towards polyhydroxyalkanoates production. Pol. J. Microbiol. 58: 131–139. Consolo V.F., C.I. Mónaco, C.A. Cordo and G.L. Salerno. 2012. Characterization of novel Trichoderma spp. isolates as a search for effective biocontrollers of fungal diseases of economically important crops in Argentina. World. J. Microbiol. Biotechnol. 28: 1389–1398. Cúndom M.A., S.M. Mazza and S.A. Gutiérrez. 2003. Selection of Trichoderma spp. isolates against Rhizoctonia solani. Spanish. J. Agr. Res. 1: 79–82. De Figueirédo G.S., L.C. De Figueirédo, F.C.N. Cavalcanti, A.C. Dos Santos, A.F. Da Costa and N.T. De Oliveira. 2010. Biological and chemical control of Sclerotinia sclerotiorum using Tricho derma spp. and Ulocladium atrum and pathogenicity to bean plants. Braz. Arch. Biol. Technol. 53: 1–9. Dennis C. and J. Webster. 1971a. Antagonistic properties of speciesgroups of Trichoderma: III. Hyphae interaction. Trans. Brit. Mycol. Soc. 57: 363–369. 1 Biocontrol efficacy of Trichoderma sp. against R. solani Dennis C. and J. Webster. 1971b. Antagonistic properties of species-groups of Trichoderma: I. Production of non-volatile antibiotics. Trans. Brit. Mycol. Soc. 57: 25–39. Dennis C. and J. Webster. 1971c. Antagonistic properties of species groups of Trichoderma: II. Production of volatile antibiotics. Trans. Brit. Mycol. Soc. 57: 41–47. Edington L.V., K.L. Khew and G.L. Barron. 1971. Fungitoxic spectrum of benzimidazole compounds. Phytopathol. 61: 42–44. Eziashi E.I., I.B. Omamor and E.E. Odigie. 2007. Antagonism of Trichoderma viride and effects of extracted water soluble compounds form Trichoderma species and benlate solution on Ceratocystis para doxa. Afr. J. Biotechnol. 6: 388–392. Eziashi E.I., N.U. Uma, A.A. Adekunle and C.E. Airede. 2006. Effect of metabolites produced by Trichoderma species against Ceratocystis paradoxa in culture medium. Afr. J. Biotechnol. 5: 703–706. Hajieghrari B., M. Torabi-Giglou, M.R. Mohammadi and M. Davari. 2008. Biological potential of some Iranian Trichoderma isolates in the control of soil borne plant pathogenic fungi. Afr. J. Biotechnol. 7: 967–972. Harman G.E. 2000. Myths and dogmas of biocontrol: changes in perceptions derived from research on Trichoderma harzianum T-22. Plant Dis. 84: 377–393. Harman G.E., C.R. Howell, A. Viterbo, I. Chet and M. Lorito. 2004. Trichoderma species- opportunistic, avirulent plant symbionts. Nat. Rev. Microbiol. 2: 43–56. Harman G.E., T. Bjorkman, K. Ondik and M. Shoresh. 2008. Changing paradigms on the mode of action and uses of Trichoderma spp. for biocontrol. Outlooks Pest Manage. 19: 24–29. Howell C.R. 2003. Mechanisms employed by Trichoderma species in the biological control of plant diseases: the history and evolution of current concepts. Plant Dis. 87: 4–10. Komoń-Zelazowska M., J. Bissett, D. Zafari, L. Hatvani, L. Manczinger, S. Woo, M. Lorito, L. Kredics, C.P. Kubicek and I.S. Druzhinina. 2007. Genetically closely related but phenotypically divergent Trichoderma species cause green mold disease in oyster mushroom farms worldwide. Appl. Environ. Microbiol. 73: 7415–7426. Kubicek, C.P., M. Komoń-Zelazowska and I.S. Druzhinina. 2008. Fungal genus Hypocrea/Trichoderma: from barcodes to biodiversity. J. Zhejiang. Univ. Sci. 9: 753–763. Lewis J.A. and R.D. Lumsden. 2001. Biocontrol of damping-off of greenhouse-grown crops caused by Rhizoctonia solani with a formulation of Trichoderma spp. Crop Prot. 20:49–56. Montealegre J., L. Valderrama, S. Sánchez, R. Herrera, X. Besoain and L.M. Pérez. 2010. Biological control of Rhizoctonia solani in tomatoes with Trichoderma harzianum mutants. Electron. J. Bio technol. 13: 1–11. Osorio-Hernández E., F.D. Hernández-Castillo, G. GallegosMorales, R. Rodriguez-Herrera and F. Castillo-Reyes. 2011. In 103 vitro behavior of Trichoderma spp. against Phytophthora capsici Leonian. Afr. J. Agr. Res. 6: 4594–4600. Pugliese M., B.P. Liu, M.L. Gullino and A. Garibaldi. 2008. Selection of antagonists from compost to control soil-borne pathogens. J. Plant Dis. Prot. 115: 220–228. Punja Z.K. and R.S. Utkhede. 2003. Using fungi and yeasts to manage vegetable crop diseases. Trends Biotechnol. 21: 400–407. Rouf C.A. 2002. Biology and management of black scurf of potato. PhD Thesis Quaid-I-Azam University Islamabad, Pakistan. Schmoll M., E.U. Esquivel-Naranjo and A. Herrera-Estrella. 2010. Trichoderma in the light of day-physiology and development. Fun gal. Genet. Biol. 47: 909–916. Schuster A. and M. Schmoll. 2010. Biology and biotechnology of Trichoderma. Appl. Microbiol. Biotechnol. 87: 787–799. Shaban W.I. and M.A. El-Bramawy. 2011. Impact of dual inoculation with Rhizobium and Trichoderma on damping off, root rot diseases and plant growth parameters of some legumes field crop under greenhouse conditions. Int. Res. J. Agr. Sci. Soil Sci. 1: 98–108. Shoresh M., G.E. Harman and F. Mastouri. 2010. Induced systemic resistance and plant responses to fungal biocontrol agents. Ann. Rev. Phytopathol. 48: 21–43. Suwannarach N., J. Kumla B. Bussaban and S. Lumyong. 2012. Biocontrol of Rhizoctonia solani AG-2, the causal agent of dampingoff by Muscodor cinnamomi CMU-Cib 461. World. J. Microbiol. Bio technol. 28: 3171–3177. Ting A.Y. and C.C. Choong. 2009. Bioaccumulation and biosorption efficacy of Trichoderma isolate, SP2F1 in removing copper (Cu(II)) from aqueous solutions. World J. Microbiol. Biotechnol. 25: 1431–1437. Vinale F., K. Sivasithamparam, E.L. Ghisalberti, R. Marra, S.L. Woo and M. Lorito. 2008. Trichoderma-plant-pathogen interactions. Soil Biol. Biochem. 40: 1–10. Vinale F., R. Marra, F. Scala, E.L. Ghisalberti, M. Lorito and K. Sivasithamparam. 2006. Major secondary metabolites produced by two commercial Trichoderma strains active against different phytopathogens. Lett. Appl. Microbiol. 43: 143–148. Viterbo A., M. Harel, B.A. Horwitz, I. Chet and P.K. Mukherjee. 2005. Trichoderma Mitogen-Activated Protein kinase signaling is involved in induction of plant systemic resistance. Appl. Environ. Microbiol. 71: 6241–6246. Wolska K.I., K. Grześ and A. Kurek. 2012. Synergy between novel antimicrobials and conventional antibiotics or bacteriocines. Pol. J. Microbiol. 61: 95–104. Yedidia I., M. Shoresh, Z. Kerem, N. Benhamou, Y. Kapulnik and I. Chet. 2003. Concomitant induction of systemic resistance to Pseudomonas syringae pv. lachrymans in cucumber by Trichoderma asperellum (T-203) and accumulation of phytoalexins. Appl. Environ. Microbiol. 69: 7343–7353. Polish Journal of Microbiology 2014, Vol. 63, No 1, 105–109 ORIGINAL PAPER Prevalence of EBV Genotypes in Polish, Taiwanese and Arabic Healthy Students and Association Between Genotypes and 30-bp Deletion in the LMP-1 Gene Phylogenetic Analysis DOROTA POLZ*, ŁUKASZ PODSIADŁO, AGNIESZKA STEC and MAŁGORZATA POLZ-DACEWICZ Department of Virology, Medical University, Lublin, Poland Submitted 10 May 2013, revised 1 June 2013, accepted 16 November 2013 Abstract The aim of this study was to compare the prevalence of EBV genotype and del-LMP-1 in saliva from Polish, Taiwanese and Arabic healthy students. The study group consisted of 56 healthy students; 24 of them Polish, 25 Taiwanese, and 7 Arabic. Typing was carried out using PCR with EBNA-2 primers. A detection of LMP-1 variants was also performed using PCR. EBV DNA was detected in 22 investigated samples (39.3%). Type 1 of the virus was dominant in both Polish and Taiwanese group. Among 62.5% Tai wanese with EBV 1 and 55.6% Polish detected EBV with 30-bp deletion in LMP-1 gene. K e y w o r d s: EBV, saliva, LMP-1 Introduction Epstein-Barr virus belongs to the Herpesviridae family, Gammaherpesviridae subfamily, Lymphocryptovi rus genus and is also known as human herpesvirus 4 (HHV-4). Herpesviruses have double-stranded DNA genome (Peh et al., 2003). EBV is an enveloped virus with an icosahedral capsids symmetry. The genome takes on a linear form in mature virions and a circular episomal form during the period of latency in the infected cells. Epstein-Barr virus express six nuclear proteins: EBNA (EBV nuclear antigens) which include EBNA-1, EBNA-2, EBNA-3A, EBNA-3B, EBNA-3C and EBNA-LP (leader protein), next are three latent membrane proteins LMP-1, LMP-2A, LMP-2B and two untranslated RNAs termed EBV-encoded RNA (EBER-1 and EBER-2). LMP-1 is a transmembrane protein, it is a major oncogenic protein of EpsteinBarr virus and EBV strain are categorized due to nucleotide base-pair (bp) changes in the LMP-1 gene. Del-LMP-1 (variant with deletion) has a greater tumorigenic potential thus being responsible for an increased risk of nasopharyngeal carcinoma (NPC), and is less immunogenic (Perera et al., 2010). This is one of the most common viruses in humans (Alipov et al., 2005). EBV was the first human virus to which oncogenic potential was attributed, and is classified as a group 1 carcinogen by the World Health Organization’s International Agency for Research on Cancer (IARC working group 1997). EBV is correlated with nasopharyngeal and gastric carcinoma, squamous cell carcinoma, Hodgkin’s lymphoma, and Burkitt’s lymphoma (Slots 2005, Slots et al., 2006, Peh et al., 2003, Chen 2011, Tiwawech 2008, Perera 2010). Nasopharyngeal carcinoma is the most common head and neck cancer in southwestern China and Taiwan (Lin et al., 2001). This virus has the ability to replicate and enter a latency phase in B cells, which can lead to a development of viral types of cancer (Chen 2011). So far, two types of EBV (EBV-1 and EBV-2) have been distingu ished, with the significant differences in the EBNA-2, EBNA-3A, EBNA-3B and EBNA-3C gene sequences (Peh et al., 2003, Correra et al., 2007, Tiwawech et al., 2008). Type 1 is found primarily in Europe, North and South America and Asia, while type 2 is mainly dominant in Africa(Peh et al., 2003). EBNA-2 protein plays a key role in initiation of carcinogenesis by disrupting mitotic checkpoints and causing chromosomal instability (Pan et al., 2009). EBV is an etiological agent of infectious mononucleosis also known as ‘the kissing disease’, because the virus spreads through direct mouth-to-mouth contact with saliva being the main * Corresponding author: D. Polz, Department of Virology, Medical University, Lublin, Poland; e-mail: [email protected] 106 1 Polz D. et al. vehicle for EBV transmission from human to human. Current investigations suggest that EBV is correlated with many diseases localized in the oral cavity such as gingivitis, periodontitis, pulpitis, periapical inflammations and periodontal abscesses (Slots 2005, Slots et al., 2006, Grinde and Olsen 2010). Experimental Material and Methods Sample collection. The investigated material was saliva. Samples were obtained from healthy students of the Medical University of Lublin, Poland. The study group consisted of 56 healthy volunteers: 24 Polish, 25 Taiwanese, and 7 Arabic students. In the study group there were 26 female and 30 male in 18–37 years of age (22.2 average). Saliva samples were collected anonymously, and all volunteers were healthy; there was also an a survey containing clinical about general and infectious diseases data attached. The research received approval from the Ethics Committee number KE-0254/150/2010. DNA extraction. DNA from 200 µl of saliva samples was extracted using QIAamp DNA Mini Kit (Qiagen, Germany) according to the manufacturer’s instructions. PCR. All PCR reactions were carried out in final volume of 25 µl using HotStartTaq DNA Polymerase (Qiagen, Germany). Concentrations of PCR reaction components were prepared as follows: 2.0 mM MgCl2, 0.2 mM dNTPs, 0.5 µM each forward and reverse primers and 0.5 U of HotStart Taq polymerase. During each run samples were tested together with one negative and positive control. Amplification of EBNA-2 gene. The nested PCR was carried out for amplification of EBNA-2. The sequence of primers used for PCR was as follows: outer pair 5’-TTT CAC CAA TAC ATG ACC C-3’, 5’-TGG CAA AGT GCT GAG AGC AA-3’ and inner pair 5’-CAA TAC ATG AAC CRG AGT CC-3’, 5’-AAG TGC TGA GAG CAA GGC MC-3’, (R = A/G, M = A/C). 2 µl of extracted DNA was subjected to the PCR mixture with the concentration as described above. The first-round amplification consisted of activation of polymerase 95°C for 15 minutes, 35 cycles of 94°C for 1minute, 55°C for 1minute, 72°C for 2 minutes and the final extension at 72°C for 5 minutes. The secondround amplification was performed with 1 µl of first round PCR product in 30 cycles with an annealing temperature at 60°C.The amplicons 368 bp, 473 bp in length (depending on the EBV type EBV-1 and EBV-2, respectively) were separated on 2% agarose gel and purified using Gel-Out kit (A&A Biotechnology, Poland) for further analysis. Purified PCR products were send to Genomed Warsaw, a company dealing with the field of genomics. Amplification of LMP-1 gene. Primers used for the amplification were 5’-AGCGACTCTGCTGGAAATGAT-3’ and 5’-TGATTAGCTAAGGCATTCCCA-3’. The reaction mixture containing 3 µl of extracted DNA was amplified under following conditions: 95°C for 15 minutes of initial hot start activation, then 40 cycles of 94°C for 1 minute, 57°C for 1 minute, 72°C for 1 minute with the final extension at 72°C for 10 minutes. The PCR products were subjected to 3% agarose gel and LMP-1 variants (316 bp – wild type or type with 30-bp deletion) were analyzed. Phylogenesis of EBV (phylogenetic analysis). The results of sequencing were analyzed using the following computer programs: Chromas Lite 2.0.0.0, ClustalX 2.1.0.0, GeneDoc 2.7.0.0 and BioEdit 7.0.9.1. Typing was performed using the BLAST algorithm (basic Local Alignment Search Tool; http://blast.ncbi.nlm.gov/Blast. cgi). EBNA-2 gene sequence were used in order to construct phylogenetic tree. Phylogeny was based on the maximum likelihood method (ML). This method requires the use of computer programs such as PAUP 4.0, ModelTest 3.7, PhyML 2.4.4 and MEGA 4.1. In order to choose the appropriate model of molecular evolution hLRTs (hierarchical Likelihood-Ratio Test) and AIC (Akaike Information Criterion) test were used. The reference strains sequences used in the study was taken from the public database GenBank (http://www. ncbi.nlm.nih.gov/genbank/). Statistical analysis. PQ Stat 1.4.6. program was used for the statistical analysis, and the relationship between investigated parameters was verified by means of V-Cramer test. Statistical significance was defined as P < 0.05. Results EBV DNA was detected in 39.3% (22) investigated samples, EBV type 1 was detected in 18 cases (81.8%) and EBV type 2 was detected in 4 cases (18.2%). The findings revealed that more Taiwanese students was EBV-positive compared to Polish and Arabic students (44%, 37.5% and 28.6% respectively). Type 1 of the virus was dominant in both Polish and Taiwanese group (100% and 72.7% respectively). The phylogenetic tree and percentage similarity of EBNA-2 gene sequences are shown in Figure 1 and in Table I. In the group of Arabic students EBV was detected in 2 cases out of seven respondents, amounting to 26.8 %. The low number of EBV-positive representatives enables an interpretation of this result (1 case of EBV1 and EBV2 was detected). Among 54.5% Taiwanese and 55.6% Polish students EBV with 30-bp deletion in LMP-1 gene was detected. 1 Prevalence of EBV genotypes and del-LMP-1 in different groups of students 107 Table I Percentage similarity of EBNA-2 gene sequences. Among Taiwanese students with EBV 1 group deletion in LMP-1 gene was detected in 62.5% (5 samples), so deletion in EBV 1 was more often detected among Taiwanese than among Polish students. Fig. 1. Phylogenetic tree of EBV constructed based on the maximum likelihood method (ML). Discussion Saliva is a very interesting diagnostic material, sometimes described as the “mirror of the body”. The undeniable benefit of this material is the way of obtaining samples; non-invasive nor stressful for the patient (especially when compared to collecting blood samples), the risk of needle stick is eliminated and at the same the risk of infection reduced. What is more, if blood is not visible in the saliva, the sample is not considered a class II biohazard (according to the US Centre for Disease Control) which also provides safety benefits for researchers. It is a painless method, which is of particular importance especially in the diagnosis of children. In addition, because of the way of collecting samples, it is inexpensive and the medical personnel does not require specialized training. Also the method of storing and preparing the material for further research is less complicated than in the case of serum (blood) (Shirtcliff et al., 2001). Saliva is used in the diagnosis of hormonal disorders (determination of cortisol concentration), it is considered to be good material for detecting oral cancer markers and monitoring the course of disease: the main biomarker is the tumour-suppressor protein TP53. Mutations in the p53 gene are considered to be the most common changes found in cancer, including squamous cell cancer of the oral cavity. Another cancer marker detected in saliva is CA125, used to diagnose ovarian cancer. Saliva as a diagnostic material has its application in virology: it is possible to detect anti-HIV IgM antibodies, using techniques of molecular biology (PCR) it is also possible to detect HSV, EBV, measles, and mumps (Farnaud et al., 2010). EBV infection is transmitted from host to host via saliva, and the virus passes through the oropharyngeal epithelium to B lymphocytes (Thompson and Kurzrock 2004). The Epstein-Barr virus belongs to a group of oncogenic viruses. The spectrum of diseases associated with being infected with this virus is very broad and the virus itself is common in the population. In our studies, the EBV DNA was detected in 39.3% of the students. Type 1 was detected in all of the Polish students (100%) while in the Taiwanese the detection of type 1 amounted to 108 1 Polz D. et al. 72.7%. 30-bp deletion in the LMP-1 gene was detected in 54.5% of Taiwanese and 55.6% Polish students. The results of our studies are consistent with the experiences of other authors e.g. higher incidence of EBV-1 in the healthy population is also confirmed by Correa et al. (2007). LMP-1 EBV is a viral oncoprotein, which has an in vitro confirmation of the ability to transform cells and of inducing tumor growth (in vivo), it can disturb the growth and maturation of human keratinocytes and induce the expression of epidermal growth factor receptor connected to the nasopharyngeal carcinoma (NPC), and is probably associated with the tumor being more aggressive. Some researchers (Tiwawech et al., 2008 and Peh et al., 2003) report that the variant with deletion (del-LMP-1) is connected to changes which induce the protein’s oncogenic properties, Sandvej et al. (1994) combine the EBV-2 and del-LPM-1, suggesting the genotype transforming ability. There is little information on prevalence of del-LMP-1 in healthy individuals. In Brazil and Mexico this deletion was detected in 59% (Chen et al., 1996 , Dirnhofer et al., 1999), among healthy Italian blood donors in 44% (Dolcetti et al., 1997), in Argentina only in 7.4% (Correa et al., 2004). Tiwawech et al. (2008) present studies where EBV-1 is dominant (86.5–96%) in nasopharyngeal carcinoma (NPC) among Asians, and EBV-2 is less frequently detected (4–13%). They also confirm a strong correlation between a virus with deletion in LMP-1 and NPC in comparison to the wild-type gene (without deletion) and NPC. An increasingly interesting and still valid is the question why EBV causes NPC only in some populations and maybe the answer lies within the genetic differences between the strains. Tiwawech et al. (2008) indicate that type 1 (A) of the virus has a greater potential of transforming B-lymphocytes than type II (B). The result of studies of Tse et al. (2009) and Bei et al. (2010) (genome-wild association study) indicate that the increased incidence of NPC among the Taiwanese and eastern China population are an outcome of genetic differences in the human leukocyte antigen (HLA) and multiple loci (HLA-A, HLA-F, GABBR1) within chromosome 6 p 21.3 is associated with this type of cancer. Also Perera et al. (2010) indicate that the genetic differences between populations may influence the degree of risk of NPC occurrence, they provide the example of HLA-A11 restricted cytotoxic T-lymphocyte response is directed toward a specific epitope of the EBNA-4 EBV protein. They also confirm the reports on the influence of genetic alterations in virus strains, which determine the active infections in humans. Available literature does not provide studies comparing nationalities studied by us, it is worth to underline however that the study was conducted among healthy young people. Perhaps this is related to the significant differences in the incidence of this cancer. Significant differences in NPC incidence depending on the geographical location were observed; in south-east Asia (an area covering southern China, Hong Kong, Taiwan), the annual incidence rate is about 25 times higher than in the western world (Tse et al., 2009). It is believed that NPC in South East Asia is endemic, while the annual incidence rate for the rest of the world amounts to less than 1/100 000 (Ruan et al., 2013). The incidence rate of NPC in the Guandong province (China) is 30.94/100 000 for men and 13/100 000 for women, in Taiwan it is estimated at 6/100 000, being eighth among cancers leading to death. Mortality is 4/100 000 and mainly concerns middle aged patients (Lin et al., 2001, Ruan et al., 2013). Hong Kong recorded some of the highest rates of incidence: 4.8/100 000 for women and 15.0/100 000 for men (Pow et al., 2011). In Poland, this type of cancer is rare among both men and women. In 2010, the absolute number of men affected with nasopharyngeal carcinoma was 119, crude rate 0.6, standardized rate 0.4, percentage 0.2. and is in place 49 in sequence number with regards to the location of particular organs. In the same years there were 50 cases of women suffering from the nasopharyngeal carcinoma, crude rate 0.3, standardized rate 0.2, percentage 0.1, and is 67 in sequence number. NPC is so uncommon in Poland that there are no available data apart from those provided above (Wojciechowska et al., 2010). EBV DNA is detected in the majority of cases of NPC among Asians and about 75% of case among Caucasians (Pow et al., 2011). Conclusions. As with other cancers, early detection is most significant for the prognosis. If the cancer is detected at an early stage , the patient’s chances of survival increase. In case of cancers with a viral pathogenesis it is worth to consider the possibility of virological testing. Although in the Polish population NPC is rare, nevertheless it is recorded and one should remember about the correlation NPC/EBV DNA. What is more, in the age of globalization, the number of patients from the most remote parts of the world is likely to increase, and thus the number of rarely recorded diseases may also increase. In conclusion, the knowledge on EBV prevalence in healthy population of Polish students will be useful in analyzing the role of EBV and regional factors in the pathogenesis of EBV-associated cancers. Literature Alipov G., T. Nakayama, M. Nakashima, C.Y. Wen, D. Niino, H. Kondo, Y. Pruglo and I. Sekine. 2005. Epstein-Barr virus-associated gastric carcinoma in Kazakhstan. World J. Gastroenterol. 11: 27–30. 1 Prevalence of EBV genotypes and del-LMP-1 in different groups of students Bei J.X., Y. Li, W.H. Jia, B.J. Feng, G. Zhou, L.Z. Chen, O.S. Feng, HQ Low, H. Zhang, F. He and others. 2010. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat. Genet. 42: 599–603. Chen W.G., Y.Y. Chen, M.M. Bacchi, C.E. Bacchi CE., M. Alvarenga and L.M. Weiss. 1996. Genotyping of Epstein-Barr virus in Brazilian Burkitt’s lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. Am. J. Pathol. 148: 17–23. Chen M.R. 2011. Epstein-Barr virus, the immune system, and associated diseases. Front Microbiol. 2: 5. Correa R.M., M.D. Fellner, L.V. Alonio, K. Durand, A.R. Teyssié, and M.A. Picconi. 2004. Epstein-Barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene. J. Med. Virol. 73: 583–588. Correa R.M., M.D. Fellner, K. Durand, L. Redini, V. Alonio, C. Yampolsky, A. Colobraro, G. Sevlever, A. Teyssié and others. 2007. Epstein Barr virus genotypes and LMP-1 variants in HIVinfected patients. J. Med. Virol. 79: 401–407. Dirnhofer S., Angeles-Angeles A., Ortiz-Hidalgo C., Reyes E., Gredler E., J. Krugmann, F. Fend and L. Quintanilla-Martinez. 1999. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin’s disease and reactive lymphoid tissue. Hum. Pathol. 30: 781–787. Dolcetti R., P. Zancai, V. De Re, A. Gloghini, B. Bigoni, B. Pivetta, S. De Vita, A. Carbone and M. Boiocchi. 1997. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin’s disease. Blood. 89: 1723–1731. Farnaud S.J., O. Kosti, S.J. Getting and D. Renshaw. 2010. Saliva: Physiology and Diagnostic Potential in Health and Disease. Scien tific World Journal 10: 434–456. Grinde B. and I. Olsen. 2010. The role of viruses in oral disease. J. Oral. Microbiol. 12: 2. Lin SY., N.M. Tsang, S.C. Kao, Y.L. Hsieh, Y.P. Chen, C.S. Ksai, T.T. Kuo, S.P. Hao, I.H. Chen and J.H. Hong. 2001. Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma. Head Neck. 23: 194–200. Pan S.H., C.C. Tai, C.S. Lin, W.B. Hsu, S.F. Chou, C.C. Lai, J.Y. Chen, H.F. Tien, F.Y. Lee and W.B. Wang. 2009. Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability. Carcinogenesis 30: 366–375. 109 Peh S.C., L.H. Kim, K.S. Mun, E.L. Tan, C.K. Sam and S. Poppema. 2003. Epstein-Barr virus (EBV) subtypes and variants in malignant tissue from Malaysian patients. J. Clin. Exp. Hematopathol. 43: 61–69. Perera RA., L.P. Samaranayake and C.S. Tsang. 2010. Shedding dynamics of Epstein-Barr virus: A type 1 carcinogen. Arch. Oral. Biol. 55: 639–647. Pow E.H., M.Y. Law, P.C. Tsang, R.A. Perera and D.L. Kwong. 2011 Salivary Epstein-Barr virus DNA level in patients with nasopharyngeal carcinoma following radiotherapy. Oral. Oncol. 9: 879–882. Proceedings of the IARC working group on the evaluation of carcinogenic risks to tumors. Epstein-Barr virus and Kaposi’s sarcoma Herpesvirus/Human herpesvirus 8. Lyon, France, 17–24 June 1997. IARC Monogr Eval Cacinog Risks Hum. 1997; 70: 1–492 Shirtcliff E.A., D.A. Granger, E. Schwartz and M.J. Curran. 2001. Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results. Psychoneuroendocrinology 26: 165–73 Slots J. 2005. Herpesviruses in periodontal diseases. Periodontol 2000. 38: 33–62. Slots J., I. Saygun, M. Sabeti and A. Kubar. 2006. Epstein-Barr virus in oral diseases. J. Periodontal. Res. 41: 235–244. Ruan H.L., H.D. Qin, Y.Y. Shugart, J.X. Bei, F.T. Luo, Y.X. Zeng and W.H. Jia. 2013. Developing genetic epidemiological models to predict risk for nasopharyngeal carcinoma in high-risk population of China. PLoS One. 82:e56128. doi: 10.1371/journal.pone.0056128 Sandvej K., S.C. Peh, B.S. Andresen and G. Pallesen. 1994. Identification of potential host spots in the carboxy-terminal part of Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases; High frequency of a 39-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood. 84: 4053–4060 Thompson M.P. and R. Kurzrock. 2004. Epstein-Barr virus and cancer. Clin. Cancer. Res. 10: 803–821 Tiwawech D., P. Srivatanakul, A. Karalak and T. Ishida. 2008. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais. J. Clin. Virol. 42: 1–6. Tse KP., W.H. Su, K.P. Chang, N.M. Tsang, C.J. Yu, P. Tang, L.C. See, C. Hsueh, M.L. Yang, S.P. Hao and others. 2009. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am. J. Hum. Genet. 852: 194–203 Wojciechowska U., J. Didkowska and W. Zatoński. 2012. Cancer in Poland in 2010, http://www.onkologia.org.pl/doc/Nowotw2010.pdf Polish Journal of Microbiology 2014, Vol. 63, No 1, 111–114 SHORT COMMUNICATION Microbial Transformations of 3-methoxyflavone by Strains of Aspergillus niger EDYTA KOSTRZEWA-SUSŁOW*, MONIKA DYMARSKA and TOMASZ JANECZKO Department of Chemistry, Wrocław University of Environmental and Life Sciences Submitted 15 July 2013, revised 13 November 2013, accepted 16 November 2013 Abstract Microbial transformation of 3-methoxyflavone into 3’-hydroxyflavon-3-yloxymethyl myristate was presented. Six filamentous fungi were used as biocatalysts: a wild strain of Aspergillus niger KB, its four UV mutants (A. niger MB, SBP, SBJ, 13/5) and the strain of Penicillium chermesinum 113. The highest yields were observed for the strains of A. niger KB and A. niger SBP (69.8% and 63.1%, respectively). K e y w o r d s: Aspergillus niger, Penicillium chermesinum, biotransformation, 3-methoxyflavone, myristic acid Microbial transformation of flavonoid compounds is a natural method which may be a green alternative to chemical synthesis. Using biotransformation we can modify structures of compounds in order to improve their biological properties and to increase their hydrophilicity or bioaccessibility (Das and Rosazza, 2006; Wang et al., 2010). Regioselective O-demethylation of tangeretin and 3-hydroxytangeretin by Aspergillus niger gave 4’-O-demethylated biotransformation products (Buisson et al., 2007) while transformations of 7,8-dimethoxyflavone by Mucor ramannianus gave five biotransformation products involving hydroxylation at C-3’ and C-4’ with the methoxyl groups retained and products of hydro xylation in the B-ring along with demethylation at C-7 or/and C-8 (Herath et al., 2009). This manuscript reports the microbial demethylation of 3-methoxyflavone by strains of Aspergillus and Penicillium, followed by non-typical esterification with a fatty acid and hydroxylation in the B-ring. The analytical procedures were as described previously (Kostrzewa-Susłow and Janeczko, 2012a; 2012b). The substrate for biotransformation – 3-metho xyflavone was purchased from Sigma-Aldrich, Poznań, Poland. 3-Methoxyflavone (C30H38O6): M.p. 114–115°C. Rt 19.35 min (HPLC). 1 H NMR (DMSO-d6) δ: 3.81 (3H, s, -OCH3), 7.49 (1H, t, J6.5 = 8.0, J6.7 = 7,0 Hz, H-6), 7.58 (3H, m, H-3’, H-4’, H-5’), 7.75 (1H, d, J8.7 = 8.2 Hz, H-8), 7.82 (1H, ddd, J7.5 = 1.5, J7.6 = 7.0, J7.8 = 8.2 Hz, H-7), 8.05 (2H, m, H-2’, H-6’), 8.10 (1H, dd, J5.6 = 8.0, and J5.7 = 1.5 Hz, H-5); 13C NMR (DMSO-d6) δ: 60.2 (-OCH3), 119.0 (C-8), 124.1 (C-10), 125.4 (C-6), 125.6 (C-5), 128.8 (C-2’, C-6’), 129.2 (C-3’, C-5’), 131.0 (C-4’ ), 131.4 (C-1’), 134.6 (C-7), 141.3 (C-3), 155.3 (C-2 ), 155.5 (C-9), and 174.4 (C-4). In this research we used a wild strain of A. niger KB and four UV mutants of A. niger (13/5, SBJ, SBP, MB). The KB strain comes from the collection of the Department of Biotechnology and Food Microbiology of Wrocław University of Environmental and Life Sciences (Poland), strain 13/5 comes from the University of Life Sciences in Lublin (Poland) and strains SBJ, SBP and MB come from Wrocław University of Economics (Poland). Microorganisms were maintained on sterilized potato slants at 5°C. The wild strain of P. chermesinum 113 was obtained from the collection of the Department of Chemistry of Wrocław University of Environmental and Life Sciences (Poland). The microorganism was maintained on Sabouraud 4% dextrose-agar slopes and freshly subcultured before use in the transformation experiments. Screening tests and preparative-scale biotransformations were carried out according to the procedure described earlier (Kostrzewa-Susłow and Janecz ko, 2012a; 2012b). The spectral data of the product obtained are presented below. 3’-Hydroxyflavon-3-yloxymethyl myristate (C30H38O6): Yellow oily liquid. Rt 17.06 min (HPLC). Purity 97% (HPLC). HRESI-MS: m/z = 495.1032 [M+H+]; found 495.1026. 1H NMR (DMSO-d6) δ: 0.86 (3H, t, J = 7.0 Hz, 13”-CH3), 1.229–1.231 (14H, m, H-4”-H-10”), * Corresponding author: E. Kostrzewa-Susłow, Department of Chemistry, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland, fax: +48-71-3284124; e-mail: [email protected] 112 1 Kostrzewa-Susłow E. et al. 1.239–1.261 (6H, m, H-3”,11”,12”), 1.55 (2H, tt, J = 7.67 Hz, H-2”), 2.25 (2H, t, J=7.4 Hz, H-1”), 5.22 (2H, s, O-CH2-O), 7.30 (1H, m, H-4’), 7.39 (1H, ddd, J6.5 = 7.9, J6.7 = 7,1 Hz, J6.8 = 1,1 Hz, H-6), 7.49 (3H, m, H-8, 2’, 5’), 7.66 (1H, ddd, J7.8 = 8.4 Hz, J7.6 = 7.1 Hz, J7.5 = 1.7 Hz, H-7), 7.85 (1H, m, H-6’), 7.91 (1H, s, -OH), and 8.19 (1H, dd, J5.6=8.0, J5.7 = 1.7 Hz, H-5). 13C NMR (DMSO-d6) δ: 14.3 (C-13”), 25.7 (C-2”), 29.1 (C-10”), 29.3 (C-8”), 29.3 (C-9”), 29.4 (C-7”), 29.5 (C-6”), 29.6 (C-5”), 29.7 (C-4”), 29.8 (C-3”), 30.1 (C-11”), 31.8 (C-12”), 34.1 (C-1”), 83.0 (O-CH2-O), 111.5 (C-2’), 116.9 (C-4’), 117.3 (C-6’), 119.4 (C-8), 124.2 (C-10), 125.6 (C-6), 125.7 (C-5), 130.0 (C-5’), 132.6 (C-1’), 134.7 (C-7), 149.2 (C-3), 151.0 (C-3’), 155.5 (C-2), 155.7 (C-9), 175.1 (C-4), and 180.8 (O-C = O). Screening tests revealed six strains of filamentous fungi capable of biotransformation of 3-methoxyfla- vone: a wild strain of A. niger KB, its four UV-mutants (A. niger MB, SBP, SBJ, 13/5) and the strain of P. cherme sinum 113. The initial study was performed according to two procedures: in the first the substrate was added to the cultivation media at the time of inoculation with the microorganism, whereas in the second, it was added 72 hours after the inoculation. After 3, 6 and 9 days samples were analyzed for product and unreacted substrate (Table I, II). All of the tested strains of Aspergillus transformed 3-methoxyflavone into 3’-hydroxyflavon3-yloxymethyl myristate, using either cultivation procedure. P. chermesinum 113 was also capable of this transformation, but only when the substrate was added to the cultivation media in the last phase of logarithmic growth of the mycelium (Table II). For all of the tested Aspergillus strains the biotransformation was more efficient when the substrate was added to the cultivation Table I Biotransformation of 3-methoxyflavone (substrate added at the time of inoculation) – yield (%) of product determined by HPLC Time of incubation (days) → Microorganism 3 6 Product 9 Yield (%) A. niger KB 3’-hydroxyflavon-3-yloxymethyl myristate53.764.869.8 Unreacted substrate A. niger MB 3’-hydroxyflavon-3-yloxymethyl myristate25.130.737.2 Unreacted substrate 38.224.115.5 73.263.253.0 A. niger SBP 3’-hydroxyflavon-3-yloxymethyl myristate38.750.463.1 Unreacted substrate A. niger SBJ 3’-hydroxyflavon-3-yloxymethyl myristate22.523.724.9 Unreacted substrate 60.046.327.3 75.970.959.8 A. niger 13/5 3’-hydroxyflavon-3-yloxymethyl myristate10.120.320.5 Unreacted substrate 87.873.270.0 Table II Biotransformation of 3-methoxyflavone (substrate added 72 hours after inoculation) – yield (%) of product determined by HPLC Microorganism Time of incubation (days) → 3 Product 6 9 Yield (%) A. niger KB 3’-hydroxyflavon-3-yloxymethyl myristate 13.7 16.2 18.4 Unreacted substrate 81.2 70.7 65.0 A. niger MB 3’-hydroxyflavon-3-yloxymethyl myristate 16.3 16.2 16.2 Unreacted substrate 80.1 80.0 78.2 A. niger SBP 3’-hydroxyflavon-3-yloxymethyl myristate 26.2 26.9 27.3 Unreacted substrate 72.1 69.7 65.1 A. niger SBJ 3’-hydroxyflavon-3-yloxymethyl myristate 13.3 15.6 17.2 Unreacted substrate 80.4 75.1 70.1 A. niger 13/5 3’-hydroxyflavon-3-yloxymethyl myristate 12.7 13.5 14.1 Unreacted substrate 80.3 77.0 70.2 P. chermesinum 113 3’-hydroxyflavon-3-yloxymethyl myristate 16.7 19.2 23.8 Unreacted substrate 80.1 73.3 65.1 1 Short communication 113 Scheme 1. Biotransformation of 3-methoxyflavone in the culture of A. niger (KB, MB, SBP, SBJ, 13/5) and P. chermesinum 113. Scheme 2. Mechanism of demethylation. Scheme 3. Probable course of biotransformation of 3-methoxyflavone. media at the time of inoculation with the microorganism. A. niger KB and A. niger SBP gave the highest yields of the product after 9 days, i.e. 69.8% and 63.1%, respectively. The least efficient strain for this biotransformation was A. niger 13/5 (Table I, II). The preparative scale biotransformation of 3-metho xyflavone was carried out using the strain of A. niger KB in a 9-day reaction. 3’-Hydroxyflavon-3-yloxymethyl myristate was isolated in 65% yield (Scheme 1) and identified by 1H NMR and 13C NMR. In the 1H NMR spectrum the signal of the substrate methoxyl group at C-3 (δ = 3.81 ppm) disappeared and a two proton singlet at δ = 5.22 ppm attributed to a –O-CH2-O- group appeared. Seven new signals integrating for a total of 24 protons and a singlet of 3H at δ = 0.86 ppm indicate the presence of a 13-carbon alkyl chain of a saturated fatty acid (myristic acid) bonded at C-3 of the flavone by means of the ester bond. The ester carbonyl group is confirmed by the signal at δ = 180.8 ppm in the 13C NMR. The presence of a hydroxyl group in the B-ring was proved by the new one-proton singlet at δ = 7.91 ppm which was not present in the spectrum of the substrate. The location of the hydroxyl group was determined by analyzing the shape and chemical shift of the B-ring protons. The 2’ and 6’ protons and the 4’ and 5’ protons are nonequivalent in the 1H NMR of the product. In the 13C NMR the C-3’ signal is shifted from δ = 129.2 ppm for the substrate to δ = 151.0 ppm for the product. The mechanism of oxidative O-demethylation of methyl ethers by cytochrome P450 proposed by Watanabe is presented in Scheme 2 (Watanabe et al., 1982). In the biotransformation of 3-methoxyflavone catalyzed by the strains of Aspergillus and Penicillium the intermediate hemiacetal is presumably esterified with myristic acid present in the cultivation mixture. Miristic acid is produced by the strains of Aspergillus. The pre sence of considerable myristic acid has been observed 114 1 Kostrzewa-Susłow E. et al. in conidiophores of A. flavus (Budínská et al., 1981) in the cells of A. ochraceus (Chavant and Sandolle, 1977) and in the cells of A. niger (Parang et al., 1996). The first step of enzymatic oxidation of 3-methoxyflavone resembles metabolism of methoxy derivatives in mammals. The reaction is probably catalyzed by the fungal monooxygenases of cytochrome P-450. The proposed mechanism of the biotransformation is presented in Scheme 3. Earlier research on microbial transformations of monosubstituted flavones with methoxyl groups in the A-ring (Kostrzewa-Susłow et al., 2012) indicate that the strains of Aspergillus and P. chermes inum used for this study perform non-typical demethylation which ends with introduction of myristic acid in the favourable C-3 flavone position. Conclusions. Transformation of 3-methoxyflavone in the cultures of A. niger (KB, MB, SBP, SBJ, 13/5) and P. chermesinum 113 is a two-step process involving enzymatic oxidation of both the methoxyl group and the B-ring of the flavone and then esterification of the –O-CH2-OH group with myristic acid. The highest yield of transformation was achieved for the strain A. niger KB, when the substrate was added at the time of inoculation. Acknowledgements This work was financed by the project “Biotransformations for pharmaceutical and cosmetics industry” No. POIG.01.03.01-00158/09, which is partly-financed by the European Union within the European Regional Development Fund for the Innovative Economy” Literature Budínská O., V. Kubin, J. Franĕk, J. Julák and J.A. Panos. 1981. A lipopolysaccharide from Aspergillus flavus conidia. Folia Micro biol. 26: 212–216. Buisson D., J. Quintin and G. Lewin. 2007. Biotransformation of polymethoxylated flavonoids: access to their 4-O-demethylated metabolites. J. Nat. Prod. 70: 1035–1038. Chavant L. and M. Sandolle. 1977. Les lipids de deux moisissures: Mucor mucedo et Aspergillus ochraceus se dèveloppant sur meme milieu. Physiol. Vèg. 15: 209–213. Das S. and J.P.N. Rosazza. 2006. Microbial and enzymatic transformations of flavonoids. J. Nat. Prod. 69: 499–508. Herath W., J.R. Mikell and I.A. Khan. 2009. Microbial metabolism. Part 10. Metabolites of 7,8-dimethoxyflavone and 5-methoxyflavone. Nat. Prod. Res. 23: 1231–1239. Kostrzewa-Susłow E., J. Dmochowska-Gładysz, T. Janeczko, K. Środa, K. Michalak and A. Palko. 2012. Microbial transformations of 6- and 7-methoxyflavone in Aspergillus niger and Penicillium chermesinum cultures. Z. Naturforsch. 67c: 411–417. Kostrzewa-Susłow E. and T. Janeczko. 2012a. Microbial transformations of 7-hydroxyflavanone. The Scientific World Journal. 2012:1-8. doi: 10.1100/2012/254929. Kostrzewa-Susłow E. and T. Janeczko. 2012b. Microbial transformations of 7-methoxyflavanone. Molecules. 17: 14810–14820. Parang K., E.E. Knaus, L.I. Wiebe, S. Sardari, M. Daneshtalab and F. Csizmadia. 1996. Synthesis and antifungal activities of myristic acid analogs. Archiv der Pharmazie. 329: 475–482. Wang A., F. Zhang, L. Huang, X. Yin, H. Li, Q. Wang, Z. Zeng and T. Xie. 2010. New progress in biocatalysis and biotransformation of flavonoids. J. Med. Plants Res. 4: 847–856. Watanabe Y., S. Oae and T. Iyanagi. 1982. Mechanisms of enzymatic S-oxygenation of thioanisole derivatives and O-demethylation of anisole derivatives promoted by both microsomes and a reconstituted system with purified cytochrome P-450. Bull. Chem. Soc. Jpn. 55: 188–195. Polish Journal of Microbiology 2014, Vol. 63, No 1, 115–119 SHORT COMMUNICATION Zeaxanthin Biosynthesis by Members of the Genus Muricauda SUDHARSHAN PRABHU, P.D. REKHA and A.B. ARUN* Yenepoya Research Centre, Yenepoya University, Deralakatte, Mangalore, Karnataka State, India Submitted 3 March 2013, revised 3 May 2013, accepted 16 November 2013 Abstract Zeaxanthin, a C40 xanthophyll carotenoid, has potential biological applications in nutrition and human health. In this study we characterized carotenoid composition in 5 taxonomically related marine bacterial isolates from the genus Muricauda. The pigment was characterized using high performance liquid chromatography (HPLC) and mass spectrometry, which confirmed the presence of all-trans-zeaxanthin. Muricauda strains produced zeaxanthin as a predominant carotenoid. M. flavescens JCM 11812T produced highest yield (4.4 ± 0.2 mg L–1) when cultured on marine broth at 32°C for 72 h. This is the first report on the presence of zeaxanthin among the majority of species from the genus Muricauda. K e y w o r d s: Flavobacteriaceae, Muricauda, marine bacteria, zeaxanthin Zeaxanthin is a potential biomolecule having antioxidant, anticancer properties and is known to prevent age related macular degeneration (Krinsky et al., 2003). Apart from plant sources, microbes have been found as an important source of carotenoids particularly zeaxanthin (Hameed et al., 2011). Though many bacteria are known to produce zeaxanthin, the major limitation for their use in large scale commercial exploitation is that they often produce mixed carotenoids similar to plant source. Separation of zeaxanthin from total carotenoids involves multiple purification steps and turns out to be expensive. Selection of strains that grow faster and accumulate high amount of zeaxanthin can facilitate efficient extraction and purification processes. Isolation of bacteria producing biocompatible natural zeaxanthin as the major carotenoid in higher concentration will be vital for meeting large scale demand. Most important members that were reported earlier for the production of zeaxanthin are Flavobactrium multivorum, Meso falvibacter zeaxanthinfaciens, Zeaxanthinibacter enoshi mensis, Muricauda lutaonensis and recently described Siansivirga zeaxanthinfaciens (Asker et al., 2007a; b; Hameed et al., 2011; 2012). However, zeaxanthin production dynamics in closely related strains or species have not been studied. Muricauda is a genus under the family Flavobac teriaceae (Bruns et al., 2001) of marine origin. It currently encompasses seven type strains known to pro- duce characteristic orange-yellow pigmented colonies (Lee et al., 2012; Arun et al., 2009; Hwang et al., 2009; Lee et al., 2012). M. lutaonensis CC-HSB-11T isolated from a coastal hot-spring was first reported to produce high amounts of zeaxanthin (Hameed et al., 2011). However, no other details are available for zeaxanthin production pertaining to other species in this genus. Hence, this study was undertaken to investigate the production of zeaxanthin by other members of the genus Muricauda. Four type strains of the genus Muricauda, namely, M. aquimarina JCM 11811T, M. flavescens JCM 11812T, M. lutimaris KCTC 22173T and M. lutaonensis KCTC 22339T and two environmental isolates, YUAB-SO-11 and YUAB-SO-45 isolated from Ullal and Cochin beaches, South-West coast of India respectively were used. All strains otherwise indicated were sub-cultured on marine agar 2216 (Difco) at 32°C, whereas, M. lutaonensis at 42°C and stored in 30% glycerol at –80°C. The two environmental isolates YUAB-SO-11 and YUAB-SO-45 were identified using 16S rRNA gene sequencing according to the method described earlier (Kämpfer et al., 2003). Sequence data was analyzed after multiple sequence alignment. Sequences were submitted to GenBank (GenBank Accession Number: YUAB-SO-11, JQ257008 and YUAB-SO-45, JQ346699). Optimum growth and carotenoid production of the strains was determined. Approximately 108 CFU mL–1 * Corresponding author: A.B. Arun, Deputy Director, Yenepoya Research Center Yenepoya University, Deralakatte, Mangalore- 575018, Karnataka State, India; phone: +91 824 2204668/969/70 ext. 302; mobile: +91 9980856605; fax: +91 824 2204673, e-mail: bhagwatharun@ hotmail.com; [email protected] 116 Prabhu S. et al. were inoculated into 100 mL flask containing 20 mL marine broth 2216 (MB) and incubated at 32°C, in the case of M. lutaonensis at 40°C, under shaking at 150 rpm for 120 h. Cell density was determined at 24 h intervals by reading OD600 using an UV-Visible spectrophotometer (Shimadzu 1800). Cell dry weight (CDW) was determined by centrifuging 1 mL of the broth culture at 7500 rpm in a pre-weighed vial and the pellet was washed twice in sterile water and dried at 80°C to constant weight. Characterization and quantification of the carotenoid was carried out as outlined by (Asker et al., 2007c; Hameed et al., 2011; Sanusi and Adebiyi, 2009). 10 mg of the lyophilized biomass was suspended in 10 mL ethanol and incubated overnight at 50°C in dark with agitation for carotenoid extraction. The carotenoid in solution was separated from the biomass by centrifugation (12000 rpm for 10 minutes at 4°C). This step was repeated until complete extraction. The solvent was evaporated under nitrogen gas in the dark and re-dissolved in 1 mL of ethanol and subjected to a full-wavelength scan (250–700 nm) using a UV-Visible spectrophotometer (UV-Vis 1800, Shimadzu, Japan). The peak obtained was plotted against calibration curve constructed using standard zeaxanthin. Purification and identification of the carotenoid was carried out according to the methods outlined earlier using HPLC (Asker et al., 2007). The HPLC system with a diode array detector (L-2455, Hitachi) attached to RP column (CAPCELL PAK C18 MG S-5, 35 × 4.6 mm, 5 µm particle size) maintained at 35°C, coupled to a HPLC pump (L-2130, Hitachi) was used. Identification of the HPLC purified carotenoid was carried out using mass spectrometry consisting of a linear ion trap mass spectrometer (Thermo LTQ XL, USA) attached to a LC plus system (Thermo Scientific). Conditions (ion source, atmospheric pressure chemical ionization (APcI) source, operated in the positive ion mode; sheath gas flow (N2), 50 arbitrary units; auxiliary gas flow (N2), 10 arbitrary units; source voltage, 6 kV; capillary temperature, 300°C) were maintained. Full mass scan was selected with a separation width of 2 m/z unit for collision-induced dissociation with the collision energy of 25 eV for detection. The carotenoids were identified and confirmed using standard zeaxanthin. All the strains used in this study showed the presence of zeaxanthin exclusively. The phylogenetic analysis of the Muricauda type strains and two environmental isolates along with the type strains of the genus Muricauda is given in Figure 1. The 16S rRNA gene sequence similarity in the genus Muricauda ranged between 95.4–99.2%. Identification of the two isolates based on 16S rRNA gene sequences revealed that both the isolates YUAB-SO-11 and YUAB-SO-45 (Fig. 1) belonged to the genus Muri cauda. Strain Muricauda sp. YUAB-SO-11 was closely 1 Fig. 1. Phylogenetic analyses based on 16S rRNA gene sequences showing the relationship between two recently isolated environmental strains, Muricauda sp. YUAB-SO-11 (Accession Number: JQ257008) and Muricauda olearia YUAB-SO-45 (Accession Number: JQ346699) to other members of genus Muricauda. Distances and clustering with the neighbor joining method were determined by using the software package MEGA version 5. Bar, 0.01 substitutions per nucleotide. related to M. aquimarina JCM 11811T (98.9% similarity) but could be distinguished clearly from the type strain M. aquimarina JCM 11911T in the phylogenetic analysis indicating that strain YUAB-SO-11 might represent a novel species in the genus Muricauda. The strain Muricauda sp. YUAB-SO-45 was closely related to M. olearia (JCM 15563T) (99.2% similarity). Physiological and biochemical characterization of the Muri cauda strains is provided in the Table I. Strain Muri cauda sp. YUAB-SO-11 utilized only glucose and could not utilize other carbon sources. The maximum biomass produced by different strains is listed in Table II. Among the strains, M. flavescens JCM 11812T showed the highest cell biomass yield (2.9 ± 0.1 g L–1) in marine broth, whereas, strain M. lutaonensis KCTC 22339T showed comparatively lower biomass (1.9 ± 0.1 g L–1) at 72 h of incubation in marine broth. Optimum growth and carotenoid production for all the strains was at pH 7–8 and 2–3% salinity (NaCl) and temperature 30–35°C except for the strain M. lutaonensis KCTC 22339T, which was 40°C. Preliminary spectrophotometric analysis of the ethanol-diluted crude carotenoid from all the Muricauda strains showed typical absorption spectra with a λmax at 448 nm with shoulder peaks identical to those of the standard all-trans-zeaxanthin. 1 117 Short communication Table I Differential physiological and biochemical characterstics of the genus Muricauda Characteristics Growth temperature (°C) Range 1 2 3 4 1 1 30–38 25–38 10–44 25–35 30–55 30–39 Optimum 32 32 30–37 30–32 37–4530–35 Growth pH Range Optimum 7–8 7–8 7.6 6.8–7.77.8 7–8 Growth with NaCl (%) Range 2–10 Optimum2 5–9 5–9 5–9 5.2–9.46–9 5–9 2–10 2 2–9 2 2–6 2–6 1–10 2–3 3–5 2–3 Gliding motility – –– ––– Spore formation – –– ––– Enzyme activity Oxidase + ++ +++ Catalase + ++ +++ Nitrate reduction – –– ––– Carbohydrate utilization Glucose + ++ ++ ND Fructose – –+ –+– Lactose – ++ ++– Raffinose – –– ––+ Arabinose– Melobiose – ++ ++ Cellobiose– Rhamnose – –– ––– Hydrolysis of Casein Gelatin – –– ––+ – – – – + – – + ND ND – – + ND + Strain 1, Muricauda sp.YUAB-SO-11; Strain 2; M. olearia YUAB-SO-45; Strain 3, M. aquimarina JCM 11811T, Strain 4, M. olearia JCM 15563T, Strain 5, M. lutaonensis, KCTC 22339T, Strain 6, M. lutimaris KCTC 22173T, Data from Arun et al., 2010, Hwang et al., 2009; Yoon et al., 2005 and this study. All the strains are negative for agar and starch hydrolysis. They do not produce urease and H2S. All strains require NaCl for growth. +, Positive; –, Negative; ND, no data available; w, weakly positive. Table II Total biomass and zeaxanthin yield produced by Muricauda strains cultured in marine broth at 32°C or for M. lutaonensis at 42°C at 150 rpm. Parameters Growth time (h) CDW (g/mL) Zeaxanthin (mg/L) Muricauda sp. YUAB-SO-11 48 2.6 ± 0.2 3.14 ± 0.2 Muricauda olearia YUAB-SO-45 72 2.1 ± 0.2 2.16 ± 0.1 Muricauda aquimarina (JCM 11811T) 72 2.3 ± 0.2 3.5 ± 0.1 Muricauda flavescens (JCM 11812T) 72 2.9 ± 0.1 4.4 ± 0.2 Muricauda lutaonensis (KCTC 22339T) 72 1.9 ± 0.1 3.1 ± 0.1 Muricauda lutimaris (KCTC 22173T) 72 2.3 ± 0.1 0.7 ± 0.1 Further investigation of the pigment by HPLC analysis resolved the zeaxanthin with a prominent peak (RT, 10.8) comparable to standard zeaxanthin. This fraction was subjected to mass analysis which exhibited a parent ion at m/z 569 and collusion-induced disassociation fragments of m/z 551 and 419 which were identical to that of standard all-trans-zeaxanthin (Fig. 2). The compounds corresponding to peak-2 (RT, 13.87) and peak-3 (RT, 14.65) were predicted to be other minor carotenoids respectively. The zeaxanthin produced by M. flavescens JCM 11812T (4.4 ± 0.2 mg L–1) was highest while by M. lutimaris KCTC 22173T was the lowest (0.7 ± 0.1 mg L–1) (Table II). These results indicate that zeaxanthin is the major pigment in the genus Muricauda. Zeaxanthin biosynthesis occurs via the mevalonate pathway (MVA) or 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway by enzymatic reaction of β-caro tene hydroxylase (CrtZ) which modifies the β-ring (β-caro tene) to zeaxanthin (Misawa 2011). Whole genome sequencing of the strain M. rustringenesis DSM 13258T (Huntemann et al., 2012) showed the presence of CrtZ gene. Accumulation of high concentration of zeaxanthin in marine microorganisms including strains Fig. 2. LC-MS/MS analysis of the crude ethanol extract of five Muricauda strains (A, Muricauda sp. YUAB-SO-11; B, M. olearia YUAB-SO-45; C, M. flavescens JCM 11812T; D, M. aquimarina JCM 11811T; E, M. lutimaris KCTC 22173T). Chromatogram shows a peak at 10.92 minutes compared with the zeaxanthin standard. (B) MS/MS spectrum of carotenoid from all the strains of Muricauda showed a parent peak at m/z 569, and subsequent fragments at m/z 551 and m/z 416. 118 Prabhu S. et al. 1 1 Short communication from genus Muricauda might have an evolutionary role in survival, in membrane stabilization, UV tolerance, and as antioxidant protecting cell from oxidative stress (Asker et al., 2012). Combining the information from this study and available published data on zeaxanthin, particularly from microbial source, it is evident that zeaxanthin production is an important phylogenetic trait of this genus. Increasing demand for zeaxanthin, particularly from microbial source has gained significant interest due to its identical stereochemistry to natural zeaxanthin which has lead researchers to identify potential zeaxanthin producing strains. Sphingob acterium multivorum produced high zeaxanthin yield (Bhosale et al., 2004), whereas Muricauda species produce zeaxanthin as a single predominant carotenoid in higher quantities indicating strains from this genus likely be potential candidates for large scale production of zeaxanthin. Comparison of carotenoid distribution in Muricauda strains with their 16S rRNA gene phylogeny indicates that the carotenoid distribution and composition is highly conserved between the species. In the genus Muricauda, the uniform distribution of zeaxanthin strongly suggests that the carotenoid biosynthetic pathway may be less evolutionary elastic resulting in only certain structural types existing without giving further scope for the diversification of carotenoids within the genus (Klassen 2009; 2010). The result of this study further enhances our current limited knowledge regarding the distribution and diversity of carotenoid in family Flavobacteriaceae. There is further scope for investigating the evolution of carotenoids in these species within the concept of biotechnology and exploiting their metabolic diversity. This research work was kindly supported by a grant from Board Research of Nuclear Science BRNS 28/34/2009. Literature Arun A.B., W.M. Chen, W.A. Lai, J.H. Chao, P.D. Rekha, F.T. Shen, S. Singh and C.C. Young. 2009. Muricauda lutaonensis sp. nov., a moderate thermophile isolated from a coastal hot spring. Int. J. Syst. Evol. Microbiol. 59: 2738–2742. Asker D., T.S. Awad, T. Beppu and K. Ueda. 2012. Novel zeaxanthin-producing bacteria isolated from radioactive hot spring water. Methods Mol. Biol. 892: 99–131. Asker D., T. Beppu and K. Ueda. 2007(a). Mesoflavibacter zeaxan thinifaciens gen. nov., sp. nov., a novel zeaxanthin-producing marine 119 bacterium of the family Flavobacteriaceae. Syst. Appl. Microbiol. 30: 291–296. Asker D., T. Beppu and K. Ueda. 2007(b). Zeaxanthinibacter enoshi mensis gen. nov., sp. nov., a novel zeaxanthin-producing marine bacterium of the family Flavobacteriaceae, isolated from seawater off Enoshima Island, Japan. Int. J. Syst. Evol. Microbiol. 57: 837–843. Asker D., T. Beppu and K. Ueda. 2007(c). Sphingomonas jaspsi sp. nov., a novel carotenoid-producing bacterium isolated from Misasa, Tottori, Japan. Int. J. Syst. Evol. Microbiol. 57: 1435–1441. Bhosale P. and P.S. Bernstein. 2004. Beta-carotene production by Flavobacterium multivorum in the presence of inorganic salts and urea. J. Ind. Microbiol. Biotechnol. 31: 565–571. Bruns A., M. Rohde and L. Berthe-Corti. 2001. Muricauda ruestrin gensis gen. nov., sp. nov., a facultatively anaerobic, appendaged bacterium from German north sea intertidal sediment. Int. J. Syst. Evol. Microbiol. 51: 1997–2006. Hameed A., A.B. Arun, H.P. Ho, C.M. Chang, P.D. Rekha, M.R. Lee, S. Singh and C.C. Young. 2011. Supercritical carbon dioxide micronization of zeaxanthin from moderately thermophilic bacteria Muricauda lutaonensis CC-HSB-11T. J. Agric. Food. Chem. 59: 4119–4124. Hameed A., M. Shahina, S.Y. Lin, K.R. Sridhar, L.S. Young, M.R. Lee, W.M. Chen, J.H. Chou and C.C. Young. 2012. Siansivirga zeaxanthinifaciens gen. nov., sp. nov., a novel zeaxanthin-producing member of the family Flavobacteriaceae isolated from coastal seawater of Taiwan. FEMS Microbiol. Lett. 333: 37–45. Huntemann M., H. Teshima, A. Lapidus, M. Nolan, S. Lucas, N. Hammon, S. Deshpande, J.F. Cheng, R. Tapia, L.A. Goodwin and others. 2012. Complete genome sequence of the facultatively anaerobic, appendaged bacterium Muricauda ruestringensis type strain B1T. Stand. Genomic. Sci. 6: 185–193. Hwang C.Y., M.H. Kim, G.D. Bae, G.I. Zhang, Y.H. Kim and B.C. Cho. 2009. Muricauda olearia sp. nov., isolated from crudeoil-contaminated seawater, and emended description of the genus Muricauda. Int. J. Syst. Evol. Microbiol. 59: 1856–1861. Kämpfer P., U. Dreyer, A. Neef, W. Dott and H.J. Busse. 2003. Chryseobacterium defluvii sp. nov., isolated from wastewater. Int. J. Syst. Evol. Microbiol. 53: 93–97. Klassen J.L. 2009 Pathway evolution by horizontal transfer and positive selection is accommodated by relaxed negative selection upon upstream pathway genes in purple bacterial carotenoid biosynthesis. J. Bacteriol. 191: 7500–7508. Klassen J.L. 2010. Phylogenetic and evolutionary patterns in microbial carotenoid biosynthesis are revealed by comparative genomics. PLoS ONE 5: 11257. Krinsky N.I., J.T. Landrum and R.A. Bone. 2003. Biological mecha nisms of the protective role of lutein and zeaxanthin in the eye. Annu. Rev. Nutr. 23: 171–201. Lee S.Y., S. Park, T.K. Oh and J.H. Yoon. 2012. Muricauda beolgyo nensis sp. nov., isolated from a tidal flat. Int. J. Syst. Evol. Microbiol. 62: 1134–1139. Misawa N. 2011. Carotenoid β-ring hydroxylase and ketolase from marine bacteria promiscuous enzymes for synthesizing functional xanthophylls. Mar. Drugs 9: 757–771. Sanusi R.A. and A.E. Adebiyi. 2009. Beta carotene content of commonly consumed foods and soups in Nigeria. Pak. J. Nutr. 8: 1512–1516. Polish Journal of Microbiology 2014, Vol. 63 Instruction for Authors Submission of manuscripts: http://pjm.indexcopernicus.com/ Instructions for authors: http://www.pjm.microbiology.pl/ and http://pjm.indexcopernicus.com/ Scope Polish Journal of Microbiology publishes descriptions of all aspects of basic and applied research that focus on topics of practical value in microbiology. Topics that are considered include microbiology in the area of basic bio logical properties of bacteria and archaea, viruses, and simple eukaryotic microorganisms, genetics and molecular bio logy, microbial ecology, medical bacteriology, public health as well as food microbiology, industrial microbiology and bacterial biotechnology. A manuscript of the original paper (full length paper and short communication) submitted to Pol. J. Microbiol must present reports of original research that have not been previously published and are not being considered for publication elsewhere. All authors of manuscripts are responsible for their content and it is assumed that they all have contributed substantially to the presented research, read and approved the manuscript. Minireviews in areas of particular interests and importance in microbiology are also published. They are usually invited, but authors wishing to submit a mini-review should contact the Editor in Chief directly for further information How to Submit Manuscripts Manuscripts should be submitted at http://pjm.indexcopernicus.com/. The system requires one-time registration. The selected login and password allow future submission of new articles as well as checking the status of the editorial processing of a manuscript already submitted. A hort instruction for authors on how to use the system is given below. To ensure best cooperation with the editorial office submitted manuscripts should meet the following requirements: – Manuscript files (text and tables) should be in Word 7 format (old version with extension .doc). Initial versions of figures and photos should be prepared as single jpg or pdf files –After receiving a Letter of Acceptance, please submit illustrations at their intended publication size in tiff format (with LZW compression) at the correct resolution: 300 dpi for greyscale and colour, 600 dpi for combination art (lettering and images) and 1200 dpi for line art. Halftone images (those with various densities or shades) must be prepared in tiff, not bitmap or jpg. For instructions on creating acceptable tiff files, refer to the Cadmus digital art website. – The manuscript should be accompanied by a cover letter stating the postal address, phone and fax numbers and e-mail of the corresponding author who is responsible for all correspondence regarding the submitted paper. Receipt of each manuscript will be automatically confirmed by e-mail to the corresponding author. The manuscript will be assigned a PJM number which the corresponding author is asked to refer to in all correspondence with the editors. Correspondence is mainly by e-mail. – The manuscript should contain a “running title”, about 50 characters in length, including spaces. – Before writing a manuscript the authors are advised to consult a current issue of the Polish Journal of Microbio logy and carefully read the Instructions for Authors (available at www.pjm.microbiology.pl and printed in the first issue of every volume) in order to be familiar with the general form of papers published. – The manuscript should be written in English. Grammar, syntax and spelling must be carefully checked before submission of the paper. Authors who are unsure of proper English usage should have their manuscript checked by someone proficient in both the English language and biological terminology. Manuscripts may be rejected on the basis of poor English or lack of conformity to accepted standards of style before the review process. – After submission of the manuscript, only internal messaging system available through http://pjm.indexcopernicus. com web page after login should be used. There is no page charge for publication in PJM, except for colour illustrations. If you encounter problems with electronic submission of the manuscript, please contact us at: [email protected] The Review Process All manuscripts are subjected to pre-screening by the Editor in Chief and can be rejected at this stage or returned for corrections before evaluation (if they do not meet the criteria given in the Instruction to Authors, including language quality or are out of the scope of PJM). After passing the pre-screening stage the manuscripts are processed by one of the editors and sent to at least one qualified outside referee, but the editors themselves may also act as reviewers. 122 4 Instruction for Authors Authors may suggest, in the cover letter, the names (together with contact details) of up to 5 potential referees which may be used at the discretion of the editor. When a manuscript is returned to the authors for revision, it should be sent back to the editorial office within 3 months; otherwise it may be considered withdrawn. When the manuscript is accepted for publication the transfer of copyright to the Publisher takes effect. The articles are generally printed in no more than three months after returning the corrected version and obtaining its final acceptance. The entire process of review and manuscript preparation is carried out electronically. All messages to the editor must be sent via internal messaging system available on the http://pjm.indexcopernicus.com/ web page after login. The author can also track the status of the manuscript using journal submission system http://pjm.indexcopernicus.com/ Preparation of Manuscripts Regular paper The manuscript of the full length original paper in general should not exceed 20 typed pages (up to 1800 characters per page) including tables and figures. Type every portion of the manuscript double-spaced using 12 points Times New Roman. Do not use bolded fonts except for subtitles or italics except for microorganism names (Escherichia coli), genetic loci (repA) or Latin words like: in vivo, et al., etc., journal title abbreviations (J. Bacteriol.) and book titles (not titles of the chapters). No part of the manuscript should be underlined and written using CAPITAL letters). Number all pages in sequence, including abstract, tables, figures and figure legends. The full length paper should be divided into the following sections written in sequence: Title, Abstract, Introduction, Experimental: Materials and Methods, Results, Discussion, Acknowledgments, Literature. Key words Up to five keywords or short phrases should be given below the abstract. If names of microorganisms are used, they should precede the key words, and be followed by the latter in alphabetical order. All keywords should be relevantly connected with the subject matter (avoid common terms like: bacteria, medium, soil, temperature etc.) as they will be used for indexing purposes. Introduction The introduction should provide background information to allow the reader to understand and evaluate the results of the present study and describe the purpose of the undertaken research. However, broad “academic lectures” on the subject and extensive literature reviews should be avoided. Experimental Materials and Methods The title should describe the contents of the paper in a concise but attractive for readers way. Below the title of the manuscript include: full name (including first name and middle initial) of each author, name of the institution(s) at which the work was performed, or each co-author’s affiliation if different. Street address, telephone/fax number and e-mail address should be given only for the corresponding author and placed in the footnote at the bottom of the first page. This section should contain description of materials (biological and others) used and sufficient technical information so that the experiments can be repeated. For commonly used materials and methods (e.g. commonly used media, protein determination) a simple reference is sufficient. Novel or modified procedures should be described in detail. When a large number of microbial strains or mutants were used in a study, include strain tables identifying the sources and properties of the strains, mutants, bacteriophages, plasmids, etc. For names of microorganisms, follow the guidelines of the International Nomenclature Committee (up to date names available as validation list of International Journal of Systematic and Evolutionary Microbiology). Species names are written in full the first time the name appears in text; subsequently, only use the first letter of the genus name followed by the species epithet (e.g. Escherichia coli, then E. coli). Genetic loci are italicized (repA), protein products of the loci are not italicized (RepA). The source of materials (media or chemicals) should be indicated if critical for the validity of experimental results. For centrifugation conditions preferably give the centrifuge forces in “g” (10 000 x g) rather than rpm. Units of measurement should be used in SI system, but for practical reasons, some exceptions to SI units are allowed; e.g. for litre use “l” not “L” (1 l not 1 L, 20 mg/ml not 20 mg/mL). Always include a space between the number and the unit (2 mM not 2 mM). Abstract Results Limit the abstract to 250 words or fewer. Because the abstract will be published separately by abstracting services, it must be complete and understandable without reference to the text. It should be written in an impersonal form. Abbreviations, diagrams and references are not allowed. In the “Results” section, include only the results of the experiments; reserve extensive interpretation of the results for the “Discussion” section. When justified by the nature of the paper the ,,Results” and ,,Discussion” sections may be combined (e.g. “Results and Discussion”). Present the results Title 4 123 Instruction for Authors as concisely as possible and illustrate them with tables or figures if applicable (presentation of the same results in both tables and figures is not acceptable). Avoid the use of graphs to present data that might be more concisely presented in the text. Limit illustrative materials to those that are absolutely necessary to demonstrate the original experimental findings. Number figures (Arabic numerals) and tables (Roman numerals) in the order in which they are cited in the text, and be sure to cite all figures and tables. Tables. Each table must be typed on a separate page and numbered with a Roman numeral (Table I., etc.) in the order it is cited in the text. The headings should be sufficiently clear so that the data will be understandable without reference to the text. Explanatory footnotes are acceptable. Prepare your tables as simple as possible in Word, not in Excel. No “decorative” frames should be made. Figures (graphs, diagrams etc.) should be submitted ready for reproduction, each on a separate sheet. The preferred graphic application is Photoshop or CorelDraw saved in tiff format (with LZW compression). Figures should be numbered as in the text (Arabic numerals, Fig. 1., etc.) and marked with the name of the first author. Figures should be understandable without referring to the text. Original recorder tracing (outprints) of NMR, IR, ESR spectra etc. are not acceptable for reproduction; they should be redrawn. Figure titles and legends must be listed on a separate page. Photographs need to be in good quality with proper resolution used (minimal resolution are 300 for halftones and 600 dpi for combination of photos with lettering). Colour illustrations can be made only at the author’s expense (further details are available at the Editorial Office). New nucleotide sequences must be accompanied by the accession number obtained from proper databases and should be included in the text. Discussion The “Discussion” should provide an interpretation of the obtained results in relation to previously published work and to the experimental system at hand and should not contain extensive repetition of the ,,Results” section or reiteration of the introduction. In some papers the Results and Discussion can be combined into one section as mentioned above. Acknowledgements Acknowledgements for financial support and for a personal assistance (with the permission of person named) are given in two separate paragraphs below the main text. tions of “historical” papers except if absolutely necessary. In the text references should be cited by the names of the authors and the year of publication, e.g. Nowak and Kowalski (1999) stated that...; as previously described (Nowak and Kowalski, 2000; Nowak, 2005). When a paper has more than two authors, the first author’s name should be followed with et al. and the year of publication, e.g. Nowak et al., 2002. While references occur that are not identified by the authors’ names and year, use a, b etc. after the year (Nowak et al., 2002a; 2002b). The list of the papers cited (Literature) must be arranged alphabetically according to the last name of the first author and not numbered. Papers with one only author are listed in chronological order (the earliest first); papers with two authors are listed alphabetically according to the last name of the first author and by the last name of the second author; paper with three or more authors appear as those with two authors and are listed chronologically. When the paper has more than ten authors, give the names of the first ten, followed by .. ..and others. For citations of books, books chapters, thesis, printed conference proceedings etc. see examples given below. Please follow the punctuations, brackets, capital letters etc. exactly as shown. Put “and”, not “&” before the last author’s name. Use the proper journal title abbreviations (ISO) as indicated in the PubMed Journal Database. Examples of literature citations Books and book chapters: Sambrook J., E.F. Fritsch and T. Maniatis. 1989. Molecular Cloning; a Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory. Snyder L. and W. Champness. 2003. Molecular Gene tics of Bacteria. 2nd ed. ASM Press, Washington, D.C. Funnel B.E. and G.J. Phillips (eds). 2004. Plasmid Biology. ASM Press, Washington, D.C. Belfort M., V. Derbyshire, M.M. Parker, B. Cousineau and A.M. Lambowitz. 2004. Mobile introns: pathways and proteins, pp. 761–783. In: Funnel B.E. and G.J. Philips (eds). Plasmid Biology. ASM Press, Washington, D.C. Journal articles: 1 author: Eckhardt T. 1978. A rapid method for identification of plasmid desoxyribonucleic acid in bacteria. Plasmid 1: 584–588. Literature 2 authors: Sołyga A. and D. Bartosik. 2004. Entrapment vectors – how to capture a functional transposable element. Pol. J. Micro biol 53: 139–144. It is the responsibility of the authors to verify each reference against the original article as well as make sure that each paper cited in the text is included in the list. Keep the number of citations reasonable, avoid exhaustive cita- 3 to 10 authors: Bartosik D., M. Szymanik and J. Baj. 2004. Identification and distribution of insertion sequences of Paracoccus sol ventivorans. Appl. Environ. Microbiol. 69: 7002–7008. 124 4 Instruction for Authors More than 10 authors: Roberts R.J., M. Belford, T. Bestor, A.S. Bgagwat, T.A. Bickle, J. Bitinaite, R.M. Blumenthal, S.K. Degtyarey, D.T. Dry den, K. Dybyig and others. 2003. A nomenclature for restriction enzymes. DNA methyl-transferases, homing endonucleases and their genes. Nucleic Acids Res. 31: 1805–1812. Papers in a language different than English – the title should be translated into English and the original language should be stated in parenthesis. Bartosik D. 2001. Bacterial plasmids stability (in Polish). Post. Biochem. 47: 138–145. Ph.D. Thesis: Szymanik M. 2006. Ph.D. Thesis, (title optional). Warsaw University. Warsaw. Poland. Conference materials (exceptionally): Dziewit L., M. Jazurek, L. Drewniak, J. Baj and D. Bartosik. 2006. Identification of a novel family of addiction systems. Abstracts of International Plasmid Biology Conference. Plas mid Biology 2006. Fallen Leaf Lake, South Lake Tahoe California. USA. p. 163. Papers in press or personal communication and unpublished results should not be included in the Literature citation list. Short communications A short communication is intended for the presentation of brief observations that do not warrant a full-length paper. Submit it in the same way as a full-length paper. Each Short communication must have an abstract of no more than 100 words. Do not use sections heading in the body of the text. All the required formation (introduction, methods, results and discussion) except for the Literature must be given in single section. Total length cannot exceed 8 double printed pages including illustrative material (in total no more than 3 figures and tables). They undergo the same review process as full length papers and are not printed more quickly. Minireviews Minireviews are published in areas of particular interest and importance. They are usually invited, but all authors wishing to submit a minireview are welcome. Authors need to be experts on the topic reviewed documented with published achievements in the field. Proofs The text for proofreading will be e-mailed (as a .pdf file) to the corresponding author. It should be printed out and after introducing necessary corrections, all corrections should be returned by e-mail to the editorial office as soon as possible. Reprints Beginning 2007 the Journal will not provide free reprints. The corresponding author will be provided with a pdf of his or her article by the Editorial Office. If printed copies of the article are required they can be ordered (in multiples of 20) together with return of the corrected proof. The reprints will be mailed after receiving payment (conditions of payment may be obtained at [email protected], Ms Beata Mazinska). Copyrights Submission of the manuscript implies that the research presented has not been published before (except in the form of a conference abstract or a part of PhD thesis). Transfer of copyrights to the publisher becomes effective if and when the article is accepted for publication. All articles published in Polish Journal of Microbiology are protected by copyrights which cover the exclusive rights to reproduce and distribute the article as well as the translation. No part of the published material can be reproduced without obtaining written permission from the publisher.